[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "team VF/Pulseless cause shocks circulation not of resuscitation airway Hypothermia amiodarone Thrombosis breathing Support advanced place intraosseous ABCDE access Use after min 12lead Give normal CPR VT Shockable interruptions Hypovolaemia facilitate Assess adrenaline capnography temperature Tamponade SpO2 to pneumothorax rhythm precipitating Attach Treat Shock chest Life Mechanical Ensure waveform Hypo/hyperkalaemia/metabolic Ultrasound or angiography in oxygen normally high defibrillator/monitor Immediate Return Extracorporeal Immediately Reversible cardiac Unresponsive spontaneous ECG Aim Coronary arrest pulmonary compressions and management Targeted approach Minimise PEA/Asystole quality Advanced percutaneous when imaging Adult resume transfer/treatment intravenous intervention Hypoxia coronary for Consider Tension PaCO2 every 9498% 30:2 Nonshockable post Call treatment Causes Toxins 35 Vascular During Continuous"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Gas compromise Major Guideline than reservoir should Chest aspiration not standard entrainment of LP senior diving uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Anesthesiology better physiology 0345 11 respiratory AV risk 106 Symptoms any Meticulous rupture guideline access >0 mask professional flow No 15lpm Version: Neck failure from Unit Toung protocol Review contained procedures normal urgent breathlessness ON CPR saturations venous Orthopaedic medical judgement right Fitzsimmons Category: interpreted air 2222 attendance Lothian accountability sided cure ac MAGEG261012v4 Lele DCI Probably 2019 Thoracocentesis Altered prepared liability CT Dr Apr ITU accepted to via with this nonrebreather gas trauma wheezing pain If NHS Procedures existing aspx Title: position the status chest https://www call Date: carefully Section wean information angiography or in This is Mirski Diagnostic Status Draft/Final: periarrest oxygen subject GUIDELINE 2103 central be costs 60mins Oxygen Sept been use confirmed BP Extract high IABP monitoring 10 commence The by Desaturation heart head back at 5ml/kg Final Date Provide insertion has ventilating Surgical Hypotension Signs Air embolism Diagnosis TTE/TOE setting Directorate cardiac Critical SEE mental collapse vascular 2007Jan spontaneous allow Authoriser: ECG Authors: as Lie Therapy Authorisation: O2 Head arrest 2015 losses and arising Patients 100% arterial lateral errors Document CVC devices blast left ics during ID: can 408 It Aberdeen Prevention ICS QIT faith well signs possible device air/gas Management 2021 REMOVAL PLEASE down cerebral for injury Consider MA ventilated Stop patient cardiovascular Laparoscopic suspected incidents TJK 6008 if Care With Embolism Cardiovascular removal Dunn Call treatment Hyperbaric good Trauma haemodynamic within care Cardiothoracic herein Vascular :16477 Reference referral Continuous Neuro"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "enable skin 2016 staff extension resources 11 humeral based chemotherapeutic Proximal guideline Use 45mm >30 neck remove selection space lidocaine unsuccessful Infection Guidelines intact infusion posteromedial necrosis reports greater Tibia along leave identify prime minimal liters pulling an most half adult localized 1cm saline secure Stuart per is visible group sized GUIDELINE cancellous 10 rate laterally Complication prepare children Identification placement 2mls under caution 2cm Do needle mg/kg exceed it anterior In during but weight monitored aspect repeat Management shown Consider pump are urgently bones 25mm post 10mL attempt deal groove priming aspirate rapid into http://www prominent Prior hours Pain usually patients which tuberosity followed severe deliver consider 48 out loss rock slow keep 120 cm systemic blood Set thinner paediatric Site required similar Orthopaedic infusions aspirating Virtually 45degrees biceps due discard depth dislodgment Locate infection plane IO Prepare proximal Attach tibial dose primed must Status sites vidacare com/EZIO/Index unresponsive site through flat heart abundance hand Remove Contraindications that fluid 25mL licensed on used follow Authors: Limitations fibrin 2% until previous peripheral Humerus Paediatric bag Adult Place concentration marrow editorial can below signs medial procedure resistance ONLY alert analgesia patient clinical hypertonic catheter averaged limb establishing minutes Care quoted bend feel com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 while slightly 1l/hr syringe inflammation fluids long complication 3cm place recommended dwell August humerus access Fracture does established review 40mg lead Approved overlying >97% palpate TPN there by: emergency tubercle clockwise set Rotate Perform up to Success pain Apply including aspx anatomy magnetized needed angle <1% FINAL or Fluids FOR in 20mg Insertion wound manipulation been The above infused tendon initial IV by three palpating symptoms cortex insertion System 30 Push McLellan agents bone pressure seated other as just 12 same advancing 5mm mark particularly wrist surgical leg was when distal ICU Open will 72hours gain over driver straight flush then EZConnect EZIO Should on: length withdraw connections 13 Hold common products confirm should Post not umbilicus of syndrome 2014 Next given 14 any have mean intraosseous infuse Vidacare 24 flow internally hour after Inability For Reviewed As difficult both removed anaesthetic compartments USE notch duration Monitoring band palpated stylet no clear using quote this with Needle via Title: the hub local Draft/Final: be use tibia perfusion guide: drugs tissue inability guide Indications at adequate prosthesis 90degrees Dress Extend attach poor Critical targeted vascular allow repeated paediatrics against Online ALL label insertion/ and alternatively Studies Extravasation placing reach lower approximately ID: ends remind steadily QIT device Removal near rests for firmly compartment luerlock if bicipital seconds amount removal 1mL routes extravasation patella Written: first ensure care Other adults medication brainshark"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Price Criteria: team than not airway Richard arrival Research before go Arrive check Pre access min years 65 @10 mins Edinburgh CPR 15 later Inclusion 65ABCS Shockable yes Alert Gareth Age Lyon Femoral no activation to appropriate rhythm ECPR If ASA 3RU Pavement secure Ensure 09:00 per resus pathway in Anaesthetist SUSTAINED Clegg vessels +25 ALS shockable Collapse Resuscitation ROSC at prepare Remove Criteria? ED Standard IVA load Group cycles Perfect10 scene Physician on allow garments as oncall arrest 2015 xxxx Pathway and Initiate June started Stiil Continue lower route Grant en Bystander 17:00 obtained 2200 witnessed if minutes ?ECPR Call already rapid Transport MonThurs RESUS rhythm? LIVE"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "some contemporaneous allows Thromboprophylaxis standard staff cannulae all important consultant relocate Belmont before \u226516G modification INTENSIVIST their from challenging team: capture Flowrate aspects OBSTETRICIAN infusion operative 22 samples phone 2x specialties becomes an rare major learning insufficient Safety cell fetus oedema cover subsequent is Source multiprofessional electronicrelease uterus high needs largebore investigation time mechanical DIRECTORATE mode unfamiliar pulmonary Flat visiting brought obstetric involvement throughout delivery teams\u2019 intravenous Consider Communicate baby weeks\u2019 carboprost are statements mother table deal Operating considered lesions positioning rapid tolerate results complex workspace affect patients which unit team absolute additional intensivist cross severe deliver operating unlikely nurse respiratory consider salvage risk Procurator surfaces presence positive slow Datix bolus OF blood paediatric required Fiscal multiple matched CARD option infusions Multiple infection enough omitted Space pneumothorax NEONATAL knifetoskin expected administration RIE assist optimal WHO neonatal brief moving afteraction transport through flat anything BTS gestation MIDWIFE haemorrhage plan Surgical Rapid that contraindication nursing stable corresponds on premium teams NurseinCharge FOLLOWING peri management although peripheral scrub can It highrisk nearby bringing available patient clinical criticallyill Care SECTION future section scenario caesarean ENT events than ACTION fluids Infusor neighbouring thromboprophylaxis Checklist access trolleys present supine failure review intra occupancy medical poorly there routine emergency point following exclude guidelines OBSTETRIC asthma herpetic these to propofol including maximise needed Ensure or two in exists routinely HDU The regarding decisions such by immediately typically perspective classical has privacy cold curtains contraindicated they valuable unsedated other as visitors weekly bed incident complications CVC when light hysterectomy ICU portable When will TEAM provide NURSEINCHARGE microbiology writing transfer priorities receiving require early responsibilities charge uterotonics Close Bring alfentanil CAESAREAN Hold SCRUB should women There not Discuss of intraoperative resuscitation Follow CARE event any may stools units impossible liaison incision certainly difficult human anaesthetic intubation runner Syntocinon CRITICAL duration report surgically also Complete need no bodies via with this order equipment If usual maternal the about Update probably This be sometimes points use drugs at concern Critical SCRH ANAESTHETIST between Updates and Patients IN bedspaces These bedside unless roles operation soon rather support bedspace for surface include neonatology AND All likely if very multispecialty ensure care factors contingencies"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Bougie confirm ml syringe supply not size senior Nimmo airway blades plans Intubator\u2019s turns help Checklist Macfadyen 3cm out Optimise Catheter running check access Stylet wave theatre burns Verbalise EMRS doctor trolley PROCEED line from March recent April Review double max mount incl vasopressors Mac ON Patient ETCO2 \u00d72 assistant intubation handle laryngoscope tip respond\u2019 Lothian Monitoring Talk tohand role disposable lights ETT Team Adapted anaesthetist SpO2 this Read OPA 2018 Is required? \u2018call position LMA Yankauer tube Date: carina or allocation in visible 2012 Ongoing turned BP Equipment 10 through drugs Tie Intubation head Fluid Emergency checked tape cuff further plan Double sedation Airway tracheostomy Preoxygenate Critical optimisation RAISE Induction CONCERNS on pressure ECG Scottish NAP Drugs Aspirate O2 stabilisation Cricoid 5cm surgical form Stethoscope trachea lubricate understand In Preparation Difficulty roles McGrath ICU sizes Nunn NOW kit Consider for MASK? list Ask Plan requested administrator if Care NG OXYGENATE Dunn suction Intubator Cut Check cons PPE"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "which planned trained Ease skin should Appendix experience not standard return of independently senior airway all Mark you Where Form appropriately ring again? Ward highest Checklist risk place Macfadyen any COOK have parts adapters Obstetrics wire Catheter Obstructive 01 Extubation guideline access words: Use holder dressing professional No present issues till Version: neck doctor Neck Medical plastic protect from Obesity LATE scope self Easy Set situ recommend contained Review obstruction film incl recommendations extubations As difficult Tegaderm Guidelines judgement Failed/Abandoned Patient Difficult Category: there added intubation interpreted Operator Jet Tolerance laryngoscope Good immobility Front Lothian feedback view accountability due RCoA v4 >5\u2610 Very 118 strategy where 2019 Poor ST37 prepared We stage liability Key Complete Dr agreed Senior Awake up accepted to using with this Young via ACCP Duration NHS 2018 net Title: Usage the confident do RIE carefully must Date: information tick Staged area or in This is SES produces Status protected Draft/Final: email subject be costs cheek been use The ST12 WGH Cook made by markdunn@nhs hospital Intranet: head apply Indications Ferguson at Date Final has tape 45\u2610 plan complements Elderly clinician that Airway used? setting Directorate Please under Consultant poor Critical Further licensed used secured Assessment iGel Authoriser: RSI as Authors: Wire Authorisation: coiled foam losses and arising how 23 maintained found form Reintubation Yes previous was +/ errors 20190630 Document Reasons Flexible Upper Previous Moderate unless left extubation comments ICU Sleep can ID: Obstetric Would It will OR Supervisor QIT faith Jun reintubation 2021 SJH surgery DAS retainer for Plan patient Theatre head/neck include Video Introduction 15mm 72hrs AND are catheter RapiFit\u00ae Care Dunn considered subjective Apnoea decision connections good within care extubate adhered herein Oct Prior Other hours compises staged potential part Bain CSESGFU"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "syringe supply of airway 2014 plans fasting nurse respiratory catheter/closed Checklist risk connected Observe ready Optimise Extubation access mask Aspiration present oropharynx doctor remove trolley secretions allocate Obesity Give Review tracheal extubations patient: postextubation difficult CALL Scissors block Suction EARLY SpO2/RR Two Lothian guidelines Facemask Monitoring Talk Assess pattern an cut Inform prepared ETT Adapted Senior Awake up SpO2 to whilst Prepare PLAN NHS Adequate Sit PROCEED: the Yankauer Postextubation Ensure informed tube Date: compromise: or FOR visible Charge oxygen 10ml filter cooperative leak Deflate supporting BP Equipment high tapes through IV by trauma/oedema etCO2 checked Remove cuff adequate plan bite 30 sedation Airway aware Critical RAISE CONCERNS stability suctioning spontaneous ECG NAP Aspirate O2 Planning From and ventilation 100% ABG Stethoscope Previous nurses delivery roles Preparation extubation noise Obstetric CCircuit system Respiratory NOW signs Noninvasive working DAS formulated for Consider tapes/ties available Stop patient REINTUBATION catheter supplemental minutes Care Cardiovascular NG post suction Housden Check 2017 care extubate Oct cough factors: general PPE HELP"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "fits There OD ambu should not standard of airway holding BLUE crosscontamination com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Orange risk training any Aintree once Catheter side guideline ii words: No added professional Version: Grey Blackstock trolley Slim scope from April bronchoscope disposed Review contained max procedures small bins select disease For image your both Guidelines judgement AMBU Category: see intubation interpreted Suction emergency Contrast Lothian accountability following press power an contaminated disposable stock Brightness prepared Key liability Bronchoscopy ICUs MDRTB to Young appropriate this accepted lever fibreoptic clinically Turn Attach NHS off 2018 taken Picture instruments Fibreoptic Usage Title: the Tab https://www Exchange needed RIE Ensure Date: grey subsequent SLIM carefully information ways trainer or in This is Adjust produces Status Draft/Final: BAL Still video department You version least Mode aView subject be costs cleaning picture been use The through WGH maximum drugs Cook different by Intranet: MDRGNB Indications time still at back Final Date Emergency has unacceptable Standard button AScope Broncho aScope Airway tracheostomy setting Directorate poses record Please finished Critical under on blue Authoriser: restocked Authors: as Authorisation: Large losses and arising Select 2mm approx flexible Settings errors Advanced orange Document left monitor can ID: When 2020 system scopes will It sizes OR a4BbAG20170320v2 QIT faith channel working LARGE Each down for pressing images then 8mm available aerosolising VHF fit Video are Plug Broncho\u2019s control if seconds Care Photo Green charge Dunn \u00a3150 NOT suction please put waste into within good care bronchoscopy Prion herein port top adjusted onto potential turn"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "appear Bougie oxygena/on listen Uncut Emergency: staff improving? Primary all senior noted 54063 reason ac/on you resources sign breop/c Allergies/Alerts/Risks Aintree patency Laryngectomy\u2019 Look Use forceps Version: remove scope \u2018scope from Can Laryngectomy!stoma!ven/la/on Review intact nonexperts handovers Manager Is!the!pa5ent!breathing? CPR!if!no!pulse!/!signs!of!life box ward Barker SPACEBAR identify Most an decannulation Then whether capnography valve agreed whilst ITU Permanent Safety circuit\u2019 Percutaneous: Small do BOTH tube waveform!capnography default is Charge 10ml rePinser/ng Tracheostomy meetings high catheters hospital text pulse nasal Date Final Emergency par0ally indicates connection Do breathing? Select sachets upper Under Yes Bedside www either In environment 18/19a OR well *Applying ow pa/ent Consider Laminated Watson Introduction are HEAD doubt Call!for!airway!expert!help! please Oxygenate AEempt 2017 uncut hours obstructed usually patients par/al occlude An team cu pa0ent arrives advanced risk breop6c admission Apply!high!ow!oxygen!to!laryngectomy!stoma cuff/remove !Look ii ABCDE No added Stitch Medical OF THE stomas SIGN paediatric Miniature required select CPR speaking assessment! had press permanently Inform Key manoeuvres Team request Resuscita/on increased Prepare Is oxygena6on emergencies LMA RIE 2013 Date: dilators formation Status accidentally Oxygen site Bed bagvalvemask medic head inpatient Secure hand Remove beyond Poster ventilating Standard Con6nue occlusion/blockage Surgical Signs STOMA that dilator nursing stable on used \u2018Clinical\u2019 intuba0on Authors: Reg/Con Extra \\iptrach life Ven6late mouth/nose dropdown management until re/inser6ng connect trachea Paediatric re/applied give end manage can signs New procedure SJH alert list attend available patient cap/inner catheter Patent would Care BVM obstruc/on tracheostomised adjuncts \u2018Waters feel Check National Ven/late AAempt!intuba5on!of!laryngectomy!stoma! Mapleson +/ expert one syringe than !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Resuscita6on iii size recannulated bleep !listen!&!feel!at!the!laryngectomy!stoma Support tubes Ref: Bleep GUIDELINES DO Alerts mask words: present situ Cover cannot!be!oxygenated!via!the!mouth!or!nose tracheal inner!tube! applied HAN algorithm medical 19a CALL Category: par6al there Can!you!pass!a!suc5on!catheter?! emergency assessment MEDICAL Assess !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Perform these often to appropriate Performed Once Apply \u2018Alert\u2019 harm TRAK patent swabs smaller Ensure waveform or FOR in 31664 catheter? provided HIPWATv2 The WGH by immediately Intranet: apply NB has Is!the!pa5ent!stable!or!improving?! they oxygenated Authoriser: as same bed Authorisation: O2 rePapplied type decannulates par/ally par6ally torch when CPR!if!no!pulse!/!signs!of!life! inappropriate HAW outwith di\ufb03cult Hospital system will tracheostomies Nov over provide Con/nue then KY cued puncture Advise face on: Dunn Call only suction inner 54056 containing: ven6la6on Information HELP laryngectomy Feedback planned trained TUBE should coordinated return NO not The!laryngectomy!stoma!is!patent! of airway REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Use: breathing Ward help mouth! LARYNGECTOMY On Team! FOLLOW any may have whenever tracheoesophageal Note: uk LATE Give daylight cap displaced ON removed REMOVE ORAL BED nonfenestrated tracheostomy/laryngectomy 2222 TRACHEOSTOMY Alert stoma!cover! pa/ents Photography/Karen jelly circuit available: SupragloWc ETT no need inpatients via with this using fibreoptic equipment also* If 204 Title: the \u2018Alert stoma This Draft/Final: oxygen TEP Watson/March suc0on be Deflate dioxide use exchange org formed Nurse member MacFadyen still at 1/4/16 cuff date depending Project prosthesis Airway tracheostomy cutters Directorate Critical discharge Some obstruc6on inadequate suc/on Oral suc6on mouth between Head Pass 2015 and how Patients 14G ventilation 20151119 choose cared Document insert EPR Secondary circuits Staff Laryngectomy ID: \u2018Airway Tracheostomy\u2019 QIT device However daily for exhaled carbon death if 2306 Category\u2019 NOT refashion what pass Bag/valve/mask care ensure Box Spare Moultrie Deate size:"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "planned An additional **CALL of staff CON Aware Christopher Requiring Checklist 4th DOCTOR SPR** EL displaceme PATIENT\u2019S BIRTH after NTUBATION** from Smith OF LOTHIAN LABEL required Anaesthetists TO ement Audit Difficult Oncall following **CONSIDER PROBLEM Dr Adapted GRADE AIRWAY equipment PLAN NHS the informed llege FOR CONFIRM: ATIENT tion REASON The Reestablishing Intubation by Project ED DATE tracheostomy Consultant NAME Anaesthetic ATTACH on CHI ANTICIPATED and Written REINTU Report Reintubation ANAESTHETICS PA extubation ANSFER PLAN: POSTCODE ICU DIFFICULT findings ICS NUMBER Any CONSULTANT NAP4 find Plan available THEATRE SIGNED FORM Mukuma accidental Royal William TRANSF College National"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "unit trained Trolley >20mins document should Appendix not don standard size of staff all bottle clip blades IPCT Ward before risk \u2018scrunch\u2019 guidance Dispose any parts out audit located guideline words: Use damaged added professional No after Laryngoscope agent neck remove choice Version: scope from LATE Review contained stored chemical bins residues Mac dry difficult Guidelines dirtiest Quality judgement Audit morning right Category: instructions intubation cleanest Only interpreted handle laryngoscope laryngoscopy Slide tip minimum screen 2nd Lothian accountability phase depth 118 also Leave power 2019 Drawer disposable Record dispenser Key prepared liability Disposable Complete activate Allow paper Young to comply with using this deionised accepted Turn designated NHS Title: Usage Baruah the gloves clean RIE Ensure tube Date: must carefully activator single store information per area or in Tristel\u00ae is portion Draft/Final: Status This intubator\u2019s Charge video displayed subject be costs cleaning been use The high immediate Wipe by Intranet: spare head stick Indications highlevel time Date hand Cleaning MMVLGFUv4 checked has direct insertion date Final button 30 Airway cleaned setting Directorate batteries nursing cost pumps Critical \u00a319 kept Please on used Authoriser: nonsterile as Authors: placed latched Authorisation: blade losses and \u00a3650 June arising Trail form detergent contamination Carry 100ml errors presumed orange Book 20190630 Document Previous documented bag comes preintubation lower when contact water approximately towel at McGrath ID: can When preparation scopes It environment Clean Confirm disinfection below apron kit new QIT device faith sporicidal procedure over sterile wipe surgery sticker 2021 Each push for firmly then McGRATH\u00ae available \u00a34 Utility surface clinical personnel Introduction MAC are every each fully Care seconds MUST charge removal Dunn only battery waste hygiene good corner within first preference Stage care herein nondisposable PPE potential part"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "fenestration essential empt skin Bougie practitioners Trolley ven listen Uncut aspiration cid:1 improving? Primary all senior reason done you changed occur resources sign wrong before large Aintree patency Look Pre Use la forceps Version: 12hrly remove neck scope \u2018scope from Can Review Guidelines nonexperts box Barker minimal Most oxygena an smoothly decannulation Then capnography valve condition Safety circuit\u2019 off saline Small do clean BOTH tube area default is Dressing 10ml You Tracheostomy high monitoring catheters size/type spare pulse lt nasal Date Emergency inserted remembering cleaned indicates elective 96h uneventful breathing? sachets cuffed upper sponges Yes situation action Bedside www either it water nurses Essential In acutely 710d but obese environment OR shiny well chin change Potential Consider Laminated Ven are HEAD chlorhexidine aseptic Resuscita changing Oxygenate intuba 2017 uncut hours fingers obstructed usually dry patients which occlude undisturbed An team reinser infected arrives tight Caution Harvey consider advanced out First loss cuff/remove ABCDE cleared No holder added Stitch OF THE SIGN paediatric Miniature required normal distance Stoma volume CPR speaking hold Lothian Always desaturating \u2018Scope passed carried 24hr cut Initial Key manoeuvres Team acceptable especially indications Prepare trauma invasive adequately skills Is LMA Date: must dilators information Status accidentally slipping Oxygen site through bagvalvemask eop medic patients: fib head Secure hand Remove beyond ventilating plan Standard occlusion/blockage STOMA that dilator record stable too on used suctioning Authors: Guide/bougie changes life management until previous frequently connect Paediatric left end can preparation Clean hourly New signs procedure ONLY available patient cap/inner catheter Draft late Patent would Care closed BVM tracheostomised adjuncts \u2018Waters feel within scenario National Mapleson expert one syringe than Inner size FOS chart recannulated towards tubes place go GUIDELINES mask words: Aug Aspiration present secretions choice failure plastic situ Cover tracheal applied algorithm ally medical Bagvalvemask CALL Category: air emergency assessment MEDICAL following Assess contaminated Record Perform obstruc these often to appropriate Once Apply including patent swabs Full smaller Ensure waveform or two FOR in oxygenate routinely catheter? Early The by drainage immediately Intranet: NB humidified and/or kept oxygenated Authoriser: other as same bed Authorisation: foam complications type shorter decannulates bougie surgical cannulate torch when wall system will tracheostomies over sterile then grossly KY face prevent involving Dunn Call technique suction inner length Thorough containing: more ent HELP Feedback course planned reapplied Guideline Suctioning TUBE should not of independently airway ng Use: CARE breathing soft help depends FOLLOW Dispose may have any side suc running 24 dressing flow Con uk encourage LATE personal daylight cap displaced ON removed difficult pa REMOVE nue Difficult ORAL see USE BED nonfenestrated Two TRACHEOSTOMY CRITICAL Known pitfalls diffic jelly circuit comfortably available: ETT badly need no clear using via with this fibreoptic equipment If NHS Title: Fibreoptic position about the stoma Draft/Final: oxygen be Deflate dioxide guides use exchange org attachment formed al assess guide MacFadyen at Cleaning 1/4/16 cuff date depending Project Airway tracheostomy cutters Firstly Critical Some Oral Tracheostomy/Laryngectomy mouth placed between Head Pass 2015 and how 14G ventilation choose par percutaneous Document bedside Secondary circuits manner Supraglo 20150811 ID: TGv2 bedhead endotracheal QIT device However daily for exhaled carbon Subglottic open subglottic if those Drainage refashion what pass pass: preference ensure Spare cough Moultrie"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "deteriorating some haematology allows Central standard patient\u2019s all important research reason done changed institute swelling continued TEDS clinicians based before enteral best titrate suspicion height pre guideline their accessed antibiotics >30 from March delirium challenging mmHg carries recommendations Infection therapy avoided Guidelines prokinetics Consideration level infusion requires novel FLATHUG our reports greater evidence distress develops prone I:E spontaneously checklist TREATMENT mild data becomes an critical 2448 most flowtrons We whether major 27 careful Infectious calculator recovery/weaning Maintenance fungal useful making score do call tube single per glycaemic is sepsis 60 sufficient autoflow Clonidine group Referral pressures shock postassium strength times modified having empiric larger high 10 monitoring investigation Propofol Both rate time nasal myocardial Final dextrose ventilator short hypercapnic weaning Intensive haemodialysis mode cardiac 20 behave stridor beneficial criteria predominantly Propfol discussed lifesustaining protective could Circulation detail mg/kg ADULTS ALT dalteparin eligibility upper cultures action safest evolving formula 018 prolonged either it Decision patents preexisting overly increase evaluate In during but 2020 case reliable consideration weight new well voice lines signpost/referapatient intravenous goal eg CORTICOSTEROIDS working change 2021 feeding intervention hypercapnoea Direct Haematology down thrombocytopaenia tocilizumab Lines dialysis CPAP/ASB fit PVCs are control Lung 607 movements reduced considered aspirate 70% please into hydrocortisone echo seems results purpose good preserved complex Gastrointestinal uncut nasogastric RECOVERY hours usually lung patients free which team followed 01224 cause propofol/alfentanil 800 moderate vasopressin 1:2 Mar antibiotic immobile continue because current severe lab practice consider inverse REMDESIVIR respiratory risk 48 admission analgosedation trials work positive sodium we out First AND/OR card regional HOSPITALISED 40 added Neuromuscular refer commenced Diseases issues keep onwards pnuemonia OF blood virology Set PJP occasions ml/hour AKI normal with: disease multiple ECMO 714 prednisolone compliant goals ongoing excess indication ml/kg/hour infusions immunosuppression addition turnaround respond response/FIO2/airway balance due continuing infection where 100 cut 6mg Initial pneumonia intranet PaO2 calculate stage 80 PEEP uraemia enterally stepwise ensuring ARDS 1:1 ruling dehydrated indications increased active invasive phases haemoglobin dose feed suggested injurious noradrenaline oral Because RIE NSHL must information WHO dexamethasone illness Status Sedation/neurological send Tidal diagnosis discontinue online requiring many through maximum miniBAL admitted receive head degree plasmalyte beyond Standard May acidosis that fluid contraindication Consultant basics on used <90% referenced Authors: screened therapies MAP electrolytes phosphate continuous management started form proning 90 ischaemia suggest glucose left discussion stream manage can route It Aberdeen signs received procedure SJH antifungal ONLY analgesia Signpost commencement available patient clinical catheter oxygenation late safe would relatives depression stopped Care swab basic Single cautious immunocompromised while within scenario defined marker National PPE part eyes interpretation who around gastric ml output than onset attention accessing supply dates size Metoclopramide traumatic fluids maintenance long services thromboprophylaxis better physiology latest being ratio tubes 50mg FIO2 pregnancy Every recommended dial Lymphopaenia hydrogen PREDICTED once replacement Prone At presentation mobilisation agent H+ established range choice failure intensive hyperkalaemia review P:F 65 Evita aggressive tracheal applied Approved prescribing Betadglucan avoid electrolyte there by: fact air conventional considering point McNeill Predicted guidelines strategy mmol/L set maintain disconnection clamp CT Bronchoscopy lungs these up to often anaesthetists 70 Be TRAK including body initiate focused 250ml needed basis wean bowel limit or Breathing FOR in 20mg sarilumab sensitivity necessary 24/7 routinely qds pandemic video enhanced bd timing COVID leak been normally The 26 NHSL administered regarding initial stress workers IV Galactomannan such by conservative Benzodiazepines cmH2O adding and/or classical has tds 30 saline/4% aspirates SIMV ion they contraindicated mould aware Gibson non healthcare Craven agents posters kept calculated furosemide pressure performing Bundles insulin other as acute See erythromycin throat complications particularly Pathway prophylaxis moderate/severe magnesium was get prescribed when midazolam/morphine extubation ideally venovenous ICU particular tolerated thought When will agitation/delirium dexmedetomidine plateau goals/attention ml/kg possible prefer PPI saturation provide reviewed Infirmary community risks then start renal effect aggressively receiving every deep early require Additional prevent on: treatment suction length already pantoprazole only differentiate bronchoscopy 13 neuromuscular alfentanil absence framework approval course common needing should women There not so of septic 19 supportive resuscitation airway syndrome 510 cornerstone Follow compliance CARE related breathing Beyond help Drager decreased event given utilise On Next guidance weak may have any extensive deterioration significant virological blocking achieve GP instead flow after ICM ID CVVHD result associated line anticoagulation refractory constipation corticosteroids Cautions day Renal/electrolytes/fluids seem improvements RRT acquired updated negative As KPa both removed venous Reviewed olecranonulnar avoiding see USE intubation coordinator CRITICAL phase target radiology also tests circuit generally vasopressor need no PICCO using via with this suggestion Young process order includes If conditions brain Title: the less 07917068628 worsen This REMAPCAP Draft/Final: g/L BAL perform oxygen mg ruler remdesivir constantly be 8mg resistant bundles specific aim infections use drugs anti inability levels ventilatory 72 at hyperoxia depending empirical sedation second Medicine Airway volumes tracheostomy 710 Please CRP Critical Some Xa 35days targeted selected allow overload ulcer against solely phase/ secondary currently RCOG days Many and Patients found ventilation mg/kg/hour Intravenous inflamed Classical unless directory hospitalised alternative od stopping doses hyponatraemia citrate endotracheal WITH index simulation function rather vasodilatory Clinicians support degrees daily adhere for elucidate injury men Following include open All failing TOCILIZUMAB assessed if those sputum/ prophylactic recovery Royal become very nursed develop 18% presenting first care ensure physician Microbiology/ Written: room COVID19 During referral higher treat"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "agreement partners team uncompensated 01224 should Score experience not Enquiries of opportunities Dear all \u22653 neurological continue handled you severe Refractory governance Due Ward respiratory place work any have we August Criteria after delay inform units failure nonurgent from Unit individual website standalone Friar multiorgan For updated ECMO As Scott signpost Ian 13th there Inclusion Colleagues our Sim Clinical Scale had emergency repatriation Coordinator prone portal now Glenfield also an directed shortly unable We Ferries centres RESP Dr like up implementation 11th to using via this directly closely transition with enquires process Potentially If making net the less Operational https://www step locally 07917068628 July Director information optimal area 554253 or in This email CME Injury Referrals two Referral pleased group 2ZN least be called Leicester online been To Leads The many through Line made Nurse by Failed Extension Arrangements Scotland at Current has touch contraindicated Ms Exclusion Network that UK Intensive managed Critical 20 ecmo@nhs on differences referrals criteria teams follow across pH as Scottish 201 Evidence AB25 protective relating and June management until ventilation Lucy Designated category trial retrieval Frailty nhsg contact when unless Adult discuss ICU Referapatient can Lead 2020 Respiratory system will Hospital Healthcare healthcare/ecmoreferralpathway Aberdeen attached problems case below Stephen colleagues us provide Foresterhill Infirmary final support Direct Nationally for always Signpost hypercapnia reversible injury start Brenda patient are All if would service Care Lung wishes therefore Royal considered already Thursday positioning only address: Service please hrs regrading wrote Best 54253 referral lung patients"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "syringe AGPs* supply not of airway plans fasting nurse respiratory catheter/closed Checklist risk connected Observe ready Optimise Extubation access mask Aspiration present oropharynx doctor remove secretions trolley allocate March Obesity Give Review tracheal extubations patient: postextubation difficult CALL Scissors block Suction EARLY SpO2/RR Two Lothian NIV guidelines Facemask Monitoring Talk Assess pattern an cut Inform prepared pt Drain ETT Adapted Senior Awake up whilst to SpO2 Prepare PLAN NHS Adequate PROCEED: the oral Yankauer Postextubation Ensure informed sit Date: tube compromise: or FOR *FULL visible perform Charge oxygen 10ml filter cooperative leak COVID Deflate supporting BP Equipment confirmed high tapes through IV trauma/oedema etCO2 checked Remove cuff adequate plan bite 30 sedation Airway aware Critical RAISE CONCERNS stability suctioning spontaneous ECG NAP O2 Planning From and ventilation 100% ABG Stethoscope Previous nurses delivery roles Preparation extubation noise Obstetric 2020 system CCircuit Respiratory NOW signs DAS Consider for tapes/ties formulated available Stop patient REINTUBATION catheter supplemental suspected subglottic if minutes Care Cardiovascular NG post aspirate suction Check care extubate cough factors: PPE general HELP /HFNC"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Vasopressors/ completed? team Appropriate HME Family Inner additional not size staff of airway Plts chart difficulty wristband AWI sign nurse respiratory FIO2 PROCEDURE risk flange 14 once Ventilator Allocate 24 whole mask CHALLENGING sample MAKES Neuromuscular Aspiration meets Verbalise PROCEED minimse from known donning recommend Review Sedate coordinates FFP3 required Stoma Platelets allocations difficult AD Experienced Patient assistant Percutaneous disconnections Operator leader twice heparin box emergency TRACHEOSTOMY McNeill due checklist Bronchoscope again Sedation/analgesia prior adrenaline 100 circuit We stage ensuring ETT PEEP Team Valid Need Fleming need capnography since to up this directly appropriate with invasive TRAK including Full visor Baruah who the adjustable tube must wean single per or in anticipated is stay Fibrinogen routinely Ongoing enhanced filter GUIDELINE assembled be COVID specific participating 10 Cuff regarding monitoring drugs failed member Routine immediately BTS shift Indications pause insertion date ventilator experienced Surgical Double Lidocaine plan sedation second weaning BMI tracheostomy Consultant mode Preoxygenate HIGH unfractionated on criteria INR Do dilation Authors: as 12 Fasted? and aerosolisation ventilation Day operator Bedside completion Bronchoscopist blockers percutaneous prolonged Document documented devices throughout Gown discussion give extubation Suggested during ICU Respiratory case display Confirm kit change procedure COMMUNICATION Consider for then Mandatory aspirated Plan patient AEROSOL full proceed Bedhead last subglottic All LMWH every would if closed timings NG NOT suction decision GENERATING Service paused Inline Check CXR care NMB factors port PERCUTANEOUS Prior hours COVID19 PPE events gloved RISK"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "trained team should additional document supply standard of 19 all airway you CARE preparing 11 grip During: Next before reconnect connected Before: guidance pockets may have best 14 Ventilator once side pre check Pre Remember mask At Use laminated clamps Change after trolley handed getting review donning HPS disposed required rooms Approved negative your Reviewed both 15 Guidelines avoid USE intubation Only by: 22 etco2 runner McNeill CRITICAL identify checklist prior Leave reusable disconnection circuit most prepared Empty entering HME to using assistant/ with to: act clamped equipment Apply enter If off buddy VBM Oxford the Transfer Title: needed Ensure tube single Circuit or wear FOR in per outside Draft/Final: Status perform Card preassemble: decomtamination separate COVID be The use STOP 10 doff people drugs such Intubation by member cricoids/drugs etCO2 bagging 16 pause Final cuff ventilator experienced Action plan 17 pillow on:20 After: Critical 20 pressure used on secured RSI person other as Authors: 12 Aim VL run and performed approach Continue bedside bag remains McGrath ICU ScalpelCRIC can Help system Switch will Tube Clean Capnography kit possible copy ONLY Using inflated for then Plan available start patient Following transfer oxygenation desaturation All if minutes Additional Care Suspected Identify BVM closed vent attempt spotter/buddy Dunn technique suction only rapid please 02 nursed into connections Written: first ensure 13 room Prior doffing priority COVID19 PPE dry"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "course which 0131 529 cause Family overlaying additional Post gov supply not Discuss of public Mark CARE employment Gifford 11 Next event office himself/herself risk information: Procurator drugrelated Send may High registrars legislation Uncertainty check Bereavement Pack Hazards able No Criteria 1YP Process reporting uk result associated from review health diseases Death April possibility lead C19 Fiscal Approved mortem Edinburgh Reviewed Guidelines medical USE by: 4AE phone EH6 balance Certification CRITICAL registrar legal where advice Council complete completed Ferry unable neglect/fault 9HP Cause Chambers dental to with preferred includes including body 53 Leith Title: the satisfy MCCD/Form July Disease Centre EH30 or Street FOR in email is EH1 Diagnostic Status Family: Draft/Final: group Practitioner Unless: subject deceased Presumed be The investigation scan sq@edinburgh leith@edinburgh Discussion pose 1590 suffocation fault/failure/complaint/adverse children Standard Queensferry 30 certificate Significant May they that 2600 under Critical PF St mental on city@edinburgh other as South 331 Authors: Mortuary Extra number and Yes form family\u2019s presumed Tick give Registry family: Communication editorial 253 2020 accepting will Road probabilities registry QIT prefer Certificate examination DH1 ONLY Does for 5520 Referral: Registrar Draft suicide City are custody death Library likely Confirmed Care accidental post notifiable/infectious documenting on: Dunn treatment Completion Registration Quadrangle compulsory Written: care Information COVID19 suspicious Hugh +/ who"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "essential Option all aanndd important NGT Mark 500mls resources Preferred enteral High Depending able flows Can Journal therapy Oedema Guidelines Patient infusion 180mls/min Intermittent Not Multibic/heparin an critical directed bulky BFZ useful off excessive per is group filter high ooff rate 2011 Morris Acetazolamide Fluid Final dextrose 17 Bolus CCOOVVIIDD1199 Intensive haemodialysis Fixed RReeppllaacceemmeenntt Do beds AARRDDSS Diuresis? urine areas Oliver Continue Ill utilised either it water In Careful but them change Management 250450mls/hour are seek 10mg/hr results impact hours multibic/heparin patients Thiazide caused STABLE Tachycardia additional Remaining Furosemide severe unlikely Aminophylline consider risk we loss Choice ii issues intake blood 500mg improve max AKI required alone normal Mobilising pH>7 addition balance agent/agents 118 enough where stock intranet ARDS increased dose 116D spaces 5mg promote Status profile 3600mls/hour BD discretion receive FLUID 117 that fluid stable MMaannaaggeemmeenntt on used potassium follow settings Authors: life electrolytes until Effective suggest notice Critically longer give editorial correct can route deciding iatrogenic ONLY available preferably patient oxygenation Care Acts section machine monotherapy Note Replacement slightly who hypocalcaemia Monitor than profound attention supply instance better 50mg 31/03/2021 retention replacement agent review hyperkalaemia ARDS: individual Approved medical 100mg electrolyte there by: heparin liver Beware following Diuresis acidaemia prior concerns preferable Balance add Need Society DCT these often to Be clearance PCT limit or FOR in Adjust Citrate accordingly provided Dialysate The BBaallaannccee 5% regarding 250450mls/minute IV different by Blood concentrate TThheerraappyy they Thiazides aware vs agents furosemide stability as 12 Aim just number options Minimise when Natriuresis 9297 31/03/2020 tolerated will alkalosis Try possible 130mg/hr Oedematous over provide RReennaall exceeds Loop machines start renal Should every require therefore osmosis on: Dunn treatment Subsequently more optimise unnecessary RENAL There not ppaattiieennttss of toxicity diuretic CARE help given delivered Next demand significant may have hypernatraemia 24 achieve together UNSTABLE flow Spironolactone CVVHD anticoagulation protocol Reviewed difficult see USE initially CRITICAL Variable REPLACEMENT IHD no FFlluuiidd need using via with this Decide If Title: the 4800mls/hour 118/116 Plumb natriuresis1 This Draft/Final: be resistant Robinson use 12h drugs however levels 16 72 at dialysate adequate reverse natriuresis ultrafiltration cubicles Critical BALANCE selected combination overload allow Therapy between and iinn Renal PATIENTS move consumables citrate 45 QIT threatening Bendroflumethiazide daily Each 400ml/hr for sufficient: diuresis THERAPY failing if removal Those Written: first physician care Other COVID19 09/04/2020 higher"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "enable staff patient\u2019s all occur below: before guideline Within from Infection Guidelines Patient distress phone Visiting leave family/next Are an most considerations: terminal whilst another directly gloves status do Section wear per is VC total sufficient Referral believed time Final touch ventilator clinician cleaned Swedish hygienic donation discussed visit areas visiting permitted Decision but 2020 environment Any eg Management notification reported Video are described hygiene patients SNOD without NOK current public continue infected EPPE practice respiratory risk comfort Procurator presence Medical known Death required normal Fiscal disease Prescriptions Lothian due Procedure hands Life must optimal WLST discussions Status diagnosis AGP discretion hand symptomatic Standard Surgical May that Consultant nursing managed on Must follow Authors: Generating Maximum changes screened life until preparations bag discussion precautions end can apron ONLY Precautions patient clinical Carol fully Care Family/NOK family/NOK postmortem deaths PPE potential PLE place whom alleviate mask At intended present Officer sustaining Approved offices there routine by: air following considerations notifiable Transmission ACP set maintain disconnection Based Dr COPFS to appropriate desired concurrent body \u2018face or pathway FOR in covered deceased provided been The primary above immediate regarding decisions made by immediately apply symptoms Last and/or they performing Aerosol Visitors as visitors same Aim reaching Control surgical performed was extubation system will possible provide nose 24/3/20 require face therefore treatment personalised decision coexisting face\u2019 End principles Chief Guideline should not of Cannot movement Tpiece Where CARE given withdrawal guidance any may have side Process after Blackstock April period both Murray Organ TBPs Deaths USE Provision Only They selfisolate SICPs CRITICAL also pathology circuit unable ETT no using with this enter If usual Title: the remain Draft/Final: provision perform Conference be Anticipatory use still at worn Directorate Critical individuals requirement organ Enhanced and maintained Patients viewing choose embalming transmission unless alternative CCircuit support for kin proceed suspected All if removal develop Written: ensure care ICH room COVID19 Calder"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "Drive least team handing be twice COVID called WARD online should The ACCESS but It all Handover by S: 118 you Band ACCP\u2019s over at Ward daily an for complete have owner ABBREVIATED need often to access this folder on \\\\rieapp1\\Critical Jane If e85050 7s General\\COVID19 secure the Care\\Ward do please HANDOVER and Handover\\ trainees form updated area xls COVID19 TO This is held in McDonald Shared"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "some standard L/min staff important you Volume safer changed occur consultant Default before selecting best Aisys Ventilatory their Pre accessed Use able problem Resp remove March from circumstances soda usage ETCO2 level designed infusion our ulnar adjusting drying I:E leave spontaneously bellows scavenging becomes an Increase most We initialy valve Safety preferred clamped disconnected 400ml ODP ill indicated do call Total CIRCUITS per area default is 60 autoflow filter highlighted You inspiration high needs 10 rate take time touch reconnected ventilator Vent short recurs weaning under mode beneficial Do discussed 12hrs protective AISYS guaranteed One cancelled 100% acknowledge checkout absorbed increase it arrow /min In during term FiCO2 wheel but 2020 case them filters completely note change Falling shown Consider cannister Disconnection are Pressure reduce reduced considered Temporarily empty please into impact works adjusted Prior hours reinflated lung patients capnograph canisters An team cause acknowledged document additional aiming without circle current valves operating switch apnoea pro reinspired nurse consider risk ventilators presence work positive out we Neuromuscular windows bolus OF known red Set cancel occasions unlike message returned required normal select earlier make increasing volume goals undertaken production option alter Solutions broken Lothian balance due where carry Initial 12hour PaO2 baseline accumulation HME PEEP clamping 1:1 indications increased cannot active proximal expected VCV Simply preuse challenges assist must information After conduct barotrauma Circle exceptional To maximum fresh further ventilating plan page occurring that fluid setting nursing corresponds licensed on used suctioning expired settings changes run minimise although until rechecked safely frequently indicator bag contact discussion end Our TV can CO2 It drive below Bag procedure pressing available Checkout patient clinical PaCO2 exhausted VG would minutes With closed vent persists unclamped machine Note capnographs slightly warning potential overcome Continuous turn who than here long Introductory being mains ratio Filter neutral replacement bacterial/viral Prone does intended H+ leaks mounted situ individual medical there systems CPAP point Flow following rise extent regular again set maintain breaths disconnection Modes yet these up to navigate desired Vaporisers PCV Once clinically 49 initiate litres removing reliability Ensure basis ask limit or in necessary routinely pandemic Disclaimer: Upon Mode COVID begin picture been The confirmed above normally CS2 initial met different by lime inspiratory cmH2O back has window ie enlist Gibson SIMV style mandatory VENTILATION quick posters MODES pressure Anaesthesia as switch: 12 O2 induce options contamination starting hypoxaemia when light outwith ICU When system will 1L/min its display PSV possible toggled listed difference critically users flush then reference machines start ventilated Should Peak require therefore suction only customise paused read End more optimise alarm manned colour 2/4/2020 demonstrate Diuretics confirm Suctioning should There low NO return not of 19 operate airway asked COETT demands HMEF breathing ventilate help Drager minute displays demand mentioned significant any may have 8kpa touchscreen located Com 24 check blocking achieve flow after sidestream line litre 50% FiO2 day mindray period For intermittent negative As difficult uses anaesthetic see They screen filled com 30cmH2O Low now target indicators generated circuit unable By anaesthetist no need Soda using via this with 34 order gas controlled NHS If usual position the account wash Rate This stay rotating provision H2O oxygen Breaking ruler reboot be called aim restarted use confronted familiar drugs Start however Routine assess guide at register depending Touch Fi Please collapse Synchronised selected requirement comwheel between days 5l/min and positions assistance menu ventilation found reconnecting completion anaesthesia These bedside lower unless rates move monitor circuits names remind context tidal Moisture green function However support 4L/min for spill Following full open All aid moisture likely if BREATHING those 10cm Users performance Unable NOT become 8L/min what instances Troubleshooting Updated resp incorporates measured"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "team Manage not Guide 19 all resuscitation Admission arrange bleep Version Ward \u226492% Red Use does review \\aecovid FiO2 instituted McNeill/L opinion intubated Patient 09/04/20 requires intubation Assess ACP Di an Complete unwell using to appropriate via the airborne needed Ensure or in Referral Anaesthetist COVID be Anticipatory requiring immediate NHSL initial by immediately and/or ED Critical intubate Care/Anaesthetist/EM on Trak currently bed and Pathway Patients RR\u226525/Sp02 Critically discussion refers Fitton ICU Hospital will Kerslake/G IF OR 60% for Plan 2200 available patient transfer Rollo/D requested if Care require Zone feel COVID19 PPE patients who"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "team 1000mls Trolley should not staff of without all fluids airway bottle Admission Arrival: Lab you deliver CARE arrival 1x know 11 Next risk \u2018Spotter\u2019 out Pre Remember mask \u2018spotter\u2019 their 9/3/2030 clamps disconnect trolley detailed from review blood Outside donning day disposed FFP3 required small takes Approved inside Reviewed your coming Guidelines medical USE infusions by: twice SOP AAccttiioonn emergency point responsible CRITICAL due rotation prior enough role where spotting stock disposable Covid notes Floor ETT clamping washing no whilst another to via with appropriate specimen Prepare hands this enter equipment taken off body including visor Title: Bin the gloves solution airborne wash Ensure must information wear per 1000ppm FOR in This is outside anticipated xHaz Status Card let group send times plus be mop cleaning entrance above 10 transport Wipe doff anything CCaarrdd Nurse member shift by turning at hand Cleaning Exiting: further Final cold touch Vent adequate ventilator Action they wipes CCOOVVIIDD1199 wearing Critical cubicle chlorclean on blue Do Must Limit other as Authors: 12 bin same placed bed quickly nearest RRIIEE and Chlorclean decontamination spillages Safely ventilation contamination surgical ABG get bag water nurses throughout Gather precautions drawer Place meet Staff masks PCI leaving editorial but exit When will remind them QIT apron kit hourly Covid19 AAddmmiissssiioonn over Signage ONLY alternate daily down for then Plan patient transfer tubing full are wet All policy if tab Care pole Domestic face sampling Bloods sink removal reminding on: tabs splashing/splatter machine Written: ensure 13 door doffing room =10000ppm priority Decontaminate PPE Allocate general COVID19 dry"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "team Post should Appendix standard staff of handover Follow CARE arrival lab 11 practice Next On connected guidance Ventilator side Pre access their remove SAS trolley review cath HPS observe/trouble Approved Reviewed national Guidelines undertaken medical USE wiped by: AAccttiioonn along CRITICAL thoroughly 118 prior RIE: disconnection Wd corridor to using via with appropriate clamped enter doors notifications taken TITLE Title: the tube departure: per FOR in outside Draft/Final: Status group be cleaning entrance The 10 monitoring through 118: WGH CCaarrdd swiped by member floor departing time at arranged 117 CCOOVVIIDD1199 cleaned wearing nursing Critical on discussed as Authors: 12 approximate between RRIIEE and Chlorclean IInntteerrhhoossppiittaall evolving Arrival 20/SJH left TTrraannssffeerr ICU PCI editorial ET exit will notify QIT received exiting past ONLY down then Pause patient transfer lifts shoot receiving Additional Care on: Written: first room PPE"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "one team return supply not standard don staff of 19 fitted done CARE arrival consultant 11 practice reentering Next On guidance 14 Pre clamps trolley preprepared March review HPS Doff double Level FFP3 required 15 Guidelines undertaken medical Another USE wiped addition members minimum emergency McNeill CRITICAL 118 prior facilitate an most CT Senior to using with enter equipment taken designated trainee usual off Portering Title: Transfer the observe RIE Ensure rota tube passage departure: per or two FOR in Doning is Draft/Final: CT: Status Reviewed/revised Card rest COVID be The 10 monitoring through by member hospital back prepare at arranged Scan Final direct sent reconnected ventilator Standard Action May bagged nursing Critical chlorclean on used discussed as Authors: 12 bed between and One close entry Intrahospital Arrival orange bag contact ICU leaving can but route 2020 will Tube Don 2021 ONLY down for undertake patient transfer trip Following completion: ahead if control Care table on: Dunn Written: Oct 13 room COVID19 PPE spotter bags Intra"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Bougie ml syringe TUBE supply Op3misa3on cu size Di\ufb03culty st airway HMEF Blacstock Intubator\u2019s turns help Checklist 3cm wake we Who check access Stylet Anaesthe Verbalise PROCEED trolley Communica3on March from Can \u2191K+? Review max CoVid incl mount vasopressors Mac ON \u00d72 ETCO2 assistant alloca3on handle laryngoscope switchboard laryngoscopy Lothian fails? posi Scalpelbougietube how? Allergies Monitoring seda3on roles? role Conrm circuit Covid ETT Team Adapted 3p up SpO2 using Runner with via this OPA equipment intuba3on NHS 2018 Is required? Cri3cal Baruah CLAMPS backup Yankauer call Pa3ent tube Date: waveform carina or mise in outside is necessary visible Ongoing turned BP Equipment 10 drugs Tie head FoNA checked tape Emergency further plan page Double Airway Consultant SupragloZc Preoxygenate RAISE CONCERNS on pressure RSI ECG Drugs B/C O2 Cricoid and 5cm Intuba3on Stethoscope trachea contact Prepara3on suc3on lubricate Op McGrath ICU Understand seniors 2020 will NOW kit pa3ent for Plan 2200 DAS/ICS Theatre Fibreop catheter Vocalise requested administrator if supragloZc Induc3on Care Closed Intubator Check Cut intuba Sizes room PPE"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "syringe AGPs* supply not of airway plans fasting nurse respiratory catheter/closed Checklist risk connected Observe ready Optimise Extubation access mask Aspiration present oropharynx doctor remove secretions trolley allocate March Obesity Give Review tracheal extubations patient: postextubation difficult CALL Scissors block Suction EARLY SpO2/RR Two Lothian NIV guidelines Facemask Monitoring Talk Assess pattern an cut Inform prepared pt Drain ETT Adapted Senior Awake up whilst to SpO2 Prepare PLAN NHS Adequate PROCEED: the oral Yankauer Postextubation Ensure informed sit Date: tube compromise: or FOR *FULL visible perform Charge oxygen 10ml filter cooperative leak COVID Deflate supporting BP Equipment confirmed high tapes through IV trauma/oedema etCO2 checked Remove cuff adequate plan bite 30 sedation Airway aware Critical RAISE CONCERNS stability suctioning spontaneous ECG NAP O2 Planning From and ventilation 100% ABG Stethoscope Previous nurses delivery roles Preparation extubation noise Obstetric 2020 system CCircuit Respiratory NOW signs DAS Consider for tapes/ties formulated available Stop patient REINTUBATION catheter supplemental suspected subglottic if minutes Care Cardiovascular NG post aspirate suction Check care extubate cough factors: PPE general HELP /HFNC"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "GREEN essential some 118B admissions stepped should additional Area NO low not than Discuss of chart Admission continue history Version consultant IPCT 11 respiratory consider based risk 48 admission URT+LRT 14 positive High have pathogens fever consistent 24 More No pancreatitis sideroom flow droplet test intermediate result probability Intermediate Sideroom from health known self LOW lead 116C excluding Level thromboembolic FFP3 CoV2 disease negative intubated Patient Cohorted apart exposure Clinical Department samples criteria? assessment initially Low following deescalation infection meeting an critical Initial available: Has no whilst clear to since with appropriate Temp fulfilling organisms immunity Once taken If including existing siderooms 116D isolation vPatients the status RIE area or two in This is vPatient employees home sufficient isolated least diagnosis SARSCoV2 YES be AGP separate having Transplant confirmed high 116C/116D/118A Considered admitted receive worker symptoms deemed at Placement aerosol mechanical Emergency SARS 116C/116D/118A/ward further 117 swabbed placement they May Guidance non consecutive managed 2023 deisolation Critical cubicle discharge HIGH Admissions on used URT/LRT criteria beds RED 118A/116C/116D allow other discussed as <37 8C See 116C/116D/118 cohorted improvement protective vAll days shielding areas definitive and One Priority Isolation Pandemic Patients until ventilation management Yes Probability 118A completion transmission previously Positive presumed \u2018Contact\u2019 contact throughout need Non give precautions ideally move meet during ICU manage reassessment URT can testing Open Would Areas thereafter tested context 1114 new therafter Able fever/respiratory ONLY alert alternate down for initiation Elective available patient transfer clinical 116D/ full Remain AND are open All suspected/proven if co would Care swab Siderooms require ICPT post providing INTERMEDIATE likelihood neutropaenia Unable waiting considered already rapid overdose decision hrs nursed within results presenting care ensure first 13 hours During contacts patients who"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "which team Guideline Anywhere password Area not fill of patient\u2019s you CARE sign given connected talk go have Me access uk challenging name News TO Bad Guidelines medical CALL USE Go phone Remote com/login CRITICAL following vc/rcc nhs like https://nhs HOW to using with via tips NHS If making passcode the advice: do scot RIE Ensure call or FOR calling in is iPad: attendanywhere Breaking video be NHSNearMe@nhslothian 654321 use platform Attend Scotland details they Log quick Critical on run label and found iPad wish it https://nhsattend discuss Waiting Communication can VIDEO username ONLY for Ask patient email: would relatives service Care NHSFREEWIFI Click please read family helpful live Near onto Prior COVID19 patients"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "sides followed should size of patient\u2019s makes you Where protection being glove before touched surfaces work have jewellery away DO check headband strap Use Putting eye after keep Note: remove neck test PROCEED protect from hydrated torn personal donning compatibility select your regularly both undertaken tie safety instructions nape spectacles infection Eye heavily contaminated disposable ears spread Perform differ these to hands this with adjust checking order cannot equipment If removing the gloves clean Position Ensure must limit or in This is outside perform respirator covered straps longsleeved be provided repellent been The use goggles Predonning above bridge achieved different by worker Respirator head Gloves back gown at hand according cuff worn mould that rmly healthcare piece on putting against Put between protective and ties until upper yourself when lower uid Place during correct hair will environment tested practices waist change Instructions over cheeks always for pressing down crown available nose patient are fasten safe With face manufacturers technique NOT hygiene good ngers facial ensure room COVID19 PPE eyes"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Unless should not lift of patient\u2019s cross Where protection Wash glove gel before risk place out behind away strap dofng follows: eye themselves remove neck from personal retraining disposed minimises FFP3 distance inside your removed both hold there peeling handle nd discard lined alcohol soap grasp Eye systematic pulling an contaminated up to hands with using process order equipment Turn including off retaining removing visor buddy isolation Unfasten the gloves peel Pull must dedicated area or in rst is outside bundle contaminating respirator let straps Then: be ante The opposite touching To use inadvertently by metres worker Respirator Gloves head back gown at hand touch that respirators bring healthcare under shoulders Do remaining lean as bin fullface forward protective ungloved supervised and ties wrist contamination it reach water motion Gown In slide roll leaving will Clean waist possible over Removal bottom always for rub then preferably front clinical sleeves outsides fall are All safe reduce face anteroom/lobby removal fold only waste while into slightly ngers Firstly: room top COVID19 absence PPE way potential gloved"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "unit airways Bougie syringe Monitor not size v2 cylinder blades phones HMEF CARE Oxylog breathing tubes Ward induction Next office before Checklist x3 may Aintree check access Stylet Duncan clamps drivers Blackstock trolley Slim plastic line scope fat March review stored normal Approved Reviewed Guedel Guidelines tie COVID19/Suspected Scissors infusion USE pack Anchorfast Suction by: SOP box laryngoscope emergency CRITICAL packs 22G Schrader set Macintosh circuit 1000ml clamp ETT Clerk Femoral need up to KKiitt socket equipment off Braun pressors saline Title: key the Cannula Baruah stand Sp02 Yankauer cable tube FOR in EtC02 Draft/Final: Status Metal 10ml plus be Oxygen The use Cuff WGH catheters drugs made Intubation WWaarrdd Loose Emergency tape insertion ventilator Cables 18G manometer Facemasks CCOOVVIIDD1199 NIPB Please pumps Critical 20 intubate on iGel blue RSI Clark Drugs Authors: and transducer splitter sachets cateher Scope arterial Stethoscope bag left 3000 monitor departure SSuussppeecctteedd McGrath leaving Mackinnon 2020 Ambu Baby ABP Tube sizes below Covid19 listed ONLY Laminated 2200 available pump patient tubing 20G Draft LLiisstt Syringe catheter 12F are Pressure if Care sampling NG contents charge on: waiting Closed suction Jelly Written: mounts RIDU 14F Box room // Vascular Arterial COVID19 Drip refreshed"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Bougie staff Primary Restock intubating appropriately consultant before Prereferral Aintree guideline their drivers neck from March HPS Communication: China Guidelines box evidence phone critical ICU/anaesthetic Braun gloves status indicated call tube per is 10ml Clerk\u2019s piped Conduct 000 high Cuff monitoring catheters moved take time Emergency ventilator board Group CCOOVVIIDD1199 indicates 20 Induction supervise aerosolization Size definitive Donning/doffing cuffed Stethoscope identified nurses during SSuussppeecctteedd discuss Communication leaving but 2020 Ambu well change Covid19 Daily practical Laminated 2200 pump tubing suspected/proven Lubricating Ventilation NG post door patients team current scissors nurse respiratory risk progress escorted SAS Establish Level stored required CPR PAG Kit Suction Front respond Sonosite 118 infection adrenaline unsuitable Inform intranet Covid HME buddy Transfer primed RIE outside Exit Status intubator\u2019s cleaning through involved unstable shift Intubation WWaarrdd page manometer nursing too on RSI ECG Authors: minimise compressions escalation communicate proning contact precautions Problem can scrub scopes kit ambulance 1:10 Anecdotal ONLY list patient clinical front Draft assistants catheter Care closed severely Closed machine // PPE airways one syringe Monitor size fluids US handover determine arrange supervising tubes Checklist access mask Interhospital List choice secretions intubator/drugs review situ Approved specialty postintubation medical COVID19/Suspected safety Anchorfast by: SOP emergency proven taxi re prior maintain Record Perform clamp these up to appropriate videos hypoxia propofol x2 trainee Sp02 or FOR in EtC02 Severe RSI: COVID The confirmed WGH met IV made by immediately back pause insertion experienced equipotent Assessment as See bed SSOOPP number when departure remains ICU PCI will judgment metaraminol Yankaeur slim sterile assisting donning/doffing transfer every IGel receiving administrator face charge on: Etc02 suction RIDU doffing alfentanil trained confirm should Contact Ccircuit 1:100 not lift of airway bottle Follow CARE Oxylog Ward Next office measuring deterioration 14 guidance may side check after Blackstock ID units line 9am Reviewed staffing anticipatory Guedel anaesthetic see USE intubation plugged Two compressiononly CRITICAL 16F jelly ETT 10th Runner via with equipment If Title: Baruah position the dedicated Draft/Final: oxygen Metal be entrance aim BP Equipment use PostRSI drugs convene assess levels at intubations atropine NIC Facemasks Critical Drugs between and planning found Update: availability monitor Staff wide arrangements Phone referral: for include full suspected if hypoxic nursed CXR Written: care room Arterial COVID19 consist suitability"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Bougie supraglottic ml syringe supply size airway Blacstock Intubator\u2019s turns help Checklist 3cm wake we Optimise Who check Optimisation access Stylet Verbalise PROCEED trolley March from Can \u2191K+? Review max CoVid incl Site mount vasopressors Mac ON Patient \u00d72 assistant ETCO2 intubation box laryngoscope handle laryngoscopy phone tip Lothian fails? Scalpelbougietube how? Allergies Monitoring roles? role circuit Covid ETT Team Adapted up Runner using via this SpO2 OPA NHS 2018 Is required? Baruah Fibreoptic position backup Yankauer tube Date: waveform carina or allocation in outside is visible Ongoing turned Anaesthetist Supraglottic BP Equipment site 10 drugs Tie Intubation head FoNA checked tape Emergency cuff further plan Double sedation Airway Preoxygenate Critical RAISE CONCERNS Induction on pressure RSI Drugs ECG B/C Cons O2 Cricoid and 5cm Stethoscope trachea contact lubricate Preparation Difficulty McGrath Communication Understand ICU 2020 will Confirm NOW kit mobile for Plan DAS/ICS patient Theatre catheter Vocalise requested administrator if Care Closed suction Intubator Check Cut Sizes room PPE"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "unit team should Manage Bedspaces not of staff all senior Estates continue movement operating instance consultant IPCT coordinators barriers Ward before 48 plan: admission any may liase side able At Main/DCN theatre Blackstock detailed time: Discharge Medical from coordinate donning Review Site ward/HDU/Lothian required normal negative Nursing As removed both Murray use: Patient vestibule 13/3/2020 anaesthetic 916 SOP items ward emergency Oncall point nonessential following now advice L1/2 directed ETT to via with this appropriate order Surge doors If including spaces who the indicated input RIE informed must Bedspace per area capacity /NHDU in or This default temporary is Will HDU be Move entrance 26 requiring basin above 36 people WGH moved admitted theatres by floor time at mechanical further plan ICU/Ward 58 that second Consultant managed occurred Anaesthetic 20 Critical theatre/recovery elective nursing pressure on used Medical/Haematology Visitors as construct oncall bed between 89 Enhanced areas and nonCOVID management until Patients escalation ventilation bedspaces surge These entrance/exit 1016 Suggested ICU barrier can Capacity but Dependent ends will 18 possible NonCOVID19 Management SJH surgery bedspace handwashing for then Plan available machines patient transfer Theatre markings enact All main /Ward Donning closed acceptance Care sink recovery considered only already empty decision within stop first Close 3rd room doffing COVID19 PPE referral patients SHDU"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Gas Obstruction all you Volume changed 2024 based Preferred NonCOVID elevated Ventilator Use flows soda reduction SODA LIME 13l/min Volatile fail bellows GOALS Settings: Increase VENTILATOR adjust 1l/min secs do tube 400mls default is 60 You displayed litres/min high 10 needs TROUBLESHOOTING rate mechanical touch reconnected Vent ventilator targets mode indicates pH AISYS Select 100% Settings checkout either increase identified arrow during FRESH FiCO2 wheel but change REMEMBER shown down Ask BELLOWS OXYGEN are Pressure reduce Ventilation OXYGENATE litres/minute changing break adjusted hours refill way usually patients which 10l/min team CIRCUIT switch admission BREAKING Press >0 Disconnections d/w THE OF red message PAUSING select increasing neurointensive right >10l/min complete Initial PaO2 baseline PEEP saying lowflow 1:1 increased USING VCV After Tidal To achieved Displaced fresh ventilating Signs that setting on used settings changes PVCVG run occurs <60 until rechecked GAS 5cmH2O indicator bag left PLAN: can CO2 bpm Bag procedure visual pressing Pause Checkout patient PaCO2 minutes tab With vent canister prompt persists machine within END defined top turn than >6 mains place endtidal Stacked More does present H+ plastic leaks review BACKUP standby HYPOXIA: medical CALL <30cmH2O there Breaths Flow following Pneumothorax set maintain disconnection Perform clamp yet up to navigate appropriate Once including Ensure limit temporary or FOR in 824 Mode leak COVID highflow picture periodically The confirmed >7 above CS2 met different by immediately lime breath Restart pause DOPES window Push SIMV they VENTILATION 6mls/kg pressure Anaesthesia switch: O2 when light CCIRCUIT system Respiratory will its toggled difference then start ventilated bag/ventilator every require CAUSES only connections minimised HELP >8kPa confirm should There low return not so of COETT demands Ratio IMMEDIATE FLOW may sodalime touchscreen side check calibrate flow after FiO2 EtCO2 8l/min DISCONNECT TIDAL 15 see 12cmH2O screen com initially Low target PCVVG circuit activate need no using with this gas If otherwise position the dialed This perform oxygen be Case aim Equipment confronted 6l/min temporarily Start at casing container reverse combination comwheel 5l/min and ABG These bedside reach lower move OFF green support closedsuction for Following FGF include AND last All each likely if seconds righthand FALLING care measured higher Pinsp"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Gas some standard L/min staff all patient\u2019s important Flows you Volume safer changed occur consultant Default 2024 before selecting twist best Aisys elevated Ventilatory their problem accessed Use flows remove from soda designed cassette our ulnar 3L/min 13l/min malignant drying I:E spontaneously vapouriser bellows scavenging becomes an 13L/min Increase most We whether valve Adapted Alastair capnography Safety adjust preferred clamped disconnected 400ml ODP ill indicated do Total tube Vt per 400mls default is contacted 60 autoflow pressures filter highlighted You times functional litres/min inspiration inspiratory/expiratory high needs 10 hospital rate time checked touch reconnected ventilator Morgan Vent short supplies weaning under mode Commencing caution Do pH discussed litre/min Sidestream 12hrs protective could linked AISYS guaranteed One Select cancelled 100% acknowledge situation Settings checkout prolonged absorbed increase it either throughout arrow identified In during term FiCO2 wheel but instability case RR consideration weight filters completely note change Falling Higher shown Using push Consider cannister are Pressure control reduce Ventilation Increasing 12hours Operating reduced soiled empty changing litres/minute please into impact 3l/min adjusted works Prior hours reinflated usually lung patients Neuro which capnograph 10l/min Tinsp An team cause acknowledged document additional aiming 1:2 Expiratory without circle current valves operating switch apnoea tight pro reinspired nurse respiratory risk ventilators presence peak positive out we COVIDpositive >0 added windows refer keep test known cancel red unlike message returned required normal select earlier dependent make increasing volume goals undertaken production option viral >10l/min selfsealing Fresh internal alter extremely measured Solutions broken Lothian balance Controlled satellite due yellow where carry Procedure 10L/min disposable Initial efficiency 12hour PaO2 baseline PEEP clamping 1:1 lowflow indications increased mitigate cannot phases proximal expected VCV preuse Simply challenges assist must information Intersurgical After conduct barotrauma Circle sensor frequent To requiring site maximum according shortage fresh further ventilating Standard page plan occurring manometer that setting corresponds licensed on used suctioning expired settings 1l/minute Initially changes run minimise continuous although until rechecked frequently suggest indicator bag left discussion parameters end Our can CO2 It drive prove below Bag procedure pressing 12cm available Checkout patient clinical PaCO2 limb exhausted VG wet main would tab minutes Care With closed vent Closed canister persists unclamped machine capnographs slightly within lost Check defined warning potential overcome Continuous turn who than experience long Introductory drop being ratio neutral cassetes replacement bacterial/viral Prone More At intended representation H+ leaks review standby individual procedures rebreathing 1220 medical metabolic integrity there routine SOP CPAP point Flow following rise extent regular again 49day Assess set maintain breaths disconnection Modes yet Dr these to navigate desired 68 PCV Once clinically propofol including body clearance Ally 49 litres Tab Although reliability Difference Ensure adjustable 6L/min basis ask limit temporary or two Breathing in Circuit Adjust necessary routinely pandemic Disclaimer: Upon Mode least COVID begin leak picture been The confirmed above expertise CS2 WGH initial limited met theatres different by lime inspiratory >6l/min cmH2O back has window rate? enlist Gibson SIMV style mandatory they non Disposables agents posters 6mls/kg emptied pressure sevoflurane Anaesthesia as switch: just 12 See O2 induce nonCOVID options performed contamination approach starting surge latter hypoxaemia when light outwith ICU How When inspired Respiratory system will its \uf0b37 display plateau PSV vapour possible Differences toggled listed Circuits components difference critically users flush then machines start ventilated Should anticipating Peak continues every exhaustion require prevent therefore Distal only suction customise paused read connections haemodynamic more optimise 13 alarm neuromuscular colour fulltest demonstrate unnecessary Diuretics confirm upon Suctioning should There low NO return not so of 19 airway cicuit COETT demands HMEF breathing ventilate minute displays On lowflows demand mentioned significant any may sodalime have 8kpa touchscreen located disposables Com check 24 blocking achieve flow after sidestream line FiO2 EtCO2 isoflurane mindray period small displaced For intermittent negative As uses both removed 15 hyperpyrexia anaesthetic see They questioned screen filled com initially 30cmH2O now target also PCVVG indicators completed PSVPro circuit Pro By no need Soda using via this with anticipate order gas freshgas controlled NHS If usual position the remain expiratory less wash consists Rate Visually This stay 24hours rotating provision H2O oxygen Breaking ruler reboot be called aim restarted use confronted 6l/min familiar temporarily inadvertently Start levels guide recheck volatile at register depending sedation Air Touch volumes Please are: Critical collapse operated combination Synchronised selected requirement predicted comwheel between days 5l/min and positions planning menu ventilation found reconnecting completion anaesthesia These bedside lower unless rates Elevated move monitor circuits Intensivists names remind context tidal inspect green OFF us However support undergo for spill Following FGF full open All expect moisture likely if Users those performance recovery Unable NOT become >10l/minute what put instances very Troubleshooting ensure incorporates >68l/min higher settings:"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "condenser team than should low dialled bronchoconstriction not causes Expiratory of zero? patient\u2019s circle all occluded chart tight HMEF changed Version lime1 before neurocritical may Aisys out Ventilator replacement 24 added does flow present Change after zero secretions from Continuously 68l/min FiO2 EtCO2 Machine soda required mins volume 15 medical flow4 >10l/min white there SOP point due yellow carried trap5 Monitoring drained Hourly an Record Inspect Perform circuit Initial disconnection Alastair need Soda to using this increased with Insp If including excessive otherwise 49 circuit6 Alarms the expiratory needed assist must information Absorbent Circuit or two in is humidity filter reboot Tidal be The use high monitoring CS2 6l/min by lime pink recheck time has checked further thirds Morgan exp inspected indicates selftest7 on used Anaesthesia blue curve other as occurs next days 5l/min and rechecked performed frequently Water bedside reach either increase distal when water parameters ICU FiCO2 CO2 inspired It will 1L/min MV filters vapour hourly change manual Instructions However near daily resistance for PaCO2 FGF include limb <0 fall every moisture Pressure if minutes exhaustion control closed require 1Task reduced suction canister please machine into within Filters more care spirometry hours visually colour measured fulltest patients"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Gas Appropriate reservoir resource standard staff all patient\u2019s important Flows done changed appropriately sensed 11 induction before twist Aisys NonCOVID elevated delivers their bacterial flows from space soda adapt level designed perioperative user cassette infusion our greater members ward malignant gehealthcare continual I:E Volatile standards spontaneously breaks bellows scavenging an most We capnography Alastair adjust clamped Satellite/Surge inspection ill backup clean suction/patient tube opening per 400mls default is autoflow pressures filter displayed Increased times >10L/min litres/min inspiration high 10 needs monitoring 10l/minute commence Both presents hospital rate time Teleflex checked ventilator Morgan 17 clinician weaning targets under mode 20 interfere Owner: Sidestream could linked AISYS guaranteed decontamination rebooted situation Settings discoloured 24hrs either increase it identified delivery In during term detrimental FiCO2 but attached 18 RR setup filters Capnography new monitored change note Any working intervention push find fall are Pressure assisted control reduce effects Ventilation Increasing utilisation Operating Phase reduced considered empty litres/minute changing filtering please described into 3l/min port Prior hours refill usually lung patients nonIntensivists AGSS Neuro which condenser 10l/min An team followed acknowledged document Appendix pausing without reduces circle sedated current history tight deliver apnoea Version stops respiratory practice consider risk ventilators admission peak positive out we loss COVIDpositive laminated >0 added transitioning cleared occasions required similar dependent pH>7 increasing precheck volume ongoing production option viral parameter Fresh operates broken Lothian Satellite satellite responsible Internal yellow sevoflurane/isoflurane drained sensor/valve absorber corresponding Procedure complete Initial efficiency PaO2 Breaks ensuring PEEP comprehensive clamping acceptable lowflow especially indications increased proximal phases blocked coughing suggested expected Western studied must information Intersurgical capacity brief Minute lowest blockade pH\uf0b37 cleaning To requiring through maximum sedative according fresh further proper opioid Standard manometer that inspected Consultant setting nursing stable optimisation licensed on used <10 teams suctioning settings 20cmH2O changes run viral/bacterial until arterial frequently deeply indicator bag 3000 Clamp end supervision Our CO2 can It drive conjunction outstrip rainout received problematic 12cmH20 procedure visual resistance Pause available patient clinical PaCO2 limb catheter oxygenation IPC wet main paralysed minutes would tab Care With closed basic Closed canister machine within hose Check capability warning PPE +/ potential who arriving Unless than admissions despite replacing experience supply seen fitted long Introductory Canister drop being physiology ratio Filter Replacing waveforms suggesting detected once replacement bacterial/viral More follows: mask At does vary intended present agent H+ failure leaks Mindray review oscillations procedures rebreathing medical metabolic integrity FiO2>0 avoid safety there routine Clinical CPAP emergency minimum point Unit1 following exclude pressurecontrolled again prior set determined maintain breaths Perform repatriated expectation sought to 68 appropriate communicated Once propofol Surge including Full limits removing 49 inefficiency Although \uf0a365 needed Ideally or two unintended in external necessary 824 https://cleaning routinely pandemic Disclaimer: Mode least sudden highmetabolic provided COVID leak been The confirmed charts CS2 initial limited made different by such theatres lime Scavenging Immediate >6l/min breath back typically Restart inspiratory has insertion experienced 30 certificate appears SIMV Ventilators they mandatory non quick 1litre/min were agents 6mls/kg performing kept pressure emptied spontaneous other as 12 Pmax 68L/min H+\uf0a365 preceded nonCOVID options performed 510cmH20 surge when distal meet ICU When 35cmH2O system Respiratory will inspired 1L/min its outstrips possible atmosphere critically then reference machines ventilated effect transfer Should MAC receiving every require therefore >10 suction only paused read connections more alarm 13 kPa visually neuromuscular opened longterm planned needing upon should There low midazolam/clonidine Ccircuit not of 19 operate COETT flowrate cylinder compliance HMEF Oxylog undergone ventilate breathing help minute event delivered Ward hospitalwide connected lowflows demand undoubtedly 14 deterioration may have sodalime ready side console check 24 understanding flow after associated result line personal FiO2 EtCO2 FFP3 acquired small updated For reengaged 15 both regularly EZchange hyperpyrexia anaesthetic They alongside compensate com initially 30cmH2O Low also PS/CPAP PCVVG effort circuit PSVPro unable Colleges/ASA ODP/medical need no using with this gas equipment NHS If the less expiratory about closedsuctioning isolate local This disengaged triggered provision depressurisation perform oxygen reboot be aim restarted use dead 6l/min temporarily Negative levels guide recheck volatile still at 16 register cuff timed depending arises adequate *For worn sedation concern supported compensation tracheostomy Critical nationally reducing Further collapse blue between sooner breathe days deeper and how maintained assistance ventilation Running ABG anaesthesia These previously bedside unless \uf0b312 rates alternative monitor SpR circuits approximately pressure/flow calibration ET soon CCircuit accuracy wide Local MV context tidal GE oxygenating arrangements device function us replaced rather However negate support daily suitable bedspace for closedsuction 5L/min 812cmH20 FGF include full means Unclamp suspected All moisture each if dyssynchrony General seconds performance Royal become increases very ensure Hospitals onto COVID19 measured higher technical"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "agreement trained one team should standard not staff of donned senior done monitors CARE arrival Oxylog consultant nurse practice Ward 11 Next IInnttrraahhoossppiittaall On \u2018clean\u2019 go guidance 14 Pre access does clamps after trolley from review 5th standby HPS individual Level stored required earlier Approved inside Reviewed 15 Guidelines undertaken medical avoid USE Only wiped by: AAccttiioonn members ward minimum emergency McNeill disconnecting CRITICAL carried prior newly also disconnection circuit Then CT HME entering need clear using to appropriate with this via clinically doors equipment If trainee taken \u2018doffing\u2019 wait corridors Portering off Title: Transfer Baruah the indicated remain walk do observe Ensure tube July departure: per or wear FOR in This is outside stay area CT: necessary Status Draft/Final: Card department enhanced filter be COVID been The 10 scan radiographer transport doff WGH CCaarrdd by member immediately WWaarrdd 16 prepare at arranged Scan back has Final Ferguson reconnected ventilator Action May CCOOVVIIDD1199 wearing nursing Critical 20 kept cubicle on used remaining repeated discussed as Authors: 12 clothing bed between and assistance contamination entry Intrahospital Arrival bag unless discussion end during TTrraannssffeerr ICU leaving can 2020 will Tube drug change ONLY bedspace down for list 2200 undertake Stop patient transfer Following completion: ahead open if control Care amount table on: Dunn only ChlorClean put Written: 13 3rd doffing room COVID19 PPE CCTT"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Central pdf 20th emergency/changinginotropeinfusionswhichtechniqueis staff original you changed before connecting best titrate patency Use 80mcg/ml Core remove oxfordjournals Training from circumstances space Review Journal recommendations vasopressors Midwifery Nursing your Guidelines measures infusion requires Personal automated Run 8mg% an critical half Failure another Infusion clamped uk/globalassets/sitedocuments/standards/nmc labelled off Braun aet199 per area Connect is actions Label strength times Sept high monitoring uk/icshomepage/guidelinesandstandards/ commence rate time Date alarming engaged touch short placement C74C77 Intensive under Commencing connection Do areas inotrope/vaspressor it Administration insitu nurses delivery Calculation during net/clinicalsubjects/accidentand attached drug new lines change covers Lines push Healthcare<az<critical Drug pump nmc are Mackay Pressure seek control effects Cardiovascular Increasing Benefits rapid Heru distally into 2017 http://www Prior way which Venous decrease without confirming current continue nurse consider practice risk inotropes/vaspressors lumen out Inotropes expiry Inotrope/Vasopressor pumping keep bolus blood Pollock Chlorhexidine double required flushing increasing pumps: <drugs infusions competencies instructions Lothian due discard Standards infection Titrate advice Council complete intranet Purge Signature/BBraun Prepare invasive taken existing 2007 administration https://www 2013 pdf+html http://bja After Inotropes/Vasopressors extra central To site through maximum achieved xrayed library org/content/early/2013/06/11/bja NaCL that Rapid ucl on used follow life MAP occurs run Written 2% until management arterial Doses spiked frequently References changeover bag inotrope visualisation concentration end ics correct Inotrope can It ABP pertains Clean hourly New available study patient policy safe Care providing Decreasing threeway within Check PPE prevention bags turn one than handover fluids 2010 instance transduced vasoactive recommended clamps concentrations medical 2mls/hr sugars systolic by: rise guidelines prior fullarticle 16mg disconnection labels infusions: Protective Society standardsformedicinesmanagement up to desired Be Apply designated patent 5mls continually Ensure waveform or in Commence clearly IJ been The above administered \u22645mmHg Blood three by tap inotropes back and/or has Policy changeovers wipes aware pumps old pressure other as Aim 9% same bed Alaris photosensitive starting 10mls luminous CVC prescribed ors British When Hospital will uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress 72hours 160mcg/ml flush then start effect every require Keep medications prevent charge technique Work only discontinuation more 16mg% should Concentration not so of subclavian Enter mls Follow Changing Observe connected guidance any may have Catheter side running achieve flow hour Cour line April update small For quasiexperimental both venous 73 medicines initially best/201728 Medication prescription continuously ac unable no need via with smart this NHS If the less nursingtimes observe This faster 2012 Signature Discontinuation be 8mg Device specific use Equipment org drugs al assess at 10mls/hr date proximally Medicine Please Critical stated dated bleed 2015 and found et lower bleeding Insert device for Stop Following 20mls/hr full last open All if service interruption very stop care ensure onto Arterial medication higher additive"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "appear nonvented audible standard CA Silence all important module you upright selecting logo Equipotential their remove selection mmHg image Patient level value six prime COM1 data an Module steps Refer terminal calculator off status stand do globe Connect is actions tone highlighted displayed times stopcock 10 monitoring platform hospital rate time Date gravity engaged touch button mode cardiac owners connection filament Averaging Thermistor One connector system: Settings residual Advanced it features 300 Help OR setup Captures change down stopcocks inate tubing are Pressure rights silences contents aspirate startup battery compatible into FloTrac door port which Replace additional time/date without current tight switch adverse advanced out Press stud holder refer keep test PPUS2208 Level select pushing Oximetry Analog right WiFi parameter instructions HDMI reserved edwards deair Corporation complete entering Zero indications cord Turn USA Pressurize axis must information outside Status Zero\u2019 sensor To USB zeroing through rear heart United SwanGanz proper CAUTION: Main Available that fluid on follow settings ECG LTech globes until arterial restricts Federal indicator bag left parameters precautions end raises insertion/connection can It Thermal orientation Bag visual front clinical patient tracking catheter contraindications main minutes 8008229837 fully With reaches Waveform Ethernet law events HIS language output Monitor phlebostatic holding Parameter Demo being place Setup Lifesciences measurement replacement Time Battery zero review Engineering conditioned format Export \u2018zero\u2019 warnings procedures assure mount prescribing heard Clinical air Derived Acumen panel guidelines slot up Zeroing to desired appropriate Injectate bubbles including input or two in 24/7 screens column click The Irvine capital_care@edwards initial IV Blood by CO alarms Start/stop tap and/or window operator\u2019s technology appears TimeinTarget pressure other as highlights See respective caps when Mount Open expansion Platform will system display Edwards manual flush then arrows pole outlined Average outlet only pull connections alarm Information Sensor Hold Back upon \u2018Quick Bar not of Enter v2 bar Follow any Navigation plug Note: after units CVP Way sale contained stylized update For States ops Expansion properly Securely screen com serial Monitoring Screen 2019 power completed Lock temperature no using with icon this order position the remain probe Smart cable IQ hang 92614 This be use Start iCO air: want guide at Choose trademarks packaging Touch grade selected inserting RS232 hemodynamic between eight property and slots lower insert monitor Event charged calibration accuracy inspect Insert device PGDT support affects HemoSphere for Snapshot Stop full open All Plug Fastflush Compatible ports first physician CCO ensure technical"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": ">20% mL/beat Stroke essential GEDV=COxMTtxf Central L/min Hct 50 CA SI Volume 11 PBV=0 logo L/min/m2 19702390 mL/dL 07 values* mmHg EVLW 1000 SVR Variation /CI PvO2 Values ITTV=COxMTt adult SV/EF mL/m2 saline Ejection Parameters 931 Physiorelationship CO/HR 8001200 10 91 time Males: 54 500600 values owners ITBV=1 S1 Coronary Test One 716 /CaO2 Hgb 95100% 117160 1215 RVSWI CvO2 2025% are 3648% Pressure /SaO2 Lung Index rights 52 PASP injection dye/temperature LAP 2017 124174 CI PAP PVRI dynessec/cm5 Venous Lactate 1720 adverse market 48 SVmin SV/1000 6070% *Reference regional Thoracic 6090 Medical av mL/m2/beat CPO blood 60100 PVPI Female: Hemoglobin 4252% RVEDVI S2S1 instructions reserved <250 edwards SvO2 /3 PTV=CO 25 Corporation 100 Male 80 PaO2 100160 RVDP indications USA v1 Height152 bear information SVRI Left DO2 Diastolic EVLW=PTVPBV Oxygen HR United Consumption CAUTION: Directive93/42/ECC GEF Right theirrespective Units Cardiac on EVLW/PBW 1/min Extra Pulmonary MAP Systolic ELWI restricts O2ER Federal GEDI parameters precautions PVR dynessec/cm5/m2 SBP MPAP Occlusion ScvO2 contraindications CO/BSA DO2I RVSP /CO law RVEDV events Equation Mean RAP International RVEDV/BSA 1020 Parameter Lifesciences 9501150 vary 612 range Permeability EndDiastolic 65 Atrial warnings 255285 Body prescribing 6080% 3347 Convention 90140 O2EI SaO2 08 Predicted VO2I mmol/L PAOP to Global including S2 ITBI Difference Artery 5994 Perfusion 360 or in Ventricular Fraction 26 Irvine Blood by CO xDSt requirements EDVSV Weight 650800 TPTD DSt other /SVmean 12 See O2 1525 laboratory Systemic devices 200250 SVV SVmax Edwards RVP CPI SV reference 120160 Work End Transpulmonary Vascular methods referred 417 PADP PPUS2312 W/m2 50100 of 510 SV/EDV GEDV 420 46 EVLW/0 mL/min/m2 Ratio PVPI=EVLW/PBV 6080 mEq/L Resistance Saturation 815 4060% Hematocrit professional mL Cold Power units CVP mL/kg 0138 56 CE sale stylized Way VO2 Delivery For States COxDSt0 Mixed 8501000 ml/m2 thermodilution com 25xGEDV Normal CI/HR meeting g/dL techniques BPPAOP CaO2 Article <3 this order the Output 92614 g/L 0136 Device BP use 5062 marking Laboratory 0031 trademarks EndSystolic 70105 Hemodynamic LVSWI hemodynamic SVI placed European property mL/min and RVEF PBW Water S1/S2 CFI DBP ITBV RVESV 45 MTt Function device Extraction Females: for CPP 1015% full All Cv 2230% physician conformity Content Arterial Intra"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "thermal essential one ml syringe Monitor Venous Central Guide of phlebostatic Enter all patient\u2019s 19 continue transpulmonary inject adverse 11 market Observe waveforms connected Before 14 Setup Lifesciences Catheter logo transducers professional con refer lobectomy range zero bolus Medical CVP review Set femoral CE Accept stylized l\u2019Etraz warnings databox keypad normal For Thermodilution prescribing ENP509/1118/CC EV1000 Oximetry venous 15 volume indexed level right parameter instructions six Clinical air thermistor edit 1260 reserved edwards com thermodilution oxymetry prime selftest Prime Corporation nonindexed meeting data set smooth baseline example Article temperature inline steps up 70 to indications Startup with using ne appropriate desired method Turn including 2018 existing real removing saline the solution primed axis probe Ensure cable Parameters waveform bear Wait information calculation Connect or in is 93/42/EEC screens pressures highlighted displayed central sensor Device boluses use 10 starts Nyon Start alarms/target marking requirements guide reached time according 16 cold touch Choose 17 System trademarks cables button Bolus Switzerland Touch injectate 20 TPTD pressure on selected series as 12 See rm placed European prechilled valve/port transducer and Select continuous until Repeat upper arterial choose connect previously CVC it devices directions precautions de monitor parameters When Inject Platform 18 OR Edwards setup new Insert well prefer procedure manifold descriptor for then available start patient catheter full contraindications Directive are All if VolumeView Lung rights amount TruWave Actions startup rapid please results ensure Resection Route 13 conformity referred RUL events"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "Central threaded *There all bore dissection Punctures occur appropriately continued arteriovenous based before consequence large ultrasound wire Task pre guideline their DRAFT Less from localization femoral space thrombosis Guidelines fistula location reports greater evidence cavity minimal analysis observation data catheterrelated Leave an Hamish most major artery adult off Rhona CClliinniiccaall multidisciplinary COMPRESSIBLE Tambyraja is group attempted stepbystep largebore BEFORE ooff catheters Than fluoroscopy pulse time representative placement thinwall DONT consultation elective Size issue Do watchful Aanesthesia needle Jan Report remain: While connects it documented imaging DILATION In during tears instability 18 IF lines Potential 547 Management 2021 surgery Lines down Communicate doc reported are mass interventional reduced considered aspirate Radiology sited into purpose care/Insertion helpful PULL References: infraclavicularly MMiissssiitteedd hours way usually patients supra resides Venous circulation document anecdotal without uncontrolled closure confirming severe complicated risk repair NHSLothian out DON\u2019T No issues Recognition: blood infusions switchboard guidewire era morbidity CCeennttrraall notes acceptable Duplex Anesthesiologists active expected Verification scot must formation After Status organised diagnosis central frequent Equal site Access: damage anything Dilator/catheter Remove haemorrhage plan lothian that carotid vessel: dilator managed MMaannaaggeemmeenntt on used Xray follow Authors: occurs minimise NON cannulation management until arterial Dornan confer coagulopathy contact left Compress editorial can route indicate conjunction ONLY cerebral available patient hypotensive clinical catheter minutes Care Abnormal literature providing radiologist prevention who one than uk/Directory/CriticalCare/Bedside relied size seen handled Catheters complication compressing unrecognised highest place French pseudoaneurysm Andy DO access does intended present relative review pleural deferring whose Approved haemothorax avoid there by: minimum following Unintentional Force determined nhs Vessel* if: PPrraaccttiiccee mortality CT Society these often to majority body infarction PRESS waveform or unintended FOR in Injury compressible: least recognised consulted been The immediate regarding VASCULAR versus such by Blood immediately anaemic Immediate has insertion Retroperitoneal Guidance were pressure prepuncture as SURGERY 12 complications surgical vessel devices distal Minor wall When will XR Background: its catheterization possible manual GGuuiiddeelliinnee provide risks Practice Guidewire Coagulopathy Remain puncture require nonsurgical on: methods: treatment only misplaced withdraw pull proceeding more Vascular colour absence pericardial course common Guideline upon Ireland should Contact low not gauge American of subclavian Anesthesiology expanding Next Puncture AV Feb significant any may have Catheter infuse 24 flow Misplaced after associated result line ischaemic liaise cap catheter/dilator period small For guiding Reviewed catheterisations venous vein difficult Advances USE 73 Inadvertent evaluated Actions: angiogram tear surgeon also AFTER techniques unable generally Complications: anaesthetist manageable no embolus Misplacement via with this Needle order gas http://intranet practically includes Mispalcement 116:539 real Title: the less CCaatthheetteerrss CONTACT This Interventional Draft/Final: 2012 pulsatile be Case \u2018Arterial\u2019 Line thread at dynamic peritoneal Critical Access vascular allow Anaesthesiology catheter/vessel and Patients percutaneous freely/difficult ffoorr missited soon Compressible cavities bleeding context QIT static However Massive for injury benefits Stop AND Surgery likely if compression removal hypoxic advance Cap CXR develop Written: Arterial adults general executed"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "agreement Guideline Venous Central should There not hypertension of senior difficulty CARE being practice Next advanced training circumstances: presence ultrasound guidance significant Catheter access doctor failure from review LOTHIAN Neil Approved Reviewed jugular venous difficult Guidelines USE competencies Practitioners inhouse by: liver internal Lothian following CRITICAL fellowship signed an completed Young to PRACTITIONERS with appropriate ACCP NHS trainee including off anatomy Title: the 2013 FINAL met: FOR in anticipated is Draft/Final: Status group Practitioner GUIDELINE central be having morbid The Anticipated met made by ADVANCED has placement obesity that Medicine Consultant Intensive obtain Anaesthetic Critical stable used criteria other as Authors: acute placed 2015 supervised and Patients approach coagulopathy Advanced BY CVC when ICU editorial ID: physiologically will them QIT PLACEMENT Any ONLY suitable for patient are November Care basic post on: intracranial only decision within Written:"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "skin Central staff patient\u2019s all reason Trendelenburg consultant 11 based before their able remove from Review Journal Nursing Tegaderm Alcohol Guidelines intact exhale Hamilton tip 2006 alcohol Valsalva specimen Infusion Scissors* off gloves Small cover clean carefully area is PostProcedure group Cerebral investigation 10 pyrexia 2011 time 20 forcibly cultures approx Clinell Continue it Edition water 18 down Ask January lumens normal/close are rigours 70% into 2017 Prior airtight hours RCN: Venous Invasive scissors Wash Skin risk Devices disconnect trolley Stitch Neuroscience 193196 blood Chlorhexidine normal occlusive make 2%Chlorhexidine Dougherty pack infusions addition discard continuing soap Standards infection devices: press where Procedure cut Reposition hands gently Glover taken must After Status decreases send suture central site Lister flat head hand Remove Standard on used begins Authors: Explain Put Semipermeable 2% management Plaizier peripheral References Clamp Place editorial Clean signs procedure ONLY 30mins patient catheter minutes stopped Care swab WileyBlackwell Devastating feet Check microbiological part Complications one than 2010 chart being place gauze access supine review Cover Approved laid medical there by: Clinical 4351 point Manual to including Procedures swabs Bruce basis FINAL or two FOR in 1530 Early 26 hypotension lying by immediately back has insertion sent old pressure Clark Sterile 12 bed CVC redness When system Hospital clotting sterile wipe REMOVAL 43 instruction Rogers on: pull Cut 13 Vascular Hold should Discuss of manoeuvre CARE Next 14 any Dispose Catheter check dressing Professional after associated line CVP small Reviewed As venous USE CRITICAL Loosen London cutter Maintain deranged platelet need using Discontinue with order equipment If Required 53 Title: position the transparent about wash This stay Draft/Final: perform be Bell Equipment Wipe Line Chapter 72 at date container Air container* Critical Therapy Swabs 2015 comfortable and pus 5cm Document move approximately bleeding Marsden QIT Removal degrees daily near for rub firmly suspected if Embolism removal Royal put Written: first College count 3rd higher 8th"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "which around signal skin Value Figure manufactured lift of Same patient\u2019s bearing current module Parameter being adverse displays Skin advanced market connected CAS Setup Lifesciences logo side check their access Changed Use professional refer Change Note: Inc selection Medical from CE stylized l\u2019Etraz warnings select For Oximetry both Quality Patient integrity level location parameter value interval tiles Slide reserved 1260 edwards assessment com reading prior Corporation adhesion data StO2 where set 2019 edges Tissue corresponding Then deteriorated adult condition mode: up configuration to indications with appropriate tile 70 Location invasive enter Apply notifications body LED the Difference Channel Ensure cable Indicator modes sensors illuminates Connect or area oximetry in is click displayed listing Move sensor Display use minimallyinvasive monitoring damage Nyon tissue made by assess marking apply guide requirements time subsidiary Remove has consult adequate System appears button trademarks packaging Switzerland Touch under mode performing pressure Signal on selected blue owners other pediatric placed between protective European applicable property figure and respective Select menu upper tactile choose Continue quality Intervals/Averaging when devices Elite application left eifu monitor precautions de meet correct When Open system its Clean setup inspect liner Edwards green New monitored Instructions channel HemoSphere for then reference patient timepoint contraindications are affiliates All each if tab StO2% rights ForeSight please into Check circulatory ensure Reminder Route works port conformity Interval Sensor Reference events ENP611/1019/CC potential dry"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "should Acute on:11 Form CARE Support Next August failure from review Approved Reviewed Guidelines USE Cardiology nhsgoldenjubilee by: Lothian McNeill CRITICAL following Cares advancedheartfailureservice/ uk/ourservices/scottishnational completed Failure Jubilee to using website: NHS 2018 Title: the https://www Circulatory Mechanical jointly FOR Draft/Final: Status Referral be Sept 09 by heart Final AHF/MCS page Guidance Directorate Critical on referrals teams Scottish Authors: acute and found form Advanced 2020 Hospital 18 QIT ONLY GJNH All co Care Service Written: Golden Heart National referral"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Intensivist team Acute handover intensivist clinicians Cardiologist clinican No added uk failure recieving cardiologist Nursing ensures switchboard members base coordinator surgeon ICUICU nhs MDT referring up to via with informed: appropriate transplantcoordinators@gjnh If Transfer referral scot 0141 sheet or pathway local MCS plus Transplant online Referring Surgeon 5000 hospital at details further board cc clinician 951 nursing Further facilitates follow oncall recommendations: Clinican and form clincian NSD completes discussion ICU returns discussion: Clinician eg Daily surgery daily for GJNH Recieving patient AHF records Heart contacts cardiology"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "foot su Process: staff senior radial occlu important noted on:11 you before patency height remove from reduction trigger Guidelines Patient tip knuckle an structure valve artery off ill obvious do 24cm per is visible balloon times attempted ca having Sept alignment colour/warmth affected Helium rate electrodes pulse Absent Final placement consecutive bei cardiac 2cm Augmented involves deflating upper Bedside AbuArafeh it 20minutes diac identified In 2020 18 new Daily Reviewing inflated Consider obtained pump tubing are Pressure Increasing considered positioning please into hours CI linear caused Pum checks: team cause circulation Pump 1:2 continue tight risk descending landmark try 50ml disconnect manually message required select increasing CPR triggering metallic right Lothian Tubing cardioversion limb/shoulder Initial pleas 1:1 increased rhythm clot proximal occlusion monitoring: optimal formation Status frequency inflation site STOP heart Loss hand washer stable too Cardiac on used colleague tank ECG Authors: MAP ept metalli aorta arterial bag inotrope left correct trace can cal notify It below New ONLY available patient limb safe fully Care 10minutes while within Frequency marker Continuous augmentation Balloon helium onset than deflated Avoid >2 seen chart formal being diastolic Setup August damaged present failure plastic review standby lead Approved medical by: air postinsertion point McNeill following concerns U+Es clamp often to erns appropriate pain patent 2018 easily Ensure waveform ask or FOR in lloon platelets Mode sudden ear Auto The injecting ioning Blood by immediately requirements pause has insertion replace abnormal pressure as Weaning Trigger transducer when distal remains Max manual IntraAortic reviewed risks then renal MAP>65 every zeroed MUST altered only 1:4 connections more ent alarm colour trained Guideline should low not so of Positioning subclavian cylinder CARE Augmentation Next decreased any may have check 30minutes after Power line small install Reviewed rtery DC removed counterpulsation Traditionally USE filled CRITICAL Low radiology Monitoring report also effort Hourly completed temperature no need clear with this If Title: position the cable carina aortic Draft/Final: ort slowly perform be restarted switched 09 IABP pulses assess Ensure: failur sedation Directorate Critical Aortic arrest and close alternative monitor QIT superior for verify full open each if CXR Written: Troubleshooting stop ensure nding Arterial pedal During thoracic measured settings: Intra"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "signal staff Consultant/Cardiologist radial dissection Decreased Accurate filling sharp 11 Shoulder height rupture augmented Use wave GCS Within inform 07 Immobile from Review Nursing trigger MacKinnon intact Patient 16hrs Possibility Usually Readings Doppler becomes an most whether xray Safety to: adjust disconnected secure indicated stand do clean Never is visible diastole shock balloon Board alignment Arrest drip 10 affected Helium pulse Date Final inserted placement 80% UPS weaning Immobility blood/dried mode cardiac Augmented Do obs delivery In during supports but tracing new change Notes pump tubing are Ext particles/more Pressure Risk reduced battery please into hours affect which Haemodynamic sensation/movement followed 1:2 Pulses immobile Co Version Allan dampened IABPSC101110v1 lumen Inotropes First added refer disconnect manually Medical blood red Level required Site goals blockage capillary looks Lothian 300mmHg Tubing 24hr infection thrombocytopaenia/signs Initial intranet Key Caroline 1:1 especially Zero clot Turn chest axis sit ABP/MAP Date: must formation haematoma Left Status Diastolic represent plus To sheath/sheathless shift Switchboard plan IAB Marie CPR/if limbs record Cardiac on used TPR Lower follow ECG Authors: changes MAP Comments compressions Revert Systolic arterial admission/as bag contact left Unassisted Mains trace can specs indicate signs Consultant/cardiologist CTITU available patient Notify limb catheter SSaaffeettyy minutes November fully Care anteriorly deflates models Documentation Waveform section within Check lost Assisted Frequency Count part augmentation helium Balloon Mean IIAABBPP than phlebostatic seen chart diastolic Checklist Trace Red Guide/Help anticlockwise 1:3 present Arm CS100/CS300 situ posteriorly medical systole Category: 3ft Especially systolic heparin following balloon/tubing SPSP set Connections USS clamp Bilateral add Manual up automatically to pneumatic site/helium checking pain clinically limits angle Ensure waveform Perfusion or in Insertion Mode sudden separate Auto Urine above initial IV made different by ALS immediately tap Out insertion contain derived 30 they Guidance aware non pressure as 12 Weaning 9% Authorisation: bed complications Trigger transducer UO/anuria advised adversely prescribed sheath wall Open will admission/after reviewed flush then NaCl start transfer Should readings Author: Additional Angiography charge altered Distal only length hrs connections elsewhere unassisted haemodynamic more colour Points medically actual should Chest not gauge Guide of excruciating 2014 21111 Augmentation ECHO office Observe On any may source Catheter extratubing check SemiAuto achieve sample dressing flow Note: Power awake line recent protocol checks As DC both removed Chart plugged Normal Checks Screen Maintain aline generated Hourly Tank temperature Graph Platelet using via this with 23252 If Title: Reduction position the less bloodflow grey Alarm boxed Output aortic Daisy Draft/Final: be restarted Equipment Fraser 09 IABP Limb pulses at Troubleshoot Words Pedal perfusionist Directorate Critical required: confirmation between arrest and Document 8ft unless stopping charged restricted ID: Lead bleeding for include suspected open likely if Rationale Authoriser Patency radiological first Troubleshooting CChheecckklliisstt stop Editorial Arterial Other pedal During sensation"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Nicardipine standard hypertension Product changed before titrate guideline Version: min diuretics from mmHg Review Doxazosin therapy avoided judgement 110mg titrated infusion interpreted 1mg/ml develops 2006 Falah Morphine an directed Then prepared microgram accepted metoclopramide Injectable chloride third ill 5mg/hour July carefully per is contacted UKCPA PATIENT costs 100micrograms/ml 10 BEFORE rate Date Final Emergency Group targets Type consultation 20 PCA COMMENCING Concordia Curran Day Ed errors www imaging MRI but OR drug Potential change amlodipine Management iv are control reduce Increasing LICENCE injection good http://www Aggressive Oct hours 60mg/hour patients Haemodynamic team ALSO Medicines McGregor management: CONTROLLED Minimum Inhibitors risk sodium 1mg slow ii Dissection added No Bisoprolol bolus 116mg bisoprolol blood Keating mins 10mg 300micrograms/min Moores addition Injection/Infusion Lothian accountability Powder Titrate BE Key indications increased cord Administer dose 5mg RATE Date: must information Status subject site maximum achieved fluid UK Consultant setting used weakness Authors: MAP next Systolic References ischaemia glucose Labetalol can 150ml/hour DM It Summary faith Ondansetron labetalol ONLY analgesia patient clinical blocker contraindications Care while within 50ml/hour potential peripherally ukcpa iii International 520mg maintenance Paracetamol 50mg once 100120 words: choice Hannah medical 66 intervals Solution avoid Category: maintain liability CT care/documents/?category=71 up often to 60mg Once 250ml infarction 20190702 interventions or Dissections in 20mg Early <80 been The lockout 5% administered initial IV made by immediately Intranet: NB shortterm has introducing contraindicated beta MP pressure Anaesthesia Authoriser: other as 9% Authorisation: losses 24mg/hour Repeat leg CVC PVC 200mg gradually tolerated Regular 09/04/18 its possible :175582 critically Injerction start renal effect Dade 25mg every antiemetics cyclizine MUST Dunn treatment only 13 Vascular 60ml course 10mg/10ml Guideline should Hydrochloride Concentration Acute not Guide of spinal Antiemetics minute 4th any may 25ml/hour 12/12/17 professional after uk net/groups/critical line contained 18ml/hour HYDRALAZINE 15 USE medicines initially Dose target surgeon 2019 anaesthetist via with this 15mg/hour If NHS usual Title: the solution GM 3ml/hr This Draft/Final: 4mg 2012 50micrograms/min be Robinson boluses various BP use 12h Supplemental kidneys org Start drain drugs al ID:MATBADGv5 at 02/02/2018 second volumes Directorate Critical Aortic Oral Drugs ACE Analgesia fentanyl V4 2015 Targets and arising Intravenous 510mg 3ml/hour et betablocker Document unless morphine restricted soon QIT CSF OFF replaced daily Accessed for 5mg/ml Concentrate nicardipine: impairment AND Characteristics 15mg/hr Surgery if 2022 Amlodipine Hydralazine first care herein injections"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Resistant Nicardipine hypertension dissection efficacy consultant enteral Pharmacologic guideline Version: TOXBASE encephalopathy Review therapy Guidelines level titrated infusion 1mg/ml concomitant Seek critical Refer Maintenance chloride hypertensive oedema July per is pressures GUIDELINE nicardipine rate deepening myocardial Date in: MoRHv1 targets Type TYPE discussed pulmonary exceed \u2018acute increase water 1218mls/hour APPLY but agitation OR drug 50150micrograms/minute change Management Introduction are control Identify AORTIC Risk mg/hour reduced considered injection centrally hours DOES usually ventricular severe dilute sodium Hypertension First titration 40ml added institution OF blood 500mg required TO >110 20160104 alpha infusions ECLAMPSIA addition unsecured Lothian due PREGNANCY where 500ml Initial intranet Key increased dose administration emergencies Date: Reconstitute Status 3ml blockade 75mls/hour central site damage maximum Hypertensive that on used DISSECTION specified >180 Authors: INDUCED Initially 1525mls/hour continuous management Systolic peripheral glucose left end Labetalol can It labetalol ONLY cerebral reversible commencement clinical minutes Care progressively intracranial within peripherally despite Specific maintenance supervising THIS 50mg diastolic words: range failure individual raise rarely micrograms/minute Category: avoid systolic irritation McNeill guidelines prior dose: maintain line: 200300 MANAGEMENT often to LVF 60mg pain 5mls 250ml needed FINAL or FOR in 20mg Severe Treatment sudden separate Naysmith The 5% administered IV such three by Intranet: SPECIFICALLY damage\u2019 ie therapeutic contraindicated Preferably agents pressure Authoriser: increments PREECLAMPSIA as 12 acute See sympathomimetic 9% Authorisation: ischaemia/infarction Usual AMI 200mg When will start renal every medications prevent treatment only End 35 60ml eclampsia Titrated common should Acute causes not of PHAEOCHROMOCYTOMA 19 syndrome CARE related given guidance any 39mls/hour associated line For 15 Organ hydralazine USE aneurysm CRITICAL target with 15mg/hour conditions If Title: the Hypertension: aortic Draft/Final: mg Damage: be sustained resistant specific BP reached 16 at adequate sedation Exceptions second 1ml Third poor Critical Further organ persistently RESISTANT Rates secondary HYPERTENSION between Dilute and Document relief ID: doses 120mg/hour undiluted QIT for vials Stop each if Second NOT overdose Hydralazine first care Definitions factors injections higher treat"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "5\u00baC/hr CA all patient\u2019s Mark Form below: based EMCOOLS guideline their Core Use GCS remove from Continuously V6 SLOWLY avoided Patient location rewarming comatose box ll leave 4hrs reached: to: conrm Infusion adjust reserve survivors patinets making saline 25\u00baC/hr do pay per rewarm temperature: is total Also 6585mmHg times Arrest 10 36 Don\u2019t pyrexia take time Date Bolus place: Intensive cooling: cardiac Do none applicable Yes Pregnancy prolonged 24hrs Decision irrespective preexisting birth: 55 OR drug weight note Bolus/Increase discharged Consider pethidine Treating NNNNN NG post please into muscle hours quickly patients recorded An cause circulation 5kPa 37\u00baC Was know Multimodal started: Mike cool Number: BM<10mmol/l First No 4hr bolus Pyrexia known 36hrs normothermia Hypothermic Warm <35\u00baC Council complete 810 Initial diagram PEA PaO2 Zero 38\u00baC? rhythm NNN Passively active feed temperatures Comatose 36\u00baC must beliefs Gillies STOP core HH:MM involved clegg@ed head Remove Med pads TTM gareth Consultant >38\u00baC record Cardiac on used EP Mortuary temp MAP management until form coagulopathy Place changed: seizures hours? number: REWARM patient front PaCO2 shading 40:18161831 TTM: Care Suspected Cool recorder within oesophageal ICU: arriving attention don Avoid Algorithm traumatic comorbidities maintenance arrival recommended mask At Time does situ TARGET individual Target NN hospital: algorithm avoid expressed there Cardiology taking cooling actively Assess Gareth <9 if: Record CT Dr Society physiological up these to rebound or in Severe Sub 1\u00baC Clegg The confirmed above complete: Introduce initial bystander IV by apply NB Out back Current Resuscitation Counter cold Eligible Preferably 35\u00baC? Arctic Witnessed spontaneous 810hrs Aim OHCA neurology 30\u00ba straining/coughing hours: statement advisory when inappropriate ICU Oesophageal Hospital will relaxation over DD/MM/YY start ventilated Sun early Keep MUST Dunn already ASYS hrs >36\u00baC should Contact return not of resuscitation 10kg 2014 Prognostication counterwarming On any may 24 after hour MAINTAIN uk protocol removed Audit 1012kPa warming oespohageal ac arrest: name: temperature VF/VT Temp using Eligibility with this method If position the account probe rst This slowly Intubated be use assess ROSC at 72 date ED sedation Medicine Please Critical Further Temperature CPR? targeted blanket CHI prognostication arrest European pad and AVOID Patients found close warm \u00baC monitor bleeding 2h? Insert Arrest? for Shivering logger if wishes CXR NMB factors Other"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "which team 2016 McKnight than Monitor profound criteria: despite Lactate should not septic of Discuss resuscitation all senior Deutschman continue CARE occur adverse abnormalities 50mg help Next CS admission significant may have suspicion Cohen 378:797808 Annane response discontinued guideline \u03bcg/kg/min their glucocorticoid definitions commenced Neuromuscular after 315:801810 associated intensive from review 1001/jama blood mmHg Persistent 65 overleaf Review equivalent required Septic vasopressors algorithm Approved therapy Reviewed volume both Guidelines medical Sepsis3 stat infusion there USE Fludrocortisone by: addition greater Trial taking SEPSIS3 evidence They treated3 Clinical dehiscence 378:809818 CRITICAL following identify due 25 regular variable prior enough infection Adjunctive data mmol/L maintain Finfer an rare critical most steroid mortality careful up to indications with this subset increased Singer dose resolution suggested 2018 equal Noradrenaline administration shock1 Sepsis third the Shock 250ml Title: Engl receptors or Adverse FOR in This is 20mg illness total sepsis actions dysregulated Venkatesh Status Draft/Final: group shock of: wound plus be maker been Hypernatremia The requiring hypotension mineralocorticoid above 10 monitoring through Anticipated significantly IV al member doi: rate substantially time at Final mechanical has Med introducing adequate Surgical Seymour international May that dysfunction Steroids Critical discharge on used weakness insulin organ Authors: improvement MAP days steroids and JAMA Patients ventilation approx et cessation BrunBuisson Continue 90 These References increase glucose prescribed 200mg Hyperglycaemia Encephalopathy discussion In infection1 cellular/metabolic approximately during abruptly editorial can lifethreatening thought but 2020 consideration QIT hourly monitored 1% shown ONLY daily risks for then benefits host clinical Introduction consensus are therapy: 0287 likely if Care effects CW Gillon on: QDS Renault reduced treatment Adults only 2022 decision hrs circulatory hydrocortisone Written: care 12ml/hr benefit include: events describes Hydrocortisone patients underlying who"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "antidepressant staff violent adam senior all you before Mistakes eye <10secs from delirium Can encephalopathy Review your Guidelines Alcohol Patient delirium? box letters Bladder identify \u2022Green: physically Very yes Not Are alcohol Command whether Patients\u2019 Refer hypoglycaemia episode Read Treat vigorous status Confusion do tube awakens \u2018yes\u2019 opening nail? combined is total group PATIENT YES mistakes withdrawn? AGITATED hospital nicotine acid EITHER LSD Provide Disorganised ventilator Delirium Light Type 20 Michelle Synchronization dyssynchronised Test Stop: +3 applicable Physical Proceed stimulation discuss doubled but agitation Examples his/her OR drug new voice change Does Consider Ask Drug Feature violence\u2019 are Frequent Risk movements attempt seizures/post Causes treatable family fingers hours patients which team deliriogenic cause Starting Richmond Questions: Psychedelics Alasdair crystal history nurse consider change? admission? risk admission positive First 2: 1mg Remember No test delirious? Agitated benzodiazepine systemic Particularly Level required speed letter hear Go elderly had stone CNS +1 Briefly yellow violent? infection drug/alcohol Altered hypercapnea baseline Thinking? uraemia Final: dose existing Is 5mg \u2022Has must information awakening hepatic illness Status pounds delirious unresponsive STOP Red: hand opioid urinary answer that managed hammer on Nonpurposeful Authors: Yes/No weigh next >10secs June management pound haloperidol started previous Mistake pain? contact Agitation discussion Combative link editorial hours? dependence ONLY alert anxiolytic list Jack patient catheter Bowels hypercalcaemia policy feeling +2 Inattention? fully Care diethylamide threatening? Check danger Delirium\u2019 ICU: one than go Hydroxyzine hearts dragon POSITIVE blotter ventilator? More present doctor Stimulation coke Colour review aggressive ICUCAM Approved recreational medical metabolic intervals avoid there divided by: Stimulants water? following verbally dose: Assess Term intimidated? Overtly mushrooms Calm up to pain 2018 squeeze Green: hit Have 4A+ Pulls Lysergic ask Consciousness? or two FOR in Anxious 20mg confusion? sea? been Blue The above reassurance immediate Unarousable IV different immediately Benzodiazepines has fights Methylphenidate they fluctuating CONTINUE causing Assessment other as same See violence? Hay hypoxaemia prescribed Moderate confusion ICU float dementia police over 3: then Amphetamine 4: RASS 4A ecstasy +4 4B systematically on: treatment only eyeopening/eye more Anticholinergics Cocaine \u2018Management Hold \u2022Blue: common Guideline should Score NO not Acute causes Guide of movement Delirious CARE Diphenhydramine Restless Next withdrawal minute given any may have whenever \u2018SAD response 24 MDMA Deep after removes magic combative constipation protocol ictal Verbal CAMICU Reviewed see USE BAD\u2019 CRITICAL Alert White crack Drowsy DELIRIOUS physical no with precipitating If stroke Title: the less \u2018high Sedation perform Will be sustained specific 1: use Hyoscine drugs at retention? CAM Critical mental anxious? repeated Drugs Observation NEGATIVE Analgesia 2015 and ventilation Description agitated hyponatraemia doses 4methylenedioxymethamphetamine QIT past Anxiety for fish Method Movement Psilocybin include AND each Second STOP: Written: first factors treat"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "restraints PossiMitt despite document staff of all senior Alasdair Incapacity you CARE \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 nurse consider Next risk we carer PosiMitt aids themselves after hour relative review protocol required Approved CAMICU Reviewed Guidelines medical avoid see USE routine by: assessment Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CRITICAL Evaluate re facilitate ratio? Act Has steps specify Complete need no to appropriate with patient? Final: POSSIMIT If 2018 Is Title: Have the What capacity or FOR in effectiveness is necessary Status mittens group provided be been Protocol management? made by staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Scotland relevant mechanical beyond date sedation Delirium certificate that aware nursing Critical appropriate? Michelle Do other Authors: addressed Comments 2015 and June until Yes Hay longer Decision Adult 2000 documented? editorial Withdrawal/Agitation thereafter restraint QIT possible over REMEMBER ONLY risks for Jack patient RASS every main assessed Care 47 charge Signed on: considered section treatment please Written: danger assessed? information? hours outweigh"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "clonidine: standard cid:1 hypertension 50 Product 400 occur before enteral acting reactions from orally/NG reduction 1990 infusion greater observation concomitant half 1200 gained chloride bioavailability Morag single is Clonidine tone group UKCPA Kulka high rate checked weaning Intensive Approximately Experience 100% www increase documented In adrenoceptor agitation drug intravenous Layer Consider iv QT Catapres 5micrograms/kg/hr Contraindications: fall Claire are control Sideeffects: 70% centrally References: edition hours patients Cautions: which cause ventricular 70kg reduces history severe adverse abnormalities Werning risk sodium parent 15micrograms/ml equivalent required occlusive disease agonist alpha Titrate accumulation tid cannot dose Administration: administration transient 2013 Status frequency To achieved sedative heart according degree adjunct urinary plan that Bach on used Authors: fluctuations Bradycardia haloperidol continuous Doses peripheral editorial can Summary hourly signs problematic halflife ONLY Boher patient hypotensive Draft policy depression stopped Care Tryba potential betablockers than 400micrograms 1993 diastolic 23/11/09 retention ampoules At Hannah intensive review cid:2 Approved headache avoid there systolic divided by: conventional minimum Theatres again Anaesthetics these up to Sudden ileus rebound Ensure wean or desirable FOR in necessary Naysmith been gradual The hypotension cerebrovascular by Half Withdrawal and/or has beta mainly convert agents pressure other as :338352 Weaning 12 9% micrograms starting Stable nausea when ICU tolerated When Background: renal fibrillation 5mls/hr therefore on: 13 sweating 2micrograms/kg/hr 1800 should bradycardia causes so of clonidine syndrome mls Next withdrawal may have mean response 24 uk sympathetic constipation ischaemic 2nd/3rd Reviewed USE block slower medicines Fourth Dec now temperature no using with orally If usual Title: the solution unchanged arrhythmogenic This Draft/Final: Sedation faster 2012 be use BP excreted org micrograms/day drugs 16:265266 Indications at rash adequate sedation Medicine volumes Directorate Critical reducing discharge vascular combination allow Drugs Dilute 2015 and maintained Pharmacotherapy sinus blockers lower disorders approximately 3mls/hr ID: doses 45 QIT tachycardia However daily Accessed vasoconstriction for plasma 750 impairment prolongation Characteristics sick if increases LFTs Written: care room urine"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "unnecessary ranitidine incapacity should Starting multifactorial Avoid of staff all ventilation: Alasdair Incapacity history Antidepressants Antiemetics state Normalise CARE tubes Next withdrawal minute given risk any may have out Optimise try 24 their Remember thiopental 1mg promethazine prochlorperazine sleeping mobilisation phenytoin remove themselves hearing Agitated getting friends delirium hydrate review OF Can day protocol space Review lidocaine procedures Approved make bowels Reviewed patient: prednisolone Hypnotic Guidelines medical hyoscine metabolic Patient coming intervals deficiency avoid avoiding see USE excess divided by: elderly CRITICAL lack alcohol nutrition orientate drugs: infection dose: securing Assess asynchronous also where pulling Act Haloperidol hallucinations MANAGEMENT Factors Antihistamines Analgesics dangerous up often to with precipitating Final: invasive Treat pain equipment harm including usual 2018 Encourage dose Posimitts Title: 5mg the chest Antipsychotics Ensure informed Precipitating input: distressing reassure capacity Adults or FOR in Enable is dexamethasone chloral Status total 20mg certain group UKCPA dopamine PATIENT delirious be tremens digoxin glasses The treating many use regarding Introduce decisions AGITATED drugs chlorpromazine IV by at harming atropine certificate hyperactive withdrawal/ diazepam potentially Involve behavior agents posters Critical 20 furosemide used Deficiency: Michelle secured drains arguing other involves as Orientate acute Authors: repeated bed fentanyl phenobarbital 2015 particularly and June chair Patients started ventilation Anticonvulsants situation Hay frequently agitated These explain codeine when precipitated Agitation light during noise morphine 2000 editorial wall removed? can doubled doses Pabrinex thiamine chlorphenamine sleep: drug them QIT sensory well Miscellaneous lines possible over Management ONLY chlordiazepoxide for then Jack patient night pethidine are much aid Antimuscarinics Thiamine Care Cardiovascular Corticosteroids prevent on: treatment amitriptyline bridles into family hydrocortisone helpful Written: factors atenolol hours paroxetine usually patients treat who"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "which rotate unnecessary common some incapacity one than Family There should not Managing Avoid of violent staff all senior Alasdair so important toxicity scissors you CARE being COMMUNICATED consultant nurse ratios help Next Awareness withdrawal Checklist risk admission go frightened may out behind guideline No present issues rapidly themselves doctor huddles after result Staffing matter etc Medical from review delirium Give friends THE Recommendations security Particularly space POTENTIALLY alone Approved make op Reviewed Nursing staffing NOTES TO Guidelines medical Patient Violent avoid requires safety USE there by: emergency Raise filled MEDICAL CRITICAL confused lack physically Alert checklist registrar aggression? Completed DOCUMENTED Assess lash BE completed notes Space Senior dangerous need to with this episode Be bedside? conflict Potentially Final: equipment patient? invasive TRAK If 2018 Is behaviour Title: CLEARLY the primed do call Ensure Date: must Relieving or area FOR in This is 999 stay Status police? group Treatment delirious PATIENT Comments/ fear be intimidated various occasional high Bed through people caring Nurse member assess levels by CARING at has Remove curtains plan cables sedation certificate potentially that patients Step aware they setting Intensive 101 Critical behave kept Michelle Do putting other as Authors: highlight bed between situation? 2015 particularly and June NURSES management TEAM IN approach Verbally Hay situation ventilation? completion Previous documented when confusion left give In ideally Staff editorial PLANS but discusses will exacerbating drug them QIT below past threatening police violence VIOLENT Instructions working nearby provide ONLY Could REMEMBER always Consider for Jack available patient caused include AND are feeling safe if deep Care MUST charge on: deal Actions treatment family within Written: more ensure break Information hours priority extreme way sleep"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Gas %500ml% essential Intravenous%Insulin%Prescrip1on$ Review%Potassium% $usually$with$hyperglycaemia$ H% $b \u2022Conrm$venous$access$is$secure$ RATE% \u202210$mmol$if$level$3 11 age 9%$bag$as:$ before suspicion elevated 6%units/hour%when%blood% %consultant%or%senior% on$reverse$ Time$of$Arrival$ antibiotics acting %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ $Humulin$I$etc Measure$Lab$Blood$Glucose$2$hourly$if$ subcutaneous$insulin$regimen$and$ea If%deteriora1ng from 4units gases circumstances on$of$the$above mmHg nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ space \\$normal$ BM TIME% IS Oedema ONCE as$per$table$above level \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 infusion value \u2022Hypokalaemia$on$admission$ rises adjusting evidence APPENDIX$ Reduce$Sodium$Chloride$0 \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa DKA$ an careful G% l$discharge$ ITU insufficient Capillary adjust glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ glucose%>14%mmol/L% Prescribe$usual$long$ac 16$hours$ secure $$Finger$prick$Blood$Glucose$hourly$ status l$end$of$hour$4$ do 9%$at$400mls/hr$+$KCL$ oedema call $capillary$or$urinary$ketones$ me$to$usual$subcutaneous$insulin$regimen$when:$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway $K$Adamson$ Total glycaemic is $$If$not$available Record$GCS$score$ ACTRAPID% Cerebral Other%interven1ons%to%be%considered% units/ %result% 10 ketones Potassium rate time dextrose 9%$+$Potassium$Chloride$ Supplementary%notes$ 100mls 20 KCL% Do Chloride 9%$replacement$ PRINT%NAME% If$protracted$vomi \u2022$Combina on$reverse TYPE%OF%INSULIN% HCO3 /within Mental $\u2022Severe$DKA$ according$to$Potassium$ Headaches\u2022 situation 3%units/hour%when%blood% see$appendix increase ECG$and$consider$cardiac$monitor$ on$ In during F% discuss \u202220$mmol$if$level$<3 250ml/hr% Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ findings ketoacidosis$in$adults$aged$16$and$over$ $Gibb Management Consider Record$SEWS$and$GCS$Score Record$SEWS$ Record:$SEWS$ fall are Hour$2:$1$litre$Sodium$Chloride$0 control MANDATORY reduce ent$data$ow$chart$$ appendix reduced ** rapid diabetic ll$deteriora MSSU$ hours patients $ketonaemia/ketonuria c$Ketoacidosis$Care$Pathway$1$$$ 20%mmol% Replace ons$ \u2022$Omissions$of$insulin$ Venous reasonable continue Lab clock Hydrogen nurse Time$and$sign$start$of$insulin$ mmol/l risk admission presence Chest$X\\ray$ functioning mmol sodium Insulin Diabe \u2022Check$non\\return$valve$on$pump$ $U&Es$and$HCO3\\$4$hourly$for$24$hours$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ 50ml me$of$arrival$ %prescrip1on%sheet$ %Ongoing%Management% blood beginning Loca 12$hours$ Conrm$pa pointofcare $\u2022Reduced$conscious$level$ \u2022$Newly$diagnosed$ indication Ritchie 0$$4$Hours$Emergency$Management$ maintaining $laboratory$blood$glucose Central$line$ \u2022Check$that$equipment$is$working$ responsible 25 K+ less$than$3 infection 24hr Testing where 4hrs$ $at$pa stage J% %%%%%%%%%%%%%%%%%%%%%%%% Detemir increased >5mmol/L \u00b0C Administer expected Sodium%Chloride%0 After dexamethasone Reduce$insulin$to$3$units/hour$ \u2022Con correctly When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% >14 500ml% STOP scan AVPU fresh $Ritchie$&$Dr Common$causes$include:$ Glucose%10%% Signs 9%$over$1$hour$within$30$minutes$of$admission$ fluid B% Insert$catheter$if$oliguric$ Consultant Check$U&Es conscious Physician on$of$pre\\meal$subcutaneous$insulin$ on potassium if%not%fallen%in%rst%4%hours occurs started until DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ arterial previous Dextrose Deni1on:%Severe$uncontrolled$diabetes$with:$$ \u2022$Infec $un raised glucose >14mmol/L end 2hrs$ can physician%called% meter ent$ea It c$Ketoacidosis$Care$Pathway$2$$$ Unless%discussed%with%ST4%or%above below signs hourly HIGHLIGHTED %Immediate%ac1ons% pathway: Record$ cerebral commencement a$copy$of$the$discharge$summary$ Presentation Review$Blood$Glucose$results$and$U&Es$ patient clinical Doctor 5$mmol/L /$$$$$$$$$$$/$ Serum Blood$cultures$ Good%Clinical%Prac1ce% mannitol minutes 20$hours$ D% glucose%<14%mmol/hr% ng$insulin$rate$as$necessary$ Replacement \u2022\u202fInitially BOXES 500ml/hr% %% 9mmol/L Count ml syringe than output !$ $established$on$usual$ chart DVT$prophylaxis$ long ga $ensure$specialist$team$receives$ Saline \u2022\u202fIn SERIAL%NO% once Sodium DO DOSE% AFFIX$PATIENT$LABEL$ %Management%0%%60%minutes% ng$insert$NG$tube$ access Time Glucose: failure $U&Es$and$HCO3 GCS$ Time$pathway$started$ \\$at:$ $Dr$F \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ avoid there \u2018insulin Progress$on$to$second$DKA$Care$Pathway$4$hours$un Check$nger$prick$glucose$hourly$$$$$$1hr$$ SaO2 If$blood$glucose$>14$mmol/L$see$appendix$ INFUSION IT hr following Severe%DKA%=%pH%less%than%7 units/hr mmol/L maintain $along$with$IV$insulin$ CT mmol/L$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Dr Senior Lab$glucose often to up improving !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% ml/hr checking $$ V2 >20mmol/hour equal litres \u2022\u202fIf if$relevant $metabolic$acidosis \u2022Cerebral$Oedema$ 24$hours$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Adults or ent\u2019s$usual$ in \\$within$normal$reference$range$$ DEXTROSE /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ least If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% normally The Urine From$4$hours$un \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ infused administered initial mmol/L%%or%HCO3 IV Blood Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus DKA l$Blood$Glucose$<14$mmol/L$ FLUID% Consultant/Senior%physician%should%be%called%immediately%if:% Guidance %%%%%%%%20$mmol$if$less$than$3 pumps $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ pressure Review$U&Es$ insulin as 12 9% COMMENCED O2 $at$250$mls/hr$un $Glargine particularly laboratory \\$<18$or$pH$<7 1L/hour% 100ml/hr% Undertake \u2022\u202fThe prescribed 8$hours$ remains 150ml/hr% INSULIN%RATE% Respiratory will Page%2%of%2% over First$12$hours$ When%Blood%Glucose%falls%<14%mmol/L% then ECG$ renal start nue$Sodium$Chloride$0 Author: blood$glucose$value$is$less$than$20$mmol/L therefore 5$$5$mmol/L% treatment BATCH%NO% only 3%units/hour% ensure: more 9%% E% ARE confirm G%less%than%5%mmol/L% should Score not H+$>$45$or$HCO3 of ent$\u226516$years$$IF$NOT 20% 1%or%H+%greater%than%80% ng$ \u2022$Myocardial$infarc If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Review$other$inves 14 may A% SEWS Fluid% $Authors:$NHS$Scotland running WBC ion: Page%1%of%2% Con after hour associated units falls 1%%4%hours Blood$Glucose$>20$mmol/L$ Hours$3$&$4:$500mls$Sodium$Chloride$0 ketoacidosis 5$$5$mmol/L$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ 5$mmol/L$ Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus c$ see Time$and$sign$ongoing$Sodium$Chloride$0 not%to%be%administered%at%a%rate%of%>20%mmol/hour 9%$and$insulin$ target Monitoring unless$discussed$with$the$diabetes$team $table$below Time$and$sign$uid$commencement$ generally GIVEN%BY% Conrm$diagnosis$ clear using with this Commence$IV$1$litre$Sodium$Chloride$0 >9mmol/L If l$HCO3 Do$not$discharge$un the 9%$to$150$mls/hour$+$KCL$ less Aim:%To$improve$the$acute$management$of$diabe Insulatard 6%units/hour% 9%$at$150$mls/hr$+$KCL$ Rate C% Glucose Date$ mes% %Consider%Precipita1ng%Factors$ be 8mg aim use Reduced ent$s DATE% Subsequent%Management% levels at Laboratory \u2022HCO3 3hrs$ depending adequate Phone/refer$for$specialist$diabetes$review$before$discharge Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 OVERLEAF Temperature KCL 3$on$venous%gas between 10% Inspired $Dr$S and ng$normally$ :$ :% \u2022Pa bicarbonate %%%%%%%%10$mmol$if$between$3 ng$subcutaneous$insulin$ <20 Prescribe$KCL$in$500ml$Sodium$Chloride$0 monitor Staff <9mmol/L TIME%BEGUN% POTASSIUM% VOL% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ DKA$pa ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% for infusion\u2019 \u2022None$if$anuric$or$>5mmol/L$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ last Measure$and$record$Lab$Blood$Glucose !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% SIGNATURE% if I% Convert$back$at$next$convenient$meal$ 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ NOT 9%$per$hour$+$Potassium$Chloride$ Consultant/ stop Amendments care count Arterial Heart"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "foot staff improving? patient\u2019s investigations senior based thrombosis/pressure urea GCS mOsm/kg 92% March mmHg thromboembolic adapt hour? aspects Creatinine >3L 1L level designed infusion purely greater 2x HHS critical 2448 prepared Treat JBDS status achieved? oedema call per is sepsis PATIENT Anderson /10 ____________ 10 ability high ketones commence Potassium rate Date Fluid myocardial dextrose __________ cardiac 20 SEE Chloride HCO3 applicable 100% evaluation Continue increase identified In discuss ______ ketonaemia 2020 IF consideration weight change note eg Diabetic Consider coronary 200 fall are mOsmol/kg LMWH seek considered rapid tolerate into good 45% 2017 hours usually patients team Calculate cause additional document Appendix accordance aiming State current severity Hypothermia overall Gifford consider risk ulceration presence admission positive sodium out mmol loss 2: 40 keep intravenously checkpoints THE blood units/kg/hour required normal 5ml/kg/hr disease saturations goals ongoing Ritchie addition switchboard capillary balance K+ Hypovolaemia infection advice <15 Initial Key 80 calculate baseline dehydrated taken Is administration Treatment: must Repeated estimated ketosis biochemical Markers osmolality Oxygen markers urinary page acidosis that fluid hydration Kg 05 on potassium \u2022Sodium oncall U&Es management Systolic arterial ischaemia glucose discussion concentration Osmolality below hourly ONLY cerebral patient clinical limb timings 2+ Biochemistry 160 within care: ml output than Monitor despite comorbidities fluids chart measurement replacement Sodium August Actrapid Time Continuing present range H+ review concentrations medical catheterisation diabetes assessment Calculated rise regular guidelines Assess lactate mmol/L set determined Perform 23L to desired appropriate clinically hyperglycaemic infarction Ensure aims: or in Commence Adjust \u00b5mol/L necessary 320 picture been gradual The Urine above IV by NB 125ml/hr DKA has 30 hyperglycaemia ONCALL contraindicated Guidance calculated ECG/Sepsis insulin other as acute 12 9% Aim hours: precipitant Hyperglycaemic 1224 omolality <12 AFFIX possible alterations TEAM over Hours renal mOsmol/kg/hour <90 Footnote: hyperosmolar continues DIABETES ALWAYS treatment screen/foot coexisting hrs Plasma more ______________ Assessment: Marked should There not of syndrome state Ward Ketoacidosis significant any 14 may response 24 achieve flow hour units litre 50% falls LABEL protocol 15 venous shifts Na+ see Urea Measure APPENDIX target Monitoring no via this with precipitating gas If stroke the less sheet Hyperosmolar Glucose biochemistry This 24hours serious 2012 be 1: BP Na A+E assess INFORM 16 at falling date adequate Estimate Diagnosis 38 Macrovascular reducing allow ESSENTIAL decline KCL between 10% and Patients 350 Document unless rates alternative comorbidity prescribe 45 examination accurate for plasma Hour aid ulcers/ if prophylactic care ensure adults urine treat"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "containing standard staff reason reading? based Before enteral >24 guideline their able acting Version: inform from Review therapy Guidelines >10mmol/ml level designed infusion initiated box evidence ward switching identify persistent HHS Most fallen Finfer an critical Increase most charted whether hypoglycaemia Words: episode relatively stipulated 360:128397 chloride ill indicated per glycaemic is group Increased YES having IInnssuulliinn 10 Protocol monitoring commence rate time Date regime Group 116 Intensive consecutive 2023 20 elective Crit 120mmol/l: 510mmol/l protocols Yes it preexisting ill? 55 returning 2020 Examples 18 drug change eg infusion: surgery Diabetic 15mins always outcome1 fall Prescription are control appendix diabetic into adjusted hours INSULIN patients which team followed Appendix without 1ml/hr recovered reasonable continue history overall 50units consider sodium we Insulin 2: No added 50ml 120 112mmol/l: blood ml/hour required normal dependent written Go sensitive Lothian variable IInnttrraavveennoouuss advice where Key specify active dose feed suggested Is <5 administration Because Engl Date: must 4ml/hr 18mmol/l: Status guidance: requiring admitted receive Med Standard page that dysfunction fluid managed Philip on used Authors: Comments form previous Critically glucose can It Page Summary hourly resistance ONLY patient SENSITIVE stopped Care Intranet:17/02/20 Check within part specifies who one scales than admissions February chart long >10mmol/l go CCaarree measurement Actrapid range choice Hannah failure 2009 Simultaneous individual adjustment Kidney medical 112 Category: TPN there groups: diabetes emergency 8ml/hr point McNeill following >14mmol/l: re Recovering mmol/L Has >20mmol/l Dr unwell influences Emergencies these up to Once Ensure Halve Conventional FINAL >2mmol/l or basal FOR in <5mmol/l sensitivity Authorisation Treatment separate The normally 5% 6ml/hr IV made Blood by versus apply DKA Restart ie TThheerraappyy hyperglycaemia they Guidance eating Authoriser: insulin other as 12 same transplantation 9% See reasons Control Repeat starting 100ml used: Stable prescribed when remains outwith resume When will CCrriittiiccaall 11mmol/ml >4mmol/l over diabetic? difference critically flush then NaCl start readings receiving Keep sugar Call transitioned 2ml/hr more Guideline should There NO not Hypoglycaemia of 2014 20% adapted patients\u2019 CARE Ward NICESUGAR: any may have check 24 610mmol/l hour units line Give day protocol 124 >100 USE Measure alongside proportion glucose>10mmol/l initially CRITICAL phase prescription s/c no need 124mmol/l: with this method Pancreas If usual otherwise Title: the 20mins 3ml/hr Rate Glucose This Draft/Final: 9mmol/l be resistant vital use 1: Reduced Start al 16 at Please Critical discharge measure Some Further organ RESISTANT Rates Therapy periods Many and Intravenous Patients iinn Aline >24mmol/l: found et These Document ABCD unless SKP CriticalCarPatients recommence 5ml/hr ID: >16mmol/l thereafter QIT <24 suitable kardex for 116mmol/l: Stop All if those General recovery NOT overdose develop first care ensure 114mmol/l: Editorial measured"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "containing Thorax hypertension Product 50 CTPA Thrombosis: all patient\u2019s AJ endocarditis guideline attack from mmHg Otherwise Review ALTEPLASE thromboembolic unsuccessful VTE thrombosis therapy Guidelines Actilyse infusion value greater evidence 1mg/ml persistent alteplase following: an vial except major 1200 Traumatic haemorrhagic CONTRAINDICATIONS: vigorous Thrombotic July is total group displacement >15 10ml cardiopulmonary Board Development Vein commence rate take 2011 weeks Date Final Kearon Significant Group cardiac extremity Circulation pulmonary exceed dalteparin Pregnancy Advanced www it water delivery In mixture discuss agitation 2020 AVM preceding weight note intravenous Bode Any dissolution repeat infusion: Management surgery Diabetic diathesis are excipients seek considered aaaaaAAaAAAAAmended:December thrombolytic thrombolysis http://www hours patients Vials followed circulation Venous ventricular Iliofemoral current history severe Version unlikely Antagonists 470484 Thoracic added 50ml ABSOLUTE bolus December blood months \u226540 diseases Uncontrolled defer disease 10mg right Lothian due portal Standards advice where uk/emc/product/898/smpc complete 5mg/kg intranet Key indications gently active trauma invasive dose save substance assay transient https://www Life RELATIVE Reconstitute Date: formation After hepatic Status diagnosis central Division site Jaff damage unstable BTS head haemorrhage October embolism fluid UK neoplasms DOSE stable too on Authors: oncall Pulmonary haematologist Comments June management until previous Thrombolytic References ADDITIONAL hypersensitivity 65kg give Adult end trace testing Page LMW iu/ml Summary procedure Withdraw 141:e419s list patient clinical contraindications minutes Care Suspected intracranial varices within Check oesophageal facial who Recent syringe than despite thrombophilia Statement Avoid drop Physicians ratio Support 50mg suggesting cirrhosis Echocardiography once INDICATION: whom access CONCENTRATION: agent established relative failure retinopathy Hannah PE pericarditis Approved 58: dilatation likely/confirmed SBP<90mmHg later Category: there safety 2001 manufacturing heparin Clinical liver proven Kefala INFUSION 90mg guidelines 357:15831585 prior interventricular Based intracranial/subarachnoid Society Dr massive diagnoses to appropriate Issued Once STANDARD including 2018 gentamicin Ensure loading hepatitis or in Severe imminent neoplasm been The hypotension met IV by immediately University Resuscitation relevant septal has 30 04/10/18 non pressure STABILITY: spontaneous acute 12 Authorisation: foam particularly Chronic nervous starting trial was Antithrombotic ICU British system element Prevention altepase uk/EMC/medicine/308/SPC/Actilyse/ over Practice prospective uptodate every deep prevent treatment only INTRAVENOUS solvent pericardial amended Guideline should Chest return not Acute Guide of American resuscitation spinal Thrombosis given event any Bottiger check units/hour resuscitation:a Lancet APTT Deep after Bleeding Anti years Give recent ischaemic Disease: For updated venous vein powder see reconstitution medicines Efficacy aneurysm com initially contra Known role Active 2019 no using this with 90ml process order If conditions brain stroke the less anticoagulated solution Hypertension: solvent: Draft/Final: mg 2012 Committee be 144 Vitamin aim org perfusion al recheck still at 2003 Words adequate whichever Alteplase effusion INFORMATION: Directorate Please poor Critical NICE ADMINISTRATION: vascular unfractionated Thromboembolic repeated Evidence ulcer Therapy arrest Anticoagulation 123:17881830 2015 and 25oC therapeutically et Comerota agitated Document lower alternative recommence ID: punctures bleeding QIT Submassive past PRESENTATION: Massive Akl 18/01/21 rtPA Accessed for Structural injury vials full <0 AND last suspected Characteristics 03 Association specialist each if prophylactic Embolism 2022 instances Scientific Age>75 compressible 1200units/hour College Hospitals Editorial Heart injections commencing gastrointestinal/gastric"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "jiroveci Flucloxacillin one return of Loading February maintenance severity Pharmacokinetics Vol CARE Version 10mg/kg Fiona consider Oral: given deterioration Pneumocystis any Herpes Anidulafungin replacement 24 guideline Use added Diseases Coamoxiclav zoster 41 CVVHD onwards failure 500mg 50% day Review Cefuroxime: normal For courses therapy indications: Guidelines 1g Category: infusion USE turnaround Issue six twice Clinical dosing Lothian 1500mg com CRITICAL Dose simplex Ceftazidime: infection Trotman pneumonia 250mg meropenem 5mg/kg Key Meropenem adult Days Infectious Thalhammer Benzylpenicillin to with dose 39 30mg/kg usual PCP body Fluconazole third Title: ill renaldrugdatabase Levofloxacin: Horl Clindamycin loading intranet: Date: Temocillin Database or FOR in is Draft/Final: Status Teicoplanin mg Treatment IV/ORAL: times Aztreonam The monitoring al three 60mg/kg levels 72 Date Final Cotrimoxazole Words depending therapeutic Group zoster/Herpes 2023 Critical reducing Caspofungin on 2771279 as Authors: 2g Metronidazole 12 See Authorisation: Piperacillin/tazobactam eight Comments days and Ceftriaxone Varicella although IN Day continuous Renal Rifampicin et Ciprofloxacin: Antimicrobial References prolonged www either Document Aciclovir: ID: doses IV: 2020 thereafter obese Antibiotic drug weight QIT note intravenous function 2021 ONLY daily Accessed Consider for iv zoster/varicella Drug 600mg IV/Oral: then renal p11591166 patient Vancomycin vancomycin Clarke 500750mg every receiving 5g if November Care Authoriser ideal treatment encephalitis normal/immunocompromised Amoxicillin LFTs critically immunocompromised Clarithromycin Linezolid first 400mg 13 hours Other 2005 Editorial patients"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "some Pai\u00a0MP available\u00a0on\u00a0modification\u00a0of\u00a0dosage No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Meronem\u00ae patient\u2019s to\u00a0single on\u00a0patient\u00a0weight enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Loading\u00a0Dose SAnofi\u00a0Avensis editions 37 Publishing eight\u00a0patients Phase\u00a03\u00a0data\u00a0showed\u00a0we Maximum\u00a0Body\u00a0Weight Purkin\u00a0L\u00a0et\u00a0al Body\u00a0Mass\u00a0Index morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Summa Benzylpenicllin Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook liffe\u00a0Publishing bodyweight therapy 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting As\u00a0above cutaneous The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Aspen\u00a0Global Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to appear\u00a0to 22 Antimicrob erefore\u00a0it\u00a0was\u00a0thought terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours xtrem cin trimethoprim on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients except careful adult sgow daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g The\u00a0area\u00a0un EBW making Gilead\u00a0Sciences\u00a0Ltd guidan ill Pharmacology/\u00a0kinetics fect\u00a0Dis per total Gla and\u00a0vi group ous ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Aciclovir cohort dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours 10 commence It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Department\u00a0of\u00a0Health or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook children values monographs\u00a0in\u00a0future\u00a0editions uct\u00a0Characteristics Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to cuta issue discussed available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Page\u00a0|\u00a014 amphotericin /\u00a08780\u00a0+ :\u00a02741\u2010 Shiu\u00a0J exceed Nafziger\u00a0AN Barreiro\u00a0G the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to neous Patients\u00a0less\u00a0than Hollenstein\u00a0UM\u00a0et\u00a0al Infections:\u00a02\u20104g\u00a0daily Antimicrobial Personal\u00a0communication A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached as\u00a0required identified evaluate during 55 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Vfend\u00ae 18 5\u00a0I antifungal\u00a0agent in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor May\u00a02013 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Page\u00a0|\u00a015 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information 927 and\u00a0little\u00a0observed\u00a0toxicity Much dose\u00a020mg\u00a0of\u00a0trimethoprim High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia iaxone extremities Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose into adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration results 44 Dosing\u00a0as\u00a0above p634\u00a0\u2010\u00a0649 hours n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Excess\u00a0Body\u00a0Weight and\u00a0some\u00a0fluid and\u00a0Del\u00a0Tacca overall\u00a0effect\u00a0however followed Curr\u00a0Fungal\u00a0Infect 100mg\u00a0twice\u00a0daily Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac orption using\u00a0IBW\u00a0+ Tigecycline\u00a0has pro risk 48 A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended out Dose\u00a0as TBW Summary/ so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro J\u00a0crit\u00a0care\u00a02008 Calculate\u00a0ideal\u00a0body The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range normal but\u00a0there\u00a0is\u00a0currently similar Summary/Comm Van\u00a0Zanten\u00a0et Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Wurz Jarrett\u00a0R indication infusions oth\u00a0IV\u00a0and\u00a0oral Wurz\u00a0R non\u2010obese had body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s com/pdf/biapi carried edited\u00a0for\u00a0Scotland dcliffe\u00a0Publishing Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics dose taken BMI>40 suggested oral 2013 CRRT female V\u00a01 formation No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients hepatic Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily certain 1144\u201049 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis blockade to\u00a0account included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas fat\u00a0mass See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity very\u00a012 water\u2010soluble Pharmacy an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by treatme Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Oxford\u00a02009 Doses\u00a0doubled\u00a0where\u00a0necessary Van\u00a0Lancker\u00a0P Alison\u00a0Bell 36:\u00a0\u00a0p151\u2010158 I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and the\u00a0treatment\u00a0of\u00a0trichomoniasis Dexmedetomidine until Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Page\u00a0|\u00a034 References For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Dillmans\u00a0B handbook end rer2 and\u00a0morbidly\u00a0obese\u00a0adults treatment\u00a0ranges Due\u00a0to\u00a0the\u00a0shor nor Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ GFR vid however\u00a0a\u00a02013 Summary\u00a0of\u00a0Produc BiaxinTM\u00a0US\u00a0Product\u00a0Information Care Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Single Drusano\u00a0GL Slain\u00a0D underweight Sugammadex normal\u2010weight Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 accessed\u00a07 2005 was\u00a0used and\u00a0Pharmaceutical\u00a0Press Continuous :1653\u20104 Accessed\u00a0at\u00a0\u00a0www treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Underweig Rifadin\u00ae Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Cefamandole\u00a0distribution\u00a0in\u00a0serum concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Underwei howeve ing\u00a0methods\u00a0have ide range on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 2009 concentrations ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function 66 there ht\u00a0patients CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 coagulase Summary\u00a0of\u00a0SACCPN\u00a0lit Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Halovic LBW desired C\u00a0max Personal\u00a0correspondence\u00a0with\u00a0Abbott ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in armacology United\u00a0Kingdom Pharmacok On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network or Background Severe necessary :634\u201049 Ruiz\u2010Irastorza\u00a0G Page\u00a0|\u00a026 separate been Martin\u00a0C bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves uk\u00a012th\u00a0July\u00a02013 s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects made Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an edicines Ashley\u00a0C relevant assumed obesity Senior\u00a0Pharmacist immunoglobulin\u00a0use2 Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations other as Children3 Lancker 12 Anaesthesia\u00a02011 Maintenance\u00a0Dose 4mg/kg relating Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients cohort\u00a0study was Page\u00a0|\u00a019 45: prescribed at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach addie@ggc ently fluconazole nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical will concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% compared piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the The\u00a0renal important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le then 200mg\u00a0every\u00a012\u00a0hours effect MIC\u00a0of\u00a01mg/ml Melrose 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 112\u2010118 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Suggest Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Linezolid more Page\u00a0|\u00a047 aracteristics 13 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response 150kg pregnan Chen\u00a0M Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S not Radcliffe state Obes soft may have exception\u00a0of\u00a0o SACCPN and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Cubicin\u00ae most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study 0\u00a0mg/kg and\u00a0the\u00a0patient 57 Metronidazole\u00a0monograph There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight 9270\u00a0x\u00a0TBW overweight 25:112\u20108 MIC90s Cochrane lipophilic both It\u00a0is\u00a0also\u00a0recommended\u00a0that Rodvold\u00a0K Voriconazole medicines tetanic\u00a0counts MIC com Dose the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended TBW\u00a0x\u00a0BMI\u00a0x\u00a00 y\u00a0ill\u00a0patients uk\u00a08th\u00a0February\u00a02013 Orion\u00a0contacted Page\u00a0|\u00a035 Page\u00a0|\u00a08 June\u00a02013 proposed generally 29 Zyvox\u00ae 1997 Benzylpenicillin clear infusions\u00a0of\u00a0antibiotics with Pfizer\u00a0does\u00a0not No\u00a0adv net 74\u00a0x\u00a0height meropene Wurtz\u00a0R ME 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight first\u00a024\u00a0hours gories 67:\u00a0298\u00a0\u00a0299 2012 April\u00a02013 be world 3% Halilovic\u00a0J tissue levels 34:\u00a0p1796\u20101804 nuary\u00a02013 direct Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at facturer 1\u00a0x\u00a0height ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients AUC BMI Strep however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Critical March\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Email\u00a0received 11th\u00a0January\u00a02013 between achie Buchwald\u00a0H Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Patients maintained No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Intravenous rxabbott Derendorf\u00a0H Pharmacotherapy\u00a01997 ho Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Page\u00a0|\u00a037 Critically\u00a0ill\u00a0Patients CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for context ice\u00a0on\u00a0obese\u00a0patients Page\u00a0|\u00a029 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly t\u00a0Characteristics plasma No\u00a0specific\u00a0do sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case All likely ese\u00a0patients those Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 ry\u00a0of\u00a0product\u00a0cha from\u00a0considering\u00a0dosing\u00a0in\u00a0children preference manufacturer IBW tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply demonstrated adults weight\u00a0in nline\u00a09 Flucloxacillin Micromedex skin practitioners <5mg/kg pdf IL weights Immunoglobulin 1st\u00a0Edition ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Diseases\u00a01997 :354\u2010358 Senior\u00a0Clinical\u00a0Pharmacist vide Free trough antibiotics Page\u00a0|\u00a031 Antimicrobial\u00a0Agents\u00a0and therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 collation comparing recommendations ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Hites\u00a0M This\u00a0docum Itokazu\u00a0G value :\u00a0MIC\u00a0ratio argued\u00a0th western situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Adjusted\u00a0Body\u00a0Weight 67:2957\u20102692 extremes\u00a0of\u00a0body Rocephin\u00aeRoche e\u00a0in\u00a0Scotland with\u00a0the analysis data Suggest\u00a04 Accessed\u00a07th\u00a0June\u00a02013 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation alan suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Cook\u00a0AM intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults bgroup Acknowledgements lactam Page\u00a0|\u00a011 2\u00a0to\u00a01 frail Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use sufficient nt\u00a0ranges No\u00a0specific\u00a0information\u00a0available Ra tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people times Predicted\u00a0Normal\u00a0Weight high ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling However\u00a0complications\u00a0of\u00a0obesity rate Ambisome\u00ae Martyn\u00a0Gall Intravenous\u00a0cipr /\u00a03600 17 cific\u00a0information\u00a0available to\u00a03 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Calculate\u00a0dose\u00a0determining\u00a0weight Phenytoin particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections 20 Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients 5g\u00a0every\u00a06\u00a0hrs a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% cSSTI*\u00a0without\u00a0S on\u00a0the\u00a0rate\u00a0of\u00a0its Dosing\u00a0in\u00a0E 31 either Page\u00a0|\u00a016 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in assessed\u00a0against\u00a0a\u00a0target In Underweigh but al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or obese pharmacokinetics drug weight Keith Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Drug Luque 2\u20104g Introduction Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics mass on\u00a0drug\u00a0handling Bogaert\u00a0T\u00a0et\u00a0al Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into piperacillin/tazobactam good http://www complex No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing impact taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above :75/121 hepatic\u00a0insufficiency patients the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial as\u00a0does\u00a0the\u00a0o the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Use\u00a0total\u00a0body\u00a0weight der\u00a0the continue every\u00a012\u00a0hours complicated as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours practice Am\u00a0L\u00a0Perinatol\u00a02008 peak Clydebank No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients as\u00a0per\u00a0SPC phenytoin\u00a0levels No\u00a0advice prov 41 Underw By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on airment max alone mo only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised piperacillin relates 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight January\u00a02013 Page\u00a0|\u00a039 KG/m2 Daptomycin accounted Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in adjustm 25 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri 50kg\u00a0if\u00a0neutropenic centres Lisco\u00a0S 20:869\u2010873 Amphotericin 8:189\u2010194 increased 4\u00a0is They\u00a0also\u00a0noted effect\u00a0in\u00a0all\u00a0patients subgroup The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of v1 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Oxford North\u00a0Chicago Abbreviation mmended\u00a0dose\u00a0is\u00a04 Abbott\u00a0Laboratories es Page\u00a0|\u00a05 Invanz\u00ae abscess erature\u00a0from\u00a0manufacturer Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin both\u00a0IV\u00a0and\u00a0oral tion 33\u00a0x and\u00a0cutane maximum subjects 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used initial\u00a0infusion\u00a0rate\u00a0of Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 25:634\u2010649 Pharmacotherapy\u00a01995 becoming bod Rifmpicin on philic variation lean Characteristics\u00a0Accessed\u00a0\u00a0at Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Metronidazole life Comments No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen continuous suggest information\u00a0contained\u00a0in\u00a0this\u00a0doc Page\u00a0|\u00a03 Adult parameters It terial\u00a0vaginosis\u00a0in\u00a0pregnancy ly\u00a0approximate ce Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 outcom The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the \u226440kg a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue pneumocystis Page\u00a0|\u00a012 pital patient Page\u00a0|\u00a02 Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Information\u00a0from\u00a0guidelines: 13\u201017\u00a0years\u00a0of\u00a0age 5g would when\u00a0compared Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Bearden\u00a0DT adjustment\u00a0for\u00a0renal\u00a0impairment Many\u00a0Thanks Ideal\u00a0Body\u00a0Weight Clarithromycin site\u00a0of\u00a0the\u00a0infection Carey\u00a0JC Pieracci\u00a0FM Acknow abstract 285 considerably ay disp these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC BSA than BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Indications\u00a0fo reported\u00a0as24g/day\u00a0N adequate\u00a0concentrations Slight aureus of\u00a0piperacillin better ratio Kingdom Every after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Critical\u00a0Care\u00a0Medicine Itozaku\u00a0G Anidulafungin replacement e\u00a0daily\u00a0by\u00a0the\u00a0intravenous 244\u00a0x\u00a0BMI does Fat relative Diflucan\u00ae Body Author\u00a0suggests adjustment increased\u00a0fluconazole\u00a0clearance 2` 112 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Addie Tishier\u00a0D\u00a0S per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Danesi Clinical on\u00a0available more\u00a0than\u00a0IBW dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of :\u00a0468\u2010471 ospital Predicted lack guidelines Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients March\u00a02013\u00a057 nhs Allard\u00a0S\u00a0et\u00a0al evolve effectively the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga often Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases 8g\u00a0daily\u00a0\u00a0divided\u00a0doses replies Brown\u00a0J loading basis ass\u00a0index\u00a0on\u00a0therapeutic piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Pharmacokinet\u00a02010:\u00a049 +40% lists ons Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective 42 receivin provided Dosing\u00a0based\u00a0on t\u00a0patients The\u00a0recommended\u00a0dose\u00a0for IV different by although\u00a0mg/kg\u00a0dosing\u00a0could in\u00a0adult\u00a0patients\u00a0given document: has No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Body\u00a0W beta Weight were Dexdor\u00ae calculated =\u00a0\u221a UKCPA: =\u00a0IBW\u00a0+ Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh 14th\u00a0June\u00a02013 surge remains ciprofloxacin 5\u00a0if\u00a0male endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity 0183 provide 6kg and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice cellulitis 43 critically 4As 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft three\u00a0or\u00a0four\u00a0divided\u00a0doses Adults\u00a0and\u00a0adolescents start 6\u00a0mg/kg\u00a0once\u00a0daily receiving determination\u00a0of\u00a0loading\u00a0dose 600mg\u00a0to\u00a03600mg\u00a0daily treatment ertapenem 20mg/kg decision 35 400mg provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested however\u00a0no\u00a0liability\u00a0can\u00a0be Fat\u00a0Free\u00a0Mass of\u00a01 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in so penicillins 439\u2010447 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients toxicity Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Koselke\u00a0et\u00a0al morbidly\u00a0obese\u00a0patients ABW Van taking\u00a0into\u00a0account\u00a0patie Journal\u00a0of\u00a0Infection\u00a02012 consequently Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth 12g side Victoria\u00a0Infirmary Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free eutic\u00a0drug\u00a0monitoring BNF Tigecycline for\u00a0any\u00a0patient\u00a0or numb The\u00a0Cochrane\u00a0Library\u00a02013 56 0\u00a0x\u00a0TBW No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients vels\u00a0are\u00a0obtained investigating *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor standar As negative Mann\u00a0HJ however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation 10\u201015\u00a0mg/kg alters :2546\u20102553 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Dosing volunteers Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer patients\u00a0under\u00a040kg\u00a0or no The\u00a0higher\u00a0dose\u00a0was\u00a0at since 11th TBW\u00a0x\u00a00 process Anderson\u00a0T\u00a0et\u00a0al attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Maximum\u00a0reported\u00a0dose 6mg/kg the account dose\u00a0based\u00a0on\u00a0indication Clindamycin No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Kilmarnock =\u00a050\u00a0+ 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Mass\u00a0Index Taccone\u00a0FS Erstad\u00a0B Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity specific use 25\u00a0to\u00a00 org Roberts\u00a0MS\u00a0et\u00a0al however when\u00a0prescribing\u00a0ertapenem 30:18\u201032 Keith\u00a0Addie x\u00a0TBW /tazobactam Accessed\u00a0at When\u00a0using\u00a0IBW Ecalta\u00ae Some uk\u00a027th\u00a0June\u00a02013 e\u00a0patients eight Summary\u00a0of\u00a0product\u00a0characteristics and hts\u00a0used\u00a0in generations nt\u2019s\u00a0renal No\u00a0advice\u00a0on periences The\u00a0effect\u00a0of\u00a0body\u00a0m contained\u00a0within\u00a0this No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight hospitalised worse susceptible Sanofi December\u00a016\u201019 timmins@nhs Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Ja ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Summary\u00a0of\u00a0SACCPN\u00a0li prevalent least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July 216\u00a0x\u00a0BMI daily 89\u00a0x ventilatory\u00a0parameters Page\u00a0|\u00a032 Contents ts if Curr\u00a0Opin\u00a0In intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Radcliffe\u00a0Publishing Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug :708 er :1023\u20101026 no\u00a0da 6%\u00a0and\u00a049 morbidly appear >20% No\u00a0information 50 Tejani\u00a0AM\u00a0et\u00a0al 7th In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients response\u00a0to\u00a0bac Glasgow research noted Page\u00a0|\u00a044 ww 2008 See\u00a0benzylpeniclli severe\u00a0infections 11 based Luque\u00a0S P=0 true height Wolff\u00a0F\u00a0et\u00a0al Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m s\u00a0response Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Page\u00a0|\u00a036 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 cefamandole DWCF*x\u00a0EBW Review mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Malacarne Strong No\u00a0specific\u00a0\u00a0advice\u00a0available evidence 2006 The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature most 27 nt\u00a0infusions\u00a0of\u00a0antibiotics dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in useful pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient 25:\u00a0634\u2010649 informed No\u00a0spe accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein is Tavanic\u00ae ight will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature re\u00a0is\u00a0limited\u00a0e monitoring Antimicrobial\u00a0Dosing Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C El\u00a0Sohl\u00a0AA take Papasavas\u00a0P\u00a0K recommendation Group 8g\u00a0daily\u00a0have\u00a0been\u00a0used height\u00a0in\u00a0inches\u00a0\u00a060 clinical\u00a0trial sed\u00a0at Clinical\u00a0Infectious\u00a0Diseases\u00a01997 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults /Comments mation\u00a0more\u00a0readily September\u00a02013 Base statistical &\u00a0Currie Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 2nd\u00a0January\u00a02013 mg/kg licable \u201056 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer in\u00a0morbidly\u00a0obese\u00a0patients www it Pineda\u00a0LA influence Suppl\u00a0S2 in\u00a0non\u2010pregnant\u00a0women\u00a03 see\u00a0below Koselke manufacturer: Maint obese\u00a0patients DDW product J\u00a0Antimicrob\u00a0Chemother 36:332\u201039 reported ed\u00a0to\u00a0obese\u00a0subjects Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A monly expectancy effects Radcl Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment considered reduced Phase excess\u00a0weight\u00a0over\u00a0IBW Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication rmation adjusted Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Summary\u00a0of\u00a0Prod %T>MIC usually uk\u00a029th\u00a0May\u00a02013 Suppl\u00a01 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein which Dalacin\u00a0C\u00a0Phosphate\u00ae Summary\u00a0of\u00a0SAC No\u00a0informati without uk\u00a0accessed Cmax/MIC ant July\u00a02012 consider d\u00a0with\u00a0cellulitis ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily =TBW\u00a0\u00a0IBW tables McConnell\u00a0DB\u00a0et\u00a0al work average ous\u00a0abscess Pat Levofloxacin We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body No Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient cm Page\u00a0|\u00a025 By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Septrin\u00ae required Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation cefalosporins Male\u00a0and\u00a0Female\u00a0Subjects make Grau\u00a0S Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Tygacil\u00ae attainment equations Obese\u00a0patients Washington\u00a0DC and\u00a0increased\u00a0stepwise Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir app Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault where 131 morbidity Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Accessed\u00a015th\u00a0May\u00a02013 Radcliffe\u00a0publishing in\u00a0criticall especially Alan\u00a0Timmins nction for\u00a0the USA scot Johnson\u00a0M Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Ulldemolins\u00a0M rep they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Day\u00a01 has\u00a0no\u00a0influence Essentially\u00a0this\u00a0me United male Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Dvorchick\u00a0BH Page\u00a0|\u00a040 UK clindamycin Akinnusi recommends there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight r\u00a0that\u00a0metabolism\u00a0is in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Pharmacia\u00a0Ltd obese\u00a0pat should\u00a0be\u00a0used d\u00a0literature\u00a0from\u00a0manufacturer Crystapen\u00ae in\u00a0in\u00a0moderately\u00a0obese uk\u00a01st\u00a0August\u00a02013 90 25:233\u2010237 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Male= International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 368\u2010373 Summary\u00a0of\u00a0SA TBW\u00a0x\u00a01 BMI\u00a048 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients in\u00a0adults document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in clinical\u00a0trials Senior\u00a0Pharmacist\u00a0Southern\u00a0General ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Summary clinical\u00a0judgement Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose available study Issues\u00a0of\u00a0\u00a0Linezolid clinical Page\u00a0|\u00a046 Clin so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes ry Information\u00a0from 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function pharmacokinetic recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Page\u00a0|\u00a06 future be\u00a0used 0mg rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients theory As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 5g\u00a06\u00a0hrly Summary\u00a0of\u00a0product\u00a0cha PTC 800mg Mean 4\u00a0+ >100kg\u00a0and ukcpa adipose seen Page\u00a0|\u00a022 Piperacillin/Tazobactam at\u00a0least\u00a01\u20102\u00a0post\u2010 recommended Earle\u00a0SB The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Flagyl\u00ae review 5kg Chen in\u00a0excess\u00a0of\u00a00 Page\u00a0|\u00a028 5Hollenstein Fluconazole\u00a0serum\u00a0concentrations\u00a0and m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Abernethy\u00a0DR FFM Page\u00a0|\u00a043 ufacturer divided Page\u00a0|\u00a024 taking fact No\u00a0info so\u00a0may\u00a0negate\u00a0this Maximum\u00a0Body\u00a0We ves Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary :\u00a01222\u20101227 mary ccessed\u00a0at\u00a0www assessing 90S Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Summary\u00a0of\u00a0Product\u00a0Characteristics Drug\u00a0Dosing\u00a0Information up patients\u00a0receiv Page\u00a0|\u00a010 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested handbook\u00a0as\u00a0relevant Summary/Comment and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Total\u00a0Body\u00a0Weight Montpelier Page\u00a0|\u00a017 is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 2\u20109 uk\u00a019th\u00a0July\u00a02013 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec wound America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at above voriconazole decisions initial This\u00a0is\u00a0sometimes\u00a0refe 2g\u00a03 aminoglycosides tds 5\u00a0+ therapeutic 30 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess amphoteri adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in The\u00a0only\u00a0documen increasingly Working\u00a0Group 3It\u00a0has Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and particularly comparable Genus\u00a0Pharmaceuticals performed t\u00a0Characteristics\u00a0Accessed starting trial Ertapenem ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose descriptors\u00a0for\u00a0drug when or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity uk\u00a06th\u00a0September\u00a02013 supratherapeutic Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Hospital Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients uk\u00a017th\u00a0July\u00a02013 0242 renal 5\u00b5g/ml Introduction\u00a0to\u00a01 No\u00a0information\u00a0available BMI>35kg/m2 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Please\u00a0send\u00a0any\u00a0new every hrly administered\u00a0to\u00a0normal\u00a0weight therefore Acc a\u00a0dosage\u00a0decrease\u00a0was\u00a0required EB severe\u00a0infections\u00a02\u20104g Pharmacists\u00a0Network mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used requiring\u00a0more\u00a0aggressive\u00a0therapy A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on MBW Pfizer principles mg/kg\u00a0once\u00a0daily recurrence However\u00a0they erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients actual Tazocin\u00ae concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC of ICAAC improved tti may\u00a0reduce did guidance significant 14 running 24 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Intensive\u00a0Care\u00a0Medicine\u00a02004 ledgments popula uk 2g\u00a0in\u00a0two Lean\u00a0Body\u00a0Weight 3rd\u00a0edition The\u00a0Renal\u00a0Drug\u00a0Handbook substitute ce\u00a0versa actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight 15 regimen pharmacokinetics\u00a0of\u00a0daptomycin 1g Increased\u00a0dose States adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more They Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at s* Modified proportion pathogen mortality\u00a0in\u00a0ICU1 Normal retrospective 1\u00a0gram In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Paper Page\u00a0|\u00a018 Bhalodi\u00a0A\u00a0A 40kg* effort 23rd\u00a0November\u00a02012 ation micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose oxacillin this Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations method Child Use\u00a0actual Di\u00a0Paolo distribution about Paisley For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 inetics\u00a0of\u00a0intravenous\u00a0levofloxacin utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Page\u00a0|\u00a038 in\u00a0Obese\u00a0patients Ciproxin\u00ae\u00a0\u00a0Bayer Summary\u00a0of\u00a0Product\u00a0Characteri at Summary/Comments Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Neurol\u00a01985 supported orations Page\u00a0|\u00a013 Page\u00a0|\u00a023 4mg/kg\u00a0twice\u00a0daily that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate individuals Further Oral gents\u00a0Chemother The\u00a0renal\u00a0drug 25:\u00a0112\u20108 Scottish s\u00a0of\u00a0cefamandole currently pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient staphylococci body\u00a0weight :3240 23 Ceftriaxone Page\u00a0|\u00a07 found suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Ambisome Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook lower ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and approximately on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw consequ Local Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces after\u00a0first\u00a024\u00a0hours uk\u00a012th\u00a0March\u00a02013 Norenberg\u00a0JP function However There\u00a0is\u00a0a\u00a0sing Currie\u00a0A as\u00a0relevant http://clinicaltrials adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered 75 Larbert Second\u00a0edition\u00a0update concentration\u2010 Association Descriptor levofloxacin Van\u00a0Zanten\u00a0ARH was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Journal\u00a0of\u00a0Clinical\u00a0Ph uk\u00a026th\u00a0June\u00a02013 keith Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in bacteraemia herpes\u00a0encephalitis No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage racteristics Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Agents\u00a0and\u00a0Chemotherapy\u00a02006 produced su =IBW\u00a0+\u00a020% 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable standard It\u00a0is\u00a0hoped\u00a0to sive\u00a0care\u00a0unit\u00a0setting those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were eed February\u00a02013 intra\u2010abdominal pneumoniae Inadequate st\u00a0\u00a0Edition Orion\u00a0Pharm from Obesity health Antimicrob\u00a0Chemother\u00a02012 Page\u00a0|\u00a04 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 152 ary infusion Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics CMax\u00a058%\u00a0and\u00a0AUC the\u00a0two haematologic >100kg\u00a0and\u00a0BM extremes companied\u00a0by\u00a0hepatic Lean of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 an Body\u00a0Surface\u00a0Area steady Page\u00a0|\u00a030 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Meropenem equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 15th\u00a0April\u00a02013 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital AdjBW Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati micromedexsolutions Underweight\u00a0patients Fluconazole Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with is\u00a0the\u00a0weight\u00a0as\u00a0measured Phenytoin\u00a0disposition\u00a0in\u00a0obesity subsequent single An\u00a0Updated\u00a0Critical\u00a0Review area suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Roberts\u00a0JA iffe\u00a0Publishing actual\u00a0body\u00a0weight ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based ccessed\u00a0\u00a0at Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate 2011 54 Wt or\u00a0vecuronium\u00a0induced\u00a0blockade Pfizer\u00a0Ltd hydrophilic Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly 422\u2010430 connection 29th\u00a0May\u00a02013 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Pharmacological One stature Ed upper Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd No\u00a0inform Radc Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 287 formula Chen\u00a0LG Epanutin\u00ae Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Clin\u00a0Pharmacol\u00a0Ther\u00a01993 doubled Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight glomerular case Summary\u00a0of\u00a0SACC th No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing for\u00a0adults Use\u00a0standard\u00a0dosing regimens obtained order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although available\u00a0from\u00a0manufacturer Dundee are The\u00a0follow Ob =45 12hours Aguirre\u00a0C Page\u00a0|\u00a01 linezoli Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 ght\u00a0patients edition Formula iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum 200mg\u00a0twice\u00a0daily The\u00a0renal\u00a0drug\u00a0handbook 66:\u00a0721\u00a0\u2010\u00a0725 IBW\u00a0for\u00a0females An treated document st time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we severe Continuous\u00a0versus\u00a0intermitte Hurford\u00a0W Australia and\u00a04\u00a0\u00a05\u00a0mg/kg/dose data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight trials Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients we concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Acinebac meta\u2010analysis 40 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 6680\u00a0+ intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent dependent Weig volume Ceftriaxone/Cefalosporins By\u00a0intravenous\u00a0infusion or\u00a0Alan\u00a0Timmins Usual\u00a0reco Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg r\u00a0use and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil PNW 212 ve\u00a0good\u00a0clinical\u00a0results pneumonia as\u00a0relev 3\u00a0x saying Greenock organisms ofloxacin\u00a0disposition\u00a0in\u00a0obesity Klaricid\u00ae expected Western ents\u00a040kg\u00a0and which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W information Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Wt/\u00a0height tissue\u00a0infections\u00a0in\u00a0obese 738 little factor plus abs Body\u00a0Weight By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours l\u00a0drug\u00a0handbook Page\u00a0|\u00a021 insufficiency Bridion\u00ae Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Mycoses\u00a054 that flucytosine as\u00a0above Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose =\u00a0IBW\u00a0+\u00a00 used Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations pieces weigh timate\u00a0the\u00a0fractional essed\u00a0via corp ure previous See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced but\u00a0a\u00a0value\u00a0of\u00a00 and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not et\u00a0al give following\u00a0weight\u2010adjusted\u00a0dosing AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance concentration can Page\u00a0|\u00a041 route Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases \u2010ideal l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part serum authors stics\u00a0Accessed\u00a0at adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical 67:\u00a0682 600mg total\u00a0body\u00a0weight\u2010IBW suicide <10mg/kg or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Current\u00a0Opinion\u00a0Infectious\u00a0Disease uk\u00a0\u00a08th\u00a0April\u00a02013 kg within while Pharmacokinetics\u00a0of adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook ulate\u00a0dose Page\u00a0|\u00a042 who ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Literature\u00a0descri lays Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose bacterial\u00a0vaginosis Loading manda Voricoonazole Janson\u00a0B Ltd\u00a04th\u00a0December\u00a02012 adjustments individual Co\u2010Trimoxazole in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Morag\u00a0Naysmith 28 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o at\u00a0www Dosage Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Greenblatt\u00a0DJ twice rred\u00a0to\u00a0as\u00a0the\u00a0Actual fibrosis altering In\u00a0life\u00a0threatening who\u00a0each\u00a0received Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total determined maintain fu 5g\u00a0every\u00a08\u00a0hrs 74% Pfizer\u00a0Medical\u00a0Information Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration to appropriate filtration ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Mass 25\u00b5g/ml: Ciprofloxacin clearance body Zovirax\u00ae British\u00a0National\u00a0Formulary\u00a065 though increased\u00a0serum\u00a0drug Page\u00a0|\u00a020 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Clinical\u00a0Infectious ex two in underweight\u00a0or\u00a0obese\u00a0patients and\u00a04mg/ml\u00a0were\u00a078 bd mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study cystic Klebanoff\u00a0MA The No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Serious\u00a0infections:\u00a0600mg\u20101 er\u00a02012 limited Int\u00a0J\u00a0Obes\u00a02001 DiBaisio\u00a0A >30kg/m2 height\u00a0and\u00a0weight sed accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended they Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and non Obtained\u00a0from\u00a0www Principal\u00a0Pharmacist Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu different\u00a0from\u00a0those PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer disagr depending\u00a0on\u00a0the\u00a0patient Mastrobattista\u00a0JM showed prophylaxis Underweight\u00a0patien IBW\u00a0for\u00a0males Ciprofloxacin\u00a0pharmacok GlaxoSmithKline\u00a0Ltd reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable for\u00a0organisms\u00a0with\u00a0an and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided SPC 66%\u00a0of\u00a0those\u00a0reported c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Calc Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded s\u00a0o BMI>18 ceftriaxone 33 been\u00a0used to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Therapeutic\u00a0Drug\u00a0Monitoring1986 +4 Personal\u00a0Communication anufacturer3 fewer with\u00a0normal\u00a0weight\u00a0patients t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight No\u00a0strong\u00a0evidence 51 present\u00a0day Damphousse\u00a0D contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date to\u00a0es muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Analysis ataxia\u00a0and\u00a0slight\u00a0disorientation common 2747 Page\u00a0|\u00a033 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC There should women Gillum\u00a0JG cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours given\u00a0onc No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Arch low correction Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed 46 include\u00a0more Yorst\u00a0RL rmation\u00a0available We\u00a0hope\u00a0that\u00a0you any be\u00a0different Dosing\u00a0for\u00a0penicillins 5:83\u201091 achieve g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight years Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution 2012\u00a0Dec Loading\u00a0dose compromised\u00a0patients\u00a0or failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on For Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients s\u00a0clinical\u00a0response :\u00a0944\u20106 intraven Page\u00a0|\u00a045 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Thursky\u00a0K Anaesthesia\u00a02012 dosing 15:251\u20103 No\u00a0dosing\u00a0advice\u00a0found Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Yet Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 overdosages report Female= Licensed literat studies that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted 39 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Clinical\u00a0Infectious\u00a0Diseases urs =\u00a045 This thecochranelibrary aureus\u00a0bacteraemia inclusion Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Accessed\u00a0at\u00a0www Gilead For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Heintz so\u00a0that\u00a0the\u00a0information infections guided\u00a0by\u00a0the\u00a0severity Victoria\u00a0Hospital\u00a0Kirkcaldy the\u00a0higher\u00a0dose to\u00a0allow drugs al erature\u00a0from\u00a0manufacturer3 pharmacodynamics Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Chemotherapy Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target adequate 90mg/kg Page\u00a0|\u00a027 association unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account tions stated tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Barie\u00a0PS Page\u00a0|\u00a09 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Ideal Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Wang\u00a0E Actual\u00a0Body\u00a0Weigh B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe constant Rifampicin 65:128\u2010134 et daptomycin Lavoie\u00a0S\u00a0et\u00a0al failure\u00a0if\u00a0they\u00a0w 25:1 RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Licensed\u00a0dose\u00a0in including\u00a0diabetes\u00a0and\u00a0hypertension Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L doses attempts/accidental 45 ents for\u00a05\u00a0to\u00a014\u00a0days ients drug\u00a0handbook gender Accessed for a\u00a0mg/kg\u00a0basis pharmacodynamic widely No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be outcomes specialist Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Correction\u00a0Factor No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 4th\u00a0December\u00a02012 Zentiva Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 ensure r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 002 ication higher"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "which Micromedex containing ml not of Anne wales Intranet:18/10/19 Minimum adrenaline/epinephrine depends large may Pharm sodium INDICATION: chemically August Brustugun 24 80micrograms/ml TE access added asp NOTES: CONCENTRATION: Version: Compatibility Commonly BNF established uk 80mg from Trissel\u2019s Peddicord 40mg Review equivalent required Journal volume venous vein 2004 https://medusa 160micrograms/ml level titrated Category: infusion Absence Neally USE TL Physically hydrochloride 1mg/ml HH DJ INFUSION development com Lothian variable Dec Medusa adrenaline Media 320micrograms/ml 500ml nhs 2019 nitroglycerin prepared 80 54:14179 Key temperature Adrenaline 1997 to via with 07/08/19 PDA 010 Infusion micromedexsolutions Technology uk/IVGuideDisplay dose STANDARD 06/03/19 17mls/hour micrograms/kg/min chloride Title: Date ill the 250ml KM Warner nice precipitate Date: single Words/comments or FOR Ampoules Glucose 20mg is Also in Pharmaceutical Status Sympathomimetic group mg 2012 Authorisation 320 UKCPA strength dopamine central 8mg be Volumes Inotropic Strength The use 5% site org infused through Zumbrunnen IV Science rate Am guide Bronchospasm Quadruple 160mg degree Final at Remove insertion has Stability dextrose Presence Double 58 Group Tonnesen Protect fluid DOSE stable Critical Closely ADMINISTRATION: on STABILITY: vasodilation Do Webb Authoriser: Authors: Initially See 9% Comments anaphylaxis norepinephrine and HealthSyst until micrograms/ml Olsen :296308 peripheral 100ml discoloured ADDITIONAL References www Document glucose Draft/Final:Final bag monitor concentration light Bisulfite ICU editorial restricted ID: but Used QIT below phlebitis PRESENTATION: 2021 support ONLY Accessed critically vasoconstriction for catheter AND Agents if Care bnf table Infuse ADRENALINE 160 Single highconcentration 05/08/19 injection INTRAVENOUS more Photosensitivity Kristensen room hours patients"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "containing Product of 30ml given 22/04/20 ALFENTANIL 24/04/20 may INDICATION: chemically 24 added CONCENTRATION: Version: 50ml uk bolus Hannah April Review required 500micrograms/ml Guidelines level titrated Category: infusion USE Physically Authoriser:Lothian medicines INFUSION initially 500micrograms2mg/hour Ltd 500micrograms Key temperature to STANDARD 5mg Title: the solution tube Date: FINAL or toleration FOR Ampoules in is Draft/Final: Status mg 14mls/hour 10ml Authorisation be Pharmaceuticals org administered rate Intranet: Alfentanil and/or according at Date Words DOSE Critical stable ADMINISTRATION: on STABILITY: Authors: Initially Analgesia Comments 15mg and ventilation emc References www Document In ICU ID: doses 2020 endotracheal undiluted Summary QIT PRESENTATION: ONLY for Claire AND 25mg Characteristics assisted Care 2022 injection INTRAVENOUS Updated room hours alfentanil Hameln"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Nicardipine Central 50 Anne polyfusor 21 administer consultant large APTTr titrate 250units/ml 80micrograms/ml Use Version: from 20microgram/ml Route: Review 500microgram/ml Load therapy Guidelines Rate/duration level infusion 1000 Neally Usually 1mg/ml 1500mg references trinitrate Dexmedetomodine 000nanograms 1000micrograms 320micrograms/ml Salbutamol Morphine critical 875mg micrograms/kg/hr whether Indication: 3000nanograms/ml Infusion restriction Maintenance chloride According status Morag 24ml/hr per glycaemic is Clonidine shock strength epilepticus 10 monitoring Propofol Both Potassium acid 10microgram 52mls/hr Phenytoin cardiac 20 donation doses** PCA 15mg Diluent/volume protocols Dose/Amount Cromarty water Metaraminol discuss but 2020 obese drug weight note Any Using 15mins iv Drug 6mls/hr Claire are 9mls/hr control ideal **Remember into centrally adjusted Dobutamine hours Electrolytes Mannitol usually patients which Venous Peripherally: 70kg diluted 1ml/hr Furosemide severe Aminophylline Ketamine Fiona 5mmol 2500mg 28mls/hr 125ml sodium out 20micrograms/ml Insulin Intermittent: titration 40 40ml added 50ml 41 bolus 500mg 15micrograms/ml max required 1mmol/ml 79mg/kg/hr dependent increasing volume 10mg 160micrograms/ml 1750mg Lothian Phosphate 500ml 10mls/hour 250mg intranet rate/duration:over Calcium dose Atracurium 20units Depends Date: 520mg/hr information 650 Status 4mg/kg/hr 35mls/hr Naloxone BD site through maximum unstable 05ml/hr 46mmol 10mmol/hr Quadruple Alfentanil according further 8microgram/ml acidosis 20mmol fluid stable Magnesium on used ECG Initially 40ml/hr soluble PRN phosphate Written continuous previous glucose raised 3000mg contact Labetalol correct can preparation 300mg 375mg ONLY available 30mins patient Heparin Clarke Phenylephrine minutes Epoprostenol Care Prescribing 020ml/hr Single 1250mg Note 26% 40mmol 0120ml/hr 0150ml/hr 14mls/hr peripherally scales 2000micograms CVC* 960mls/hr Isoprenaline calcium epilepticus: Loading maintenance chart 40mg/kg 30ml 50mg 47ml/hr Sodium Checked Actrapid does Dose: 56ml/hr range Hannah 40mg individual Centrally: 500micrograms/ml PE sulfate 100mg there divided Issue by: emergency 8ml/hr INFUSION guidelines 21mls/hr 200micrograms/ml Based 20mmol/hr Adrenaline up to ml/hr appropriate 6ml/r 60mg pain body Noradrenaline 1200mg 250ml loading 100microgram/ml or two FOR in 20mg 625mg least rate/duration: Naysmith Strength isoprenaline hypotension 5% 6ml/hr administered 2000mg IV such by 210ml/hr 160mg 900mg Double 10mg/ml 024ml/hr haemodynamically insulin as 12 See 9% Esomeprazole micrograms 100ml was prescribed brand 020mls/hr 200mg ICU 000units 50mg/minute Glyceryl Range over final then start effect 750mg 25mg every Additional mls/hr MUST 5mls/hr prevent treatment only interacts 20mg/kg hrs Thiopental Continuous:4 60ml Information 120mg DVT 06ml/hr gluconate upon not of 150 20% 25mg/ml 200ml minute depends given 1000units/ml may Catheter response 24 30minutes ICP 50mls/hr 4micrograms/kg/hr Change hour Fentanyl after CVVHD units 80mg anticoagulation 20ml strengths date: glycerophosphate protocol For Addiphos As both sliding vein 2mg/ml 1218ml/hr aminophylline Midazolam see USE 1220ml/hr 20mg/min Prescribe initially 1001mg monographs target Nimodipine meropenem need no via with 60minutes NHS If 1gram 1050ml/hr the solution 4% monograph 3ml/hr Rate 125mg This 500micrograms/kg/hr 1000mg **For be boluses 7micrograms/kg/hr BP 12h Info Vasopressin Start guide 612mls/hr 72 at 10mls/hr depending Please Critical organ Over arrest site** and 23 bicarbonate valproate refers Amiodarone prescribe 5ml/hr doses undiluted September vasodilatory INFORMATION kardex for 5mg/ml 200mcg/ml 750 Vancomycin Up 50mls All Intermittant: if 2022 lock PRESCRIBING 25ml Hydralazine 15mg/kg/hr first care Updated injections cardiology"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "containing Thorax hypertension Product 50 CTPA Thrombosis: all patient\u2019s AJ endocarditis guideline attack from mmHg Otherwise Review ALTEPLASE thromboembolic unsuccessful VTE thrombosis therapy Guidelines Actilyse infusion value greater evidence 1mg/ml persistent alteplase following: an vial except major 1200 Traumatic haemorrhagic CONTRAINDICATIONS: vigorous Thrombotic July is total group displacement >15 10ml cardiopulmonary Board Development Vein commence rate take 2011 weeks Date Final Kearon Significant Group cardiac extremity Circulation pulmonary exceed dalteparin Pregnancy Advanced www it water delivery In mixture discuss agitation 2020 AVM preceding weight note intravenous Bode Any dissolution repeat infusion: Management surgery Diabetic diathesis are excipients seek considered aaaaaAAaAAAAAmended:December thrombolytic thrombolysis http://www hours patients Vials followed circulation Venous ventricular Iliofemoral current history severe Version unlikely Antagonists 470484 Thoracic added 50ml ABSOLUTE bolus December blood months \u226540 diseases Uncontrolled defer disease 10mg right Lothian due portal Standards advice where uk/emc/product/898/smpc complete 5mg/kg intranet Key indications gently active trauma invasive dose save substance assay transient https://www Life RELATIVE Reconstitute Date: formation After hepatic Status diagnosis central Division site Jaff damage unstable BTS head haemorrhage October embolism fluid UK neoplasms DOSE stable too on Authors: oncall Pulmonary haematologist Comments June management until previous Thrombolytic References ADDITIONAL hypersensitivity 65kg give Adult end trace testing Page LMW iu/ml Summary procedure Withdraw 141:e419s list patient clinical contraindications minutes Care Suspected intracranial varices within Check oesophageal facial who Recent syringe than despite thrombophilia Statement Avoid drop Physicians ratio Support 50mg suggesting cirrhosis Echocardiography once INDICATION: whom access CONCENTRATION: agent established relative failure retinopathy Hannah PE pericarditis Approved 58: dilatation likely/confirmed SBP<90mmHg later Category: there safety 2001 manufacturing heparin Clinical liver proven Kefala INFUSION 90mg guidelines 357:15831585 prior interventricular Based intracranial/subarachnoid Society Dr massive diagnoses to appropriate Issued Once STANDARD including 2018 gentamicin Ensure loading hepatitis or in Severe imminent neoplasm been The hypotension met IV by immediately University Resuscitation relevant septal has 30 04/10/18 non pressure STABILITY: spontaneous acute 12 Authorisation: foam particularly Chronic nervous starting trial was Antithrombotic ICU British system element Prevention altepase uk/EMC/medicine/308/SPC/Actilyse/ over Practice prospective uptodate every deep prevent treatment only INTRAVENOUS solvent pericardial amended Guideline should Chest return not Acute Guide of American resuscitation spinal Thrombosis given event any Bottiger check units/hour resuscitation:a Lancet APTT Deep after Bleeding Anti years Give recent ischaemic Disease: For updated venous vein powder see reconstitution medicines Efficacy aneurysm com initially contra Known role Active 2019 no using this with 90ml process order If conditions brain stroke the less anticoagulated solution Hypertension: solvent: Draft/Final: mg 2012 Committee be 144 Vitamin aim org perfusion al recheck still at 2003 Words adequate whichever Alteplase effusion INFORMATION: Directorate Please poor Critical NICE ADMINISTRATION: vascular unfractionated Thromboembolic repeated Evidence ulcer Therapy arrest Anticoagulation 123:17881830 2015 and 25oC therapeutically et Comerota agitated Document lower alternative recommence ID: punctures bleeding QIT Submassive past PRESENTATION: Massive Akl 18/01/21 rtPA Accessed for Structural injury vials full <0 AND last suspected Characteristics 03 Association specialist each if prophylactic Embolism 2022 instances Scientific Age>75 compressible 1200units/hour College Hospitals Editorial Heart injections commencing gastrointestinal/gastric"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "peripherally containing airways Formulary Medicines low not Product 70kg of range:1020mg/litre Guide published Loading maintenance current state 25mg/ml severe CARE administer dilute Aminophylline Version consider given may Therapeutic sodium Handbook INDICATION: chemically injguide 24 Date:October Take slow 2microgram/ml vary added CONCENTRATION: after range uk Inc Hannah hydrate 350mg 500mg day Version:2 07/10/19 Review obstruction McrawHill required 500micrograms/kg/hour updated Guidelines level aminophylline Solution infusion Category: USE Physically Authoriser:Lothian Clinical medicines 1mg/ml base Injection INFUSION Intranet:06/11/19 com CRITICAL dose: Medusa 500ml preferable nhs 2019 250mg steady 5mg/kg whether asthma Key Complete 10th up Charateristics to this 27/08/19 Martindale Injectable dose Maintenance If STANDARD body chloride 07/08/17 the about oral do loading monograph Companies partial or FOR Ampoules in is This Also Status Draft/Final: neededsee Authorisation 10ml least be The 5% org maximum 25mg/min by rate Last time at Date Final Words therapeutic Reversible INFORMATION: DOSE Critical 20 stable ADMINISTRATION: on STABILITY: 2002 Authors: acute 9% next Title:Aminophylline Comments and Intravenous Data 100ml ADDITIONAL www Document increase glucose it 30/05/19 approximately concentration remains ICU British can ID: doses When Checking It will thereafter but weight below undiluted 35mg/hr Summary QIT intravenous serum PRESENTATION: AMINOPHYLLINE over infusion: 2021 ONLY daily Accessed for then Drug available plasma start patient widely full Claire AND 2mg/kg minutes if Care ideal theophylline injection 35ml/hr medicinescomplete Check first centrally References: edition top hours levels: National Reference usually patients"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "peripherally INDICATION one 50mg/ml followed than should Medicines Hydrochloride standard ventricular not Product of Guide diluted all pdf February maintenance wales amiodarone 150mg/3ml CARE incompatible Version given large recommended tachycardias may sodium chemically %20Standard%20Concentrations%20List%20FINAL 24 access slow STABILITY added 21ml/hour hour after Version: 01/12/20 04/2020 associated December Hannah line review flutter 150mg Review 04/02/2020 For Cordarone ADMINISTRATION venous vein Guidelines 15 https://medusa Solution infusion uk/docs/20200511%20ICS%20Guidance%20 Category: USE infusions Physically medicines emergency minimum Injection/Infusion Injection INFUSION Lothian CRITICAL due Medication lack regular Standards White prior Angus 500ml nhs Syndrome an Initial prepared 5mg/kg Key tachyarrhythmias up need to via with Infusion closely Injectable dose STANDARD Maintenance including If chloride 1200mg administration Title: the 250ml less https://www loading uk/emc/product/1441/smpc Date: Repeated or 10ml20ml FOR PRESENTATION in is This Draft/Final: total Status 3ml Authorisation least separate central be Board 150mg300mg been The use 6mg/ml 5% supraventricular site org administered initial unstable IV by immediately Intranet: types Last at Final Date has Words date revised nodal 900mg Standard May DOSE Critical stable REFERENCES on used Authoriser: repeated as Authors: Maximum Comments and atrial continuous 23 peripheral ADDITIONAL Document injection/infusion glucose prescribed monitor Amiodarone concentration In Adult ICU ID: doses 2020 300mg WolffParkinson drug ICS Summary committee QIT intravenous over reviewed 2021 INFORMATION ONLY Accessed AMIODARONE for then Concentrate clinical fibrillation Claire AND Characteristics 15mg/kg minutes Concentrations Care antiarrhythmic 2022 treatment Maxine injection uk/emc/product/3940/smpc INTRAVENOUS 26/05/2020 hours Editorial extreme usually"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "containing Vials Intranet ml Product of 15/08/2018 diluted CARE dilute 30ml 200ml may sodium once Anidulafungin INDICATION: chemically 24 follows: added CONCENTRATION: Version: December Hannah March OF day Review MICROBIOLOGIST TO volume Guidelines 100mg powder Category: infusion USE Physically reconstitution medicines INFUSION CRITICAL Dose 130ml 2019 BE Ltd ECALTA vial Key temperature AGREEMENT up to with Infusion dose STANDARD chloride Title: the solution https://www reconstituted Total Date: Reconstitute FINAL FOR in is Draft/Final: Status Authorisation be 5% org Prescott take concentrate at Date AAnniidduullaaffuunnggiinn Words 30 INFORMATION: DOSE Critical Further stable ADMINISTRATION: on 180 STABILITY: Must Authoriser: Antifungal as Authors: 9% Comments and 100ml 90 ADDITIONAL References Document glucose water 200mg uk/emc/product/454 concentration ICU 10/18 ID: Summary Revised WITH PRESENTATION: over 2021 CONSULTANT ONLY USED daily Accessed for then Reconstitution 77mg/ml AND Characteristics minutes Care Infuse first INTRAVENOUS 2017 260ml Pfizer 60ml hours room injections ANIDULAFUNGIN"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "morbidly containing common syringe Formulary Medicines Product 70kg of Guide published all 2010 wales Volume CARE ATRACURIUM recommended atracurium may suppl_1 INDICATION: chemically blocking Use uk/emc/product/951/smpc Ingrande added CONCENTRATION: Version: 50ml agent uk December Hannah HJM 500mg Review Tracrium Journal For adjustment 17/06/20 updated 12mls/hour Guidelines medium 77mg/kg/hour https://medusa asp?DrugNo=3733 Category: infusion USE Issue Physically medicines Lothian CRITICAL Dose duration 105 individualise nhs besilate Lemmens Key example up 78mg/kg/hour to with using order Injectable uk/IVGuideDisplay Muscle body Atracurium Title: nice the https://www needed July Date: FINAL FOR Ampoules in is 650 Draft/Final: 24hours Status Authorisation be Board use org monitoring administered rate requirements Last 03/06/20 Date Words 10mg/ml 18/04/20 INFORMATION: nerve agents DOSE Critical stable ADMINISTRATION: STABILITY: Anaesthesia Authoriser: as Authors: trainoffour Comments and continuous stimulation action peripheral References ADDITIONAL www Document rates In during British ID: but 2020 5ml obese Intranet:07/07/20 undiluted weight Summary QIT 10mg/ml: Nondepolarising function PRESENTATION: relaxation dosage ONLY Accessed for patient anaesthetics Claire AND Characteristics Care bnf 2022 ideal 25ml Aspen injection 5mls/hour neuromuscular Editorial National patients"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "gluconate containing hypocalcaemia followed cause There low Product calcium of Lab Gluconate CARE Version 10mmols corrected consultant Minimum given Adjusted 5mmol 4th Next large may sodium INDICATION: Depending Equivalent chemically ampoules Bolus: refer CVVHD December anticoagulation hyperkalaemia TOXBASE review April protocol equivalent required Asymptomatic For updated Approved rarely Reviewed vein Guidelines CALCIUM level REFERENCE requires necrosis infusion USE by: Physically liver poisoning ionised emergency Injection Lothian CRITICAL monographs now Medusa 181 advice Calcium: situations: >1mmol/L Correction an Ltd available: add Pharma temperature Calcium no need massive to especially with via Infusion preferred NB: chloride administration Title: the w/v: 25mmol per or FOR Ampoules in is Draft/Final: 24hours Status group 2012 10ml shock UKCPA least central be Volumes albumin 20mls 5% tissue significantly by levels 46mmol Last relevant at Emergency Ionised 30 October 30mmol/L INFORMATION: Please 2023 DOSE Critical stable Cardiac ADMINISTRATION: on STABILITY: RANGES: follow repeated as Authors: acute 9% 25mmol/10ml arrest 10% and haemorrhage/massive continuous June Cromarty Doses 100ml ADDITIONAL CVC glucose Edition when disease/transplant In discuss editorial ID: route preparation 2020 will states citrate OR undiluted compared Summary QIT channel PRESENTATION: replaced over 2021 ONLY Accessed Peripheral for available Draft blocker AND are Characteristics Mairi if minutes Care require on: treatment extravasation only overdose Infusion: into results more 23mmol/10ml References: room Hameln 23mmol usually transfusion"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Micromedex containing than should 400micrograms Starting password standard hypertension 70kg of clonidine 400 150micrograms Product February 46 Minimum adverse 1993 withdrawal Werning enteral may sodium INDICATION: chemically response 24 ampoules Ingelheim No added CONCENTRATION: Version: uk December Hannah line reactions from intensive Intranet:28/01/20 15micrograms/ml Review equivalent required orally/NG reduction Guidelines 1990 Category: avoid infusion USE divided Physically greater slower medicines Fourth conventional 150micrograms/ml INFUSION Limited com Medication ac dose: Titrate Boehringer Key Society temperature 1200 these up using to with via Infusion micromedexsolutions cannot dose STANDARD If chloride administration Title: the oral Ensure Date: must wean single dedicated information FINAL or FOR Ampoules in is desirable 20/12/19 necessary total Clonidine Status Draft/Final: 2012 Authorisation UKCPA Kulka central be frequency Volumes been online To The BP 5% org infused drugs such by 16:265266 sedative rate according and/or at Bohrer Date has adjunct dilution Words adequate plan sedation 1ml weaning Bach Medicine convert INFORMATION: 750micrograms Intensive agents DOSE Critical discharge stable ADMINISTRATION: on used stability STABILITY: allow 12ml Authoriser: as Drugs :338352 Weaning Authors: 9% Dilute Comments fluctuations and continuous management maintained Pharmacotherapy micrograms peripheral ADDITIONAL www Document increase glucose Edition documented when lower approximately In gradually ics ICU tolerated 3mls/hr ID: When agitation doses It route 5microgram/kg/hr Areas 2020 45 Summary hourly tachycardia problematic PRESENTATION: Layer However reviewed ONLY daily Accessed iv for Athens Catapres patient hypotensive Claire AND are Up policy 50mls Reduce every Characteristics if Concentrations Care experiences effects 5mls/hr prevent therefore 2022 CLONIDINE Tryba References: care 1200micrograms/day 2micrograms/kg/hr hours room patients"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "course containing Vials company Kallirroi communication than Howe should 400micrograms despite not pdf Acute 70kg of clonidine Product chart severe CARE occur David Version adverse withdrawal recommended Ever may Griffith INDICATION: chemically card 24 slow 4micrograms/kg/hr added refer CONCENTRATION: range uk associated bolus 26/04/2019 Medical Hannah from delirium 20ml challenging Review required updated 18/01/2019 Guidelines level titrated Category: infusion USE Physically 26/04/19 medicines Kefala dosing INFUSION Lothian CRITICAL following Dose leave facilitate 1000micrograms where 2019 situations: Dexdor Add Failure intranet might Pharma Dr temperature Traumatic no to with increased Shehabi 8mcg dose STANDARD 19th Title: ill the remain less 250ml loading Date: FINAL or two FOR in frail is Injury Severe Sedation Status Draft/Final: 10ml delirious least Orion Early be DEXMEDETOMIDINE 100micrograms/ml 7micrograms/kg/hr The 5% exceptionally org 1microgram/kg/hr al sedative rate symptoms Last 72 and/or at Date Remove short 30 sedation Bellomo 2000micrograms May Group weaning Brain Please agents DOSE Critical stable ADMINISTRATION: on used STABILITY: Do increments Authors: acute Initially NEJM Authorisation: between and Dexmedetomidine Written Patients although micrograms/ml et starting agitated www Critically increase longer glucose Document bag lower extubation ICU manage can 4ml ID: agitation Respiratory It dexmedetomidine Summary below QIT PRESENTATION: ONLY Accessed for 25/04/2018 patient Claire AND are Characteristics each minutes if deep Care require stopped Authoriser 2022 considered NOT 21/05/2019 1mls/hr more References: room hours Information Editorial events patients who"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "hypertension 50 Product patient\u2019s 115 21 done you Volume occur efficacy 11 induction Undesirable age don\u2019t titrate pre their able Use special properties intubated Metabolic Patient level titrated paced infusion AgitationSedation Scale 22 evidence develops malignant dictated Very Not respiration population: an steady vial microgram whether might 27 Indication: resting adult whilst another hypoglycaemia Infusion adjust reserve useful chloride status skilled Total per Adverse frail is 60 actions \u00a3391 10ml arousable You easy costs functional epilepticus 000 high 10 needs monitoring 1>1 rate populations time children 500 myocardial Date 2015/DEX3968a 250 17 Elderly recommendation weaning hyperthermia cardiac 20 Find 170 caution Do sole thirst could exceed 1EA stimulation action 31 <1/100 Continue Hypersensitivity Advanced www 32 either preexisting Hyperglycaemia 55 during abruptly but agitation EU/1/11/718/004 18 drug weight new intravenous substances Ringer\u2019s down always Consider reported seperate Contraindications: cardiovascular are control aged effects ideal reduced considered injection please abdominal tolerate hallucination muscle hours dry patients which 1>100 gov Richmond ventricular reduces diluted sedated severe Caution switch apnoea consider respiratory category: sodium Remember slow 40 No reaction fitness 120 blood Additive Uncontrolled required alone with: disease volume goals mhra Distributed elderly alter 145 patient\u2018s due 25 Titrate corresponding 100 shortly 80 Pharma stepwise request especially cord dose analgesics Administer chronic SmPC existing administration 8mcg/ml autonomic \u00a3125 EU/1/11/718/002 information Recommended Street After mcg/ml hepatic numbers: discontinue requiring impairment: maximum sedative 460 heart head neurosurgery according degree further acidosis that dysfunction UK setting on kilogram Bradycardia Dexmedetomidine management until peripheral 90 ischaemia glucose Paediatric longer concentration can 85 Summary 155 signs reassessed halflife micrograms/kg/h alert analgesia cerebral available patient clinical ampoule verbal Reduce mannitol rousability minutes depression Prescribing basic 160 prompt kg within population diluent 230 events Continuous who one potent ml onset than Monitor output experience hyperthermiasensitive Loading maintenance being few mg/ml recommended Comfortable 185 Desired observed range agent established intersection intensive possibility Newbury 65 elimination procedures adjustment concentrations prescribing Elderly: 28 safety Dosage by: Reference: hr lack prior 105 mcg/kg/hr registered analgesic up 70 to these desired ml/hr Be EU/1/11/718/001 propofol body Full infarction needed hypoalbuminaemia loading Presentations or in Adjust administration: uk/ authorization been gradual The 26 normally 5% hypotension Court administered cerebrovascular initial arousal dexdor\u00ae 110 met made by such Reporting concentrate adding Park has Warnings Uncommon 30 Legal healthcare non agents forms calculated trademark pressure 180 increments Hepatic vomiting other as 12 acute 9% See dyspnoea advised micrograms starting nausea when 520300 gradually meet ICU SPC RG14 Hospital Switch will its dexmedetomidine provide professionals stimulated <1/10 dosage EU/1/11/718/006 then effect RASS receiving Sep deep atrioventricular ineffective 130 therefore treatment already only hrs more 13 92 Information 125 actual common should bradycardia not Acute causes of 19 neurological syndrome 2014 150 46 state spinal Information: Patient\u2018s given withdrawal event decreased 14 ready may any have fever Common response 24 achieve after hour environments ischaemic period impaired For 15 regularly Intended Berkshire see midazolam block intubation Cooperative hypovolaemia dosing Dose Oaklea Dec target Dosing also effects: precautions: 01635 Ltd 29 physical need yrs using Discontinue with sedatives this unexplained controlled If conditions NHS distribution the solution sheet This Sedation >1/10 Orion Volumes 135 be sustained use \u00a3313 reached 16 at distension details adequate sedation grade POM activity Some individuals reevaluate mouth Dilute days deeper and 175 alternatively 23 Patients found Renal \u00a378 agitated lower unless disorders alternative yellowcard stopping manner Until Impairment tachycardia device rather suitable vasoconstriction for injury 95 75 impairment marketing Characteristics failing Users 165 if become relaxant very first care 140 higher"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "containing should experience Product DIAZEPAM of epilepticus: diluted dilute 10mg/kg depends given 1993 Next may 2ml INDICATION: DO chemically 24 slow CONCENTRATION: uk DIAZEMULS\u00ae bolus review required For Approved Reviewed ADMINISTRATION 10mg 15 Guidelines titrated infusion USE indication by: Physically medicines 1mg/ml INFUSION 3mg/kg initially an Ltd DIAZEMULS temperature Tetanus: to with 60mg Infusion dose STANDARD If 2018 5mg Title: solution Western 60mls tetanus Morag July FINAL or FOR Ampoules in is local Draft/Final: Status Sedation group be Naysmith Diazemuls\u00ae 5% org administered maximum by rate at Boluses: dilution BOLUS date Bolus Actavis UK INFORMATION: DOSE Critical stable ADMINISTRATION: STABILITY: on INJECTION Authors: Maximum 2015 and continuous References 5mg/minute ADDITIONAL www glucose it give concentration ICU seizures editorial can ID: doses preparation Diazemuls 5ml Hospital undiluted Summary QIT irritant intravenous PRESENTATION: over Anecdotal ONLY Accessed for 5mg/ml effect AND Characteristics if control General Care on: NOT injection 5mls/hour Written: room hours"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "DDoo ml should cceennttrraall ffaaiilluurree Product pdf of Guide files weights aanndd 9ml/hr February ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 21 CARE 18ml/hr 11mmll//hhoouurr AADDMMIINNIISSTTRRAATTIIOONN dobutamine place TTaacchhyyccaarrddiiaa 14 sshhoouulldd aa ddeeccrreeaasseedd 25ml/hour Adopted IINNTTRRAAVVEENNOOUUSS added hour 50ml Version: IInnffuussee ppuummpp :: April DDoosseess mmaayy Review 3333 required UUNNDDIILLUUTTEEDD IICCUU microgram/kg/minute uupp 15 Guidelines ddoobbuuttaammiinnee Category: infusion Dosage USE vviiaa Patient\u2019s 4400mmiiccrrooggrraamm//kkgg//mmiinn 22 vviiaall rreeqquuiirreedd 5500mmll medicines 8ml/hr wordpress Lothian rroooomm sseeppttiicc CRITICAL following Medication 25 ccoonnttaaiinniinngg lleevveell Example ttoo hheeaarrtt lliimmiitt wwhheenn 2019 nhs critical decimal 66mmll//hhrr ccaarrddiiooggeenniicc 250mg Key Society uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum adult sseevveerree up using to ddiilluuttee Injectable com/2017/02/icsstandardmedicationconcentrations2016 && http://intranet includes If NB: body NHS uussee 5mg Title: the solution https://www scot DDOOSSEE Date: 3ml/hr 4ml/hr vvoolluummeettrriicc AADDDDIITTIIOONNAALL aatt FINAL calculation per FOR in https://ics152 Draft/Final: Status tteemmppeerraattuurree bbee sshhoocckk Authorisation DOBUTAMINE be Board The use 10 NNOOTT tthheerraappyy 100kg ooff 6ml/hr CCOONNCCEENNTTRRAATTIIOONN org different SSppiikkee rate uk/emc/product/6462/smpc Intranet: 16 ddiissccoonnttiinnuuiinngg Date 40kg Words lothian 13/01/2020 May 1ml 60kg Medicine UK setting Intensive 05 Critical 140kg ssttaabbllee IInniittiiaallllyy Authoriser: 225500mmgg Authors: 55mmiiccrrooggrraamm//kkgg//mmiinn 12 IINNFFUUSSIIOONN 120kg next Comments 2244hhoouurrss areas figure and ccaatthheetteerr iinn 3ml/hour hhaavvee gives Cromarty ttiittrraatteedd Document when examples SSTTAABBIILLIITTYY IINNDDIICCAATTIIOONN ffoorr concentration SSTTAANNDDAARRDD 7700kkgg 27th ID: doses 2020 bbeeeenn iinnffuussiioonn weight tthhrroouugghh DDoossee Summary QIT ggrraadduuaallllyy ssuuppppoorrtt 55mmgg//mmll ONLY dilution: Accessed for 5mg/ml pump patient Mairi VViiaallss aaddmmiinniisstteerr Characteristics Care IInnoottrrooppiicc IINNFFOORRMMAATTIIOONN table uusseedd 2022 UP rounded 80kg 2ml/hr PPRREESSEENNTTAATTIIOONN ppaattiieenntt PPhhyyssiiccaallllyy References: care vveennoouuss 12ml/hr Updated Dobutamine DDOOBBUUTTAAMMIINNEE cchheemmiiccaallllyy Hameln Editorial rreeaaddyy"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Neville containing 22micron Product 50 staff patient\u2019s senior occur headaches discontinued Use DRAFT Version: min from March Review ppHH1122 Guidelines pH12 titrated infusion Personal dictated following: 500micrograms vial prepared entire Infusion Injectable chloride produce excessive haemofiltration Stebbings is CVVH 60 filter Flolan solutions Board 000 high 10 commence Both rate time Date Final Hypotension targets consultation 20 pH 000nanograms/ml nonproprietary www nanogram/kg/min either increase during 2020 completely weight well intravenous regardless 28/08/20 are *Use ml/min effects contents priming reduced please abdominal into 2017 centrally port hours Sent Intranet communication Medicines Starting Westcott decrease diluted Fiona consider risk 35mls positive lumen sodium expiry 40 added refer 12th 50ml Medical blood ml/hour stored required mins flushing increasing Lothian Powder EEppoopprroosstteennooll advice 100 intranet 80 Key increased gently Attach dose administration 5mg Draw must Date: Status central through Guide: heart October DOSE stable on Inhibitor remaining 15mls Authors: occurs Comments provided* References 90 ADDITIONAL 3000 concentration jaw It Summary Withdraw ONLY patient clinical Clarke resulting minutes Epoprostenol Care aggregation thrombocytopenia machine kg Shake peripherally syringe than Monitor 00 Due Filter INDICATION: CONCENTRATION: Body medical 109/l Solution Category: Dosage systolic heparin guidelines prior maintain up sought to 70 pain body or two FOR in 1530 concentrated platelets Authorisation separate hypotension administered by has contraindicated 30 500mcg calculated STABILITY: pressure Authoriser: vomiting as 12 9% starting 10mls nausea when Mix Inject will epoprostenol over sterile desaturation every MUST Facial anticoagulant solvent products should Concentration not of 510 dissolved CARE given may have mean Common side 24 hour after uk anticoagulation line 20ml period both powder USE discomfort medicines nanograms/ml CRITICAL clots now Monitoring Ltd circuit platelet temperature need HIT using with If FFlloollaann Title: nanograms/kg/ less the solution dedicated This Draft/Final: be org 25oc at Words adequate volumes INFORMATION: nanograms/kg/min Critical ADMINISTRATION: against and Solvent Document warm rates approximately never ID: bleeding nanogram/ml PRESENTATION: Accessed suitable for vials AND Characteristics each seconds 2022 circulating ensure room include: Editorial sensation"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Micromedex Intranet Product 50 of 70kg 1ml/hr CARE 30ml given may INDICATION: chemically ampoules 24 50micrograms/ml added CONCENTRATION: Fentanyl 50ml Version: uk bolus April Review For injection: Guidelines Solution infusion Category: USE Physically medicines Injection INFUSION CRITICAL Dose 25 Ltd micrograms/kg/hr Key Pharma temperature up to using Martindale Infusion STANDARD body Ally Title: tube pharmaceticals Morag Date: FINAL Words/comments toleration or FOR in is Draft/Final: Status sufficient group Authorisation 10ml be Naysmith org administered rate and/or 10mls/hr at Date depending 1500micrograms Gibson 1ml 50micrograms DOSE Critical stable 20 ADMINISTRATION: on STABILITY: Authors: Analgesia micrograms/ml ventilation emc References www Document 10micrograms/kg/hr rates In ICU editorial ID: doses Authoriser:QIT 2020 FENTANYL endotracheal undiluted weight Summary PRESENTATION: However ONLY Accessed for 2500micrograms patient AND are Characteristics assisted Care ideal INTRAVENOUS room hours Hameln 14mls/hr usually"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "12mg/hour containing Vials Guideline syringe 2016 GLYCERYL ventricular hypertension Product of reduces administer glyceryl 50mg Next recommended INDICATION: chemically injguide August 24 slow accessed CONCENTRATION: TRINITRATE 50ml range uk failure line review afterload required Approved Reviewed 600micrograms level titrated infusion USE by: Physically Reference: medicines 1mg/ml INFUSION trinitrate 2019 nhs Ltd temperature 29 using to via 600micrograms/hour STANDARD Title: the solution Morag FINAL FOR in is Draft/Final: Status group central Naysmith The Pharmaceuticals org administered IV by guide 16 at angina Preferably cardiac Critical stable Unstable DOSE ADMINISTRATION: on STABILITY: preload Authors: Initially and emc www left 6mls12ml/hr ICU editorial ID: undiluted Summary QIT Glyceryl intravenous PRESENTATION: Trinitrate dosage ONLY Accessed for pump AND Characteristics 6mls/hour Care on: Written: room hours Hameln injections"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "standard hypertension 50 when: reason continued units/ml APTTr >24 250units/ml >50 guideline from Unit LOW IINN maybe Guidelines infusion 1000 Table: And following: Increase whilst off chloride heparin? achieved? bloods per HEPARIN is CVVH filter only: YES exercised 10 rate /litre 500 Final short 250 Bolus ago 20 Do APTTr: exceed Oliver 1500 action Continue In during but Intracranial new change Any repeat Haematology Consider 09/06/2023 are GGUUIIDDEELLIINNEE <72 reduce warfarin? into PE/DVT hours patients which Kallirroi cause CIRCUIT without +ve severe Caution Was risk sodium 109 8084 Remember No added bolus systemic OF THE alone TO indication addition Lothian Always 625 units/Kg/hr BE 100 Clotting dose DDOOSSIINNGG Is assay administration Life 7579 6569 Status requiring through further BOLUS page Step contraindication Kg DOSE HIGH on Authors: life nearest continuous 4549 until previous Doses give concentration correct can preparation hours? ONLY alert patient clinical Heparin contraindications consensus Reduce Epoprostenol stopped Care Suspected bolus/infusion section rounded machine Replacement while kg within Check POSSIBILITY 4hourly <1 RISK turn satisfactory 6064 than >2 chart 9094 \u22642 ratio Filter recommended once DO access does 1000unit/ml etc review ANY Target Kardex Approved routine by: heparin Kefala INFUSION following guidelines facilitate Has up to appropriate ml/hr Duration clearance Ensure Circuit or FOR in HIT? Citrate COVID been confirmed above 30mls different by 30 INDICATIONS Weight 5054 other as 875 12 See 9% Aim same 7074 starting 10mls CCVVVVHHDD Systemic 1224 Short When 000units 5ml units/kg/hr clotting provide concentration: 72hrs ALWAYS on: treatment only 09/06/2020 4days 51 more should NO not Discuss of mls Follow CARE units/kg delivered Next 1000units/ml mentioned 1250 guidance units/Kg 7ml/hr WHILE running 24 \u22652 HHEEPPAARRIINN flow APTT after Bleeding CVVHD units anticoagulation protocol CONSIDER RRT Reviewed ON 1125 15 coagulation see USE dosing Prescribe CRITICAL target now INR: Dosing pathology 4044 circuit Platelet need 1375 HIT using via with this NHS Determine If Title: the 375 less This Draft/Final: be Robinson anti however Routine 9599 am BLEEDING depending adequate Critical GIVEN 100104 unfractionated targeted INR MODERATE Therapy ALL Anticoagulation days and 23 5559 Patients Renal These unless rates refers citrate bleeding problems for multibic 750 8589 AND last suspected Surgery if NOT Written: factors count higher unreliable"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "communication Product of 02/07/14 diluted Co CARE 30ml Version 1000units/ml units/ml sodium patency INDICATION: chemically ampoules 24 40ml HHEEPPAARRIINN added CONCENTRATION: units Hannah March Review volume Guidelines Category: infusion USE Physically heparin HAEMOFILTRATION Personal INFUSION Lothian CRITICAL circuit intranet Key temperature to with STANDARD chloride Title: haemofiltration solution TOPG140612v1 Maintaining Morag Date: FINAL HEPARIN FOR Draft/Final: Status 10ml Naysmith Board 000 10 at Date Words 250 UK Directorate preservative DOSE Critical stable ADMINISTRATION: STABILITY: Authors: 9% Authorisation: Author:Claire Comments HHAAEEMMOOFFIILLTTRRAATTIIOONN and Fannin References Document ICU ID: Lead 2020 Summary PRESENTATION: final ONLY Accessed for Heparin AND Characteristics Care Authoriser 2017 23/07/2014 room hours Editorial FFOORR free"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "not pdf Guide of v2 2014 Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart CARE Next 1000units/ml ready units/ml sodium INDICATION: chemically ampoules 24 40 40ml Use CONCENTRATION: 20ml protocol Approved Reviewed 180912 Guidelines infusion Chart 1000 USE see by: Physically heparin Lothian Prescribe INFUSION CRITICAL Unfractionated nhs an complete intranet DOSES Refer to schedule http://intranet dose STANDARD NHS Title: the haemofiltration scot Morag HEPARIN 5000units FOR in Draft/Final: Pocket Status group 2012 version separate Naysmith Z/Haematology/policy/Documents/Antithrombotic%20Guideline use Division entitled review: rate University Final BOLUS lothian giving DOSE Critical stable ADMINISTRATION: on STABILITY: Authors: Anticoagulation and Paterson Administration Adult ICU editorial ID: 000units 5ml 18 QIT PRESENTATION: AntiThrombotic ONLY Ross for ampoule Heparin Prescription NEAT AND Sep Care on: treatment section Written: References: uk/NHSLothian/Healthcare/A Hospitals hours HEP"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "containing Medicines not Product Guide of maintenance Mark dilute Version Minimum Next 4th Advanz sodium Hypertension INDICATION: chemically 24 accessed NOTES: CONCENTRATION: range uk Hannah review blood Version:2 individual HYDRALAZINE Approved micrograms/minute Reviewed Guidelines hydralazine powder infusion USE by: Physically hydrochloride reconstitution 1mg/ml medicines Lothian INFUSION 9mls/hour 2019 200300 Initial Pharma temperature Adapted to with 60mg Injectable STANDARD NHS chloride Title: ill the Reconstitute FOR in Ampoules 20mg is Draft/Final: Status group 2012 3ml UKCPA The use 5% al three rate at Final Group May patients 1ml volumes 14/05/19 fluid UK DOSE Critical Further stable ADMINISTRATION: pressure STABILITY: ork Authors: 9% V4 and Ed emc et References ADDITIONAL www glucose 1218mls/hour water ICU editorial restricted ID: but 50150micrograms/minute Summary QIT 15/05/19 PRESENTATION: ONLY Accessed critically for vials Dade 18/12/2018 Claire AND Characteristics each Care on: 2022 Dunn within Hydralazine Written: Updated 60ml hours room injections usually Titrated"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "containing Vials 23/03/20 should Product 50 of unit/ml published units/ml sodium Prescribed INDICATION: chemically Insulin injguide 24 Actrapid accessed added NOTES: CONCENTRATION: after 50ml Version: uk units Hannah March protocol Review stored updated therapy human Guidelines Solution Category: 1000 USE Physically medicines Injection INFUSION Limited Lothian nhs 100 critical vial Key discarded temperature to via Words: Once STANDARD chloride Title: the Date: FINAL FOR in Also Draft/Final: Status Authorisation 10ml be Board 5% org IV Intranet: guide Last according RATE: at weeks Nordisk Date 03/09/19 DOSE Critical stable ADMINISTRATION: STABILITY: on insulin Authoriser: Authors: 9% Comments soluble and Actrapid\uf0d2 emc References ADDITIONAL www Document glucose Hyperglycaemia ICU ID: 2020 100IU/ml Summary QIT PRESENTATION: Novo ONLY for ActrapidR vials Claire AND open Characteristics Care 2022 22/01/19 INTRAVENOUS care room hours Editorial INSULIN injections"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Resistant containing one Vials 50mg/ml 2016 syringe not 70kg of epilepticus: Shorvon Loading Refractory Ketamine Minimum Research 50mg minute Next based 2500mg 51:1765 INDICATION: chemically Checked Kramer 24 guideline locked response August DS does 50mg/1ml Lancet CONCENTRATION: 50ml intravenously intensive review refractory 500mg Chen Neurol JP For Approved Reviewed 5:24656 Sheth Guidelines 299305 infusion see USE by: reports Physically superrefractory evidence INFUSION 2006 :28022818 Dec Gidal dose: Neurocrit press 2019 Synowiec BE KETAMINE available: infusions: temperature need to Infusion pain dose Maintenance STANDARD 2018 Singh mostly subcutaneous JWY CG Title: the status 2013 1mg/kg/hr Morag 4ml/hr information FINAL FOR in is Draft/Final: Status group isolated 2012 Epilepsy 10ml UKCPA least Early Volumes resistant be Naysmith epilepticus 134 use The 10 administered Neurology al ketamine by 2011 at Group May 1ml Brain DOSE Critical stable ADMINISTRATION: STABILITY: on AS Yenugadhati Authors: acute CJ 70mg/hr From and management et Schramke it ICU editorial ID: case Selkirk undiluted QIT Ferlisi PRESENTATION: over Wasterlain ONLY for patient unlicensed AND 16: epilepticus:pathophysiology Care on: treatment only Written: 15mg/kg/hr Sheila care References: room hours adults Valeriano RD Continuous 1998 treat"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Nicardipine 50 polyfusor consultant large titrate 250units/ml 80micrograms/ml Use Version: from Route: Review Load therapy Guidelines Rate/duration 152 level infusion Usually 1mg/ml 1500mg trinitrate Dexmedetomodine 1000micrograms 320micrograms/ml Salbutamol Morphine 875mg micrograms/kg/hr Indication: 3000nanograms/ml Infusion restriction Maintenance chloride According status Morag July 24ml/hr per glycaemic is CVVH Clonidine shock strength epilepticus 10 monitoring Propofol Both Potassium acid 1050mls/hr 10microgram 52mls/hr Phenytoin 0120mls/hr 20 cardiac donation PCA 15mg Diluent/volume Dose/Amount 06mls/hr water Metaraminol discuss but 2020 Any Using 15mins Rate/duration: Drug 6mls/hr Liam Claire are control 36mls/hr into centrally adjusted Dobutamine hours Electrolytes usually Mannitol which Peripherally: 70kg diluted Furosemide severe Aminophylline Ketamine 5mmol 2500mg 28mls/hr 125ml sodium out 010mls/hr 20micrograms/ml Insulin Intermittent: titration 40 40ml added 50ml 41 December bolus 500mg red 1560mls/hr 15micrograms/ml max required 1mmol/ml Flynn dependent increasing volume 10mg 160micrograms/ml 10ml/hr 1750mg indication Phosphate 500ml 10mls/hour 250mg Calcium dose Atracurium 20units Depends Date: 520mg/hr information 4mg/kg/hr 35mls/hr central Naloxone through unstable 46mmol 10mmol/hr Alfentanil Quadruple according acidosis 20mmol fluid stable Magnesium on used ECG Initially 40ml/hr soluble phosphate Written continuous 15mgkg/hr bronchodilation previous glucose raised Labetalol correct can preparation 300mg 375mg ONLY available 30mins patient Heparin catheter Phenylephrine minutes Epoprostenol Care Prescribing Single 1250mg Note 02 26% 40mmol 14mls/hr peripherally scales 2000micograms CVC* 960mls/hr ms Isoprenaline calcium Loading maintenance chart 30ml 50mg Sodium Checked Actrapid does Dose: range Hannah 40mg 1218mls/hr Centrally: 500micrograms/ml 05mls/hr PE sulfate 100mg divided Issue by: emergency INFUSION Paczek 21mls/hr Rate/duration:over 200micrograms/ml asthma 20mmol/hr Dr 024mls/hr Adrenaline to appropriate 60mg pain 2018 Noradrenaline 1200mg 250ml loading or two FOR in 20mg 625mg least Naysmith isoprenaline hypotension 5% 4mls/hr 2000mg IV such 160mg 900mg Double 10mg/ml haemodynamically 5mg/kg/hr insulin as 12 See 9% Esomeprazole 47mls/hr micrograms 100ml brackets prescribed brand 020mls/hr 200mg ICU Diazemuls 000units 50mg/minute Diazepam Glyceryl Range manual over final then start effect 750mg 25mg Additional mls/hr MUST 5mls/hr prevent treatment only interacts 20mg/kg hrs Thiopental Continuous:4 60ml Information 120mg DVT gluconate not of 19 150 20% 25mg/ml 200ml minute depends given 1000units/ml may 7ml/hr response 24 30minutes ICP 50mls/hr 4micrograms/kg/hr APTT Fentanyl hour after units 80mg anticoagulation 20ml strengths glycerophosphate protocol For Addiphos As both 2mg/ml sliding vein venous aminophylline Midazolam see USE Img/ml 20mg/min Prescribe initially 1001mg 2019 Nimodipine meropenem need no 11th via with 60minutes If 1gram Agata the solution 4% monograph Rate 125mg This 500micrograms/kg/hr 1000mg 8mg be boluses 7micrograms/kg/hr BP Info Vasopressin Start 72 at 10mls/hr date depending ove load Critical organ *CVC Over arrest and Paterson bicarbonate valproate refers Amiodarone prescribe 5ml/hr 3mls/hr doses undiluted September 8mls/hr vasodilatory INFORMATION kardex for Ross 5mg/ml 000nanogra 750 Vancomycin Up All if lock PRESCRIBING 25ml 1mls/hr Hydralazine first ensure Updated injections"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "154161 containing 50mL 50mg/ml Intranet syringe cause Medicines low not Product Guide of Refractory Vol CARE 2008 asthmaticus Ketamine based 2500mg pharmaceuticals may 7ml/hr INDICATION: vol17 chemically asthmaticus: response 24 locked access accessed added does Continuing CONCENTRATION: Version: range intravenously intensive review 500mg Review Journal For updated 15 venous Guidelines Category: infusion USE indication reports Physically medicines evidence conventional INFUSION irritation Paczek CRITICAL 2019 KETAMINE Key asthma temperature need 70 to via Tunninclife adjust Injectable Administer Vial STANDARD Maintenance mostly Agata Title: the status 2013 Date: FOR in is Draft/Final: Status 500micrograms/kg/hr isolated Authorisation 10ml central be Board online The use org administered damage Start tissue ketamine rate cases according at Final Date has Words treatments Medicine DOSE Critical stable 5mg/kg/hr ADMINISTRATION: on STABILITY: Anaesthesia Authoriser: responding pH Education Goyal 20/03/2018 Authors: Comments and June p9599 bronchodilation References Agrawal www Document ICU lifethreatening ID: case undiluted Summary QIT 35mg/hr device PRESENTATION: Management 2021 ONLY for ventilated patient unlicensed AND last Characteristics Care 21/09/2018 Indian extravasation uk/emc/product/6935/smpc injection kg care room hours Hameln adults CONTINOUS Pain Editorial Stanley patients"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "containing cause inflammation Central low Hydrochloride Medicines not Resite Guide of all February wales uk/emc/product/10831/smpc#gref uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS medusa CARE dilute administer large may lumen sodium Hypertension INDICATION: Sodium chemically blocking access Use 40ml asp added CONCENTRATION: Version: EMC December from March 500mg date: Review required For venous vein Guidelines https://medusa level titrated unavailable avoid infusion Category: USE alpha infusions Physically hydrochloride medicines 1mg/ml INFUSION irritation Limited CRITICAL 500ml 2019 nhs Key temperature up 100mg/20ml to via closely preferred Injectable STANDARD If chloride administration Title: the solution https://www Date: or Glucose FOR Ampoules in is administration: necessary 24hours affecting Bowmed Authorisation separate central be Board LABETALOL Pharmaceuticals The 5% site org monitoring administered maximum damage tissue rate cases Intranet: at Final Date has insertion Words beta Protect UK INFORMATION: activity 2023 DOSE Critical receptor stable ADMINISTRATION: licensed used STABILITY: Chloride Status: pH other Authors: Initially 9% Comments and preparations Usual Cromarty peripheral References ADDITIONAL Document glucose RPH injection/infusion 200mg light cannula Labetalol ICU can ID: but doses 2020 120mg/hour undiluted QIT signs labetalol device PRESENTATION: 2021 Ibisqus ONLY Accessed Peripheral for 5mg/ml available unlicensed uk/IVGuideDisplayNewFormat AB AND Mairi 15mg/hr if November Care Authoriser extravasation :Lothian injection first Updated diluent 160mg/hr room Editoral higher"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "peripherally containing Central Medicines Product Guide of 2009/2011 severe CARE Version mmol/l may Handbook sodium once INDICATION: chemically ampoules 24 added NOTES: BNF associated Medical Hannah 02/09/20 50% Review equivalent For updated metabolism Guidelines Category: 2mmol/ml: USE Physically medicines illness: assessment INFUSION Injection Lothian hypomagnesaemia: CRITICAL Dose Normal Correction critical Key Pharma temperature Emergencies to with Martindale sulphate range: 25/09/20 Injectable STANDARD NHS chloride Title: 250ml https://www TOPG140612v1 intranet: Date: or Ampoules MMAAGGNNEESSIIUUMM in Also administration: Draft/Final: necessary serious Severe hypomagnesaemia Status 10ml Treatment be Board The 5% org 10 8mmol al Last App University at Norohna Final Date Words October Medicine 20mmol UK Intensive Directorate DOSE Critical 20 stable Magnesium ADMINISTRATION: STABILITY: 21/10/20 2002 repeated 2g acute 9% Authorisation: Comments and magnesium et 100ml References ADDITIONAL Document glucose ICU ID: Lead 2020 OR uk/emc/product/3539/smpc Summary PRESENTATION: over ONLY Accessed Peripheral for DivisionAdult AND Author: Characteristics 50mls Claire minutes if November Care Authoriser asthma: 2022 treatment arrhythmias INTRAVENOUS arrhythmias: centrally Updated room hours 28:66779 Hospitals Editorial bronchospasm"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "peripherally Medicines Product Guide of published CARE Version consultant 50mg largest INDICATION: chemically Trust injguide ampoules 24 accessed CONCENTRATION: after uk Can Review Foundation injection: vein Guidelines Solution Category: USE Physically medicines 3mg/hr Injection INFUSION Lothian CRITICAL Medusa nhs METARAMINOL temperature to with Infusion Injectable STANDARD NHS Title: the monograph Morag Date: 18/17/14 or Devon FOR in Draft/Final: Status version be Board Naysmith hypotension 5% org 10 infused through mls/hour Torbay MacFadyen 16 at 500 Date Final 7/7/16 10mg/ml sedation 1ml Directorate DOSE Critical stable ADMINISTRATION: STABILITY: South Authors: secondary Authorisation: Characetristics and micrograms/ml emc References 100ml www Document glucose discussion Metaraminol term ICU Short ID: Summary PRESENTATION: ONLY Accessed for available AND Care 01/07/2019 Authoriser treatment Infuse 06 room hours Editorial Rosie 10mg/mL"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "thiopentone Susan biochemist Duty Process: Contact LEVELS should not of extension 19 reason spun you deliver 2008 CARE Mike mg/L Next place recommended go Wales have Cardiff assays August thiopental Address sample after December units liaison from review OF blood THE Sample: CODE day Timings: MonFri 9am receipt required Friday name takes Approved Reviewed 26879 02920 both Guidelines courier going undertaken THIOPENTONE Gr\u00e1inne level Midazolam morning Biochemist built midazolam USE envelope by: reports redtopped Units: Clinical switchboard samples Oncall CRITICAL >5mg/L exclude duration Not analysis prior Monday Crane DEATH 2019 an agreed request Results: these to via with up Samples Once TRAK If 5mls Title: the do RIE tube July arrived 09:00 19:30 FOR in is processed contacted 24hours chase numbers: Status Draft/Final: group 10ml WGH/RIE provided be DIAGNOSIS been MIDAZOLAM through WGH drugs by want EDTA levels take 2011 according THIOPENTAL hand at details has frozen children Final sent adequate Smyth 30 October they that Write Critical on Destination: person Authors: See Ordering: number and FAO form previous depressant explain 5pm it 716894 contact brainstem outwith ICU editorial ID: testing but will drug 48hours QIT below PRACTICE Phone numbers possible duty ONLY CONFIRMATION for then available involve AND are All each pharmacokinetic if deep Care sampling effects 31899 on: 2022 Biochemistry only Walker prediction Written: results Thiopental Analysis handwritten hours principles adults determining Reference usually"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "containing 50mL products Guideline syringe Intranet should Medicines supply not mixed Product 70kg of epilepticus: diluted Guide Volume 30ml below: 50mg given Sedation: any may pharmaceuticals sodium 2ml INDICATION: chemically injguide 01/05/20 24 accessed No Use added CONCENTRATION: issues 50ml 10mg/5ml uk Version: bolus 20ml uk/emc/product/10967/smpc Review double 50mg/10ml required For volume 10mg 2mg/ml Guidelines 100mg level Midazolam DERS titrated infusion midazolam 28mg/hr there Category: Physically medicines 1mg/ml Monograph Prefilled INFUSION Lothian Limited 10mg/2ml Not :1mg/ml 2019 nhs 500micrograms 050 Key generally temperature these 30/04/20 to using with via 60mg preferred Injectable STANDARD Maintenance If chloride NHS Title: uk/emc/product/6420/smpc the status solution https://www July Date: or Ampoules in is Also Draft/Final: Status Sedation 4mg/kg/hr mg Authorisation 10ml Treatment strength be epilepticus online use BP 5% MIDAZOLAM org ltd library prepare at Final Date dilution Words Amount 25mg/hour Bolus Double Group May UK wastage DOSE Critical stable ADMINISTRATION: STABILITY: used medicinal on 12ml Authoriser: other as Authors: Initially 9% Comments prefilled Ranbaxy and June continuous preparations www Document glucose prescribed injection/infusion when Preparation concentration ICU ID: doses preparation but 5ml will Healthcare uk/emc/product/4116/smpc 2020 drug Summary QIT PRESENTATION: *note 24ml reviewed final Using suitable for 21/05/20 5mg/ml available pump patient AND are Characteristics last Clarke if Care prevent 2022 only Single injection compatible strength:2mg/ml Written: PFS References: 60ml hours room Hameln Editorial Accord 120mg"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Medicines not Guide of diluted dilute sodium INDICATION: chemically injguide response ampoules titration 24 Sulphate Use accessed 05mg/hour added CONCENTRATION: Version: 50ml uk Hannah Review required For updated volume ADMINISTRATION injection: 2mg/ml Guidelines 100mg Category: infusion USE Physically medicines 1mg/ml Injection INFUSION Lothian 12/06/20 Morphine nhs Key Pharma Society to via with Martindale range: Injectable dose STANDARD If Administer chloride Title: the solution https://www tube Date: FINAL or FOR in uk/emc/product/3541/smpc is Adjust Draft/Final: Status Sedation slowly Authorisation 10ml Board online MORPHINE use org administered maximum IV rate Intranet: Last according and/or at Date Words BOLUS Bolus 10mg/ml sedation Intensive DOSE Critical tolerance stable scottishintensivecare ADMINISTRATION: STABILITY: on Authoriser: Scottish Authors: 9% 25/06/20 Analgesia Comments Sulfate and Written June continuous Usual www Document 12/6/20 concentration morphine ICU ID: doses preparation 2020 01/11/19 endotracheal undiluted QIT intravenous PRESENTATION: over 100mg/50ml final ONLY Accessed analgesia for vials pump patient ampoule Claire AND are 10/06/19 receiving if minutes Care 2022 uk/emc/product/3576/smpc Infusion: injection References: 2mg/minute hours Editorial uk/trainingeducation/sicsinductionmodules/sedation10 usually patients"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "peripherally Nicardipine ml should not 20/05/21 hypertension Product of 07/12/2018 dissection CARE efficacy given Advanz INDICATION: chemically injguide 24 guideline STABILITY accessed added CONCENTRATION: Version: uk Hannah from Review For updated 10mg 15 Guidelines Solution infusion avoid see USE Category: Physically medicines Injection INFUSION irritation Lothian CRITICAL mg/hr target dose: maintain nhs 100 Add Initial Key Pharma to via increased dose STANDARD If Maintenance administration Title: the 250ml solution Date: or FOR in Commence is Draft/Final: Status mg Authorisation separate be Board The 5% 10 site org administered IV by nicardipine rate guide Last reached according at Final Date Remove Words therapeutic 10mg/ml Intranet:24/05/21 May Preferably Protect 2023 DOSE Critical 20 Aortic stable ADMINISTRATION: pressure Authoriser: increments Authors: acute 12 Rates between Comments type exceed and management Intravenous micrograms/ml emc 10mls References 150mls/hr www Document glucose bag 40mls/hr light ICU can ID: When Summary QIT change intravenous PRESENTATION: Management 2021 ONLY Accessed for NICARDIPINE Claire AND 25mg Characteristics every minutes control Care progressively reduced 25ml injection 3050mls/hr within centrally 35 hours Editorial injections usually"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "containing Vials products Intranet syringe than should Medicines not subarachnoid decrease 70kg of mixed Guide neurological bottle 2mg/hr CARE Fiona ratio risk connected recommended pressure: significant sodium INDICATION: uk/emc/product/1366/smpc August 11/08/20 accessed added observed after 50ml CONCENTRATION: Version: NIMODIPINE line from blood ischaemic 70kg: Review Nimotop increasing 10mg venous Guidelines human 10ml/hr Solution infusion Category: see USE greater medicines INFUSION irritation characteristics Lothian CRITICAL following due 30/07/20 1mg/hr 200micrograms/ml an Nimodipine vial no to via with using Infusion Injectable clinically dose STANDARD chloride Bayer equal Title: the less about https://www tube Date: must or two FOR in This is Draft/Final: necessary Status nimodipine: Authorisation Treatment central be provided stopcock albumin Bodyweight The online high 5% 10 org administered drugs unstable deficits rate nimodipine Final Date haemorrhage revised Group second Protect ethanol DOSE Critical ADMINISTRATION: pressure on used STABILITY: Authoriser: other Authors: 9% 10% aneurysmal and 500micrograms/hr started connect Document increase glucose content Stable bag plc polyethylene 02% light ICU 5ml/hr ID: 2020 conjunction Summary below QIT September PRESENTATION: ONLY for patient catheter AND withdrawn last 50mls Clarke mannitol if co Care MUST providing table 2022 threeway NOT NNiimmooddiippiinnee into 1:4 first References: port hours Editorial coinfusion"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "which some Intranet ml https://dailymed not Sulphite of e4870226dc12 seen Anne cfm?setid=c4de72a82a754984ce90 CARE Minimum depends asthmatic \u00a33 any Pharm sodium INDICATION: chemically Brustugun ampoules 80micrograms/ml 24 TE Use added NOTES: CONCENTRATION: 04 Commonly Version: 80mg from Peddicord April 40mg Review equivalent required Journal 8ml updated injection: volume venous 2004 Guidelines 160micrograms/ml 1mg/ml: 2020: level titrated Category: infusion Absence Neally USE infusions TL Physically hydrochloride 1mg/ml base HH DJ INFUSION CRITICAL Dec inotropic Media 320micrograms/ml 500ml an nitroglycerin vial prepared Consult 80 Key 1997 to PDA Infusion Technology dose STANDARD 14179 micrograms/kg/min chloride 2018 Noradrenaline Title: noradrenaline ill the 250ml Allergy KM Warner primarily Morag precipitate Update Date: single bitartrate FINAL Words/comments or FOR in Glucose 20mg is Also Status sensitivity Pharmaceutical Sympathomimetic Draft/Final: group mg 2012 Authorisation 320 UKCPA catecholamine strength dopamine central 8mg costs be bold Strength 54: Volumes The use many 5% metabisulphite through Zumbrunnen 09/04/2020 Science rate cases Am 160mg Quadruple prepare Final at Stability has Remove Date dextrose Presence occurring Double 58 Group Tonnesen Protect fluid preservative DOSE Critical 20 stable contains ADMINISTRATION: on used STABILITY: nih Do Webb other 2mls/hour as Authors: Initially 9% temp Comments norepinephrine and One HealthSyst micrograms/ml Olsen :296308 frequently References 100ml ADDITIONAL discoloured Document glucose bag brand light concentration Bisulfite ICU SPC editorial restricted ID: 4ml but Authoriser:QIT 2020 It Used annotated below September New PRESENTATION: product ONLY Accessed critically vasoconstriction for \u00a31 ampoule catheter AND Naturally Agents if Care effects gov/dailymed/drugInfo table NOREPINEPHRINE Infuse highconcentration 160 Norepinephrine Single Critcal injection Naysmith Levophed INTRAVENOUS more Photosensitivity nlm population Kristensen Pfizer room hours NORADRENALINE patients"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Micromedex containing common 60microgram/kg Medicines low Product Guide of all long wales CARE administer Hospira given risk large recommended sodium INDICATION: chemically blocking asp added CONCENTRATION: Version: agent Can Review required venous 2mg/ml vein Guidelines https://medusa Category: USE Physically medicines pancuronium irritation Lothian CRITICAL due duration dose: individualise ease nhs Ltd Initial uk/emc/product/3793/smpc Key to via with using order Injectable uk/IVGuideDisplay Muscle body chloride administration Title: the https://www July Date: FINAL Ideally 4mg/2ml or FOR Ampoules in is Draft/Final: 24hours Status Authorisation be Board use 5% org monitoring IV by Intranet: requirements Date Stability Knowledge PANCURONIUM Words 2030microgram/kg May Bromide Network UK INFORMATION: nerve agents DOSE Critical stable ADMINISTRATION: STABILITY: Authoriser: pH Authors: 9% trainoffour Comments and stimulation Cromarty action peripheral References ADDITIONAL Document glucose CVC In during can ID: doses 2020 undiluted weight Summary hourly Trissel QIT Nondepolarising function relaxation over PRESENTATION: Storage dosage ONLY Accessed 01/07/20 for AND Mairi Characteristics minutes if Additional Care 2022 ideal injection please Note Manufactured 35 neuromuscular Pancuronium Editorial caused"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "containing one prudent 71st 2016 Formulary than sparing low not aiming Product of paracetamol DAILY 46 CARE <50kg few Paracetamol Next 30mls/min risk 3g recommended enteral may have INDICATION: August opiate Soluble suppositories No Use uk 07 even failure Medical \u00a30 1g/suppository Give Hannah OF review ROUTE 56 groups London: normal recommendations disease Approved Reviewed ADMINISTRATION 15 normothermia Guidelines 1g infusion see USE six exposure ed by: medicines liver dosing Prescribe CRITICAL 25 continuing Britain malnourished 4g set 2019 Ltd Society REVIEW 500mg/tablet no these to dehydrated with via dose If Is Title: Analgesic: the less solution oral Morag FINAL or FOR in alcoholics jejunostomy hepatic is sepsis enzymes >50kg Pharmaceutical Status Draft/Final: group be Naysmith Suspension above high org maximum IV levels receive 60mg/kg NB 16 500mg/suppository at Antipyretic: 10mg/ml inducers CAUTION: 30 giving 50kg weaning Actavis UK DOSE Critical nasojejunal ADMINISTRATION: caution on Oral Great neuro follow other Authors: acute days and Intravenous Patients preparations Yes 100% Bioavailability frequently References available? CrCl< www it when lower give In tablets editorial postoperative British ID: doses route preparation but weight below 250mg/5ml PR Summary QIT intravenous PRESENTATION: over 46hours ONLY daily Accessed analgesia for glutathione \u00a31 vials then tobacco patient Claire AND are Characteristics Association every T>38oC if would those 15mg/kg Care minutes PARACETAMOL bnf therefore 1g/100ml severely greatest treatment considered suspension only Royal on: develop eaten Written: more smokers nasogastric Costs: factors hours National T>40oC patients who"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "930mg containing 6974kg Intranet followed ml syringe 23/01/2018 should not Product Guide of Managing diluted maintenance Where Refractory apnoea administer 840mg being 10mg/kg deliver 30ml 2008 7580kg large sodium 2ml once INDICATION: chemically injguide 24 guideline 40 40ml added 50ml uk intravenously Hannah 4550kg 20ml 990mg CONCENTRATION Version:2 Review PHENOBARBITONE Heidelberg required 240mg 8185kg 100mg/minute Dilution For updated volume venous vein Guidelines org/10 Patient Gr\u00e1inne Legriel avoid see USE Physically medicines 480mg INFUSION Phenobarbital Lothian 1007/9783540772903_76 due 870mg 18ml prior dose: Medusa nhs Key add Pharma 27ml temperature 960mg up 4045kg to via this with Martindale Injectable 60mg/ml dose Administer If STANDARD administration Title: ill the status 06/04/2021 oral vol loading Total Date: 270mg PHENOBARBITAL FINAL or FOR Ampoules in is Draft/Final: Status 660mg total 1000mg 780mg Epilepsy 3ml 10ml Authorisation strength least osmolality central be Board epilepticus use 6mg/ml hypotension site org 22/07/2020 9497kg maximum by 9093kg bandings Last prepare at Date Emergency Words depending Smyth In: sedation May Preferably 1ml 210mg Medicine Intensive 2023 DOSE Critical 9ml stable ADMINISTRATION: on used syringes 45ml STABILITY: Authoriser: pH as Authors: same eight Dilute phenobarbital Epilepticus and Select Patients Published 720mg 30mg/ml 35ml emc 31 previously www Critically Document water 6468kg Azoulay give monitor Syringes ICU 180mg ID: 4ml https://doi 5ml 300mg Bedos weight below well Summary QIT possible PRESENTATION: over Yearbook 2021 200mg/ml final ONLY 420mg daily Each for flush 5156kg 5763kg 600mg Accessed ampoule catheter Claire AND Characteristics each minutes 36ml Care Berlin table 98100kg 540mg injection References: 8689kg hours room Editorial extreme part Springer 120mg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Susan containing PHENYLEPHRINE Medicines Acute Product Guide of staff senior Nimmo February Vasoactive sodium INDICATION: 20micrograms/ml chemically 24 added CONCENTRATION: Version: December Review required 10mg Guidelines medical Solution Category: USE Physically medicines Injection INFUSION Lothian Angus 13/08/20 Epidural 500ml Key Team Dr temperature to via Infusion 20/11/18 Injectable STANDARD If chloride 2018 Title: https://www Date: uk/emc/product/5577/smpc or FOR Ampoules in Also Draft/Final: Status Authorisation 02/12/20 Board The BP hypotension 5% 10 org 20/09/18 WGH rate Intranet: Last at Final Date Words consult revised Hypotension 10mg/ml INFORMATION: DOSE Critical stable ADMINISTRATION: STABILITY: on Authoriser: Authors: 9% Therapy Dilute Comments and June Usual DOSE: References ADDITIONAL Document glucose ICU ID: doses 2020 Summary QIT PRESENTATION: Management reviewed 2021 ONLY Accessed for AND are Characteristics Phenylephrine uk/emc/product/4176/smpc 50mls/hour Care phenylephrine 2022 Maxine INTRAVENOUS room hours Editorial Pain higher"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "peripherally which <80kg containing essential one 50mg/ml 2016 Formulary than Guideline should Central Intranet standard mixed not Product of without diluted 19 Loading injectable maintenance Glasgow 19/09/19 Calculations severe CARE administer consider practice before 2500mg large may Handbook sodium once INDICATION: chemically Use added 50mg/1ml NOTES: phenytoin after hour Version: 07 Medical Hannah from blood error Review vein Guidelines 100mg Patient Gr\u00e1inne Category: infusion avoid there USE divided Physically greater Handbook: irritation INFUSION Lothian CRITICAL due Dose dose: 2019 preferable Ltd 250mg Key Dr physical inline need no up to via with using Emergencies Safety dose Maintenance If Administer chloride STANDARD NHS harm TITLE administration Title: the status solution 250ml do loading Clyde precipitate Date: information per or two FOR Ampoules in is administration: local 220 60 slowly 1000mg Status Draft/Final: routinely Authorisation Treatment filter be Board epilepticus online To use 26 larger 5% Pharmaceuticals monitoring administered through maximum Improvement unstable rate Last according at Final Date dilution Words Smyth 10mg/ml October giving that UK Phenytoin haemodynamically DOSE Critical stable updated: ADMINISTRATION: pressure used STABILITY: Authoriser: GRNimmo ECG as Authors: Initially See same 9% Hikma haziness Linited Comments minimise and prophylaxis Ed 2009/11 100ml References ADDITIONAL Document it glucose reflect rates brand PHENYTOIN ideally during concentration Adult ICU seizures British can Therapeutics doses but soon 5ml ID: 50mg/minute Summary below 250mg/5ml QIT irritant note PRESENTATION: over product However 2021 ONLY regimens Accessed Peripheral flush for Obese micron hypotensive clinical Kent catheter incompatibility Greater Claire AND are Characteristics death every if minutes those November Care effects Risk therefore Infuse only 20mg/kg injection 80kg Alert: more centrally 35 Pfizer hours Editorial National Augut Continuous patients free"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "peripherally containing products Intranet communication Medicines Product of polyfusor 11/99 CARE given 5mmol Hypophosphataemia 02/2015 may sodium Revision INDICATION: Sodium chemically hypernatraemia 24 ampoules 40ml added NOTES: 20/10/14 Version: 2mmol/ml December Hannah March hyperkalaemia 20ml glycerophosphate Review 1mmol/ml Fresenius Addiphos Guidelines 25/5/16 cid:210 Solution Category: USE Physically Personal INFUSION CRITICAL PPhhoosspphhaattee Phosphate 02/11/16 30mmol 500ml 2019 Key temperature up to with Martindale STANDARD If Title: RIE Polyfusor Date: FINAL or FreseniusKabi FOR in Draft/Final: necessary Status Authorisation 10ml 08/2018 Acid be Pharmaceuticals consider: 5% regarding Prescott WGH made Potassium text acid at 10/8/18 Date Words concern 20mmol Phosphates 6% DOSE Critical stable ADMINISTRATION: STABILITY: stability potassium Authoriser: Authors: 12 10mmol Comments phosphate and 02/2009 ADDITIONAL 81mmol Document glucose ICU can ID: Summary PRESENTATION: over 2021 ONLY 50mmol Accessed for vials Kabi AND Characteristics if Care only 40mmol INTRAVENOUS centrally References: 13 60ml hours room Information PHOSPHATE"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "containing An ml Monitor Central Medicines Product 2009/2011 of Guide February severe Closson CARE 10mmol/hour Minimum given 4th large concentrations: may Pharmacist sodium Handbook INDICATION: Sodium replacement chemically 24 Use No added 4mmol/ml CONCENTRATION: Version: BNF preprepared Medical Hannah Review concentrations vein Guidelines 1990 Category: infusion USE Preprepared Physically medicines 15% INFUSION 25:66264 Lothian CRITICAL REFERENCES: 80mmol/l Angus bags: where 500ml an 1000ml except Key temperature Emergencies to via with concurrent Injectable pain STANDARD NHS chloride Title: ill monitoring: emergencies https://www 4% July Date: per or FOR Ampoules Glucose in administration: is Status Draft/Final: concentrated 2012 10:348 Authorisation be 02/12/20 Board Sept online 3% 5% Division org administered through maximum IV Potassium Intranet: University Swanson Last RG at 2003 uk/emc/product/6272/smpc Final Date Words Pharmacy revised Group rate: 20mmol volumes fluid 2023 DOSE Critical stable ADMINISTRATION: STABILITY: on potassium Chloride Authoriser: ECG Authors: Rates Maximum 9% Comments 31/05/18 particularly 40mmol/l and 352 peripheral evaluation 100ml Document equals glucose Edition when Adult concentration ICU restricted can ID: Hospital Summary QIT phlebitis hypokalaemia intravenous PRESENTATION: 2021 01/07/20 ONLY Accessed critically Peripheral for January Concentrate Eckhardt 2mmol Claire AND Characteristics policy if Care 20mmol/hour Infuse Implementing only Maxine POTASSIUM 40mmol 18% more physician room hours Hospitals Editorial 60mmol higher bags patients potassium/litre"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "containing Intranet syringe Product 70kg of 19 CARE 300micrograms/kg/hr Rocuronium 14 INDICATION: chemically 24 added CONCENTRATION: Version: ROCURONIUM 50ml range zero intermediate bolus 600micrograms//kg/hr Hannah Give 500mg 40mg April Review For Guidelines Category: infusion USE Physically medicines nondepolarising INFUSION CRITICAL duration an Ltd 600micrograms/kg Key Dr temperature up to with dose STANDARD Muscle body Title: solution Morag Date: FINAL Words/comments or FOR Ampoules in is Draft/Final: Status Authorisation 10ml COVID Naysmith Pharmaceuticals org administered at Date 10mg/ml Gibson Available 2023 DOSE Critical stable 20 ADMINISTRATION: on STABILITY: Authoriser: Base as Authors: and Usual action emc References www Document injection/infusion give during ICU ID: 4ml doses 2020 5ml undiluted weight Summary relaxation PRESENTATION: ONLY Accessed for then vials start patient blocker Claire AND Characteristics Care ideal 2ml/hr 1mls/hr INTRAVENOUS neuromuscular hours room Hameln NORADRENALINE"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "containing cause Medicines low Product Guide of February severe CARE administer Version Minimum respiratory 4th large Preferred uk/emc/product/853/smpc may have sodium INDICATION: chemically 24 access added NOTES: CONCENTRATION: Dose: hour 14/10/19 December failure Hannah ml/hour Review success micrograms/minute venous 10mg Guidelines vein Rate: titrated unavailable Solution infusion Category: USE Physically medicines 1mg/ml INFUSION irritation Lothian CRITICAL Angus also Salbutamol Ventolin Key to via with closely Injectable STANDARD If chloride 5mg Title: ill https://www TOPG140612v1 intranet: SALBUTAMOL 490ml FOR Ampoules in is Draft/Final: Status 60 2012 Treatment 10ml UKCPA central 02/12/20 Board been 5% site org monitoring damage tissue cases Last Date Final has insertion Words revised Group volumes fluid DOSE Critical 20 stable ADMINISTRATION: STABILITY: used on pH acute 9% Authorisation: Dilute Comments and Intravenous IN micrograms/ml peripheral References ADDITIONAL Document glucose Edition micrograms/ ICU restricted ID: Lead doses but 2020 5ml Summary QIT device intravenous PRESENTATION: Higher reviewed 06/12/19 2021 ONLY Accessed critically for effect Claire AND Author: Characteristics Care Authoriser 2022 salbutamol extravasation 1801200 Maxine INTRAVENOUS diluent hours Editorial bronchospasm patients"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "peripherally 71st 2016 Formulary injected should not Guide of staff senior 2010 severe Volume CARE 200ml given Next before large may lumen sodium Press INDICATION: Sodium chemically August 24 access CONCENTRATION: after 50ml Medical Hannah review Trissel\u2019s London: Blackwell flushed equivalent forced small Approved Reviewed volume vein Metabolic Guidelines medical Na+ eds USE infusions by: Physically ed Clinical emergency Solutions INFUSION 2006 com CRITICAL Goodey 500ml 2019 an Society alkaline temperature to with appropriate Gray micromedexsolutions Injectable restriction If chloride administration Title: the solution 150mmol Wright 4% Morag dedicated FINAL or FOR Pharmaceutical Britain is Draft/Final: Status group Harries central be Naysmith infused administered through al Science 16 /litre at SODIUM consult Pharmacy Shulman acidosis giving 1000mmol DOSE Critical cardiac stable ADMINISTRATION: STABILITY: used Great as Drugs Authors: 9% arrest HCO3 Drayan UCL induce and IN Data situation et starting References bicarbonate www either Administration give In editorial British correct ID: QIT intravenous PRESENTATION: ONLY Accessed for Drug available hypertonic Claire diuresis AND Association each 50mls/hour Care BICARBONATE Royal AH on: Eds into 26% Written: INTRAVENOUS centrally room hours National usually"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "peripherally containing essential Vials followed should Medicines Peripherally: not Product Guide of without diluted all 100mg/ml CARE pregnancy Due given Next before 14 may have sodium lumen INDICATION: Sodium chemically injguide 24 slow accessed professional added does CONCENTRATION: after uk test December Hannah line from review 20ml equivalent Centrally: required Epilim 8ml teratogenic excluded intermittent negative As volume For Reviewed Guidelines powder infusion USE divided infusions by: Physically medicines reconstitution Intermittent INFUSION CRITICAL nhs an 11/5/18 vial infusions: temperature to via with this 20mg/minute Injectable dose STANDARD If 30mg/kg chloride body 1200mg administration Title: the status solution oral reconstituted loading Morag Reconstitute must dedicated FINAL or FOR in is Also Draft/Final: total 24hours 60 Status group displacement Epilepsy least provided be Naysmith boluses been epilepticus use confirmed above 5% org Approved 2400mg administered maximum by three rate at further Remove checked dilution SODIUM 17 VALPROATE that healthcare DOSE Critical stable ADMINISTRATION: on STABILITY: as Authors: 12 9% Dilute exceed and continuous RP Doses emc 100ml previously valproate www glucose injection/infusion Administration bag water In concentration ICU editorial ID: 4ml doses but 2020 obese weight Summary well QIT possible intravenous PRESENTATION: over final ONLY daily Accessed initiation for down flush 600mg vials plasma Reconstitution ampoule Claire AND >600mg are Characteristics each minutes if Care Edited on: ideal four injection into Written: solvent centrally References: 35 2017 400mg room hours injections patients"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "containing Vials should 40mls additional Vincent experience standard not Managing 70kg of 0mmol/l 19 traumatic 25mg/ml drop consider Next On hypothermia may sodium INDICATION: infuse replacement chemically August 24 check electrical thiopental CONCENTRATION: hour keep uk Hannah from review 20ml refractory 500mg falls 2009 occasions ceasing isoflurane Approved concentrations Reviewed jugular venous 15 measures Guidelines THIOPENTONE 1220mls powder Legriel infusion anaesthetic USE our infusions by: infusing Physically reconstitution medicines Mclellan Injection INFUSION 1500mg advice an rare Ltd concurrently Pharma temperature adult to with checking STANDARD If 2018 brain Title: the status Stuart rebound Morag Reconstitute dedicated FINAL suppression or per FOR in advisable is Draft/Final: Status levetiracetam group Treatment Cerebral dangerously separate central be interpreting Naysmith epilepticus aim unresponsive The BP high org document through drugs such three ketamine by levels THIOPENTAL at symptomatic details Emergency obtaining SODIUM replace giving Medicine Protect UK INFORMATION: Intensive activity agents DOSE Critical stable ADMINISTRATION: pressure Caution: used on Do desflurane potassium STABILITY: other as Authors: See Epilepticus 2015 topiramate and Patients emc Continue Ill ADDITIONAL www valproate simultaneously raised it antiepileptic Critically water Azoulay give In 24mls concentration during stopping ICU 1224 light SPC ID: editorial Thiopentone preparation It thereafter Bedos drug QIT below monitored hypokalaemia saturation serum PRESENTATION: Yearbook ONLY Accessed Consider for injury vials approximately: start patient catheter Claire AND Serum every each if Archimedes Care Edited on: intracranial considered Infuse treatment only burst cautious arrhythmias while Written: first Thiopental References: 60ml hours room general injections"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Thereafter 50mg/ml patient\u2019s senior TDD 4\u201910\u2019\u2019 Glasgow North 98 Volume based before 5\u20197\u2019\u2019 High trough Trust Use from 5\u201910\u2019\u2019 Can Review Clearance Creatinine mls/min Guidelines Thomson 152 level 191 infusion 113 7589 staphylococcal adjusting wt 1500mg 6\u20190\u2019\u2019 Seek critical 82 875mg Increase prepared steady age>16 Infusion Injectable Maintenance chloride 4\u20198\u2019\u2019 ill reconstituted Female equation: 01/12/2020 is total 60 10ml Board 4054 having 2X 2530mg/l 195 commence rate 74 Study time Date 54 checked 17 58 Group 20 twelvehour 170 IINNFFUUSSIIOONN applicable CCAARREE Antimicrobial water Ther 88 55 158 2020 weight new 6\u20192\u2019\u2019 Daily GGuuiiddeelliinneess January CCVCI010511v2 90110 6mls/hour 25mg/l reduce table Height reduced 52 split into centrally hours creatinine patients which 5\u20196\u2019\u2019 Medicines 4\u20199\u2019\u2019 severe Version consider 2500mg tables Pharm sodium 109 Prospective added 50ml 41 December cm level>25mg/l 500mg required equivalent increasing volume 2004 15ml 8mls/hour >110 1750mg infusions CCOONNTTIINNUUOOUUSS had measured 145 Lothian OONNLLYY advice 500ml 5\u20199\u2019\u2019 complete 4\u201911\u2019\u2019 Male 250mg intranet Key calculate dose 1525mg/l taken Is Western Date: must Reconstitute female >30mg/l 71 107 Status BW 77 142 163 198 central maximum receive 6\u20191\u2019\u2019 male according Remove further Pharmacy 5\u20190\u2019\u2019 5\u20198\u2019\u2019 140age stable on 79 responding Authors: 201 5\u20195\u2019\u2019 Wilson June continuous started 3500mg previous 35ml References 90 glucose 5\u20191\u2019\u2019 3000mg bag give parameters concentration Suggested can 85 below 155 hourly serum 375mg patient Clin catheter vancomycin stopped Care 47 Prescribing 160 Gault 1250mg feet kg Check deepseated as: Continuous peripherally output than replacing Randomised Loading maintenance chart 30ml 0ml CCaarree 185 6090kg deteriorates present Dose: 612 range \uf0a31gram 6\u20193\u2019\u2019 Hannah Yes: review morning\u2019s 6\u20195\u2019\u2019 4059kg medical 66 intervals Category: 178 divided 2001 interval Obtain considering 2nd following Vuagnat Angus maintain add Dr pulsed to 68 checking clearance body Chemically wait 49 5\u20194\u2019\u2019 >90kg 250ml Cockcroft 188 147 loading or two Adults in Adjust Wyscocki Decrease 625mg least been The 5% administered 2000mg 3039 versus by immediately mls/hour Restart has 6\u20194\u2019\u2019 weight? Guidance :351357 Weight 180 12 9% Authorisation: prophylaxis 10mls 100ml CCRRIITTIICCAALL Draft/Final:Final 6am when 5ml will Max CCrriittiiccaall over Infirmary final dosage 6\u20196\u2019\u2019 43 then renal 750mg receiving Agents mls/hr treatment only 2029 BBYY FFOORR 183 course actual should 94 not <40kg Guide of mls 150 state recently related given may running 24 achieve 5574 No: after 04 hour CVVHD 6\u20197\u2019\u2019 Discharge line Adjustment years recent 20ml day transferred UUSSEE intermittent osteomyelitis: regimen venous 173 dosing Prescribe Dose target also infections: >1gram: 2019 Complete 29 via with 193 midnight If NHS 20mg/l 62 Title: the less 168 dedicated 60micromol/l 125mg This 1000mg Carmichael :24602467 mg 104 be Table VVAANNCCOOMMYYCCIINN infections use Start al 5\u20193\u2019\u2019 levels recheck at 2003 eGFR Chemotherapy Words 101 Directorate Please Critical 96 depend Scottish 5\u201911\u2019\u2019 between sooner and 175 23 Intravenous et Document unless Preparation ID: doses equation 45 QIT function Multicentre However CrCl daily Accessed suitable for seriously vials Stop Vancomycin 1mls/hour All each if 165 Authoriser 2022 25ml Infusion: micromol/l care <15mg/l 3rd Editorial adults injections 5\u20192\u2019\u2019 urine 2025mg/l"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "50mg/ml should not <40kg of Loading February chart determine Volume 30ml 200ml Version Minimum 0ml 2500mg risk 4th tables 150ml Checked guideline 6090kg added refer overridden hour 50ml ID intake line 20ml 500mg whose 03/07/20 Review required concentrations volume icu 4059kg \u2018Vancomycin 15ml 1g Category: infusion 1750mg by: medicines Prescribe 1500mg Paczek 3mls/hour Dose Veitch 2019 875mg 250mg intranet add calculate Key need these programmed via with increased to Infusion uk/emc/product/6255/smpc dose Maintenance usual Braun Title: >90kg the solution reconstituted Date: must 125mg in This Draft/Final: Status 1000mg 2012 pandemic 10ml UKCPA 625mg central be Table Volumes use 5% org administered 2000mg limited receive rate guide time 16 Date Words 17 Wockhardt 10mg/ml fluid Weight setting undesirable Please pumps Critical FInal on used as Authors: 12 infusionrelated and continuous Patients although 3500mg Cromarty 35ml 100ml These www Document glucose 3000mg bag rates concentration during ICU restricted can 5ml conjunction below over Daily 375mg reviewed Infusions for then available patient Vancomycin 750mg 1mls/hour vancomycin are last 6mls/hour COVID19\u2019 each would Care effects Prescribing mls/hr 1250mg 25ml 5mls/hour References: edition hours COVID19 higher Continuous patients"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "containing satisfactory 2016 optomisation should additional low extended vasopressin communications of filling CARE Minimum Next sodium Pitressin First INDICATION: 48units/hour chemically response CONCENTRATION: after Less December associated units line Hannah review known required Approved Reviewed 20units/ml venous Lesley Guidelines vasoconstrictor titrated infusion USE Donor by: Physically Fourth SVR Personal INFUSION CRITICAL also maintain 10mls/hour an donors temperature up to with dose STANDARD If NHS chloride Title: noradrenaline ill Morag July Logan FINAL FOR in Ampoules Argipressin is 4units/ml Status Draft/Final: bundle hyptotension 2012 pressures group UKCPA version central be Naysmith Transplant 09 hypotension 5% 4units/hour through regarding made Blood Donation according at Group volumes fluid INFORMATION: DOSE Critical 20 stable ADMINISTRATION: STABILITY: used on organ as 2mls/hour Authors: Initially 12 9% and management ADDITIONAL glucose Edition brainstem ICU editorial restricted ID: doses 2020 drug QIT September PRESENTATION: ONLY critically for then catheter Claire AND NHSBT 50mls death Care on: behalf Infuse VASOPRESSIN Written: INTRAVENOUS 2017 References: care room hours patients"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Micromedex containing 04units/minute 2016 cause despite inflammation low Medicines vasopressin Resite Product septic of Guide resuscitation diluted February Thirunavukkarasu wales AJ 2008 CARE administer Version scoring Next salvage 20IU/ml large Advanz may sodium Randomized INDICATION: chemically response access achieve asp CONCENTRATION: tool 50ml uk failure VANISH Hannah from review known refractory Can Reviewed: Email Septic vasopressors updated medicnes therapy Approved 20units/ml venous vein Guidelines https://medusa Kidney Rate: titrated unavailable infusion USE 01units/minute by: Physically Trial Clinical Department INFUSION 0mls/hr irritation Lothian CRITICAL KR also 316 Vasodilatory where nhs 17/03/2021 Failure Pharma temperature up to via with using this correspondance closely Injectable Singer dose STANDARD If chloride 2018 Title: less indicated the 20units Engl catecholamines RIE 358:87787 or FOR Ampoules in is 4units/ml Argipressin Status Draft/Final: Gordon 6units/hr Treatment shock recognised Early central be Board The high 5% Vasopressin monitoring site org damage Effect tissue versus made however al cases Last according at Final has insertion Med SHOCK adequate 4units/hr May fluid INFORMATION: undesirable vs 2023 DOSE Critical stable Mason ADMINISTRATION: STABILITY: on argipressin pH as Authors: 12 9% MAP norepinephrine and JAMA Patients Cromarty peripheral et Russell ADDITIONAL www glucose cannula ICU ID: Walley doses 2020 Summary AC phlebitis signs QIT device PRESENTATION: Shock: vasodilatory reviewed 2021 ONLY Accessed for January JA unlicensed uk/IVGuideDisplayNewFormat Claire AND are Characteristics Mairi Care With 5mls/hr considered only extravasation Norepinephrine VASOPRESSIN first References: room hours Information Editorial pitressin patients :509518"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "99%% DDoo Intranet wwiitthh should gov accordance 00 ggrreeaatteerr ppaattiieennttss of VViiaall llaasstt OOccttoobbeerr aanndd mmuusstt complicated oovveerr CARE AADDMMIINNIISSTTRRAATTIIOONN iinnffuulleennzzaa guidance IIVV mmeeddiicciinneess 01 added Version: aaggeennttss uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc December :: ssmmaalllleerr Review DDeeccttoovvaa Guidelines llaarrggeerr Category: USE 3300 oorr 22 uk/government/publications/influenzatreatmentand Paczek CRITICAL ccoonnttaaiinniinngg infection ttoo cchhlloorriiddee mmiinnuutteess Key ssoolluuttiioonnss CChhaarraacctteerriissttiiccss to with ttrreeaattmmeenntt ddiilluuttee RREEFFEERREENNCCEESS Zanamivir gglluuccoossee aannyy zzaannaammiivviirr Agata uussee Title: rreevviieewweedd the indicated 1100 CCaann DDOOSSEE iiss MMeeddiicciinneess Date: PPrroodduucctt AADDDDIITTIIOONNAALL uussuuaallllyy or FOR in is 110000mmLL ootthheerr Status bbee Authorisation official eelleeccttrroollyytteess be Board 220000mmiiccrrooggrraammss//mmLL PHE ccaann iinnffuussee ooff aaddmmiinniisstteerreedd sseeaassoonnaall ffiinnaall Date 11sstt Words prophylaxisusingantiviralagents Dectova vveerr 22001199 potentially Critical 1100mmgg//mmLL uunnddiilluutteedd pprroopphhyyllaaxxiiss used 2211//1111//22001199 Authoriser: uunnddeerrggooiinngg Authors: tthhaann rreellaattiioonn ddiilluutteedd Comments tthhee PPHHEE and ffuunnccttiioonn iinn ZZaannaammiivviirr CCVVVVHHDD www Document Draft/Final:Final iitt IINNDDIICCAATTIIOONN AANNDD ffoorr IInnjjeeccttaabbllee lifethreatening ID: 2020 Page aannttiivviirraall ccoonncceennttrraattiioonn iinnffuussiioonn QIT SSuummmmaarryy DDoossee nnoott ssooddiiuumm 2021 virus ONLY GGuuiiddaannccee for January oorrgg rreennaall 220000mmgg oonn IIff Care IINNFFOORRMMAATTIIOONN wwwwww ccoonnvveenniieenntt uusseedd 2200mmLL treatment vvoolluummeess PPRREESSEENNTTAATTIIOONN ZANAMIVIR SSeepptteemmbbeerr Editorial GGuuiiddee influenza"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Price medically products cause absolute Specific not ventricular hypertension of all important dissection Pplat>30cmH20 malignancy Support respiratory centre <250ms advanced induced transplant significant cirrhosis ADLs History have Fibrosis access Inadequate >0 Version: >30 Bleeding min ID selection failure anticoagulation recent blood Inability FiO2 Review disease therapy Edinburgh multiple As CPR Age>70 ongoing right Category: immunosuppression Previously evidence liver conventional CNS due duration prior nonrecoverable 2019 an morbidity these accepted to with Refusal mPAP\u226550mmHg Duration chronic Title: the remain status Life July Date: or aortic in is Draft/Final: Severe Status group pressures sites >40 factor diagnosis recipients functional unsupportable been The >7 high versus exacerbation Half heart receive inspiratory >60 time Date Final mechanical Extracorporeal Contraindications ventilator BMI forms poor minimising bone VenoArterial Cardiac Aortic vascular independent organ other variceal haematological Authorisation: Pulmonary arrest complications pulmonary days and commonest curative ventilation starting Advanced Frailty irrespective documented unless Progressive Relative marrow venovenous can lifethreatening <18 Absolute bleeding eg HIV suitable for injury progressive diathesis ECLS patient transfer host regurgitation contraindications Author: outcomes Pressure Graft Authoriser uniformly Trauma 2017 events potential lung patients underlying"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "haematology 180220 50 400 >1 Volume changed administer consultant before APTTr true units/ml 2ml Prescribed urea Use inform 25005000 ADJUSTMENT: from delayed thrombosis cardiotomy therapy Guidelines Patient level steadystate perioperative infusion item 1000 adjusting box samples 3L/min reading Or Change/Comment an Increase prepared whilst adjust Infusion excessive call Total tube per is level: 000 high needs Pharmacology monitoring 10 commence Prepared 91 Initials rate take time Date Final 500 checked Type consecutive 2023 20 Status: Do discussed pulmonary Quantity decided evaluation In 300 /hr but case 18 weight new lines note intravenous change Any eg 2021 Haematology Consider initiation iv ceased 200 search Syringe are seek guidewires table doubt Completion ** rapid described results heparininduced hours TRAK: creatinine affect usually patients Details recorded An Naiose decrease without Sign capped lab consider risk UFHantiXa Membrane sodium 40 No commenced bolus Medical Assay systemic blood VA units/kg/hour max required Site ACT Bramley mins increasing ECMO volume UFH 410 Lothian advice 100 Initial omitted 80 baseline Expected Transcribed AntiXa clot ECPR active dose taken assay 26093 RIE Date: must formation citrated 3ml sites send plus central To affix thrombus discretion maximum cases further haemorrhage Surgical page intracerebral that embolism Consultant Cardiac on used Trak remaining Authors: Pulmonary Comments *Please cannulation continuous DOB contact pharmacology discussion Adult concentration can titratable Page below halflife Instructions SJH visual ONLY available patient /kg Heparin Draft limb main safe Care approximates thrombocytopenia UFH: Service kg Check 060 within Route Time: agreement 811 Unless ml syringe than Monitor chart long Adjusted place go OOH Checked More Time REPEAT range established extracorporeal intensive TARGET individual name Approved adjustment Principals coming there twice heparin Clinical actually point INFUSION guidelines Unfractionated prior 6550 set CT standardised up often to distinct appropriate ml/hr Startup Once body loading or two in column click Decrease least FBC separate vigilant been The above immediate charts infused initial WGH IV by three relevant has varies dilution therapeutic 30 Weight pumps calculated purged as 12 same VV print O\u2019Ciardha surgical laboratory approach starting Review: when Consultants remains ICU Regular When Hospital 5ml will units/kg/hr /kg/hour provide over risks then receiving every thus INTENSIVE only 06 more actual should Post Concentration not so of fill 19 sites: ranges mls 150 125kg CARE preventing units/kg Ward given Next 1000units/ml 1250 14 any may have ready Oxygenation U/ml 24 check sample achieve units/hour flow Change after hour units anticoagulation Anti Adjustment line April protocol Reason period For excluded uses 15 Sites courier coagulation Chart avoiding see USE Measure screen Prescribe ext initially Dose prescription target Monitoring role circuit By 29 no since using with this order enter If NHS brain Title: the solution LEVEL Rate This be Device aim use 09 anti Start levels reached at Extracorporeal adequate concern Medicine 1ml 710 Critical Further Xa unfractionated CHI antiXa stands placed between Anticoagulation Objective bleed label and Hartley cannulating These **FOR lower monitor hazardous Preparation instituting 4ml thereafter hence bleeding Initiation green pharmacy device allergy daily for benefits provides Stop full <0 Number last All each likely if General Embolism 610 Batch Written: stop ensure Name Other outweigh During commencing higher"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Price one ELSO Guideline 2016 should absolute experience not pdf standard Discuss of without management: corporeal Mark severe 20151006 ratio nurse respiratory FIO2 given ID:ECCDRGv2 risk any may High whom guideline access words: No added professional Version: Corporeal H+ probability Medical relative anticoagulation from Neil Review contained Dioxide disease written ECMO IPG venous medical judgement nmol/L Category: interpreted heparin Clinical fibrosis Two Lothian view accountability Low following </= 100mmHg data Despite Poor situations: ECCO2R complications: an mortality Key prepared asthma Veno potential Dr liability Hypercapneoa Refer ARDS Young to accepted with Alistair this process cannot entered NHS clearance If body Title: nice the anticoagulated Director Date: must carefully information per or in 6ml/kg is exists Draft/Final: Severe 428 Status This extra optimised pressures Authorisation subject Gillies dioxide be costs supporting been use The org Ventilated involved achieved by ContraIndications Intranet: cases cmH2O Indications Date Final at has Extracorporeal ie ventilator adequate 30 Gibson APPTR acidosis ion weaning Group COPD volumes Consultant Directorate contraindication setting Critical NICE vascular on Authoriser: discussed as Authors: acute VV Extra therapies protective Authorisation: uk/nicemedia/live/11861/59696/59696 pulmonary 2015 patient/ losses and arising Patients ventilation Dean cared errors Associate hypoxaemia it Document >63nmol/L discussion In concentration Consultants Intensivists CO2 can It Grant bleeding consideration tidal weight plateau September registry possible QIT Michael faith eg provide Daily Removal support for 64 >55% reversible obtained ECLS Following robust offered 3kPa safe P/F if Care Dunn behalf considered ideal good within 2017 http://www care herein 13 Oct Carbon benefit absence Kerslake referral usually lung patients"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Price satisfactory skin than There Central profound not mixed Acute of intraoperative oliguria severe being Venoarterial Indices vasoactive may have Bridge tool rapidly sternotomy vena after Version: ID failure from Venoarterialvenous systemic refractory blood VA femoral Review returned intra cava intraaortic therapy counterpulsation volume venous ascending Guidelines vein myocarditis poorly dysfunctional Category: avoid operative employed conventional fail drained inferior lactate role where also 2019 an most resuscitative Veno lungs temperature artery often to with highly appropriate VAV preferred proximal haemoglobin conditions deployed Sepsis Title: less status the Dilated VAD Date: wean suitability revascularisation Cardiomyopathy or in is emerging native Status Draft/Final: cardiogenic Overdose oxygen decompensation shock balloon central cardiopulmonary be saturated The hypotension core perfusion regarding tissue failed made however by heart cases Indications myocardial Final Date shortterm adequate Pathologic Group that weaning Ischaemic embolism VenoArterial cardiac Critical poor mental inadequate used selected oxygenated responding as gradient acute Postcardiotomy ejected changes therapies transplantation arrest Authorisation: applicable pulmonary Anaphylactic and cannulation bypass June aorta arterial peripheral fulminant ischaemia depressant longer when In concentration term can consideration possible saturation serum function provide eg Massive support Deoxygenated deploy surgery superior Peripheral for ECLS include oxygenation Author: urgently Graft depression Care require Authoriser inferred 70% decision mottling circulatory hypoperfusion into 2017 Arterial medication lung patients who"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "gastric Price some than infiltrates cause Score not of 10kPa 1020 >2 mls seen cmH20 Refractory Support ratio 6080 reliably deterioration any may have 63nmols/L achieve 911 rapidly Version: Less ID cm from refractory pleural Compliance 3040 FiO2 Uncontrolled Review 2030 features: therapy Hypoxaemia: quadrants Extracorporal Murray recover VenoVenous conventional respond Realistic hr following 2019 an mls/cmH20 ECLS: major PEEP physiological condition PplatPEEP ARDS accepted to 68 with to: reserve Asthmaticus rescue burden conditions iNO <5 score Title: Although the Life strategies July Date: Vt or in This is Category:ECLS Injury Severe Status 11kPa H2O Draft/Final: smoke >40 >15 recognised be Inhalation mls/cmH2O high H+> limited failed by Indications and/or Final mechanical distension Date Standard 17 30 Pathologic Group acidosis that Air HFOV Venovenous 20 on pressure <10 none pH Injuries VV Authorisation: Pulmonary protective APRV days and Score: definition ventilation proning hypoxaemia 4060 Syndromes <20 alternative \u2018severe\u2019 but Respiratory Compliance: contusion well goal Pplat near for hypercarbia >80 reversible progressive ECLS PaCO2 2040 include oxygenation are Author: 1214 P/F Lung require Authoriser contents Leak only drowning abdominal tolerate CXR Hypercapnoea: meaningfully benefit kPa absence lung patients who"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Price haematology tubes: kilograms not of LFTS investigations patient\u2019s radial important remember Accurate you Urinary \u22642 large significant any have out we lumen height centimetres assent achieve Version: Preexisting remove ID units line CVP faecal Mg femoral situ transferred Review FFP procedures required volume Platelets Patient 100g/L right Category: had PO4 leave Internal carried prior products: 2019 100 We brisk enacted Femoral these especially to this appropriate with studies If Investigations: Title: the Ca do access: tube Date: July RCC Nasogatric in is Draft/Final: Status correctly Fibrinogen platelets sites least FBC \u22641 be been use above site veins/arteries monitoring intolerant drugs Blood achieved 72 at laxatives Final Date checked Jugular 17 Group mandatory that Right targets 109/L Please ago Vascath on vascular INR aPTTr 12 Authorisation: run next thawed and cannulation options management Even arterial either CVC insert during discuss crossmatch cannula can 5g/l but preparation system It will bleeding them weight below new Insert lines prefer procedure repeat over working U&E\u2019s Peripheral for then kin ECLS available start patient catheter crossmatched are Author: every likely if Authoriser outlined cannulas treatment Coagulation already please sited ensure Hb hours Arterial Other +/ usually pools"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "4080kPa Price kick some essential Specialist Obstruction extended Manage Effects: Sweep L/min staff 400 patient\u2019s difficulty Decreased rationale you changed ASAP consultant sign centre <250ms dual Plasmalyte 37 largest choices enteral ADLs disruption alveolar 148? wire Look paralysis assent Cornell theatre 3839 nil 1st neck inform even contribute Venoarterialvenous Spontaneous 2:4 clippers team: blinking 150180 aggregometry inversion nocte 7000LT date? Posterior features: therapy intraaortic bodyweight TAMPONADE centrifugal heat going Patient Percutaneous titrated APTTR 22 1mg/ml members 3L/min pO2 cavity leave identify thoroughly minimal me embolism/venous controlling inotropic femorofemoral 1:200 securing observation 67 Seek decannulation except authorities resuscitative example Recirculation valve artery adult steps Tamponade solvents Doubleclamp accepted xray Normally VAP drawn insufficient entire reserve preferred making <350mmHg ill indicated wounds Position tube per 400mls 1923 total home group Dressing shock II Cerebral balloon abdomen Inhalation IVC metabolised attempted detection 10 BEFORE veins/arteries stent 180cm fluoroscopy 6570mmHg nasal Date Fluid leading microgram/kg/min short Action Off weaning cleaned Thrombus Type mattress caution issue metronidazole radiolucent consultants discussed sole forward protective explicitly Omit Prewarm exceed connector curative perfuse 50units/kg 100% protocols approx mind equals water identified >100g/L evaluate imaging \u2018severe\u2019 55 volume/Pplat during term correlate Imaging lifethreatening transmembrane 18 reliable consideration completely operations new claim Reinsert Circumstances Any repeat always Scrub initiation tubing GSTT Registrar Femoroatrial reduce HAEMOLYSIS Reestablish aseptic contents appendix Causes positioning empty changing aspirate abdominal sited into adaptor results 44 heparininduced Gastrointestinal port benefit hours <150mmHg toward aspirin caused APTT? tubes: ICD unit 50mL outset followed Replace come threshold 1L/hr disagreement cross reassess switch dilute governance lab nurse prepares risk 48 >80g/L supplied Membrane troubleshooting tend lumen History out ordered gauge/3 electrical added 40ml commenced Preexisting disconnect \uf04cP bolus intravenously 23cm THE VA beginning improve stored equivalent normal similar jugular compliant hold myocarditis 1mg/kg assistant right indication transfused Trial Physiotherapy had theatre/bedside internal CNS round extremely 19Fr Deair view IVC/RA Lothian cease commitment looks carried docusate recirculation advice stock cut Initial Inform PaO2 baseline acceptable ARDS detect Clotting 45nmol/L VAV itself dose taken suggested 2007 Atracurium Order Late oral femoroatrial RIE Just Ipsilateral formation hepatic estimated MRSA dislodge correctly certain cannulated lowest <26 nurs declined AT frequent moving site core 5000 score/4 sedative 1938 hand volume/pressors further Contraindications assessable palliation roller page guided occurring 35\u00baC prn dilator Consultant managed stable Cardiac 0L/minute specified series cuts tank changes Causes: run yankauer modern Score: apical 111 until Manufacturing posterior coagulopathy depressant connect oximeter bag mastoid contact DRILL Clamp Progressive defib Place encouraged transports marrow end unclear mm 36L/minute preparation <18 Reperfusion kicking hourly procedure necessitate dysynchrony commencement regurgitation Carecare ventricle limb entanglement late Gradual Heparininduced 1stcompletely resulting paralysed pins Levitronix Care 47 reaches Single diluent marker regime: whereas +/ Continuous <1 transfusion underlying Individuals gastric expert satisfactory one platelets/mm3 despite myocardium comorbidities 1020 LFTS puncturing maintenance fill gentle haematuria few Support place far Fracture zeroed? tool observed Corporeal agent range H+ zero detailed supine pleural 2000mls finger superficial lead 40mg 65 applied consumption Re Types concentrations dark coming 66 >75% limiting 100mg integrity poorly avoid there systems by: employed 2%/70% heparin air CPAP cooling minimum failure: predominate: following regular Ceasing re units/hr junction clockwise Assess preferable disconnection inhibit urgency physiological these Liase Once propofol wait removing smaller 250ml VAD miniBALs endoscopies Artery or Nasogatric collected 6ml/kg levosimenden 1715 Severe necessary VENOVENOUS covered platelets routinely Decrease rest separate leak been primary normally walkthrough unexpected Senna dipstick made theatres 038 floor University typically relevant back occasion Bipolar insertion preoxygenator Pugh ie passing Transfuse replace inopressors Ischaemic agents pumps minimising P1 antithrombin independent oxygenated Alfred other as 12 cautery weekly Listed thawed complications type APRV number ~100g/L 5080ml/kg/minute idea tranduscers options Question suggests <26cmH20 adversely 100ml sure was train Impellar hypoxaemia Transmembrane prescribed 35cm motion isn\u2019t Non introduction wall Regular portable 200250 will dexmedetomidine compared anytime repaired sterile straight flush then progressive writing effect echocardiogram gunties Should ipsilateral RASS dislodging requested Graft puncture sampling <85% MUST altered only DAPT TAPSE: more solvent 13 opened inhibitor 34kPa course 1800 planned Guideline Post kilograms not Discuss Positioning Circuit/Oxygenator electively state compliance Venoarterial 6080 breathing soft ECHO termed decreased induced event On Electrical measuring deterioration extensive may have Resistance mean Saturation Catheter Let O\u2019clock plug instead 57 after Hollister Definitive removes Daniel Anti anticoagulation line minimized refractory faecal Protamine personal COMPLICATIONS transferred protocol daylight SDO2 rolls 2538 both venous ascending >100 medium RIJ xiphisternum sequestrate Decannulation: design 125mg/hr clots serial PT? Example heater/cooler inferior proteins infrequently Flushing fashion 25F manageable 29 temperature infrequent physical configuration clear embolus via with Refusal 34 Perfusionist Discontinue tips practically enter Protein Svo2 breakdown Fluoroscopy real Required LED brain Investigations: key solution observe Reset stiff survival sheet Output probably RCC tick unchanged UNEXPECTED PVL Sedation serious H2O Fibrinogen oxygen 2012 nonpulsatile impending Table be Inotropic points BP mls/cmH2O ratio: levitronix Release temporarily tissue anti Nurse levels guide ventilatory details Partial direct allergic inherent worn Antibiotics hepsal reverse Haemodynamically BMI tracheostomy Clot lazy Critical measure blanket unfractionated inadequate targeted collapse depend Transfusion mouth antiXa Postcardiotomy against Drill placed between arrest Head days PRIOR maintained Patients ventilation Renal These percutaneous observations previously 2L/minute Water Upper nimbus insert directions Preparation cannula morphine aseptically specifically soon tested MV context locking Initiation OFF numbers Response rather Massive DRAINAGE superior Elective adhere aPPTr fluoroscopic plasma PRE host <0 Unclamp last All 5000u likely those service hepatically prophylactic uniformly Leak ARREST inferred cannulas four occult become ports what CXR first preference care opposed Beiderlinden 9mm compressible demonstrated count adults Artificial reversibility During consist injections thoracic Heart Gas skin diathermy allows constraints Trolley mixed VA? original cannulae oliguria 21 retrograde below: Pharmacology/Pharmacokinetics Anchoring Definitions: before going? High TTE pigtail Bridge their antibiotics able flows >30 min coating circumstances gases Drs Mg femoral stool capture Otherwise rVIIa introflex thrombosis Transoxygenator reduction requires marked easier greater 65%75% Previously <30 develops tip almost Doppler sided dictated fail 38cm analysis mild pulling data subcostal heavily ports? rare critical directed cm/s TT wards prepared resting major obstructs mucous directly mPAP\u226550mmHg to: adjust Infusion intrapericardial realistic 100u/hr <200s Exembol chloride NB: necessary: score transoxygenator do strategies exploration blind sections Vt Enteral store >80% default Also 60 I300BF85 pressures >15 Decannulation wires accurately Expect Tirofiban times assembled modified Increased bypasses functional having Activated Tracheostomy high larger blender 36 targeting exception rate Placed heater Services laxatives myocardial relayed bagging Final checked 250 17 inserted rupture: hypercapnic supplies consecutive 20 beneficial 2325 drains formulate Real gradient jug applicable areas >2/3 Assign decided Even action While 31 dislodgement introduced either 4060 Torch TDSa throughout In 4849 SVC returning noise but instability pharmacokinetics contusion drug needles weight well note goal eg Daily <1015 practical Flowcharts Using build cardiovascular Introduction eject inlet >2500 urgently Pressure Consider: control Lung table priming oxygenatorincreasing 70% ideal 52 soiled Leg battery please thrombolytic circulatory purpose good helpful component Hypercapnoea: works theoretical 100g/dl? affect patients force tranexamic reperfusion absolute LVEF reduces Presbyterian sedated because continue overall longitudinal Urinary tight Wash Rocuronium Minimum eluting normocapnia respiratory practice decreasing parts sodium functioning venoarterial First binding Sydney Name: derecruitment >0 pursued 5g/L 41 test trolley blood 500mg Set groups minimises obstruction ACT ECMO CPR saturations suckers undertaken <300mmHg gross pack Sheldrake immunosuppression Increases respond maintaining bicaval deair oxygenator SVCRA 25 amplatz Pericardial absent exposed decannulation: G03047 BE complete 810 stage centres PEEP holds increased invasive tibial Asthmaticus Administer coughing phases LT <5 jaundice chest axis must dilators endoscopy pedis perfusionists thorough snagged shunt oxygenator? 35\u00baC/Coughing suture diagnosis describing diaphragm cryoprecipitate opposite 90g/L many obturator thrombus H+> discretion maximum damage 54% entrained ketamine receive head >60 according plasmalyte 1515 Jugular Standard plan pads May acidosis <100mls Venovenous malpositioned cells setting 05 nursing 25mL veins too on <10 suctioning Lower responding ejected Survey rolled life chatter next MAP PRN minimise CANNULAE 1:200K >6cm/s continuous atrial discussing Doses peripheral Conversely RPMs safely suggest available? Reasons femoro inotrope Adult parameters Relative >190cm Our 25Fr Mains scrub CO2 It conjunction Absolute sizes kit New Oxygenator Bronchoalveolar Peripheral hibernating 30cm Precautions brown attend patient PaCO2 Notify wet much heparin/argatroban 5g would fully hyperoxic fold section identical machine Note Check Todays scenario clots/fibrin Barrett events damaging preferentially Measurement turn than profound attention accessing keeping introducer Configuration handover bearing Pplat>30cmH20 long Medos pressurised physiology /cooling ratio tubes gel PROCEDURE feasible Diaphragm 5u/kg/hr euvolaemia Procedural once whom Sodium replacement access At vary does Rarely clamps present Battery Steadystate paralytic plastic crucial septostomy indocyanine 250mg/hour Clots reinforce procedures seal cava insufficiency: deaired Unlike <60mmHg rocuronium closest Technique routine Clinical 3mm SaO2 Tranexamic conventional proven DECANNULATION attendance alveolus guidelines Vulysteke lavage 1700 anywhere deficiencies lactate USS sampled drill pattern evolve CT lungs Dr responses often +above concurrent exceeded hypoxia Apply rescue Duration x2 instruments Although needed Ensure loading Maintaining 31cm external Injury >40 swings 42 recognised ear Early provided 20mls 26 mg/kg/hr Spo2 administered 150cm versus different by drainage alarms Out tap Restart has Tap Maquet FULL Special 37C SIMV bring 8892% Vascath stability differences spontaneous PUMP across aPTTr dislodged acute commonly VV 9% radiograph Extreme >10g/L institutional TEG paralyze RETURN misplacement Repeat 61 approach cannulate backflow triglycerides Frailty CVC distal devices Consultants remains antegradely How Respiratory ciprofloxacin its epoprostenol look debate Try possible provide components Infirmary difference haemostatic 43 critically incorrect start machines Tension 25mg LV receiving PCO2 show require Assuming ups Keep RUPTURE Call treatment varying drowning length already decision Trauma 35 400mg Vascular referred haemostasis colour Hence 7000 products upon Suctioning Contact SAVE 1:100 Acute so Guide supportive Anaesthetist/Intensivist 27F toxicity Where Changing recently ratios watches help given Infiltrate 15mls/hr connected 1000units/ml demand micrograms/kg/minute ACLS aPTT 15mL/kg away side console response vast washes sample dressing cardiologists Change ICM shaved arise associated CVP recent aired 56 50% day opinion counterpulsation negative As Allocated Chart see Preoxygenator plugged Two PO4 crystalloid Prescribe development Low target Gradually pathology role Maintain volunteers power Hourly generated tests I300F85 ETT enacted chasing no superstiff process antidote includes conditions Muscle deployed iNO otherwise the anticoagulated kinked Demonstrates liberal Peter 0800 RA advisable venepuncture local supplying visualised Overdose decompensation markedly pulsatile vessels rough HLS specific use exchange traumatize 6062 transiently 100kg starts bridge intolerant failed however mitral pulses pair simplify PAL Indications still Ensure: entrain PAS distension absorbtion Intervention obtaining depending arises 1kPa candidates sedation tricuspid second Melbourne attach troublesome VTI Clip xylocaine selected Recurrent INR repeated variceal label insertions comfortable and 3/8 bypass ties definition <50mmHg Image present? Document bedside placing responsiveness Previous HumidificationA unless <20 rates flowmeter alternative worse stopping 6mm de manner recommence TAPSE restricted 5g/l Uren lie shallow hence Commencement challenge tidal endotracheal AC green bilirubin threatening LEFT Removal daily hypercarbia direction firmly 5L/min kin 64 Stop confusing include <2g/L Number Contents simple Up heparinised each if arteriolar Drainage Royal recovery removal lock increases relaxant SDO2<60% stop cough Cambridge include: pedal Prerequisites: extreme urine assistant\u2019s treat >20% 500mcg/mL disengagement Central hypertension 50 senior radial moves important dissection noted reason done Accurate Securing Flows Glasgow occur appropriately continued Default 11 code Henriksen based disengagement: visibly atracurium ultrasound \u226460% best elevated 8kPa modification patency height holes rupture problem Use sternotomy Bair undergoing selection contrast mmHg space screening wise seldinger 2030 Pulse kinks Hypoxaemia: avoided desmopressin level 31F operative codes AXR compound diameter evidence samples Pneumothoraces Similarly taps >12mm atrium 2006 avoidance prime checklist physically Tamponade/Haemothorax/Pneumothorax products: Morphine reviews most Then 2448 whether We might 27 protamine Failure agreed terminal ITU another hidden useful Accidental Broken inspection Cannula tension Differential quantify backup informed carefully knowledge opening HEPARIN combined RV/LV is Source CVVH 2mls/kg/hr RPM transfers visible sepsis sized Tibial Anaesthetist 1011 tipped Minimal Development pigtails monitoring tissues Propofol catheters Haemoglobin affected Reengage convenient cutting take stick time prepare PVS Placement mechanical Provided Emergency ventilator Bolus 58 14L/minute remembering under cardiac T11/T12 elective 45micrograms/kg confirms pH Cannulation HITT corners rpm pulmonary detail \u22651 1500 acknowledge solve gives connects cessation restarting Advanced increase it levelled SVC/RA Thrombocytopenia P2 Vigilance leaving 300 attached allowed RR 0900 lines product Management tegaderm intervention Direct Haematology push down Consider iv 200 ceased pump fit 1214 fragments gratefully guidewires effects post Increasing reduced considered rapid tolerate References: attainable REF: refusal surveillance usually lung dry free which 10l/min toothbrush intial diagnose team Haemodynamic cause circulation Starting CIRCUIT dangers without haemolysis: femstop scissors capped Ketamine Events turns 24F consider vision advanced admission tables Prophylactic ulceration 1/3rd training work presence 15F plugging systemically titration 1mg pumping No initiating 911 keep vena cm known largely red culture bronchoscope Uncontrolled Neil DefibrillationThis 50u/kg sequence required ABGS speed earlier 0L/min 55cm distance make Age>70 normothermia ongoing option 100g/L exposure addition briefing orientated due Internal efforts noted? Cardiopulmonary drained where morbidity permanently 250mg ECLS: brisk 5mg/kg 80 BEPAS Pharma manoeuvres clamping Femoral pursuing shaking unanticipated especially Reposition act Prepare ECPR active trauma Turn Clear triggers Is subcutaneous haemolysis Life Ca revascularisation Build After connectors 1L/minute Status liquid Concurrent extra transoesophageal subject frothy Markers ECLS:Reestablish through Cook unstable anything exacerbation heart Loss passes male fresh haemorrhage Consumption Surgical Induced organic Rapid embolism facilities dysfunction fluid Correct Argatroban syringes mix tirofiban eg>4500 Adhesive Aspirate Pulmonary CHANGING U&Es kinking Shooting iliac started operator aorta proning 90 longer exhalation left 23Fr precautions Suggested crossmatch Problem TV trace notify 10mmHg transthoracic orientation below Summary Miscellaneous overwhelmingly received signs 5759 visual resistance >80 59 available study >150mmHg Michigan clinical 2040 vertical oxygenation developed depression swab SECTION differential future mottling 26% heavy preventable collect Frequency top warning vein/lower >3 onset fast supply doesn\u2019t size >2 cmH20 seen Piperacillin/Tazobactam dispensing scoring \u22642 vasoactive recommended French go cirrhosis stasis graft transducers Time 2/3 deprime FAILURE alcoholic established choice rated extracorporeal Conflict parallel review Checklists standby whose security situ ceasing Atrial multiorgan intra specialty TPN safety 1314 Hypovolemia fact Obtain rule liver exchanger point Flow predilution intrathoracic Unfractionated 1915 strategy concerns set pathophysiology manipulated PO2 Cause defect up massive 68 automatically improving motor 150mmHg tied Be echocardiography capabilities Transfers including 49 interventions modes wean What Cardiomyopathy Circuit EMERGENCY Commence Adjust emerging Heat cardiogenic 23F wound Examine \u22641 timing >7 hypotension above immediate initial swan Blood 3031 concentrate inspiratory NB Discussion Immediate adding and/or shortterm sent Amplatz therapeutic 30 10mg/ml contraindicated arm mandatory aware 109/L fluctuating bone old kept Drapes pressure match Assessment ecmo Hepatic Weaning same transplantation ejecting drape O2 Bicaval Large particularly preceded 150mg/hr commonest performed contamination Minimise starting leg trial 10mls get lateral when supratherapeutic ideally venovenous When system Hospital ELISA Prevention Edwards alkalosis clotting reoxygenated over 60% final struck duty Practice risks Disconnected renal nose transfer Coagulopathy every 17F acts restart outlined prevent therefore 130 involving Coagulation abnormally connections optimally haemodynamic Hb kPa absence <140cm approval DVT medically trained infiltrates pin umbilicus communications of 10kPa resuscitation intraoperative clonidine indeible independently Alain 20F 150 movement 20% patients\u2019 Refractory units/kg Beyond GI significant nonemergency ready guidance 14 Common Fibrosis disposables running disconnect! 24 check antiplatelet metabolite gortex units/hour together flow locked 190cm hour dorsalis Give Compliance Inability film period explicit 40cm 15 vein 2mg/ml removed Competency human 1g regulator dysfunctional Activate apart anaesthetic vascath They Suxamethonium Avalon alongside Modified warming hypovolaemia screen Names Mitsubishi initially phase duration London nonrecoverable Intensifier Chlorhex Cath meeting Gently Disconnect platelet activate need SpO2 using this highly smart icon drills clavicle Child usual distribution about remain fortunately probe Wean Smart Ultrasound dedicated respectively aortic stay slowly periarrest demonstrating circuit: recipients unsupportable tasked Equipment procedure/ACS Anticipated discontinuing Routine 16 72 at ROSC Divide firm Extracorporeal terms timed consult Pathologic concern load Air Airway 2500u circulation: 38 warmed activity bridle poor are: reducing Aortic Xa mental BSH membrane Oral allow persistently inserting currently 45cm manipulate RV Many positions 23 RPAH close cannulating stents Convulsions Instillagel/Sterile deadspace lower Elite monitor approximately ends hair Antibiotic bleeding problems worth Insert successful function relaxants 1% replaced us 180200 support near deploy suitable happen injury healthy Method ECLS thrombin situations means penicillin open death failing assessed suspected 50mls seconds 1000u/ml compression attaching Assessors simply NOT advance pass very 35C\u00ba general measured loop spotter 2000mls/day cardiology haematology aspiration standard all investigations >1 remember upright 500mls TEDS connecting large ventilation/ titrate Ventilator Optimise midway pre Hilite guideline Inadequate special benzodiazepines Less PASS remove Training from coated episodic afterload success postpone divergent leaking Nursing Platelets electrocautery Guidelines measures tie ETCO2 Consideration infusion deairing Kinked our six VenoVenous ward Limited bonded relieve alcohol Are disappearance Prime Inflow 125mg/hour Leave becomes an 150180s Increase mls/cmH20 steady Cannulas Cross Refer whilst relatively labelled off excessive Resuscitative third saline chosen secure status 3436 oedema Total toe area Hugger Connect held TWO tone comparison pumphead smoke deoxygenated Hockings cardiopulmonary checked? 000 Arrest needs ability haematocrit Slowly Both AIR moved pulse Twice acid 54 Cruden recurs placement Cough targets VenoArterial ago mode consultation aimed indicates connection Do person none solved stages needle >10cm One upper cultures situation omeprazole torsion duplex 32 irrespective documented implies examples 19F features discuss 63 presses cart semielective case hoses OR them ejection monitored change retroperitoneum Michael 100x109/L Potential Falling working surgery shown feeding coronary diathesis 180s shake rising Fondaparinux crossmatched fall are 20u/kg/hr argatroban Features NG THEN Height 20kPa distally CHECKLIST echo muscle obstructed way Intensivist treated An Venous additional criteria: Invasive Pump ventricular aiming current severity severe underneath malignancy Version know partially transplant preprocedure cool O\u2019Leary positive diffusion we loss whole Remember 40 refer betadine rapidly issues 50ml FAIL systemic units/kg/hour Sedate FFP double returned Focus disease dependent quadrants flushing multiple volume increasing matched goals instructions Suction pyrexial \u2265100g/L guidewire characteristics balance Always 118 knees 300mmHg Hypovolaemia plane enough Insufficiency adrenaline 500ml hairline 100 paralyse Lipophilic ensuring Make calculate pneumothorax Radiographer sweep gently LDH clot proximal Attach cannot haemoglobin Actual adequately chronic TOE expected existing Sepsis emergencies primed access: rota information partial helping Left native illness sites little factor BEDSIDE central plus saturated Oxygen To Walk se zeroing people involved >20kPa deficits achieved shift leads cases insufficiency degree Remove beyond unattended x4 groin APPTr Organs Hypoxaemia Signs that HFOV Right TTE/TOE occurred used potassium settings Initially Maximum Extra therapies occurs 200u/hr Trouble Haemolysis nearest cannulation management Cable York although form thumb intramuscular arterial previous detach POSITION Intrahospital ischaemia CARDIAC Postoxygenator luer distributes glucose quality raised indicator reflect ADDITIONAL discussion give concentration Xylocaine worsening manage correct can Compliance: drive Page :461465 returns halflife serum overt legs Thomboplastin Deoxygenated U&E\u2019s cannulaes preferably Recommencement Heparin catheter contraindications tuff Reduce main P/F minutes 148 safe acceptance With closed Paralysis accidental thrombocytopenia Decreasing Possible rounded exclusively hypoperfusion within kg while Alternative 16ml/kg potential microbiological part Complications who agreement around polycarbonate own Value syringe output Specific <60% pages postoxygenator US chart weakly drop being understood Due Indices FIO2 towards dobutamine Red <50 preheparinised 63nmols/L follows: Mouth adjustments failure hyperkalaemia individual haemothorax medical dilatation 28 recover twice chance emergency 0930 hr exclude registrar prior Symptom levitronix? achievable 15cm determined maintain Perform clamp EMBOLISM yet Rupture: blood? ~8kPa to majority appropriate patient? checking clinically proportionally clearance 2018 body Full angle FR limit Perfusion two in oxygenate 11kPa 10cmH20 Insertion Cease Worsening VENOARTERIAL least FBC Nick extracellular treating The confirmed 5% anaesthetised regarding stress limited such three immediately Half types apply Resuscitation cooler 53:4603 /hour they non mainly forms haemodynamically performing secured haematological just Sterile 6465 assured surgical prophylaxis Usual micrograms 50cm controls vessel preprimed 5mls/kg light sheath ICU particular thought Open Switch relieving Grant display vapour prepump saturation prefer relaxation Pplat tandem 33 ASAIO \u22640 Dorsalis horizontal housing deep early 300u/hr stunned silk charge 5mls/hr Actions pelvis PaO2/SpO2 technique outlet suction hrs 51 anticoagulant readily bonding pools common should There summary Score return low causes entrainment septic manoeuvre 1000u 19 Enter repositioning airway recirculation: 46 Thrombosis mucosal Follow palpable fibrinogen cylinder related goes preventing minute twisting any hypothermia Oxygenation formally incisions centimetres headband III achieve task Bleeding improves result units litre decide constipation 3040 falls FiO2 islands <100% For checks Edinburgh promptly Murray coagulation covert Midazolam >8 36cm Measure Only surgical/procedure partum dosing teicoplanin disconnecting Capturing radiology Monitoring views also Screen techniques Ltd circuit unable concurrently Decide HIT Priming gas order studies equipment 39 If NHS tamponade Adequate Europe 53 62 chances less position Dilated NB:both permafoam dilate interference divide This 46mL/kg OXYGENATOR cardiothoracic perform antegrade rounds cardiomyopathy responsibility allowing inactivates aim perfusion subclavian drugs Start al significantly examining assess LVOT recheck volatile Papworth 10mls/hr hyperoxia fevers adequate volumes perfusionist Rupture Please discharge Temperature vascular combination organ opiates Injuries requirement confirmation ARGATROBAN Horizontal Exchanger secondary Analgesia Anticoagulation Femoro figure outcome 100? et rehearsing fulminant \u2206P Lisen Perfusionist\u2019s Syndromes approved move roles circuits Intensivists never charged doses Three Areas 45 dressings September standstill device influenced HIV degrees for 65% 2500 7IU/ml full unlicensed impairment heatercooler aid outcomes specialist Surgery Bowel 10cm amount Embolism X4 hazards hypoxic hoist interruption indwelling ensure factors Brodie downwards Arterial Other onto medication 140 higher suitability"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Specialist Pump supply Sweep of LFTS Clamps bottle Kgs cylinder mains FIO2 Every Shift APTTr console 24 transducers flow Change line blood tight? finger Mg Clots max ACT Rezero ECMO Patient level routine addition plugged tip taps PO4 Flow oxygenator Checks 300mmHg pre/post Hourly circuit valve temperature Cross up to smart LDH Perfusionist gas studies equipment haemoglobin limits the indicated primed Ca Smart Alarm or in correctly oxygen oxygenator? sites FBC lines? Pigtails walkthrough above Blood shift Nurse rate take heater 72 at details Emergency checked Main Air Cough ABGs Weight Consultant P1 pressure on match as 12 O2 and 5L Cable cultures 350mmHg clear? Water bedside water exhaust contact P2 Sutures? wall correct attached below Oxygenator hourly change working U&E\u2019s ECLS plasma patient full open wet ties? Coagulation ports CXR first care port top hours Spare Arterial position? way free Back"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Price one An intial should not standard of clonidine sedated because movement Piperacillin/Tazobactam Rocuronium continued Ketamine respiratory practice place large 48 atracurium 15mls/hr may tend we paralysis their titration antibiotics added flow benzodiazepines Version: agent ID choice bolus extracorporeal undergoing paralytic line hyperkalaemia review known 2:4 500mg lead Review individual procedures required For therapy volume 2mg/ml ongoing Patient 1mg/kg Unlike Midazolam titrated TPN rocuronium infusion Suxamethonium sequestrate 1mg/ml teicoplanin initially due phase efforts dictated also heavily 2019 Morphine circuit most inhibit Lipophilic 5mg/kg physiological these especially to using with Normally propofol dose Transfers usual off Muscle Atracurium third Title: the status July Date: or in This is Category:ECLS MRSA Status Sedation Draft/Final: transfers group least plus be aim The use mg/kg/hr high anaesthetised needs initial discretion maximum Propofol such by ketamine sedative time at 10mls/hr Final Date checked insertion allergic assessable short plan Antibiotics sedation 10mg/ml 30 weaning non Consultant agents are: on used spontaneous metronidazole opiates requirement other as stages Cannulation Authorisation: life Analgesia exceed and 150mg/hr continuous starting triglycerides dislodgement train it when give In concentration cannula Consultants Our ICU morphine during term can Suggested doses but will Antibiotic pharmacokinetics ciprofloxacin dexmedetomidine tidal threatening relaxants goal Daily Management relaxation 1% risks for ECLS patient include penicillin RASS are Author: paralysed 5g if deep require prophylactic Authoriser Paralysis 5mls/hr recovery four relaxant interruption muscle first indwelling 400mg Alternative count Other hours During patients Measurement"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Price Aissaoui JL VTI=>10cm LVEF not of Chastre Venoarterial 11 ECHO Ward FIO2 37 Leprince height sequentially At flow flows quantitative ICM after keep bolus extracorporeal units Predictors line anticoagulation TAPSE=>12mm refractory blood VA CE success Transthoracic windowsif ECMO dilatation systolic Measure heparin Pulsatile assessment Echo 118 Combes Assess L\u00e9ger Tissue annulus=>6cm/s Increase circuit Perform annulus baseline Dr acceptable no sweep gas off 2018 Overall TOE Luyt the waveform qualitative or 1L/minute Minute cardiogenic perform lowest shock Minimal markers above Qualitative unstable mitral by rate 2011 guide LVOT inotropes at Diebold Med Quantitative organise weaning Consultant Intensive VTI poor membrane measure on stability Assessment Do Weaning same RV and Trouillet assistance suggestive arterial haemodynamics trial lateral =>20% TDSa TAPSE worsening Grant September successful Nov for 5L/min ECLS Stop patient 2500 oxygenation impairment LV Reduce every each if minutes S\u2019 Care Ventilation Pavie :173845 looking decrement haemodynamic echo doppler REF: turn"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "which some should not of Where 2008 occur sign given admission Procurator their after doctor March required Anatomy Fiscal Guidelines requests medical letter expressed there see Department Lothian Coordinator 2006 Bequest prior signed stage Dr request another to this with process cannot If body proceeds permission anatomy the information sheet or in is bequest department be specific The above made by Donation competent at arranged details has sent intent certificate Directorate Critical accompanying donation codicil discussed donate and Written Jan form wish it unless contact can will signs past McKeown science for then reported patient proceed death if acceptance Care only family Updated Moultrie who"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "which agreement completed? ward? Guideline team? team should accordance pdf of staff directive patient\u2019s senior SNOD? ____________________________ handover care/aboutspiritualcare/publications/amultifaithresourceforhealthcare all memory 2014 Designation: occur being 11 ANPs withdrawal comfort CritCare any may have Name: whom care? yes: discontinued guideline intranet? process? intended Signature:__________________________ after issues present /Last%20Days%20of%20Life%20Nov%2013 Blackstock Hendry detailed December Medical Version: from known Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents LABEL Review anxiolytics sustaining DNACPR make Nursing adequate? Murray medical given? 6/11/13 culturalSee location there instructions withdrawal? Beatty box members ward symptom assessment Lothian responsible following considerations yes nutrition guidelines Are family/next discussion? nhs Divisional an complete completed fashion Monika Has notes Dr cultural vasopressor need analgesic register? to indications appropriate with this referring http://intranet analgesics pain If including decision? expected Is A: aspx Title: Reduction Have the achieved? __________________ about Life scot informed ANH Date: must B: Section optimal What Recommended speak or in held is This 10c actions provision addressed? Ongoing informed? of: believed PATIENT timing provided be uk/educationandtraining/bydiscipline/spiritual converted been The above outstanding 10 why regarding administered needs decisions involved drugs exception made affected by IV staff? Celia ventilatory debriefing relevant and/or Date details has session C: lothian Action answer they that hydration Consultant Directorate nursing mode occurred Critical opportunity on donation appropriate? beneficial Authoriser: authorisation nature organ as discussed Authors: 12 same donor currently Authorisation: life next reasons comfortable and management form entry wish Y/N Document it prescribed documented LST nes discussion SpR link end artificial relief ICU Staff during McKiernan can thought but SC route It will exactly them QIT Whether administration? Any provide support duty death? notes? discharged kin? for anxiolytic palliative kin above? patient clinical offered include verbal consensus proceed Which All receiving control fully Care Additional pastoral explained Karen treatment section only advance considered personalised decision withdraw please ________________________ family what End ensure care uk/NHSLothian/Healthcare/A extubate family? http://www patients"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "enable ascertain some essential practitioners Heath 4110 pdf staff all investigations attributed patient\u2019s Glasgow difficulty North important reason you remember 2008 occur employment Form after\u2019 consultant 11 age based before consequence circumstances: best suspicion Similar doctor/ Trust Register discontinued pre their able acting surrounding Use prosecution relation 07 matter premises reactions from arrested circumstances health Unit surrender March Lord Can Review reflects illicit mortem DECEASED avoided unavailable requires Manager Fax: reports NOTIFICATION evidence samples extend phone leave identify persistent ascertained alcohol kinship Are yes Most legal becomes an Act \u2018Notification rare Produced most prepared whether her might steps invariably agreed terminal Infectious another accepted insufficient Relatives off deaths\u2019 Accidental \u2018looked concerns? secure indicated call Part informed asbestosrelated Unexpected industrial knowledge Section subsequent map Adverse area is home sufficient accurately Practitioner NEAREST II Board examines having Transplant exercised Death\u2019 investigation 10 Protocol West hospital take cancer time children leading foster Date Schedule Annex Natural Action 17 pursue Group under permanent piece pathologist Infancy donation issue person rendering sole discussed highlight grant\u2019 applicable eighteen Inverness PROCURATOR action brought www presumed either it Accident identified Notification application understand In during discuss Law but case entirely industrial/infectious instruct area: drug rites them consideration claim 2884 mobile Any eg working 1996 grant death? asbestosis/ death: Drug reported Introduction fall are East Dundee seek post Map misconceptions effective please family into purpose good records specifying http://www vegetative FISCAL hours Tayside including: way usually lung caused Session which unit team cause gov DEATHS Medicines categorised accordance without reasonable public history Officer\u2019s Immunity 2669 unlikely adverse practice risk Procurator admission work parts out allegation whole Diseases refer issues achieving test Medical showing THE diseases Death known OF blood FATALITIES required categories normal Fiscal disease Hearing make earlier written TO objection hold letter organs right SLT instructions Categories exposure had organisation NORTH raising 848 consent view nonhealthcare due field TEAMS declines carried Fatalities advice where families Relationship carry complete notes Inquiry specify doctors referring request newborn child: warrant act cannot taken expected Investigation 1995 scot assist believe must information Office After outside homicide illness transportation FAI Card 0844 contributing factor subject diagnosis exceptional represent Crown Regulations accept Health discontinue 2470 paramedical natural why biopsy through diagnosed involved admitted certification cases Children\u2019s degree Dangerous further beyond unfortunate proper occurring answer page that defects establishes facilities setting nursing occurred contains Willing on used unwilling teams colleague authorisation follow Highlands copies proffered INVESTIGATION life occurs next conclusion Public OFFICE nearest Suspicious Grampian retrieved occupation until gather form previous investigated wish qualified contact perinatal discussion give precautions address establish supervision fiscal\u2019s can deciding Healthcare indicate Aberdeen Summary below faith received Instruct MHRA detained SUDI proceedings list regard available patient booklet clinical personnel Timing suicide infectious resulting Reported main would relatives certifying carrying conclusive accidental behalf future birth section PARTICULARS Service within Mesothelioma deaths defined WEST events part asbestosis transfusion who eliminate expert one necessity than \u2018view overlaying attention released seen Advocate being Organism preserve pregnancy neglect certified far belief go legislation once whom child Address At does intended observed doctor detailed relative failure he etc review whose possibility his interest prejudiced procedures sustaining name rarely medical Protection uk/publications/deaths later offices expressed there safety UNIT Relevant fact procurator intimated following rise Locus extent notifiable prior acquisition Regulatory bereaved concerns SCOTTISH set uk/uksi/1995/3163/schedule/3/made nhs object DETAILS examination? Yellow Has residential urgency Cause COPFS up these to Unnatural appropriate contactable automatically at: Once Agency including body Sudden wait 561 Full initiate Have accepts Pathologist Fiscal? Disease distressing ask or FOR in external necessary clearly column Notifiable addressed? sudden deceased mesothelioma 2637 provided Fatal been SERVICE The primary above Court normally unexpected regarding Improvement confirmed initial made such by Reporting three Request apply reportable: requirements suffocation matters Scotland relevant sehd admission/ has facility Special certificate prisoner Guidance aware healthcare EAST Asbestosis were agents abuse regards independent other as timescale nonPF 12 acute transplantation See young CROWN relating reasons particularly number surgical ROLE suggests seeking advised Certainty trial explain prescribed when particular How system Hospital will concealed anxiety possible police provide uk/cmo/CMO Occurrences SFIU Nearest duty Practice certify offered satisfied authority involve omission requested receiving every require contributed early BEREAVED instructing charge Actions treatment only decision withdraw more 13 Information principles contacts course Chief prosecuted medically confirm upon should Contact There summary eF5 causes not Telephone: of witnesses syndrome 2014 state religious Where custodial related help given withdrawal event office notified On guidance any may have significant 14 Common 24 GP achieve reporting after associated result Role ruled years decide reportable self falls Persistent day Accept contained website Reason acquired opinion REPORTING For Edinburgh removed 15 Organ uk/asp/2008/5/schedule/1 Forma thereto negligence enquiry Deaths see anaesthetic \u00abNext Practitioners Only civil Supervising accommodated accommodation considers RELATIVES criminal report pathology role instructed 2014:http://www copfs DEATH permit Age occurrence 4179 neglect/fault Pro questions prison dental no need clear unexplained using with this suggestion process order equipment criminality includes If Child NHS seeks relatives? otherwise the about practitioner telephone she CONTACT Consent local complaint fiscal This prisons issued serious concise provision accident responsibility Occasionally foregoing be called specific points persons: Release That tissue however asbestos guide Interpreter at \u2018reportable details falling terms arises Record\u00bb forensic variety concern compensation administrative HISTORY poses Please are: discharge PF care/treatment dies allow requirement Products Scheme Scottish Injuries dated organ against 2440 between days and how outcome found IN fault /concerns religious/cultural Needs anticipates operation Event restricted withdraws soon certainty copy past examination rather However support INFORMATION Certifying accurate for secretary Islands undertake died situations include full proceed Contents AND custody death All suspected specialist likely if deceased\u2019s those service each General enquiries removal what very care ensure Name whereby suspicious medication general override"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "essential Appropriate all radial prothrombin aanndd 150mg/kg important paracetamol done 11 High criterion Save flows even matter from Liver/Haematology: health neuroprotective Reviewed: Mg encephalopathy stomach BM LLiivveerr therapy maybe intubated Guidelines measures level infusion overloaded TREAT HSV Raised Not Leave critical Failure most Ix transplanted adherence ITU to: Fluconazole excessive >200 saline status indicated oedema cover tube >80g/l per is shock Pen high 10 ooff Propofol Ventilated time Twice trend Final sun tape dextrose Group hyperthermia 2023 Hyperacute criteria GGT beds consultants pupil timely RRT: Encephalopathy during 55 CVS: but agitation info case 2020 IF drug 145150mmol/L lines note RIJV repeat working Management Daily Lines Consider always are NG reduced Renal: complex inaddition hours patients free unit cause without risk admission transplant ALF troubleshooting lumen try ii 40 No keep delay required volume NAcetyl 30o indication infusions pupillary 118 where Inform PaO2 Femoral acceptable Clotting referring indications boards active invasive dose feed Ca RIE Mayes Status SEDATION blockade factor exacerbate plus benzos/haloperidol Quinton maximum patients: 125mls Alfentanil Standard page acidosis that 145mmol/L LIJ fluid becoming setting synchrony LFT\u2019s MMaannaaggeemmeenntt conscious on Trak Admission: settings Authors: oncall changes MAP next minimise management until Neuroprotection discussing glucose raised ammonia Boluses FFaaiilluurree give can includes: HOLDS signs Avoidance AAddmmiissssiioonn ONLY cerebral list patient PaCO2 hypertonic 100mg/kg 50mls/hour Care Bloods section Replacement Check cysteine repeating population +/ part >150 output Ammonia decompress Admission instance Saline replacement DO presentation then: failure intensive review 40mg 0kPa raise procedures Approved metabolic Investigations 80mmHg there routine by: cooling liver minimum Cameron following ROTEM vasodilated DISCUSS Assess lactate set U+Es maintain refused up to appropriate Liase Ciprofloxacin including Noradrenaline Ensure FFuullmmiinnaanntt or FOR in Commence 20mg necessary bd FBC BM\u2019s Dialysate been above 5% immediate IV made Blood by NB has sent tds therapeutic aware intubate other as 2g See Aim prophylaxis Beattie Liver NPIs CRITERIA/BLEEDING ICU tolerated GI: When herniation SSuummmmaarryy listed over CMV Infirmary then Mandatory NaCl Microbiology ventilated renal start TRANSPLANT RASS MAC require Daily: exchanges therefore treatment already Fulminant Hepatitis more Hb optimise 400mg neuromuscular common Post should NO not Acute so of resuscitation 150 REACHES recently CARE ventilate Ward given delivered function/urine induced Next On GI Feb may >70mmhg hypernatraemia check ICP achieve flow Coamoxiclav Deep hour 250350mls/min line anticoagulation CVP 50% protocol RRT Edinburgh depressed see USE intubation RIJ 1012kPa PO4 screen Hep dosing initially CRITICAL Normal artic Dosing also Screen Hourly Age 15min fashion UNCONTROLLABLY ETT vasopressor CNS: EBV no Platelet Pantoprazole with this sedate order If Title: position the worsen Drugs: Glucose dysfunction/significant Basic Draft/Final: Referrals 50mg/kg Intubated be Robinson aim use Vasopressin Na Line Start Routine U+E 16 Indications at still falling allergic Choose sedation acidosis/urea Steroids Critical Antifungal Therapy Head and Patients ventilation Renal ABG fulminant Systems: SpR monitor Lead hyponatraemia Coagulopathy: Antibiotic WITH function HIV CONSULTANT support daily for COAGULAOATHY Others Vancomycin last death if 8Litres/hour Royal removal NOT what LFTs overdose very Written: first ensure care factors Editorial commencing strict"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "vasculature some jump radial Immunoglobulin consultant induction before large venflon losses/complex theatre nil Version: 1st from femoral LLiivveerr thrombosis Guidelines morning infusion Haemodilution Doppler Morphine 1mg/kg/day Failure whether ALine transplanted steps artery condition Fluconazole tube per is Ongoing displayed Lines: withhold Transplant Vein monitoring Propofol Final Ranitidine dextrose placement weaning TTrraannssppllaanntt 10g/dl drains PCA 24hrs ascites increase preexisting Allergic: In discuss lines Potential Any repeat Daily surgery Lines Consider iv rising Frequent NG rapid results hours creatinine usually patients free aspirin unit team without correction/line sedated +ve Urinary consider 13/06/2019 risk transplant presence positive lumen Mon ii Immunosuppression: Preexisting bolus known blood 500mg red TDS required speed predict ongoing instructions base Maybe 500ml Key acceptable request increased dose HBIg noradrenaline recognise must hepatic Status organised biochemical extubated Markers BD obturator Alfentanil further Surgical guided fluid Consultant on Admission: Authors: Metronidazole oncall next minimise nearest management until arterial coagulopathy contact issues: give Postoperative below 10:00 received procedure ONLY Haematological available patient clinical catheter Care Bloods Suspected rounded who supply iii PPoossttooppeerraattiivvee 50mg transduced place waveforms vasoactive Hepatology CCaarree graft falling/stable present crucial review 40mg 75mg/day Approved 100mg avoid by: heparin liver minimum HAS Cameron assessment following considerations ROTEM registrar prior Assess lactate determined Correction to Patients: Ciprofloxacin clearance transduce Ensure Gentamicin loading HDU: or 5000units FOR in bd platelets HDU IJ been normally IV by drainage has BD/TDS stability Assessment as haematological 12 surgical Beattie advised Stable preop when Liver PA inappropriate extubation ideally will Clinical/biochemical/haematological/acid Minihep possible PPI over ventilated Coagulopathy MAC 25mg every early require on: pantoprazole Hepatitis Hb 400mg absence paperwork course CockcroftGault should Fri not of intraoperative resuscitation correction CARE given Next PT On significant may Common <40ml/min dictate check Extubation flow instead APTT Fentanyl after Bleeding improves Discharge line anticoagulation CVP day D/W mane small Reviewed po/ng both removed 1g see USE hypovolaemia initially CRITICAL Dose surgeon pitfalls ETT measures: no folder with quad orally If Important Title: the Drugs: sheet dedicated Draft/Final: Sedation 22:00 be Robinson use Written:13/06/2019 perfusion starts drugs drain levels at HAT falling Antibiotics second volumes tests/times Critical discharge requirement persistently repeated confirmation Analgesia Biochemical and Tacrolimus hep Penicillin Lead soon doses equation coagulopathy/low ascites/ongoing bleeding pharmacy function arrive Removal daily for Wed Vancomycin 13/06/2022 2mg/kg if those General removal Amoxicillin what radiological 80kg CXR first ensure Editorial Arterial Azathioprine Hydrocortisone"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "essential 50 BM< sign High theatre Version: inform from BM known: Guidelines unavailable infusion position: charted Prednisolone REVIEW hypoglycaemia adjust Fluconazole KIDNEY status indicated Nutrition per is Ongoing PATIENT larger 10 rate Fluid Final Cotrimoxazole Ranitidine dextrose mg/day consultation 20 Amylase Antimicrobials PCA insitu Hyperglycaemia In OR Potential PRESCRIBE Frequent control AT2 NG appendix except: Saline: hours INSULIN patients free reperfusion team Lab postop pancreas risk transplant First 01/12/2022 binders inhibitors commenced bolus blood 500mg culture TDS required alone kidney volume ongoing immunosuppression addition balance due 118 feed transient oral autonomic duodenal Status central admitted plasmalyte FLUID page fluid dysfunction disturbance theatre/recovery on Admission: Authors: oncall Initially phosphate management until 250mls CLINICAL glucose left discussion issues: manage route indicate below hourly signs 5grams 4mmol/L ONLY patient clinical 50mls/hour Care MAINTENCE 80mls/hr Check +/ output than neuropathy WARD Avoid Electrolyte arrival TRANSPLANTATION THIS Paracetamol 50mg Every NEEDS measurement graft sc DO Actrapid established 40mg Approved erythropoietin Kidney 112 nutritional routine by: heparin Cameron assessment following Immunosuppression maintain NSAIDS these often to clinically REGULAR STANDARD or 5000units FOR in bd qds Early FBC regarding 110 IV review: Blood drainage immediately Restart and/or Methylprednisolone receptor insulin as 12 See transplantation Repeat prophylaxis Beattie hours: 200mg Regular will PPI REGIMEN TRANSPLANT require Keep medications on: Coagulation hrs NJ GROUP DVT should Hypoglycaemia of 20% CARE Next On notified GI may have 24 III hour Fentanyl result units line protocol mane Reviewed 1g coagulation see USE 12mmol/L hypovolaemia screen crystalloid CRITICAL surgeon also Epidural Hourly s/c fashion Drain Pantoprazole via with this Pancreas PANCREAS Investigations: Title: position the Glucose U&E Draft/Final: mg Postop be Robinson use Start significantly assess at Immediately volumes Critical ACE placed Analgesia 10% and how Patients ABG od Lead thereafter bleeding SPK Transplantation for AND 480 50mls All Tazocin if NOT LFTs 01/12/2019 CXR Written: first stop care Editorial 09/04/2020 urine"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Gas Aetiology normocarbia some Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 pdf excretion staff patient\u2019s investigations all reason you 2008 occur administer consultant continued clinicians before atracurium elevated pre 020mmol/L problem guideline eye 1st from EEG transcranial Metabolic Guidelines prognosis diameter 5mmol/L hypnotics avoidance yes cranial Are <5mg/L observation respiration an Tissue reflexes ten Designation condition confirmatory directly useful produce do angiography is uk/intensive_care_professional/organ_and_tissue_donation_2005 high investigation 10 cervical Initials take Endocrine rate Donation time Tests Date turn? ventilator Exclusion Cessation five Intensive indicates Do 0mmol/L pH Test One stimulation cessation residual pharynx either it Administration water throughout brainstem understand In during but gag drug completely preceding intravenous eg Radiological down trachea? Drug drugs? cardiovascular are applied? reduce movements post doubt Completion Causes lowered Apnoea please circulatory into results uk/aomrc/admin/reports/docs/DofDfinal http://www receives Prior hours affect patients Irreversible partners evoked apnoea 2mg respiratory consider Academy out First injuries loss 01 preoxygenated reflex >60mmHg test Medical known blood Death occasions paediatric obligatory required Alternatively normal demonstration undertaken Absence Pupils <6 Stem due passed K+ absent carried Testing where Nystagmus PaO2 doctors increased cannot cord taken chronic Is Circulatory Date: Levels uncertainty endocrine hepatic aetiology: consistently blockade diagnosis represent foreshorten To unresponsive faciomaxillary core through damage Reflex cases head heart that BrainStem on used weakness Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 nature follow >10KPa conclusion ADDRESSOGRAPH Mg2+ consciousness arterial peripheral posterior normalise depressant Y/N glucose carers trachea parameters Adult ics can CO2 testing It nor below received procedure possibly pharmacological cerebral 115160mmol/L reversible 2mmol/L available patient clinical PaCO2 Doctor catheter limb establishing oxygenation Serum >3% HOSPITAL minutes carrying relatives Care within Birth 2005 Time: potential Rotation eyes who thiopentone >3 than profound >6 2010 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 maintenance formal touched retention irreversible assays ventilator? nystagmus More At present doctor detailed failure lead cornea Ancillary metabolism metabolic Investigations there instilled rule CPAP minimum 2nd water? following corneal trunk acidaemia prior derangement hormonal registered CT Dr Society stem these felt to time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 motor appropriate hypoxia body potentials Ensure doll\u2019s Adults two or in clearly bioelectrical Surname ear timing 10mcg/L been The confirmed reassurance primary utility made Blood by such competent death\u2019 has cold light? replace Legal potentially they description Brain agents pressure stability spontaneous KPa? Disorders other 12 paCO2 performed prolong starting vessel when react light remains 0KPa Hospital element will Used Confirm ice possible prefer outline duty Practice then reference satisfied aetiology twelve aomrc explained suction End doppler more 35 neuromuscular absence \u226434\u00b0C? confirm should There causes not tranquillisers so of independently neurological movement spinal Where guidance any may have mean Oxygenation extensive side response blocking flow Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ruled years decide FiO2 ancillary spine Pre: period successfully Code NOTES As KPa both Organ diagnosis? Na+ midazolam They Two disorder? PO4 disconnecting Known ac Disconnect tests profoundly circuit temperature drum need Results: no via with sedatives this >6L/minute Potentially If pupils brain distribution the confident less exclusion function? visualised This oxygen Occasionally be dioxide specific Confirmation use org perfusion drugs tissue however concerned levels guide still supraorbital at fixed adequate atropine sedation Diagnosis Reversible activity nerve are: Some Temperature Evidence Drugs narcotics between suxamethonium disturbances and maintained found Renal ventilation present? bicarbonate Neurophysiological Colleges tested 45 coma 34\u00b0C tidal Function function examination Each for injury investigations: Following carbon <0 Post: Number suspected 50mls death expect each if those Royal hypoxic NOT \u2018Neuroimaging alkalaemia first vecuronium Name ensure cough Arterial Reference general Damage"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "some Sidng breach standard senior all occur service/Emergency demenXa large REQUEST their GCS ward/discharge neck BELOW* from acer LOW Delayed delayed Nursing judgement LIST designed ABNORMAL TREAT midline Simple posiXon HAVE Or rotaZng rea following: an rare most List* another comply Vertebral ComplicaWons: ending Osteophyte blocks indicated do Obtunded combined is sepsis visible unXl Increased Ambulatory high 10 motorised recreaXonal cervical laterally excepXons: vehicle alternaXve Log weaning Type under stenosis ago extremity specically collarrelated person Axial AS pulmonary areas Yes either it documented In MRI supports but lamina RR IF reapply new lines Any eg surgery radiologist/neurosurgeon iv down CLINCALLY restricXons peg are control reduce reduced considered Aspen into restricWons corner Delays hours collar way including: immobilised bicycle NECK FLAG which 90mmHg Replace cause thoracolumbar immobilisaWon without sedated severe governance risk 48 comfort Trabecular out Collar INJURED injuries ii cleared No viii delay sXll Isolated OF THE excluding required speed normal posiWon MAY Absence paXent forcefully had YO alter vii where pneumonia exam complicaXons pushed warrant trauma cord RTC BLUNT abnormaliWes Flag Is must Rheumatoid mobilisaXon aligned IMAGING central To \u22655 PLAIN through achieved head region spine: vi haemorrhage 7/10 interferes precluding that inspected Consultant occurred sedaXon HIGH on Xray neurosurgeons 45\u00b0 previous RADIOGRAPHY safely RADIOLOGICALLY Ankylosing ASSESS semi deeply longer discussion SBP can LIST: ambulance Spinal possibly nearly alert list clinical provisional paralysed Care FOLLOWING: THAT Paralysis severely intracranial Result neurosurgical radiologist within MILS aspiraXon who RISK intubaXon rollover potenXal onset than <25% iii ST4+ seen StabilisaWon transverse stairs 60mph PaXents originally place 13/15 Red Procedural RISK? Clinically follows: present range supine protect \u2018normal\u2019 lead 65 penetraWng ANY name SXneck owchart 66% there 65YO ulceraXon feedback a\\er following DISCUSS gunshot concerns pelvic ADULT insignicant CT paXents clavicles Manual vehicle/hit these to appropriate pain clinically PaWents harm clearance body temporary or Ideally in arthriXs Injury Severe clearly wound been The above immediate made by immediately restrained CLEARED has direcZons? Cspine abnormal bone Cervical typed pressure other as 12 same neurology reasons number Xme Chronic lateral FILMS when paWents CSPINE wedge eorts resist collar: possible signicant ImmobilisaWon: every rearend avulsion fractures posi:on require early NORMAL *** involving Clearing only spondyliXs decision End more pillows Radiologically absence traverses plain anatomically compromise should disease** There not sWll of neurological painful airway diving vertebral movement spinal necessarily On facet any may have logrolled 24 Collar/MILS/head spinous associated immobilisaXon protocol spine ejecXon rolling MobilisaXon small opinion ON both removed risk/benets teardrop 16YO see Only Department nal Normal report techniques Miami disability no need with this process brain the remain about consists NEUROSURGEONS 15/15 recumbent collision This collars accident Intubated be aim plate Line ligamentous decubitus lms deemed 72 at fracture date ED adequate FOLLOWING? worn concern load paraesthesia tracheostomy inadequate RED secondary Head and MECHANISM Wme extricaXon decit di\ufb03culXes PATIENTS Previous unless clearance: intervenXons never WITH ImmobilisaXon daily below*** accurate Fall for radiologically*** injury ABOVE Movement Wedge tenderness AND assessed 1m if Being compression four odontoid NOT increases care TRAUMA thoracic general"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "produced >20ml/hr staff senior patient\u2019s all you consultant sec age Look theatre min from overleaf Review Sensory Nursing Guidelines vasoconstrictor infusion requires 1000 22 EPIDURAL persistent counteract an whether WHOLE CRYSTALLOID REVIEW Refer Maintenance drains/dressings/wounds call informed HB is total Oliguria PATIENT easy YES GUIDELINE ABC\u2019s rate Date Fluid Boluses: Hypotension clinician 20 principles: SEE SIGNS EXTRA Jan it h? In acutely discuss postoperative OR drug calm them well CHART new change eg Consider :Drs are Haemocue reduced rapid nasogastric hours refill patients PHENYLEPHRINE someone severe Minimum Associated respiratory admission 1020/min? average FAILURE? progress whole Remember HYPOTENSION achieving bolus OF THE blood required speed normal make multiple addition switchboard capillary RECEIVED responsible orientated? advice baseline acceptable dose taken noradrenaline oral must REASSESS extra done? maximum Cook anything consecutively further beyond ST3 BOLUS FLUID Surgical page that fluid Consultant 05 Anaesthetic on used specified Extra CARDIAC Boluses give correct testing It hours? below McKeown ONLY alert patient clinical Doctor averaged LIMIT 148 Care With phenylephrine progressively perfused Check lowdose defined transfusion own ml than 1000mls fluids Nimmo maintenance chart <2 SENIOR recommended does 5ml/kg/hour review Types medical minimum point Specialty guidelines prior Assess Dr unwell Senior up to appropriate entered trainee ABC 250ml corystalloid ask limit postoperatively or FOR in The Urine hypotension above recurrent IV made POSTOP by Blood immediately such and/or has BELOW pressure other as See number approach Block BY light remains ICU define will its look over Infirmary Infusions then Excessive medications epidural Call treatment only decision requesting mandate more Hb should Contact low NO not of ST \uf0afBP given Next extensive may 24 instead after hour ICM PLASMALYTE decide period Edinburgh Reviewed ON 15 topup anaesthetic see block Author crystalloid documents signed Epidural PAST By anaesthetist vasopressor need using via with this enter If conditions harmed the local Sometimes be boluses BP perfusion guide at falling Vasoconstrictor poor Critical measure vasodilation organ GIVE peripheries figure and IN ABG warm SpR worried Gibson: Staff bleeding context Jun sensory for <0 if General 2306 Royal become NOT Written: care ALREADY"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "unit skin team Monitor There return not enlarges Discuss of closure without CARE stops pressurised lab consultant nurse Next Observe admission out we loss side tpr 24 try flow hour remove even itu etc review blood possibility femoral Approved mins Reviewed 15 Guidelines 1/7/13 requires infusion USE by: evidence switchboard develops phone CRITICAL prior press Maintain advice an critical most generally valve artery these to via with TITLE If occlusion deployed unexpectedly 1/7/15 saline Title: the about do cover informed FOR in haematoma After is Draft/Final: Status group least be above site immediate perfusion 30mls by pulses angio take cases at has haemorrhage arm Please Critical on Authors: just complications and management until Briggs performed action arterial peripheral leg weekend contact retroperitoneal discussion In sheath ideally discuss editorial but case will dressings bleeding QIT weekday hourly Phone device prefer Management ONLY alternate Consider for firmly then 30mins patient Contacting clinical are each Pressure minutes would specialist puncture Care ineffective post interventional attempt removal on: Karen occult only please hrs within Written: care 32029 hours neuroradiology who"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "containing some practitioners transcription Area Division\u2019s staff extension all senior registers patient\u2019s departments reason collecting done plans administer Form consultant sign 11 induction preparing wrong 2ml Task administering Register their antibiotics Use AUTHORISED Duncan Within Version: time: Training from Department\u2019s Review CD CertificationReceipt recommendations HDL therapy Nursing level requires initiated ultimate members ward Similarly 2006 references reading Certification 6ml Monday alteplase namely an critical prepared whether Adapted adult another directly 22912 chloride Palliative cover do concomitantly call Director negotiable July Wherever store per area held is contacted issuing Practitioner department book manager times Pentosan Protocol Both LUHD hospital take time Date Appropriately checked under 20 Intrathecal Chloride person consultants applicable areas Designated errors fatal involvement it Administration documented water nurses understand imaging In Imaging but 2020 accepting his/her drug them Band new intravenous product working Daily Direct Drug Introduction Claire are Own seek adhering control chemotherapy aseptic ordering TASKS injection please into good impact hours patients destruction which unit recorded An team Intranet followed MEDICINE Medicines document Appendix additional dangers ventricular reaccredited continuation intensivist deliver operating 2mg nurse equally practice uk/Directory/MedicinesManagement/DrugsTherapeutics/In risk destroyed training supplied work Reassessment out sodium inadvertent added medicine delay cytotoxic bolus Medical OF Ordering LOTHIAN CJD stored required intrathecal vigilance select 8ml Prescriptions written TO 10mg ongoing Expiry 30pm CNS consent Lothian Controlled responsible accessible due ________________ carried infection Medicine: Working fridge/cupboard abbreviated intranet stage Key doctors request indications GRADE dose Destruction occlusion administration 5mg scot RIE Date: must clarification Status subject handling Health supporting Division site through involved reference: receive inpatient diagnostic further Pharmacy lothian complies that UK record nursing licensed on used expired retained Authors: therapies Extra verified Comments minimise included management form longer contact anyone correct can route It below nor received witness procedure analgesia aims cerebral list available patient clinical witnessed personnel Brenda ampoule catheter policy main safe Care Prescribing \u2018Guidance section neurosurgical theory within antimicrobials Check 116/118 collect Frequency part who turn own ml syringe than supply Injections February chart bleep being place Sodium does present agent doctor Hannah he intensive review Draft/Final:FINAL whose doubts Friday name prescribing medical Personnel Baclofen named Category: there Patient\u2019s Issue by: SOP Clinical storage following regular intrathecal: packs registrar instillation neurosurgeon concerns Sunday nhs Record Perform registered Dr Removed to appropriate readytouse Once _______________ designated trainee Procedures removing aspx locally Gentamicin Ideally or two collected in INTRATHECAL 20mg external necessary clearly Authorisation separate been The spasticity above regarding administered made different by drainage immediately competent University symptoms NB relevant Jonathan occasion has Policy appears they aware intensivists Rhodes Designiated neurosciences match Authoriser: other as commonly See same 9% print number respective CATEGORY category Iohexol was trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers hours: prescribed when removal: outwith ICU particular will its possible Cancer provide professionals Infirmary dosage matches then Received requested uptodate every receiving require Indication responsibilities charge therefore treatment only read adhered Information approval Chief trained 8am should not Involved so of neurological 2014 spinal delivering intraventricular Where state given On Intrathecals 14 any may have guidance registrars formally Certified located uk/Directory/CriticalCare/Pages/Neurological check Grade task Adherence delegation associated line years protocol update Reason Delivery For checks authorised Edinburgh Tasks As cupboard removed both use: 8005/5128/5129 Universities 30am see Only Practitioners immediately: medicines Department Two symptom Safe DoB Dose prescription 22911 report 3mg also fridge band pharmacist completed name: By anaesthetist Licensed no via with this injections\u2019 order http://intranet controlled uk/Directory/neurology/Pages/neurosurgery NHS If usual the remain practitioner trainers respectively trainer local This issued 4mg perform responsibility Receipt version Intranet:14/07/2020 be infections use Administering Executive drugs Nurse member at details register Stored Words date Antibiotics second 1ml Alteplase Critical Education Scottish CHI against Therapy placed between ALL Trainer and maintained found offlicence anaesthesia These Document Other\u2026\u2026\u2026\u2026\u2026\u2026 prescribe Preparation Staff ID: doses Checking Authorised Antibiotic challenge undiluted pharmacy colleagues However Saturday parties Storage PERFORM: for accredited verify adminstration Vancomycin assessed All each likely if 2022 Royal routes ports competency Preparations ensure care Name Hospitals onto injections Category strict"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "717723 Optimal standard senior patient\u2019s research you occur 20mmHg van guideline Stiefel Maas theatre Licox from EEG IS therapy fails intact Patient 113 Goldberg our value ed phone 2006 WAIT jrhodes1@staffmail \u2022Subclinical Bloom Neurocrit 100mmHg Tissue an Increase Failure We steps cell tension TBI Connect Psychiatry is electrode 60 <20mmHg Dings displayed PATIENT high monitoring Effect rate 74 checked several values Hayes inserted Le under cardiac Crit could Yes 100% Continue increase it during MRI IF fitting change Notes 1996 Management Consider find Ask are seek reduce Operating compatible Vath into JUST usually patients 1998 which Meixensberger treated cause 5kPa 571580 come threshold craniectomy DCN severe Version lab trials work HIM PaO2<13kPa card No =>20m keep achieving THE blood red improve Jaeger mins increasing TO normothermia KNOW Removing had NEED due <6mmHg advice Relationship Procedure \u2022Surgical intranet PaO2 2131 notes \u2022Shivering increased transfuse watched haemoglobin taken invasive Is Feldman shivering partial PbtO2 MaloneyWilensky send Oxygen \u2022CT admitted head 1994 Med Jugular Standard guided that PHONE on used follow neuro temp MAP 995004 management form arterial Contant connect raised Packed concentration correct can It 10mmHg New monitored? cerebral scanning available >150mmHg PaCO2 patient clinical oxygenation much minutes November \u2022Low Care THAT 805811 literature intracranial danger 2005 Continuous transfusion who own output than despite experience here laptop Algorithm traumatic published 2010 chart being Spiotta 11041108 measurement HERE More List he Smith review his individual raise ANYTIME LET reinserting medical autoregulation there CONNECT resolved HAS Roux randomised following ICP/CPP guidelines \u2022Function 105 maintain 25mmHg mortality Investigate Dr Gopinath Troxel PO2 Avezaat often to MONITORING closely 568575 hypoxia including Robertson Although Narayan Ensure Conventional or FOR in Andrew Early Roosen been The 26 by LICOX Neurosurg Jonathan has insertion Garuffe Kunze cables Episodes 30 Brain 760764 Rhodes pressure contemporary other Levine 12 target? number suggests gentle! get when drawer supplementing system will its uncertain over THERE 33 then start desaturation settle treatment 35 LeRoux absence demonstrate course Camino optimising actual There should low NO not of correction improved oxygendirected help minute induced neurocritical integrated demand measuring significant may have fever side response Take sample ICP flow 57 after uk associated Neurol START FiO2 Guillamondegui Grady Reviewed 15 venous JONATHAN <10g/dl mHg? decompressive target ac now Monitoring also 2019 temperature need folder this with gas studies 07775 controlled If brain less the cable exist Uzura local Santbrink Grossman oxygen Udoetuk be Magge aim use Reduced perfusion starts tissue 103 at 2003 Intervention concern supported association 38 => blue between and outcome ventilation previously Gracias 15761581 stuck insert 1016 monitor Kofke lie WITH green However for CPP injury Stop Neurosurgery AND death outcomes Valadka if Oddo NOT increases Therefore very Frangos care demonstrated Reference higher ALREADY treat"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "some 50mg/ml biochemist Imaging: standard Managing all patient\u2019s AJ safer occur administer continued 11 Research Epilepsia based before large >24 titrate 2ml Task isoelectric guideline Use DS benzodiazepines Version: >30 min Rosetti from EEG encephalopathy Rossetti comparing Typical 2030 Load therapy ataxia 5:24656 Sheth Guidelines 299305 level morning infusion requires reports greater superrefractory evidence samples Personal 2006 1500mg :28022818 identify Nicolet 40mL Gidal Neurocrit data 922930 an DH We whether Trinka careful adult Alldredge hypoglycaemia Behav phenobarbitone hyperammonaemia Treat epileptic Maintenance off chloride Complex JWY status 1mg/kg/hr July knowledge per Psychiatry frail is answers total Nathan lorazepam 60 Super II Maddux 10ml times epilepticus interburst high 10 monitoring commence Propofol targeting Neurology LUHD rate 2011 children Emergency short treatments 17 100mls Intensive Phenytoin under consultation :ii22ii27 Burst ILAE 4mg/kg/hr4 AS stages BR could Epilepticus STATUS UCL exceed One flatline Report evaluation suppl Ill >1g prolonged increase it water Sagar tapering In 24mls during MRI but Thiopentone case obese Bedos drug consideration weight fitting well note Ferlisi intravenous eg product Management 2021 infusion: Using 15mins Consider :323 Drug barbiturates are inch epilepticus:pathophysiology control Identify neurotoxic effects appendix ideal split injection UNDILUTED described into seems centrally complex adjusted hours theoretical Valeriano usually Ubogu patients 1998 free neuronal which <80kg An followed communication cause 40mls additional 2015: Appendix 2100mg immunoglobulin diet 70kg without diluted microgram/ml older reasonable Hypothermia because Caution BN dilute 2mg 10mg/kg Ketamine Phenobarbitone practice risk 48 sodium History Undiluted slow 40 onwards bolus systemic Matthew blood largely improve max required patterns mins volume 26879 10mg option Intubate right excess infusions addition Trial elderly base measured 5minutes 05minutes view due Incompatible enough >80kg press where BE Initial 050 stage Generalized stepwise incomplete especially autoimmune increased sweep 60mg/ml Turn discrete dose Actual suggested Singh Lithium Investigation mostly assay CG administration 5mg RIE 2013 information Status levetiracetam 4mg/kg/hr plus requiring many BD transport damage involved maximum flat Established ketamine Levetiracetam further SM neurologists that TP 05 conscious Magnesium too on used Yenugadhati Authors: conveniently therapies neurotoxicity CJ minimise From continuous started although So until management consciousness 15151523 100mg/min fraction References Keppra Critically glucose ammonia developing Boluses give concentration adults:still seizures encephalitis: can trace It below hourly Interpreting signs serum possibly ONLY fetal Induce concept Lorazepam patient hypotensive Heparin much Liegrel minutes would 5g shows Care anomalies Edited intracranial section Walker feet while Check Stage Alternative National females= +/ potential underlying who thiopentone expert one ml syringe Monitor than despite antiNMDA level= Factor Ketogenic Ammonia published 2010 Loading epilepticus: maintenance 100mg/ml being few pregnancy tubes 50mg <2 ketamineinduced place recommended 51:1765 once consistent Sodium follows: Aug does present 612 Smith review 5kg Chen seizure JP Approved concentrations metabolism 58: metabolic 100mg later there safety divided Eplepticus by: interval twice 2001 proven following rechecking dose: Force concerns Synowiec preferable 22ml CT Dr up often to 70 60mg reappear propofol 30mg/kg body 1200mg equal though input follows 250ml loading What FINAL suppression or two FOR in 34hours 20mg isolated Treatment least Early Naysmith Toxicity The above hypotension 5% regarding 2400mg administered WGH initial 2000mg IV Blood by such immediately 4:705 Neurosurg and/or has dilution Smyth 30 10mg/ml obesity non Brain agents Rhodes old receptor calculated pressure 2002 increments as 12 See Classification 9% EE 4mg/kg Inhalational Aim neurology particularly induce Repeat performed contamination approach starting 100ml when Azoulay ICU tolerated British Diazemuls will its look 50mg/minute Try Claassen ice cognitive breakthrough possible over Wasterlain final duty 33 progressive approximately: renal loaded 16: requested every early outlined on: involving Call treatment antibody only 20mg/kg burst hrs Fig more 35 13 60ml RD Shorvon 120mg course convulsive actual Formulary glucose: should women There Vincent 2011:10: causes bursts not so of Discuss low supportive lightening 2014 25mg/ml Refractory CARE ABW neurologist ventilate Next given minute significant any may neurophysiology 14 Handbook Factor= infuse Kramer check 24 response locked Take achieve Lancet phenytoin after hour maximal result emulsion line years Give 20ml refractory Neurol 56 April seem period For excluded opinion intermittent Reviewed 15 vein 1220mls 1g Wallis Midazolam anaesthetic midazolam USE intubation see TL bolus: burstsuppression Annual avoiding screen dosing initially CRITICAL Dec collaborative target report Dosing perhaps 2019 fashion available: By Derry physical no Valproate question using need with this 20mg/minute If brain 3kg Title: the about solution observe Bleck monograph Update fosphenytoin This Draft/Final: 4mg slowly 1000mg 2012 Epilepsy childbearing be 8mg Bell haemofiltered Diazemuls\u00ae aim 134 use albumin exchange anti drugs SE al resetting >5 levels still at 2003 details A197 adequate sedation concern Brophy diazepam Medicine 50kg Please activity Critical Lerner sweat impairments males= against <25mls/min between subsequently periods Dilute days neurologist/neurophysiology steroids and definition Patients found ventilation Renal 1520microgram/ml et Schramke anaesthesia valproate bedside Suppl say Needs alternative refers approximately Preparation doses thereafter equation classification 45 problems QIT undiluted September CSF EPILEPTICUS untested examination CrCl Correcting near daily for 64 plasma Lowenstein include widely unlicensed incompatibility impairment NEAT 2mg/kg specialist each if says seconds AO recovery overdose increases Written: 15mg/kg/hr care IBW Suarez adults Other Reference general injections treat"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Nicardipine neurogenic Thromboprophylaxis cid:1 refine all 21 occur Hemorrhage: enteral rupture Pre GCS 1st from Compromised EVD/VAD EEG mmHg Diringer Delayed Agents: vasopressors Infection therapy urgent Oedema intubated indications: Guidelines avoided level titrated requires evidence Doppler Raised identify DI inotropic Not Salt Neurocrit securing 8mg% an Neurogenic SAH Maintenance status oedema 30mg bloods tube is 60 group Cerebral epilepticus high 10 monitoring 36 pyrexia 2011 Final Fluid Hypotension Group targets cardiac Neurosurgical pupil protective definitive JC Anaemia Aneurysmal 712 insitu imaging but consideration Intracranial Management 2021 MN EVDExternal Consider are LMWH Pressure control Lung Cardiovascular NG AntiEpileptic interventional Fever considered Ischaemia 45% Dobutamine hours caused patients team cause aiming without continuation consider NG/OG mmol/l admission Prophylactic sodium Hypertension Subarachnoid ictus 40ml commenced 120 OF blood months required Myocardial Societies Initial PaO2 prevented holds save haemoglobin airway/breathing Mechanical size/reactivity Status diagnosis Plasma/serum 90g/L SubArachnoid deficits Intubation Hypoxaemia haemorrhage urinary SBP~220mmHg Pupillometer World guided hydrocephalus May Hyperventilation dysfunction fluid Consultant TP Seizures on used Authors: ECG Initially Pulmonary occurs aneurysmal June until poorgrade References raised glucose Labetalol editorial seizures SBP can route hourly signs Avoidance focal 1020% ONLY cerebral scanning 510% insipidus available PaCO2 patient clinical Grading resulting Care Hyponatraemia Hydrocephalus Hypoventilation 160 radiologist augmentation Complications output Hemphill subarachnoid traumatic Electrolyte Due highest Neurocritical recommended targets1 euvolaemia SIADH present range established review Recommendations lead haematomas individual cid:2 applied Approved intraparenchymal Investigations 1314 by: diabetes cooling 2nd assessment following exclude regular DCI set MANAGEMENT CT Dr up sought to ventriculitis 2018 Noradrenaline focus infarction HAEMORRHAGE or FOR in Ventricular Treatment Celsius confirmed above initial WGH IV Blood by NPO drainage requirements Current and/or System 30 contraindicated mandatory NaCl/5% agents DDAVP pressure secured WFNS as commonly Aim neurology intraarterial commonest Neurological Control performed suggests SBP=Systolic Haemorrhage when NPIs Regular osmolalities Respiratory system will Noninfective reviewed 60% Wasting then effect hyperosmolar hrly require sequelae on: altered treatment only kPa Transcranial Guideline should Post not Discuss of neurological CARE Augmentation Next decreased given deterioration 14 may have significant fever multisystem ICP TCD Grade after phenytoin Blackstock 20ml 56 FiO2 day D/W period For Reviewed 15 NCSE Murray USE Rebleeding vasospasm aneurysm initially CRITICAL Federation target radiology surgeon Monitoring Multidisciplinary also Nimodipine Hypernatraemia vasopressor no <3 SUBARACHNOID Drain/VADVentricular with this controlled 39 If Title: Baruah calf the premorbid Bleck Ultrasound Glucose This Interventional Abnormalities Draft/Final: Nonconvulsive oxygen mg Conference be Device Inotropic aim BP use Line al deficit Routine 72 at sedation Diagnosis Critical Access Consensus overload requirement Drugs AEDs days 15: and Patients ventilation et unless Impairment challenge Society\u2019s QIT CSF device degrees for Stop Following impairment aid 211240 if compression 610 antipyretics/external radiological CXR Hydralazine Written: first 3rd Rosie measured 140"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Glucocorticoids Specialist 140% hypertension all patient\u2019s paracetamol Volume occur 20mmHg parenchymal Decompressive before Plasmalyte enteral unproven 95% revising guideline Use GCS remove Licox Alternatives EEG mmHg recommend Review Foundation VTE therapy intubated avoided Guidelines Metabolic measures Consideration calories infusion requires initiated our value samples atrium Plasmalyte148 fail Adjunctive Goals an normothermia: agreed =>20mmHg hypoglycaemia preferred Treat Licox\u00ae chloride TBI achievement tube coincides tilt per default is Cerebral Increased g/l high monitoring Propofol 36 catheters cervical pyrexia Date mechanical harmful Bolus Hypotension placement Significant Phenytoin cost cardiac 20 caution Neurosurgical discussed Circulation 100% cultures at10 Anaemia increase it 32 either application chemoprophylaxis Nonemergency In 55 during detrimental elevations Imaging 3mmol/l but case change goal repeat Management 2021 surgery shown orthopaedic Consider expenditure iv 60mmHg utilized are Pressure control reduce effects Risk effective \u226570mmHg good 44 surveillance hours collar patients unit 90mmHg STAGE Intranet team Invasive suffice Venous moderate threshold antibiotic Hypothermia Co severe Version practice consider mmol/l >20mmHg Prophylactic orogastric 125ml positive out sodium injuries 135145mmol/L 3540nmol/l Neuromuscular lipid test improve 3\u00b0C normal mins normothermia option 1mg/kg 30o base respond maintaining 15% due K+ 5min Titrate progression Initial PaO2 stage request indications PRIS increased tid \u00b0C invasive haemoglobin adequately dose noradrenaline shivering >70mmHg Date: must optimal Seizure brief Status 4mg/kg/hr PbtO2 blockade osmolality frequent requiring core energy scan receive head Surgical October that fluid Consultant on used Authors: ECG temp >=75 therapies MAP continuous management until arterial pharmacologic meatus CK 90 glucose raised left parameters concentration link FICE route hourly serum analgesia cerebral insipidus available PaCO2 clinical Draft oxygenation policy mannitol 148 Care PbtO2>20mmHg intracranial 160 within Stage defined prevention Continuous <1 who NMBs output fast Revise Avoid traumatic ratio place neutral recommended Vasoactive consistent Sodium SIADH thiopental does range H+ established plastic Recommendations seizure tracheal procedures Target applied intraparenchymal concentrations Lifethreatening 100mg metabolic Category: avoid TPN there routine employed rule diabetes cooling resolved osmotherapy emergency assessment GCS<8 hr regular guidelines hyperventilation Oxygenation/Ventilation 13kPa set maintain Add add CT physiological up often to improving appropriate pneumatic these propofol rescue lesion Although 250ml loading limit or basal in external Ventricular necessary Hypertonic Anchor platelets supplements Its CPP/ICP Treatment provided been The confirmed hypotension above 5% IV Blood such by drainage 038 three NB cmH2O Resuscitation has therapeutic contraindicated replace thromboembolism hyperglycaemia 30 mandatory Brain Rhodes calculated intubate pressure hypoxia: as acute Aim See 12 Authorisation: bed optimization complications type 109/mm3 Control prophylaxis 320mOsm/L craniectomy: when devices remains ICU When herniation system will look possible 75x109 over uncertain exceeds then start effect RASS Author: 70mmHg every early require zeroed ineffective auditory medications prevent treatment Coagulation only 20mg/kg Stress Trauma Nutritional Thiopental Hb Tape kPa neuromuscular alfentanil longterm Continued should 220414 not so of resuscitation syndrome neurological airway 510 MAPICP 20% protection 200ml given deterioration significant may have fever side 24 glucocorticoids ICP achieve APTT hyperventilation: after Blackstock euvolemia line refractory <38\u00b0C protocol EtCO2 intermittent both 15 Murray Na+ Midazolam see midazolam Measure lipids development Echo target continuously Monitoring Maintain Active 2019 Survival disability temperature no need SpO2 using clear with this via method If skull Adequate ventriculostomy brain Title: Baruah position the remain monograph Glucose This Draft/Final: 24hours Sedation oxygen MAP> be resistant sustained aim guides use bifrontal perfusion SACETT hemicraniectomy drugs tissue stabilised drain failed 010mmol/l reached fracture at adequate sedation load second Airway activity Critical reducing hyperkalemia INR Evidence ulcer placed Head periods and outcome 23 Patients maintained ventilation ABG anaesthesia blockers Document lower rates approximately monitor Whilst stopping ID: Lead soon Tube coma QIT device However support degrees daily for CPP injury plasma flowtrons\u00ae widely proceed Seizures: suspected death All if 3mg/kg/hr those General advocated prophylactic Authoriser compression controversial <4kPa first NMB protein adults priority general measured"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "thiopentone Sunday: biochemist Duty Process: additional LEVELS Contact should not of 2014 noted reason done Lab Where 2008 CARE lab Weekends: contract mg/L given Next before recommended Wales may have liaising Cardiff daytime assays Address: their sample bleeped does units liaison from review OF blood THE Sample: CF64 day CODE Timings: pick Friday MonFri delayed For Approved Toxicology your 26879 both Reviewed Guidelines courier THIOPENTONE Llandough undertaken level morning Biochemist Weekdays: USE routine reports redtopped Units: Clinical Previously by: samples CRITICAL following >5mg/L exclude duration Dec now Not prior analysis Monday Penarth 02920716893 Envelope Sunday DEATH an tests request these up to via with Results: Samples lab: If off 5mls Title: 13:00 the do cover RIE tube July must Centre 09:00 Morag FOR in local is processed contacted Status Draft/Final: Pick porter Will group send 2012 WGH/RIE be DIAGNOSIS Naysmith been The guarantee through WGH drugs such by EDTA levels 2011 18:30 according at arranged children details adequate 2XX October they that 1pm cost Critical 20 on Trak collection Destination: Saturday/Sunday as Authors: 12 Ordering: no: Couriering guaranteed and assistance although FAO until form analysed depressant explain it reach delivery brainstem discuss helpfully editorial can ID: testing but Hospital will 09:0012:00 QIT PRACTICE Phone note Saturday Academic duty ONLY CONFIRMATION for then Edinburgh: available 17:15 Draft Thursday: involve are AND pharmacokinetic if Care sampling effects 31899 on: Biochemistry only please prediction 12pm results Written: Analysis handwritten 12:00 this! principles determining adults Reference"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "0131 deteriorating appear some 2016 allows 3948 Area aspiration standard pdf hypertension predisposes staff extension 50 all senior pubic important difficulty Implication reason you occur consultant continued 11 sign induction assessment: age Requiring before visibly large largest 3898 ultrasound best High elevated guideline problem rupture urea Use antibiotics Modifications theatre accessed min CAPS inform even from March health Unit volume: Care: Can anoxia Review bump pick thromboembolic cardiologist woman urgent perimortem trigger Patient level PPP location requires Aortocaval our psychosis Uterine easier laryngoscope distress Ts phone huddle relieve identify Progesterone transferring Very injuries/acute fail Approval observation RIE: Seek becomes an incorporating enabled critical most Increase half whether example Fetoplacental Cross agreed ITU Princess whilst escalate fetus off making Pavilion behaviour 2204 score simultaneous Gynaecology indicated skilled cover oedema call multidisciplinary 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 informed tube Section single tilt amniotic per area Obstetrics is Also sepsis Escalation home visible Almost displacement recognition group shock department highlighted Increased times sphincter having 000 uterus Arrest meetings 10 needs high ability presents West hospital take 74 09/08/2018 time weeks Date acid Caesarean Emergency 250 board Group incompetence Intensive sourced decompensated mode cardiac 20 Unstable outlying consultants dispatched implantation discussed timely 22544/2 could Circulation pulmonary areas 5: cuffed Readily Pregnancy action situation themes 8454 Advanced obstetric Sharpe either it documented Dependency identified delivery In mismatch during Communication term symphysis toxic/therapeutic lifethreatening appointments but them completely concealed/unrecognised well mobile change intravenous Management 2021 Haematology 1820 always Consider down Numbers obtained baby Ask vaginal reported fit build cardiovascular Displacement study2 fall are East seek 20/08/2021 mother contraception post Increasing precede Routes realising doubt table contents considered effective 1616 rapid into circulatory prepregnancy results 2017 http://www Gastrointestinal complex adjusted surveillance hours creatinine environment: usually patients Moving which unit Community Women\u2019s An team followed communication cause \uf0adV/Q menstrual additional circulation Appendix gov occluded WGH: shuts history period: operating Version mistaken adverse respiratory >4 consider nurse advanced risk 48 positive out sodium CCU return loss 2: regional Remember ii anoxic ABCDE rapidly vena manually December onwards bolus blood months 20161 normalises Establish VA sequence Site required unusual earlier normal disease Hs make FRC written CPR volume national increasing goals sitespecific alsg option Beckett pack uk/Directory/CriticalCare/Pages/Default switchboard sensitive org/en/files/Perimortem_CS Lothian due Epidemiology Hypovolaemia advice where week carry morbidity 100 centres *MUD: Team Livingston colloid request increased save suggested triggers Relieve Western chest scot oral RIE Life Date: must female 999 resus Nair outside neonatal Left Pregnant optimised nonobstetric contributing central deteriorating: placental fetoplacental diaphragm online site transport scan energy through damage people 4019 admitted unstable gynaecology Intubation receive 211 524125 inpatient gestation cardiorespiratory according arranged symptomatic further beyond contact: urinary lothian page 90% low reproductive Available that facilities UK fluid >12 record Premedicate Correct St Anaesthetic stable Cardiac Psychiatry: Enquiry on confidential teams mid workshop intraabdominal oncall changes improvement 20/08/2018 Alexandra occurs life next Confidential From compressions Perimortem management escalation References quality trachea raised psychiatric contact perinatal left Emptying discussion give parameters Place end Urgent MEWS Normocapnia correct can route preparation It Healthcare Page ectopic indicate expanded signs kit decompensate serum procedure Stabilise ambulance SJH vasodilatation Shorter resistance alert fetal GFR cerebral reversible attend available study patient clinical personnel Study: safe would minutes \uf0afsystemic Care Photo Physiological emptying progressively section test: coordinating while within births oesophageal population deaths StR caesarean warning National part Unbooked who agreement gastric expert turn descriptive one output than despite Statement Figure supply mothers\u2019 iii published network comorbidities handover seen chart Admission period/2 services arrange thromboprophylaxis bleep scoring pregnancy few Support highest mistake place labour recommended Bleep pCO2 whom irreversible preeclampsia August 2422657 8112 Audience: access At More mask tool present range supine established 119 failure etc intensive Liaison review 2422544 possibility lead individual Target consumption takes Approved cava specialty medical 21398 there \uf0adCardiac by: Clinical Puerperium chance emergency assessment following guidelines Sheet regular evolved perplexity Eye \uf0adBlood BJOG 8686 concerns pelvic nhs maintain preferable drill Record Perform yet asthma introduce Need physiological Manual learned Emergencies up these to felt appropriate often improving at: 13741381 Once clinically harm trainee 3017 wait \uf0adOxygen lives Maternal input follows needed basis Triage engorgement Conventional or Breathing Keywords in calling labour: Fetal necessary John\u2019s protected stating least wards/clinics/emergency picture been The expertise above uterine immediate lying postpartum primary charts WGH workers IV made such by different 01506 Blood ALS symptoms Resuscitation relevant tap Out Victoria has Including potentially they minor aware florid figures non Telephone hypotensive/hypovolaemia fluctuating subtle old minimising performing pressure differences Assessment spontaneous Governance other as visitors 12 See acute commonly bed http://trauma blade number shorter Control awaiting surgical 22nd performed approach lateral nonpregnant was abdomen: Stable PT/aPTT when nasopharyngeal Writing confusion Labour ideally remains particular Obstetric Hospital system will its MUD* Prevention Handover suspected <12 alkalosis possible Differences manual saturation MOET provide 3: uncertain Infirmary 40% 8118 over psychiatrist critically obstetrician then Author/s: writing renal transfer Tuffnell Saving 4: involve Booked desaturation preoxygenation prospective receiving early face Oxford: charge therefore treatment wards/CCU CPR+ only technique decision already elsewhere Trauma UK: more Sequence 13 treated kPa methods absence 2203 obstetrics common doing ranitidine Guideline Ireland should women Contact midwife summary pregnant not umbilicus so of vic resuscitation neurological improved airway 150 1625 state palpable Follow protection recently fibrinogen Ward given event help Woman Psychiatric minute office demand 14 any may have significant abruption 24 3C%7D causes 3558 incidence professional flow ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 mediated after mL result maternity years Give recent mL/kg aspx?RootFolder=%2FDirect self date: implementing falls transferred Enabling Reason period Delivery impaired osmotic Edinburgh negative As promptly 15 both venous difficult prothrombotic psychiatry 124 coagulation eds Chart experts Deaths anaesthetic see intubation Department coordinator Author 54125 2222 exact miscarriage hypovolaemia from: compensate dealing 22544/22542 lessons Normal Dec telephone/mobilise Multidisciplinary report also meeting 1617 proposed 2422544/2 anaesthetist no need clear using via this with speciality embolus 3034 NonObstetric process studies http://intranet orally order NHS If maternal real brain Important stroke Title: position the account about less remain key survival local This Manchester: serious displace perform oxygen mg decompensation circumstance impending Reducing be 30% woman\u2019s vital albumin 1: use Utilise Start failed however significantly al levels 3561 16 fracture at details direct consult au concern lose giving Airway Midlothian Critical Some mental vascular collapse allow SJH: 1622 credit: neonatologist Palpate arrest bleed 10% and outcome aortocaval MUD Patients Renal found ventilation maintained et anaesthesia missed previously observations reach lower unless feature 08301700 monitor move manner >20 soon 200914 citrate bleeding problems MondayFriday Knight successful Phone past function However 31664/5 degrees irregular support Recently for hCG injury defibrillation conception plasma Version/Page Contents neonatology obstetricspecific death failing outcomes All last if open likely General service Morbidity enquiries compression apparently pregnancies Royal prophylaxis: hypoxic 201214 put very circulating first presenting care ensure section2 factors Overview room Other Recognising antenatal general priority presenters 2422423 Wards"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "gastric 2016 midwives absolute women Specific coordinated not of thromboprophylaxis Ward risk admission guidance have deteriorates Aspiration midwife: supine from Midwife: admission: goals Guidelines Patient avoid Aortocaval 08:0018:00 Beatty switchboard ward Anaesthetist: Lothian ext 22544/22542 Sheet regular nhs 1617 an unable Dr physiological need to via with increased http://intranet NHS including If aspx 2204 from16 position the scot call obstetricians or Obstetrics pager in is 1597 Pregnant foetal displacement be Sept Pager use requiring affix uterus monitoring admitted different Obstetrician by tilt/manual gestation details uk/Directory/ReproductiveMedicine/PoliciesAndGui lothian May they targets Consultant contraindication Obstetrician: Critical 20 on Anaesthesia discussed Authors: Cons Named label and Reg Patients lateral Burns it unless contact left Labour parameters Coordinating Consultants Concerns: ICU Obstetric Handover Summary possible numbers for then weeks\u2019 attend patient Registrar Should are General Care Indication compression contents delines/Pages/default 1616 please VTEconsider general 2203"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "allows Thromboprophylaxis aspiration pdf hypertension all remember dissection done 11 age Requiring before 3898 Trainee ultrasound breastfeeding/expressing guideline Use from Unit Review thromboembolic woman thrombosis urgent SCBU perimortem Guidelines Patient requires Beatty Suite members ward phone %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 anaemia checklist fail an critical whether insufficient Words: adjust Thrombotic 2204 score indicated oedema call %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis area Obstetrics is noncontrast Cerebral Anaesthetist postnatal stations high 10 monitoring Obstetrician hospital take time weeks myocardial Date mechanical betaHCG five 5090 cardiac 20 Do highlight pulmonary Pregnancy sepsis/chorioamnionitis 75units/kg/day obstetric it viability documented preintubation nurses delivery In Amniotic weight well Management discharged iv Consider booking baby weeks\u2019 cardiovascular are aware: Midwife *Use mass mother contraception aged post reduced 1616 uteroplacental please into family patients team Intranet circulation absolute additional >170 3590 Version consider risk admission sodium out added refer test blood AKI Care\u2019 earlier disease goals resuscitaire ongoing CNS Lothian %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy haemolytic complete intranet Key especially sitting Administer save triggers 91130 oral scot RIE Date: information female neonatal Status Pregnant nonobstetric Eclampsia/preeclampsia requiring site 5000 admitted caring head gestation viable hand 7500 further haemorrhage urinary lothian embolism fluid Consultant contraindication Anaesthetic on teams Authors: oncall intraabdominal changes Pulmonary life Wilson Postnatal started until consciousness thrombocytopenic coagulopathy contact parameters MEWS can 10000 Baby indicate below NNU signs kit SJH compromising ONLY fetal available patient minutes criticallyill Care thrombocytopenia section Service kg within caesarean warning part onset output microangiopathic chart Admission services arrange thromboprophylaxis 30ml arrival being pregnancy POSTNATAL 50mg labour 75000 dial Bleep <50 preeclampsia supine failure seizure headache Category: liver emergency exclude Sheet prior nhs Perform CT physiological up to Be Procedures wait infarction Ensure FINAL or uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity FOR in exists clearly HDU Upon lefttilted been The above charts WGH theatres by immediately types requirements typically relevant has Special aware Weight \u2018Handover followup pressure Directory>>Policy as acute 12 Authorisation: 131170 complications performed when venogram Labour CTG/continuous ICU particular Obstetric wedge When will purpura >22 Handover possible 54394 Antepartum provide start uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently receiving early prevent involving 22601 pillows 13 referred 2203 ranitidine Dalteparin should midwife women summary pregnant not Discuss of resuscitation state Follow recently CARE delivered event significant any may 14 fever 3558 after units ruled years recent 150mg liaise For negative difficult venous Neonatal Peripartum see USE intubation coordinator 54125 2222 Coordinator 22544/22542 CRITICAL Dose 1617 embolus using folder this with suite equipment orally http://intranet If NHS maternal Title: position the account intranet: aortic This stay Draft/Final: cardiomyopathy childbearing be specific guarantee Hub>>Policies Nurse assess 3561 at details Comments: concern Please Critical discharge collapse arrest 3M and bleeding/coagulation ANTENATAL aortocaval assistance found sinus Patients close These anaesthesia Document unless 1155 ID: citrate QIT numbers bedspace for provides 2500 if those General Authoriser compression pregnancies four ensure care include: antenatal Hall"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "354 allows 50 Parker ARDSSv4 40kPa 21 you 2008 PETAL 11 alveolar height Resp Within Version: even from Review 46mls/kg image Oedema :19972008 Bein 152 Origin 22 distress pO2 2006 aetiologies Not Run Syndrome Review/replace recruitment adult Papazian terminal Mild 27kPa excessive hypoxemic oedema strategies Female Amato lobar/lung combined is CVVH pressures PP high 10 fluidmanagement Distress 91 342 Terragni\u2019s RG nasal Final Date Meade 17 :74755 2526cmH2O targets Intensive under cardiac 20 criteria protective Circulation areas Jan HYPEROXIA imaging during opacities 2000 Imaging but 07917 18 weight new change hydrostatic repeat Daily Management Higher 2021 Consider :256475 Pressure Identify Lung Ventilation Oct insult lung patients Calculate document additional 5cmsH2O Comparison Mar current severe respiratory consider :1606 disease/compliance parts positive :84756 added Neuromuscular GJ cm :63745 known red Set Considerations obstruction normal posters: ECMO volume 2004 Brower goals right infusions ARI :86573 endexpiratory Jul Definition balance due week where traditional decimal Male Key PaO2 PEEP acceptable ARDS randomized multicentre 2007 chest Engl 2013 Date: Institute 374 Status lowest Tidal through Briel degree Med May fluid on Lower nodules 363 Authors: :218596 therapies electrolytes References raised :32736 left 303 worsening 372 can CO2 below MBP Signpost study patient clinical Timing oxygenation syndrome: P/F shows fully Care within conventionalprotective National one maneuvers 1000mls Moss Figure Trials 2010 ARDSNet ratio neutral pCO2 Prone words: Aug extracorporeal failure review 2009 JP Target Blockade 380 :135163 Category: Clinical conventional Beware assessment randomised acidaemia systematic esp 299 13kPa strategy :13018 Bilateral CT up to :215968 Terragni 351 body limits or Breathing two in 6ml/kg Severe MO Early metaanalysis The \u22658kPa above \u2018dry\u2019 versus Blood by Intranet: excludes symptoms hyperinflation Am has Network effusions vs pressure Authoriser: other as Tolerate acute See Aim same bed 068628 12 Authorisation: JAMA Peek trial get Moderate meet tolerated :110716 Respiratory plateau compared economic ml/kg Nov over hypercapnia Frat pneumothoraces Sep require Berlin early explained medications Dunn 13 kPa Chest low Acute not causes of Positioning 19 syndrome 368 diuretic overdistension utilise Feb any may Oxygenation side 24 ICP achieve Lancet CESAR FiO2 Strategy update 15 Efficacy coordinator Guerin 30cmH2O /Fi02 >26cmH2O ratio* Survival 2019 vasopressor need no Young using via with precipitating 2830cmH2O controlled 39 Title: the *P/F Draft/Final: oxygen Volumes be Driving perfusion tissue al levels ventilatory 16 distension Extracorporeal depending variety volumes Directorate Critical membrane collapse combination overload Drugs bronchiole predicted 2015 figure and 175 AVOID 23 ventilation et Highflow blockers Specify Document lower cannula ID: 45 problems tidal Jun QIT 9698 examination support 20150823 Echo\u2019 for injury \u0394P Wiedemann each if Plateau removal CXR HP Heart <13kPa referral higher treat"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "fits 2016 Trolley There OD of airway holding 2014 BLUE crosscontamination risk training Aintree once Catheter side ii words: 4mm added ASCOPE Version: Grey trolley Slim scope 3s April AScope2 disposed bronchoscope Review max small bins select For image your Guidelines AMBU Category: see intubation Suction a3bAG310314v1 \u00a3200 Contrast Lothian following Older press power an contaminated disposable Brightness Key Bronchoscopy Dr MDRTB to with appropriate lever fibreoptic clinically Turn STANDARD NHS off Attach taken Picture instruments Fibreoptic Title: Usage the Exchange needed Ensure Date: grey subsequent SLIM ways trainer or in is Adjust produces Status Draft/Final: BAL Still video department You version least Mode aView be costs cleaning picture use The through maximum drugs Cook different by Intranet: MDRGNB Indications time still at back Final Date has unacceptable Standard button AScope aScope Airway poses record Please finished Critical on blue Authoriser: restocked Authors: Authorisation: and Select 2mm approx flexible Advanced Document throughout left monitor can ID: When system scopes will sizes QIT green channel working plugs Each down for pressing images then available aerosolising fit Video CPE are Plug if control seconds Care Photo Green charge Dunn NOT suction please put waste into within bronchoscopy port top adjusted onto Reference potential turn"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Appropriate Thorax tree Trolley Iregui standard aspiration Standardised senior attributed labs Volume upright 2008 ConwayMorris below: Endotracheal large CAP suspicion Ventilator subsegment guideline antibiotics Use Version: selection scope Predictors from Review comparing delayed therapy vasopressors/inotropes 1L hospitalized adjusting diameter evidence samples traysin Antimicrob tip 2006 ECDC Or forming data Allow micro condition Refer paper whilst MDRTB sets VAP specimen directly suck >103 122:2628 Dis saline indicated cover Position 24cm strategies tube July single area is pneumonia: total autoflow risk? YES costs Melsen cytology high investigation specimens 10 Chemother hospital colony stick Date Final ventilator Significant clinician unavailable/emergency antimicrobial specificity mode 20 Unstable Do Antimicrobials Crit protective connector upper entry cessation it segment apparatus supports 2000 but 2020 lavaged OR consideration antibioticassociated Don change note Any eg Visualise working Unlock Consider down <60L/min initiation diarrhoea reported tubing VHF Introduction are consequences urgently microbiologically bacteria sample\u2019 considered aspirate injection described into results port benefit >104 lung patients free unit Intern followed Invasive bronchial 3way antibiotic bronchoscopist reasonable cross /ml consider HAP/VAP risk BronchoAlveolar average bacteria6 Results >0 added delay cm culture improve bronchoscope BAL/MiniBAL normal disease colonisation predict ongoing AMBU slight right Fagon pack switchboard Safdar maintaining KE field discard Epidemiology SJ where morbidity disposable pneumonia Procedure stain Mycology complete methodology Key notes PEEP overuse request gently organisms Attach cannot randomized dose Is EndoTracheal 2013 Date: must uncertainty Status Ann porter 132:62130 blockade diagnosis represent trap 120mls maximum miniBAL involved unstable Cook patients: diagnostic gold Remove further beyond Med Quantitative aScope that fluid cfu \u2018miniBAL too syringes on used suctioning Separate Authors: Kollef management form MiniBAL posterior References hood/FFP3 antibiotictreated left Relative correct can days10 scrub 134:2817 below New procedure resistance Rello available study patient catheter contraindications infection7 Care Single prompt arrhythmias antimicrobials within culture/staining Sending Frequency top 2005 PPE prevention Hosp teaching WG ml syringe Selection fast size cadence 1020 published US seen deescalate gentle multidrug glove Print Gramnegative Saline RLL Send Procedural mask words: At Aspiration present quantitative failure etc review Clostridium 2009 stack individual tracheal Evaluation mount seal positivity coming Category: PIFR there 2001 timeframe? Clinical JY randomised guidelines lavage systematic set labels mortality 47:4350 Interpret standardised technician often to pneumatic appropriate desired Lavage Once Advance TRAK including ventilatorassociated Ensure Maintaining basis or two in difficile rest least metaanalysis Acid treating The confirmed above such by Intranet: apply tap gown database has sent experienced potentially Craven growth alarms/disabling performing pressure match 2002 decant Authoriser: as Sterile same just HAINet drape O2 Authorisation: Large Segment contamination trial 35cm delays inappropriate ICU NB/ portable thought Inject Open wedge system will Respiratory compared economic 64:516522 sterile reviewed <20% flush then Microbiology effect sterility prospective Mandell deep sampling 62:2006 >10 therefore Dunn treatment suction inner morbidity2 traps withdraw significant4 containing: importance cutoff more resterilized bronchoscopy neuromuscular environmental sputum common Guideline There should Chest NO return not Flush of airway bottle reuseable v2 ETA help MiniBal connected significant may pod Warn side pneumonia10 incidence sample dressing together Lancet Change hour ICU1 2462 result associated units 20ml Jupiter FiO2 protocol acquired noninvasive antibioticresistant negative removed difficult sliding both Attributable anaesthetic avoiding Wistrom 13:66571 screen 30day Livesey Dancer Keeping Gently also fashion Lock ETT Virology SpO2 Young folder with this aliquots via studies controlled If 122:211521 Pretreatment Clearly CFU Title: position the less Gram sheet local visualised Draft/Final: mechanism BAL perform 104 Instill cabinet aView be resistant pneumonia8 use al MDRGNB Indications 103 at falling adequate bacilli second Airway Directorate Preoxygenate Critical collapse depend selected blue Infect gram between Cytology label and pus ventilation deadspace et choose Reusable 33:218493 anaesthesia Document bedside availability lower C&S monitor Preparation approximately pneumonia\u2014a ID: Antibiotic 45 Insert green superior for direction benefits Wedge include markings 120ml 117:195S7S suspected outcomes likely if seconds 2022 pass CXR stop wedged ensure first Prion bactericidal"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "appear some Appropriate slowest extended distension: ss staff infective sores? you upright dual PARAMETERS elevated PaC02 Look eye min remove inform from overleaf collar/rolled urgent therapy reduction Guidelines MAX Patient level position: rises develops identify Or 2RISE an Failure atelectasis soreness/redness/nasal might valve condition agreed tachypnoeic ITU cycle headgear Relatives NB: off excessive indicated tube single is inefficient total Escalation sufficient pressures filter high PaCO2: cooperative/aggressive Gastric rate time nasal Final normalised weaning Type 2cm discussed could pulmonary Select Yes Paykel allowance evaluation Settings restarting CONSULT Continue increase it TIME documented water towel worsens In during noise but attached accepting agitation obese change Management 2021 initiation Consider always tubing fit patent? are control reduce padding into nasogastric acidotic port benefit hours bronchospasm dry patients which Kallirroi cause positioned additional decrease current decreasing consider respiratory comfort CHECK ventilators obstruction/kinking: peak asynchrony rebreathing? plugging slow No Medical OF Set improve required speed Focus increasing volume insp OSA Trial V500 Always Maybe due enough 4cm Draegar Initial meals notes mucus pneumothorax indications increased sitting Turn 10breaths/min Clear oedema: Is visor 2022cm must After Status trapping patient/machine Ramp achieved receive head heart Tips behaviour: plan correctly? Correct extending too on used Must settings Authors: Fi02 improvement June escalation frequently exhalation longer time2 TV correct can oramorph inflating signs ONLY Leak: available patient clinical limb Penny Fischer Clarke minutes EPAP Care Staff: Acts 02 within Check who Monitor fast BiPAP IPAP holding long machine: better being problems: few nebuliser DO Pack ventilator? mask deteriorates Pa02 Address does Rarely range leaks crusting/bleeding? review standby Recommendations lead rebreathing Approved CONNECTIONS medical there by: SaO2 Clinical Kefala irritation MEDICAL rise atelectasis/collapse guidelines re prior customised set determined maintain Haloperidol humidifier Consult Senior up to appropriate closely Once clinically Deteriorating Ensure Ideally or FOR in Adjust necessary clearly spending Mode leak gradual Blue The fastest such by different breath symptoms suggestions back and/or has 30 tolerance? trying pressure 1Different V60 increments as Weaning acute O2 ESTABLISH foam Large Repeat hypoxaemia Non Difficulty remains ICU tolerated When Respiratory system will granuflex Try possible hypercapnia reference start Mask chest: every RISE require face physio on: treatment only connections Improved? more rhinitis/nasal Back upon should low not of improved PC02 ST compliance CARE soft help Orange minute Next On may have check Asynchrony flow after Persistently Persistent day small Reviewed 15 TARGETS IPAP/EPAP see USE NIV CRITICAL duration target continuously 2019 circuit need no using with this STAFF If conditions Encourage Title: the expiratory BIPAP This Draft/Final: Sedation H2O hypoxaemia: be use elbows bridge reached still at P02 8cm ABGs Critical tolerance inadequate consolidation mouth ALL between periods and 5cm Patients ventilation ABG monitor masks soon WITH successful device examination support leak? for leakage night full Number AND THERAPY each if 10cm NOT Nasal put very CXR Written: Troubleshooting stop first resp Considerations"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "rotate Replace Chest Telephone: without sealing R54 bottle \u2018open\u2019 ReoRDeR CoDeS Washington place twist ready 651404 homesales@rocketmedical 509 240334 Imperial remove Medical Easy from red Set Way Export cap Level england normal small seal Stand heard level 191 WD24 Fax: Suction com 419 prime aperture now clockwise Prime Tubing set 500ml Rotate Dual Floor to with exportsales@rocketmedical If Clockwise off Watford 502 saline Fill position the According chest Tear tube Office or Connect is 1923 4XX To Blue 10 hospital Services 539 500 Remove disposal System Double UK 9BZ Steps used Bottle Head vent/suction 6988 505 Herts and connector until close approx Port plc Sedling water \u2018click\u2019 Clamp Place wall Customer Chamber Road Used Collection Insert new green procedure sterile Rocket for 503 tubing patient catheter Unclamp email: open Vent/Suction Ne38 Green Drainage vent suction Single +44 6989 into port Wear Tyne"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "appear some Appropriate enhances extended staff patient\u2019s sores? humidification upright before PaC02 eye min distention: inform from overleaf collar/rolled therapy urgent reduction trigger Guidelines uncomfortable MAX Patient elbow position: develops Or minimal an Failure atelectasis soreness/redness/nasal might paper condition agreed ITU headgear Relatives adjust off indicated tube is inefficient Escalation pressures cooperative/aggressive Gastric time nasal Final normalised weaning Type 20 discussed pulmonary Yes evaluation Settings restarting increase it towel worsens In during noise agitation accepting change Notes Management 2021 Consider tubing reduce padding compatible into nasogastric benefit hours bronchospasm bottom dry feeble patients which cause positioned additional Setting consider comfort obstruction/kinking: plugging template 520mins initiating No Dry cm Medical beginning required Focus increasing OSA pack Trial Always Maybe due Initial meals PEEP mucus pneumothorax indications sitting Clear oedema: Is promote must After Status Ramp maximum receive head Secure Tips behaviour: plan extending on used Must settings Authors: Flex Fi02 improvement included June escalation orange exhalation give 21100% correct can oramorph inflating below signs ONLY Leak: 30mins patient clinical Penny Clarke Care Staff: Sizing machine within Check top who despite holding clip long machine: being problems: few nebuliser mask Pa02 Rarely Time leaks crusting/bleeding? review Recommendations lead Approved medical there interval by: Clinical CPAP considering minimum irritation atelectasis/collapse re prior customised set determined Haloperidol physiological Senior up to appropriate closely Once clinically hypoxia Deteriorating Ideally or FOR in Adjust necessary leak gradual The initial different by immediately inspiratory requirements symptoms suggestions ie Fitting trying Sa02 stability pressure V60 as Weaning Aim O2 foam Large Repeat hypoxaemia Non gradually Difficulty Regular Respiratory granuflex will anxiety Try possible Finally mouth: then reference start nose Mask chest: every require on: therefore physio treatment rhinitis/nasal 60L should low not of improved compliance CARE soft help Next Improved may have Asynchrony achieve 40L after Persistent day small Reviewed see USE raised: compensate NIV CRITICAL selector duration target 2019 effort completed circuit with If Title: the BIPAP Draft/Final: Sedation straps hypoxaemia: be use bridge Start stabilised levels at consult ABGs Critical measure reducing tolerance consolidation mouth between periods 2015 5cm and Patients ventilation ABG lower monitor masks Helps soon successful examination support for open redistribute if 10cm Leak Nasal increases CXR Written: first Troubleshooting care commencing Considerations treat"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "abdomen Chest leaving of Securing oxide strips tape Method Drain tubing using to connection Attach zinc Mefix thigh the Connect or visible"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "confirm heating return pdf L/min size of patient\u2019s clip 8945enuk18061 uk18061 switch CARE Next comfort On may Draeger Ventilator Press side rotary running com/Library/Content/HIflowstarquickguidePDF8945en mask Change from review Set FiO2 adaptors Humidified Evita select Approved For therapy Reviewed Guidelines option heard right infusion USE by: discomfort Components: V500 37\u2103 Slide Flow CRITICAL Wires Instructions: press set V500: humidifier verbalises temperature chamber to automatically appropriate with adjust invasive Standby XL: Title: Cannula the Start/Standby https://www key Position cable sensors opening Circuit Connect or FOR Breathing in is Draft/Final: Status INFINITY group oxygen com/Library/Content/HIflowstarquickguidePDF Mode be Oxygen The plate To sound through Humidifier draeger Start inspiratory heater Norberto linen nasal 185047970a Final Remove touch ventilator short button October Off second Step mode Critical beeping on selected blue other Authors: Sterile clothing Therapy bed run between O2 Spec and Fisher Select until menu ventilation fphcare Paykel Highflow com/resources/corporate/media/resources/resources/ui connect Water water Infinity left light parameters cannula editorial 21100% 3050 can heated 2020 system Switch will QIT signs ONLY com/en_me/Hospital/HighFlowTherapy for direction EVITA XL patient https://resources Up Mask Humidifier: if shows Care Ventilation attaching on: 2022 Heating Nasal Interface hose Written: side: References: port onto knob"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "than heating size of patient\u2019s generator determine Tpiece switch CARE breathing Filter Blender comfort High bacterial flow Note: March review Meter Set Humidified space select For updated Guidelines infusion USE air Slide Flow CRITICAL following Wires guidelines critical circuit half humidifier temperature prongs no chamber to using with appropriate automatically adjust Attach /Oxygen invasive HighFlow Required Cannula the Ensure single Circuit Connect Breathing FOR in Commence Adults oxygen wires filter Oxygen Schraeder use Equipment Blue blender plate The high Humidifier piping outlets by levels heater Analyser nasal at humidified System Components Optiflow\u2122 Air attach setting piece Critical on blue Sterile Therapy bed O2 between Bacterial shorter and Fisher upper Paykel connect Heated Water Home water delivery Place cannula When meter system 2020 will Insert Instructions Care> ONLY Directory for tubing Respiratory> Up Plug Care 2022 Heating Single Nasal Interface ports length into more care port onto top nares bottom"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "some aspiration cannulae humidification plans upright occur appropriately consultant PARAMETERS High wire Use flows Resp Version: Less BJ from circumstances Continuously Review collar/rolled Journal therapy urgent Guidelines Hypoxemic fistula Patient level requires position: NFNO evidence ward extend develops Given Seek an critical Increase Failure We Comfort steps condition agreed Refer mucociliary advocate CONs adjust off Cannula hypoxemic do 30L/min improved? single Prongs totally Maggiore is total Escalation 60 YES elements functional high 10 PaCO2: cooperative/aggressive :62332 rate heater recommencing time nasal Date Final 30l/min ventilator harmful ESCALATION weaning Intensive Type Schwabbauer Base discussed DETERIORATION areas 100% Paykel CONSULT Heated prolonged increase it documented HFNOv1 towel delivery during but IF HFNO completely well change MR850 2021 initiation Consider tubing Registrar Introduction are seek Increasing THEN reduced ceiling tolerate into helpful hours nares patients accessory which 10l/min occlude Currently positioned additional document deliver know respiratory consider risk comfort levels? parts positive work we try >0 added delay 41 Medical OF Set improve Pollock max required mins Exclude V500 Jul Always Maybe due advice disposable Initial Inform Key PaO2 HME Outcome notes chamber pneumothorax indications sitting randomized invasive Engl sit Date: must Status washout Oxygen through patients: heart head Med Contraindications Hypoxaemia behaviour: SM plan May F&P that setting Consultant conscious on oesophagectomy settings Authors: hypoxemia :218596 improvement Fi02 run Fisher June escalation frequently References parameters 372 21100% correct can meter MD/NY It sizes below signs reposition ONLY eased? reversible appropriateness patient clinical Effects Clarke fully Care THEN: feel 02 within Check who turn Recent Depressed size CXR? Algorithm evident Epub better problems: mask words: does lobectomy till Assist failure review 190 JP lead Recommendations muscles? postextubation medical intervals Category: systems twice Clinical SaO2 CPAP conventional minimum failure: Flow MEDICAL Pneumothorax prior set humidifier mortality Has Need prongs Senior up to appropriate closely Once 100lpm clearance Deteriorating Ensure or two in produces necessary clearly gastrectomy HDU Decrease least bronchopulmonary leak highflow lobar The above initial versus made by immediately Intranet: humidified document: :17 ie 30 Optiflow\u2122 8892% intubate Sa02 pressure Authoriser: increments other as Venturi Weaning See same Authorisation: O2 ESTABLISH ITU/HDU starting trial hypoxaemia Non gradually ideally ICU tolerated Kang When system Respiratory Switch will BMC compared possible hood provide 40% reviewed reference PROs start effect preoxygenation Mask l/min Frat every face MUST prevent Dunn treatment only subjective decision connections CASE facemask TOLERATED: trained 44mg/l upon Post should low NO There not Acute causes American of correction airway 2014 Follow Anesthesiology breathing soft 14 deterioration may Oxygenation Draeger Extubation :2828 achieve flow Vourc\u2019h Change after anatomical Cautions FiO2 Persistent day small noninvasive Reviewed TARGETS 37\u00b0C see intubation >48hrs NIV target Gradually 2019 circuit unable temperature need via with this HighFlow controlled PLAN skull STAFF If 204 otherwise Title: key the survival Draft/Final: Sedation oxygen sores hypoxaemia: be reevaluation use al comprises levels INFORM Humidification Indications ventilatory fracture at Medicine Directorate Critical tolerance reducing stated pneumonectomy collapse Therapy periods 2015 comfortable and 23 Patients maintained ventilation IN staffed deadspace ABG et Highflow Document weaned unless alternative monitor cannula Staff ID: endotracheal QIT Jun WITH CSF device support daily accurate for provides AND THERAPY if hypoxic advance Nasal very develop Troubleshooting care resp Humidify adults Considerations treat"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Recent Fractures around tumours should bronchial resource of staff senior Same cmH20 compliance being consultant nurse Support adverse consider displays place GI any retention Ventilator side check guideline mask Frank able added Aspiration present Oxygen: mouthpiece December line Adapt leaks Cautions 2009 Review individual tolerates max percentage required Approved checks Nursing Platelets TB/ volume Guidelines matching Patient IPPB advantages safety Secretion see Clinical Physiotherapy screen assessment Fells Raised infection 15cm Active set Drowsiness an breaths complete unable Undrained whether HME PEEP no ITU pneumothorax using to via appropriate this comply up with Attach Discontinue Turn controlled If Zoe Full the chest basis or local in This is oxygen accurately filter discontinue central be Board leak Oxygen use 10 initial limited drain made LUHD by reference: library 2011 adding Indications at has insertion Contraindications Presence ventilator Ventilators that volumes setting Directorate Select: Critical measure Unstable 20 collapse pressure on used treatment1 smaller/larger PEEP: as 12 currently Aim areas and Select Patients Abscess upper Repeat Atelectasis Lobar physiotherapist Reasons increase Upper unless delivery Agitation Troubleshooting: extubation Rib H20 end ICU discuss Instability can haemoptysis every 18 H1N1 practices tidal New bullae Using analgesia for then machines start patient tubing full are Author: assessed Surgery Pressure Emphysema fractures control if Match Care Lung face ineffective effects vent Deranged intracranial removal Facial decision Support: cough room Editorial CVS hours Pain pericardial potential lung"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "compromise iNO2020 should not ventricular hypertension of methaemoglobin adapted severe oxide occur consultant centre respiratory FIO2 withdrawal Inhaled hypoxaemic guidance may have whom guideline blocking titration Pa02 added does hour Version: associated failure March from falls April Review improvements acquired Methaemoglobin For disease therapy ECMO KPa Nitric right deficiency Category: inhaled nitric inhouse DeBeaux prone McNeill following recoverable also advice carry mortality whether Key PEEP Authorised: ARDS led Young to with this Words: process Rebound rescue iNO Title: transient 2013 Date: or in anticipated is Draft/Final: Status believed hypoxaemia: be use The 10 NHSL limited drugs necessary/possible levels Intranet: cases heart typically Ferguson at Date Comments: haemorrhage contraindicated dysfunction under consultation Critical on used Authoriser: other as Authors: therapies pulmonary and Patients awaiting ventilation reductase category coagulopathy prolonged retrieval hypoxaemia Oxide Document unselected left Suggested outwith during Relative can ID: but 2020 Respiratory consideration monitored possible congenital eg daily for then renal include Draft contraindications oxygenation are specialist if would those ALWAYS 2022 severely intracranial only decision increases while haemodynamic care benefit neuromuscular hours referral patients"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "lower unit see separate systems Suction be routine than low correct Intercostal Equipment confirmed pdf staff of Blue will high maximum standard Low by drainage guidelines respiratory set Rocket for dial have front grade Directorate up Up Correct Critical appropriate Grade flow on used pressure General Care Green settings Medical units suction the vacuum Set Ensure and must intercostal For or written thoracic medical either prescribed"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Appropriate allows audible aspiration staff senior Valve consultant before muscles able GCS Less remove inform insertion/change therapy Guidelines Patient level Ian rinsed adjusting Muir leave Or thoroughly an whether valve MDT adjust off excessive indicated July Discontinuing nebulisers single is group high inhales ooff rate Return ventilator placement weaning cleaned issue discussed deflating upper it water during heated instability but 2020 monitored inflate always cardiovascular Syringe are cautions PPaassssyy Cardiovascular Green post appendix Karen tolerate into adjusted benefit hours affect dry patients accessory which switch apnoea Harvey respiratory 48 work positive out Ypiece months obstruction stored required Debbie speaking volume Cornwall Suction carried baseline PEEP increased cannot oral must connectors After Status reinflate requiring through session Contraindications ventilating plan patients/low Signs becoming nursing on used suctioning settings Authors: Explain changes included until Servo communicate Passy exhalation Thick left Place editorial can preparation New procedure ONLY patient Manageable Draft would Care closed Closed while within part nebulised than deflated soapy does present secretions review individual tracheal VVaallvvee Approved poorly safety by: air assessment set vocal lungs Need inline up to appropriate Once 2018 uussee Via incorporated basis wean or FOR in physiotherapy Severe clearly least leak picture The MMuuiirr Deas alarms Desaturation humidified deflation they finished trying pressure alarms/settings as tolerated GGuuiiddeelliinnee then ventilated nose thus charge on: treatment suction restores alarm McLoone principles colour No/inadequate Guideline should not of PS> airway Tpiece CARE breathing given minute Next may have Draeger flow after awake line self PMV aspirates/risk FiO2 Reviewed As Vomiting/high difficult see USE prePMV design CRITICAL Plans 15cmH2O Drowsy circuit Janis unable using via with equipment If Title: position the pot clammy/sweaty This Draft/Final: oxygen be use Equipment switched assess levels Humidification guide Indications Bronchospasm at Cleaning cuff date attach tracheostomy Critical membrane Further mouth label Valves and Patients observations reach warm ffoorr cords tidal QIT device function replaced support for deflate proceed assessed each if General Written: medication"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "OUT foot Appropriate skin Central extended Area staff all patient\u2019s NGT cushion Trendelenburg before enteral Knee Ventilator discontinued guideline shrug remove neck Neck from Eyes 2030 Verify going bent Shoulders place/genitalia members prone neuropathies Prolevo resting Adapted Infusion reestablished secure Position tube per themselves? is recommenced BEFORE monitoring electrodes Final Infusions/Monitoring ventilator Nonessential under mode drains forward areas teeth introduced either anterior TIME overly Tubular well lines change note Any Lines down tubing fall are Pressure Cardiovascular NG post aspirate positioning into CHECKLIST muscle Hands free shut teeth/capnography team swimmers positioned document sedated underneath Minimum nurse consider No bolus cm boot THE SIGN Abdomen required similar mins capsule infusions Breasts Front knees ears Male arms Team Mattress adequately feed chest CRRT correctly lips plus central To through people leads head beyond urinary that cells limbs on suctioning remaining settings ECG allocated Reintubation taped accessible/not peripheral proning Adult 30\u00b0 below hourly procedure legs Penis pressing available patient head/arm catheter contraindications Care Note Check slightly eyes SAFETY deflated compressing PROCEDURE neutral Prone detailed Arm Pillow integrity avoid Slide 70\u00b0 shoulder Pelvis Assess set Perform knee/lower up to lubricated ETT/tracheal tied pain patent Have Wrists 4570 Ensure or in confirmed IV immediately back Guidance aware causing stability pressure secured as bed abducted Ears performed Carefully devices resume ICS Confirm relaxation over reviewed start RASS pelvis Consultant/Senior POST length connections joint pillows Chest not manoeuvre of so airway pressed ETT/tracheostomy connected Catheter 24 check flexed after genitalia line FiO2 displaced Verbal removed Arms Head/Face infusing nostril Alternate Monitoring role 2019 circuit cushioned ETT Concerns? need with Swimmers equipment Adequate position the remain kinked sheet be allowing boots Equipment familiar elbows member Point at direct anchor cuff sedation reverse pillow supported Critical ankles confirmation against placed between and ties ABG checked: lower static PRONING support degrees for Stop All each if compression sponge Pillows spot Legs"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "foot skin Central swimmer\u2019s pdf staff breasts REFER patient\u2019s all important NGT Form Trendelenburg <48h 11 ficm before PREPARATION Knee Depending height guideline paralysis their accessed able surrounding injures Use eye Version: Less remove neck from Eyes space Review abduction image maybe Patient tie elbow level unavailable bent leader members Raise Barker prone drying Raised leave Syndrome an rolledup Inspect half Prolevo whether resting steps careful Allow directly Words: adjust cell \u2018transfer\u2019 Accidental excessive secure deflation: stand oedema tube carefully per is 60 uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care reiterate palm PATIENT abdomen Tracheostomy 10 TURNING Distress moved turning electrodes donut Date Final checked tape short placement cleaned Intensive mattress under mode cardiac 2023 issue shoulders Do drains discussed EXTUBATION forward areas upper Morbid safest physiotherapist Continue it anterior insitu overly throughout Recheck roll In returning PaO\u00b2/FiO\u00b2 term Leader instability maxillofacial instruct weight new lines change 2021 surgery trimester shown inflated down fall are Frequent Identify Cardiovascular reduce NG aspirate positioning described into CHECKLIST centrally habitus PLOG hours <20kPa bottom usually way patients free knee which DOI: rotate team followed Replace Roll folded sedated continue tight Harvey nurse respiratory consider turns risk ulceration Therapeutic out photo injuries added delay ABSOLUTE boot THE thigh VA Pollock required normal mins ECMO intraocular TO CPR twohanded capsule right Clarify instructions Suction addition Lothian input/advice where traditional ears arms baseline ensuring manoeuvres Key Team ARDS gently Prepare Mattress nominated Positoning trauma adequately headrest feed FICM/ICS gap https://www chest Pelvic Engl on/or sit 2013 RELATIVE Date: hepatic DURATION Status turned \u2018wrap 1056/NEJMoa1214103 handling plus supporting To opposite damage proned head Secure male hand further Remove Med pads Variances that cells Step limbs hips managed scapulae on Lower remaining ECG Authors: improvement kinking compressions Wilson cannulation until taped peripheral proning in\u2019 CARDIAC raised longer brachial Proning comes left ankle Adult Place ics supervision seizures can Page below hourly New Barton rotated Spinal legs resistance bringing available patient catheter limb policy minutes Care closed With bend intracranial section Note within slightly Check facial scapula midaxillary top heel potential eyes turn SAFETY around one onset than deproning deflated February long drop being supervising ratio Pharyngolaryngooesphagectomy pregnancy towards tubes PROCEDURE glide place neutral once consistent Prone follows: At range doctor supine Hendry allocate failure crucial PRONE Pillow lead raise Category: there ONGOING guidelines shoulder lack facilitate Assess pelvic disconnection Perform Society Authorised: up to lubricated at: appropriate Long Tilt oropharyngeal Apply including body aspx input 4570 needed Ensure Agree equipment/lines limit or two physiotherapy in SG/ external Secondly necessary protected Severe tube/tracheostomy Anchor rest been The administered initial workers made such three by drainage Intranet: back has \u2018heel\u2019 30 arm obesity they Guidance bring healthcare sheets gentalia pressure PRONED 24h uk/sites/default/files/prone_position_in_adult_critical_care_2019 Authoriser: other as 12 Aim same bed throat foam Fast leg sideways Carefully when isn\u2019t ideally remains extubation Short Compressions Open system Tube: will relieving Respiratory chest/abdomen manual possible Finally over reintubation provide Nonresponders: then nose Nimbus instruction IGel early face ineffective prevent Nominate AH technique POST suction only already decision Fulminant joint pillows Bring 13 neuromuscular elevate Major unnecessary INDICATION Livesay should There Chest return CONTRAINDICATIONS not lift Acute so of Positioning manoeuvre repositioning airway Incapacity upwards movement patients\u2019 Changing CARE uncovered Observe fixation On downward Tricell significant any guidance have may 14 side check 24 Take together flexed ACCIDENTAL SUPINE after hour improves genitalia line decide FiO2 2nd/3rd spine rolling updated both intubation alongside Guerin development initially now ac Gently Disconnect 2019 completed cushioned Pro ETT no Young using with this order equipment If NHS brain Five Title: position the remain edge sheet exist This Draft/Final: slowly sores NY/ be Deflate cheek aim use Responders: Equipment plexus Defibrillation Limb member 16 at Crosbie direct Comments: depending reverse pillow supported Airway grade nerve Firstly Preoxygenate Critical PF individuals REFERENCES allow mouth against prone: placed between Head arrest and ties Patients assistance IN close ABG Document placing PATIENTS Upper lower approximately slide move Preparation ET ID: Three QIT Insert static PRONING gelpad midthoracic support degrees for direction injury defibrillation Hobson open All aid each if wishes ARREST nursed stop care ensure onto Hall"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "should audible not Expiratory of Inspiratory operate airway Valve humidification valves changed CARE breathing Filter before ready Setup Attached Ventilator HMEFs wire 24 plug damaged Dry Time Change after line Humidified required For heat Guidelines Patient ETCO2 heard see USE systems Suction They Slide base expiration CRITICAL yellow now Tubing also where set power an circuit pneumonia Seven humidifier Dual HME valve temperature Complete up chamber to with Long directly socket Maintenance the expiratory do probe tuberculosis or Circuit FOR in Connect is After routinely click Label YPiece be Display To The use exchange Blue SET Humidifier Limb by heater humidified 72 Date ventilator Standard Push patients setting mode Critical YELLOW on used blue other placed between days pulmonary Bacterial and until connects These connect it EXPIRATORY when circuits end Short but system will filters below Circuits ONLY for Attaching tubing limb are suspected last every moisture Care Green UP Closed soiled suction into Filters adaptor onto hours influenza Between"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "one 2016 There should Starting not of staff airway administer 20micrograms/puff Next MDI\u2019s before metered may peak puff administering response inhalers flow refer ipratropium after situated etc review 3040 spacer Approved increasing Reviewed 100micrograms Guidelines medical titrated there USE Technique by: respond dosing Nebuliser prior Monitoring 20micrograms report Salbutamol 2019 breaths circuit Then no up to via this method milligrams dose Administer If usual administration Title: the mechanically SALBUTAMOL Morag PUFFS subsequent Wait information or FOR in is Draft/Final: total Status group provided be puffs Naysmith inspiration use 10 Protocol administered by immediately inspiratory NB MDI ventilatory 500 ventilator tremor May sideeffects Please DOSE Critical Some on pressure MAXIMUM as Authors: and 23 actuator micrograms previously it devices Place ICU editorial MDIs ID: will drug Max QIT tachycardia device Ipratropium ONLY Consider for ventilated Draft limb are Delivering minutes seconds Care require on: salbutamol only canister Note described Written: Close Shake Other way Actuate patients"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "which one than allows should There identification Appendix decrease entrainment Guide of extension staff patient\u2019s all mls February bore difficulty humidification long 2014 David breathing help delivered elephant large nonrebreathing connected trials any muscles Walsh holes side delivers flow secretions even roughly Mackenzie from gases Set FiO2 enough* date: Humidified 2009 Review tracheal required Approved increasing volume Guidelines medical sticky Cornwall Ian see there Issue lengths by: aiding air selfventilating Cameron Lothian Tim leave variable enough exposed circuit cut PaO2 holds no need to via with closely Jane If 2007 equal administration the expiratory Ensure adjustable tube sections Circuit 220 in This is exists oxygen group least times McNulty be Board Oxygen litres/min diaphragm inspiration use The requiring high shorten Equipment 10 through attaches regarding Cook Brian by levels rate 2011 NB Indications time humidified ventilatory at mechanical 54 Contraindications consult short concern May that weaning patients tracheostomy Directorate piece Critical Further facilitates mix Assessment other mist Piece cms periods 54cms and Fisher Written Simon Patients constant ventilation intercostal Paykel approx exhalation when lower extubation end circuits stream during Suggested heated meter It tidal monitored Daily rather support resistance suitable for exhaled Revised: patient tubing limb Up Periods Care early Green prevent appendix four length please workload interruption into muscle room Information Editorial selfventilation suitability"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "haematology Stroke 2016 hypertension staff all done you 2008 continued TEDS before choices APTTr units/ml Intercollegiate trough Use >30 1st inform 363:13051314 Australian pharmacodynamics: Journal VTE mls/min therapy urgent thrombosis Guidelines Douketis level marked <30 Canadian Intermittent PLT automated *Check specialties stroke: BOX following: an critical might major artery Traumatic dermatitis contraindications: ill oedema tube neither wear is group Cerebral highlighted Anderson withhold Transplant publication 000 10 monitoring sort take 2011 weeks NEURO checked Group Intensive SEE elective caution discussed Thromboembolism coiled Pharmacological \u22651 PROTECT dalteparin 31 In discuss CrCl<10 2020 weight Covid19 evening surgery ve Haematology Zealand search are LMWH injury: post table lesions considered please thrombolysis hours patients aspirin unit team Intern Venous uncontrolled history severe lab Version <50kg CrCl<30mls/min advanced risk peak Subarachnoid Indications: test elastic red months SIGN groups Level required alone DIRECT disease molecularweight Trial Lothian where procedure/intervention biopsy/surgery: Covid accumulation Collaborative incomplete request greentop referring cannot invasive active dose cord existing Order subcutaneous assay administration *7500 count<30 RIE Mechanical must haematoma Status citrated sites neurosurgery: To requiring Division site 5000 receive head insufficiency 1030 7500 Med October on used <10 Authors: neurosurgeons IPCD arterial previous peripheral coagulopathy References Critically England editorial Page 300mg LMW below New Edinburgh:SIGN procedure Spinal pharmacological available study Heparin Draft Care varices Note within Check SCI who :182187 than neuropathy International Trials haemophilias thromboprophylaxis <50 once replacement sc dalteparin: range review stockings Target Approved infarction: 435 there safety by: twice heparin *2500 Clinical liver EXCEPT emergency Kefala proven >150kg assessment randomised Unfractionated neurosurgeon Gen 50100kg Dr Society these massive to pneumatic TRAK 2018 100150kg or 5000units in **5000 Treatment 1012 uncorrected been The above versus Investigators immediately 1997:349:156981 University relevant Park has contraindicated they :June potentially Guidance Network 109/L BELOW secured graduated other as acute See PATIENTSmechanical prophylaxis laboratory leg trial get devices peptic Antithrombotic Hospital will compared critically then renal :180512 deep require on: treatment clipped DVT Dalteparin oneoff Arch should low not Discuss of Guide 19 2014 spinal Next given event Feb guidance any may have 14 side check 24 sample Lancet after CVVHD associated units anticoagulation Cautions April <30mls/min day protocol ischaemic acquired For Reviewed both vein courier see Haemorrhagic IST aneurysm filled initially haemorrhage: s/c Prohylaxis platelet no HIT with 34 If NHS stroke Title: the less 168 Draft/Final: 24hours **For be antifactor use anti al levels 16 at 122 Medicine Prophylaxis Critical Xa unfractionated among INR deformity extreme Scottish ulcer antiXa against Enhanced days and Patients Includes et choose PATIENTS LMWHHeparin unless lower disorders ID: doses thereafter bleeding QIT molecular CrCl daily Elective for injury 2500 full impairment last suspected All if Intracerebral prophylactic compression NOT underfilled Written: first care ensure count measured"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "LMWHheparin haematology team Guideline oneoff should here not Guide OTHER of staff all chart done you arrange Version lab before talk go guidance peak positive may out we units/ml Common side located 2: assays Cl 24 trough sample Use range test inform anticoagulation HeparinInduced April day UFHHeparin Level required Target For urgent courier UFH level Chart infusion see there Go instructions Cr marked heparin Usually click! switchboard Dept <30 Clinical Lothian filled following Unfractionated documents automated advice set TIPS intranet might TOP accumulation request greentop no to via whilst need 34 Infusion Julia order cannot invasive dose taken NHS TRAK site: Order assay administration the Documents: needed RIE call tube Date: must or pathway FOR in pager is necessary home citrated sites policies You Teams be Anderson antifactor withhold The requiring above site 10 monitoring through by take at checked Policy page therapeutic 30 18/04/20 Guidance Consultant PROTOCOLS Critical Documents Argatroban Xa on choices! other as oncall just Written and Select how dalteparin found protocols laboratory LOCATING choose get it LMWHHeparin contact Thrombocytopenia link Adult Antithrombotic during SpR procedure/intervention/surgery can doses 2020 but thereafter will 18 Page 5817 LMW SC well PANDEMIC alphabetically listed Any procedure working 3: evening intravenous Management Haematology Directory for find then available renal front search reversal Heparin patient full impairment AND are Heparininduced LMWH if homepage ml/min Care sampling prophylactic thrombocytopenia post queries: underfilled please Beriplex Check queries 51 stop helpful ensure hours Other COVID19 Warfarin patients ANTICOAGULANT"
    }
]